<SEC-DOCUMENT>0001539497-24-002408.txt : 20241113
<SEC-HEADER>0001539497-24-002408.hdr.sgml : 20241113
<ACCEPTANCE-DATETIME>20241113160053
ACCESSION NUMBER:		0001539497-24-002408
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20240930
FILED AS OF DATE:		20241113
DATE AS OF CHANGE:		20241113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NIOCORP DEVELOPMENTS LTD
		CENTRAL INDEX KEY:			0001512228
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		ORGANIZATION NAME:           	01 Energy & Transportation
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41655
		FILM NUMBER:		241453830

	BUSINESS ADDRESS:	
		STREET 1:		7000 S. YOSEMITE STREET
		STREET 2:		STE. 115
		CITY:			CENTENNIAL
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		720-639-4647

	MAIL ADDRESS:	
		STREET 1:		7000 S. YOSEMITE STREET
		STREET 2:		STE. 115
		CITY:			CENTENNIAL
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUANTUM RARE EARTH DEVELOPMENTS CORP.
		DATE OF NAME CHANGE:	20110204
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>n2574_x224-10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:niobf="http://niocorp.com/20240930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_niobf_niocorp.com_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20240701_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DDocumentFiscalYearFocus_2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentFiscalPeriodFocus_Q1 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNi0zMA== -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001512228 -->
<!-- Field: Set; Name: xdx; ID: xdx_07D_XDX_n2574__x224%2D10q.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_060_USDPShares_0_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06C_Number_5_N -->
<!-- Field: Set; Name: xdx; ID: xdx_061_CADPShares_3_iso4217%2D%2DCAD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000004" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000006" name="dei:CurrentFiscalYearEndDate">--06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000007" name="dei:EntityCentralIndexKey">0001512228</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0021" name="dei:EntityIncorporationStateCountryCode">A1</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" contextRef="AsOf2024-06-30" id="xdx2ixbrl0054" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="xdx2ixbrl0092" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2024-06-30" id="xdx2ixbrl0099" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-09-30" id="xdx2ixbrl0122" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0138" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0140" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNotes" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0183" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0192" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0194" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0200" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNote" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0234" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0240" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0279" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:ValueOfWarrantsIssued" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0303" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0314" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0315" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0322" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0323" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0325" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0331" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0339" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0341" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0343" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0345" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0388" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NumberOfReportableSegments" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0409" decimals="INF" unitRef="Number">1</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0484" decimals="-3" scale="3" sign="-" unitRef="USD">2102</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0486" decimals="-3" scale="3" sign="-" unitRef="USD">3387</ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-09-30" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" contextRef="From2024-09-042024-09-06" id="xdx2ixbrl0654" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" contextRef="From2024-09-142024-09-16" id="xdx2ixbrl0662" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" contextRef="From2024-09-182024-09-19" id="xdx2ixbrl0670" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0692" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0694" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0696" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0698" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-09-30" id="xdx2ixbrl0708" unitRef="USD" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0710" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">P3Y2M19D</ix:nonNumeric>
  <ix:nonFraction name="niobf:ClassOfWarrantOrRightExercised" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0722" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExercised" contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0724" unitRef="Shares" xs:nil="true"/>
  <ix:nonNumeric contextRef="From2024-07-012024-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0803" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P3Y5M30D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0805" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P3Y8M12D</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0833" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P4Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012024-09-30_custom_TechnicalStudiesAndEngineeringMember" id="xdx2ixbrl0860" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012024-09-30_custom_GeologistAndFieldStaffMember" id="xdx2ixbrl0866" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0920" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0921" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0925" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0926" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0930" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0931" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0934" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0935" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0939" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0940" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0944" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0946" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0949" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0955" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0956" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0960" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0961" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0965" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0966" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0969" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0970" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0974" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl0975" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0979" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl0984" unitRef="USD" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="niobf-20240930.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-07-01to2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_CommonSharesWithoutParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:CommonSharesWithoutParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:WarrantsEachExercisableFor1.11829212CommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-30_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-172024-07-19_us-gaap_UnsecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-17</xbrli:startDate>
        <xbrli:endDate>2024-07-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-17</xbrli:startDate>
        <xbrli:endDate>2024-07-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_YorkvilleConvertibleDebentureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:YorkvilleConvertibleDebentureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-102024-04-12_us-gaap_UnsecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-10</xbrli:startDate>
        <xbrli:endDate>2024-04-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-102024-04-12_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-10</xbrli:startDate>
        <xbrli:endDate>2024-04-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-12_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-302024-09-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-30</xbrli:startDate>
        <xbrli:endDate>2024-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-292024-12-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-29</xbrli:startDate>
        <xbrli:endDate>2024-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-262024-08-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-26</xbrli:startDate>
        <xbrli:endDate>2024-08-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-022024-09-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-02</xbrli:startDate>
        <xbrli:endDate>2024-09-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-042024-09-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-04</xbrli:startDate>
        <xbrli:endDate>2024-09-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-142024-09-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-14</xbrli:startDate>
        <xbrli:endDate>2024-09-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-182024-09-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-18</xbrli:startDate>
        <xbrli:endDate>2024-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-232024-09-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-23</xbrli:startDate>
        <xbrli:endDate>2024-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-232024-09-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-23</xbrli:startDate>
        <xbrli:endDate>2024-09-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePrice9.70Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePrice4.60Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice4.60Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePrice3.54Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.54Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePrice2.20Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.20Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePrice3.35Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.35Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePrice3.25Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.25Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePrice11.50Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.50Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ExercisePrice2.31Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.31Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_GXIIPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-152024-09-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-15</xbrli:startDate>
        <xbrli:endDate>2024-09-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-17_custom_LindConsentWarrantIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-152024-09-17_custom_LindConsentWarrantIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-15</xbrli:startDate>
        <xbrli:endDate>2024-09-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-15</xbrli:startDate>
        <xbrli:endDate>2024-09-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-15</xbrli:startDate>
        <xbrli:endDate>2024-09-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-11_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:NonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:GeneralSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-02</xbrli:startDate>
        <xbrli:endDate>2024-09-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-06_us-gaap_SubsequentEventMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_TechnicalStudiesAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:TechnicalStudiesAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_TechnicalStudiesAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:TechnicalStudiesAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_FieldmanagementandotherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldmanagementandotherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_FieldmanagementandotherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldmanagementandotherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_MetallurgicaldevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicaldevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_MetallurgicaldevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicaldevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_GeologistAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_GeologistAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-022024-10-03_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-02</xbrli:startDate>
        <xbrli:endDate>2024-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-292024-10-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-29</xbrli:startDate>
        <xbrli:endDate>2024-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-022024-11-04_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-02</xbrli:startDate>
        <xbrli:endDate>2024-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-04_us-gaap_SubsequentEventMember_custom_PurchaseAgreementSeriesAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementSeriesAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-04_us-gaap_SubsequentEventMember_custom_PurchaseAgreementSeriesBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementSeriesBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-102024-11-13_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-10</xbrli:startDate>
        <xbrli:endDate>2024-11-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-112024-11-12_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-11</xbrli:startDate>
        <xbrli:endDate>2024-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Number">
      <xbrli:measure>niobf:N</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="CADPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:CAD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000464" toRefs="Footnote000479 Footnote000480"/>
  <ix:relationship fromRefs="Fact000466" toRefs="Footnote000479 Footnote000480"/>
  <ix:relationship fromRefs="Fact000468" toRefs="Footnote000479 Footnote000480"/>
  <ix:relationship fromRefs="Fact000470" toRefs="Footnote000479 Footnote000480"/>
  <ix:relationship fromRefs="Fact000472" toRefs="Footnote000479 Footnote000480"/>
  <ix:relationship fromRefs="Fact000474" toRefs="Footnote000479 Footnote000480"/>
  <ix:relationship fromRefs="Fact000476" toRefs="Footnote000479 Footnote000480"/>
  <ix:relationship fromRefs="Fact000478" toRefs="Footnote000479 Footnote000480"/>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_906_edei--DocumentType_c20240701__20240930_znrWYE96EQrf"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000015" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--DocumentQuarterlyReport_c20240701__20240930_zV563BbxSkjf"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" format="ixt:booleantrue" id="Fact000016" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span></span>
&#160; <b>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the quarterly period ended <span id="xdx_907_edei--DocumentPeriodEndDate_c20240701__20240930_zdAa3893ePnb"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" format="ixt:datemonthdayyearen" id="Fact000017" name="dei:DocumentPeriodEndDate">September
30, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_edei--DocumentTransitionReport_c20240701__20240930_zcSzA4dUMFWg"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" format="ixt:booleanfalse" id="Fact000018" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span>
&#160; <b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;to
</b>&#160;&#160;&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Commission file number: <span id="xdx_90F_edei--EntityFileNumber_c20240701__20240930_zWYjOdPfNa3a"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000019" name="dei:EntityFileNumber">001-41655</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><b><img src="n257410qimg001.jpg" alt=""/><br/></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b><span id="xdx_907_edei--EntityRegistrantName_c20240701__20240930_zrdItuCeUjo"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000020" name="dei:EntityRegistrantName">NioCorp
Developments Ltd.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in
its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 64%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_dxL_c20240701__20240930_z4LvnlhvMMX4" title="::XDX::A1"><span style="-sec-ix-hidden: xdx2ixbrl0021">British Columbia, Canada</span></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="width: 34%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20240701__20240930_zjfTnF3ayQj5"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000022" name="dei:EntityTaxIdentificationNumber">98-1262185</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction of incorporation or organization)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(I.R.S. Employer Identification No.)</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<b><span id="xdx_902_edei--EntityAddressAddressLine1_c20240701__20240930_zxDKoh0ppYD6"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000023" name="dei:EntityAddressAddressLine1">7000 South Yosemite Street</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20240701__20240930_zoqFiP4cXYl7"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000024" name="dei:EntityAddressAddressLine2">Suite
        115</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressCityOrTown_c20240701__20240930_zIxaLGsELgc4"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000025" name="dei:EntityAddressCityOrTown">Centennial</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20240701__20240930_zEyJ3GKiQGC2"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000026" name="dei:EntityAddressStateOrProvince">CO</ix:nonNumeric></span></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)&#160;&#160;</p></td>
    <td style="text-align: center">&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_909_edei--EntityAddressPostalZipCode_c20240701__20240930_zusm2Bvt8sp3"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000027" name="dei:EntityAddressPostalZipCode">80112</ix:nonNumeric></span></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Zip code)</p></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="3" style="text-align: center"><span style="font-size: 10pt">Registrant&#8217;s telephone number, including area code: <span id="xdx_905_edei--CityAreaCode_c20240701__20240930_zcczpoT6DvB1"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000028" name="dei:CityAreaCode">(720)</ix:nonNumeric></span> <span id="xdx_900_edei--LocalPhoneNumber_c20240701__20240930_zqXLuigiL53a"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000029" name="dei:LocalPhoneNumber">334-7066</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 34%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 33%; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 31%; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_zvViooeJXfPj"><ix:nonNumeric contextRef="From2024-07-012024-09-30_custom_CommonSharesWithoutParValueMember" id="Fact000030" name="dei:Security12bTitle">Common Shares, without par value</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_z8M1jdsl1zp5"><ix:nonNumeric contextRef="From2024-07-012024-09-30_custom_CommonSharesWithoutParValueMember" id="Fact000031" name="dei:TradingSymbol">NB</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_909_edei--SecurityExchangeName_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_zpRIAx5zCgAe"><ix:nonNumeric contextRef="From2024-07-012024-09-30_custom_CommonSharesWithoutParValueMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_zqH9T5BpQhrk"><ix:nonNumeric contextRef="From2024-07-012024-09-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" id="Fact000033" name="dei:Security12bTitle">Warrants, each exercisable for 1.11829212 Common Shares</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_edei--TradingSymbol_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_zCFvwnAhHRQ6"><ix:nonNumeric contextRef="From2024-07-012024-09-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" id="Fact000034" name="dei:TradingSymbol">NIOBW</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--SecurityExchangeName_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212CommonSharesMember_zUmklsni4tce"><ix:nonNumeric contextRef="From2024-07-012024-09-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember" format="ixt-sec:exchnameen" id="Fact000035" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. <span id="xdx_902_edei--EntityCurrentReportingStatus_c20240701__20240930_zSBpXJrAOLh1"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000036" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span> No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
<span id="xdx_909_edei--EntityInteractiveDataCurrent_c20240701__20240930_zt3w5UPoIIw8"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000037" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span> No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting
company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 23%"><span style="font-size: 10pt">Large Accelerated Filer </span></td>
    <td style="width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="width: 25%"><span style="font-size: 10pt">Accelerated Filer </span></td>
    <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 10pt"><span id="xdx_909_edei--EntityFilerCategory_c20240701__20240930_zUP6gOXpgCjb"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" format="ixt-sec:entityfilercategoryen" id="Fact000038" name="dei:EntityFilerCategory">Non-Accelerated Filer</ix:nonNumeric></span> </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td><span style="font-size: 10pt">Smaller Reporting Company </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntitySmallBusiness_c20240701__20240930_zBJX2skC02ye"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" format="ixt:booleantrue" id="Fact000039" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2">&#160;</td>
    <td><span style="font-size: 10pt">Emerging Growth Company </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20240701__20240930_z7RGdPSvDfv2"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" format="ixt:booleanfalse" id="Fact000040" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
<span id="xdx_90A_edei--EntityShellCompany_c20240701__20240930_zofF7Xx8BvR3"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" format="ixt:booleanfalse" id="Fact000041" name="dei:EntityShellCompany">No</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of November 13, 2024, the registrant
had <span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_c20241113_zuXwNvf5PISb"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-11-13" id="Fact000042" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,512,202</ix:nonFraction></span>  Common Shares outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 9%">&#160;</td>
    <td style="width: 82%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">Page</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="2"><a href="#a001"><span style="font-size: 10pt"><b>PART&#160;I &#8212; FINANCIAL INFORMATION&#160;</b></span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a002"><span style="font-size: 10pt">ITEM 1.&#160;</span></a></td>
    <td><a href="#a002"><span style="font-size: 10pt">FINANCIAL STATEMENTS </span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td><a href="#a003"><span style="font-size: 10pt">ITEM 2.&#160;</span></a></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a003"><span style="font-size: 10pt">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">15</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a004"><span style="font-size: 10pt">ITEM 3.&#160;</span></a></td>
    <td><a href="#a004"><span style="font-size: 10pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">24</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td><a href="#a005"><span style="font-size: 10pt">ITEM 4.&#160;</span></a></td>
    <td><a href="#a005"><span style="font-size: 10pt">CONTROLS AND PROCEDURES</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">25</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td colspan="2"><a href="#a006"><span style="font-size: 10pt"><b>PART&#160;II &#8212; OTHER INFORMATION&#160;</b></span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td><a href="#a007"><span style="font-size: 10pt">ITEM 1.&#160;</span></a></td>
    <td><a href="#a007"><span style="font-size: 10pt">LEGAL PROCEEDINGS</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">27</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a008"><span style="font-size: 10pt">ITEM 1A.&#160;</span></a></td>
    <td><a href="#a008"><span style="font-size: 10pt">RISK FACTORS</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">27</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td><a href="#a009"><span style="font-size: 10pt">ITEM 2.&#160;</span></a></td>
    <td><a href="#a009"><span style="font-size: 10pt">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">27</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a010"><span style="font-size: 10pt">ITEM 3.&#160;</span></a></td>
    <td><a href="#a010"><span style="font-size: 10pt">DEFAULTS UPON SENIOR SECURITIES</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">27</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td><a href="#a011"><span style="font-size: 10pt">ITEM 4.&#160;</span></a></td>
    <td><a href="#a011"><span style="font-size: 10pt">MINE SAFETY DISCLOSURES</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">27</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#a012"><span style="font-size: 10pt">ITEM 5.&#160;</span></a></td>
    <td><a href="#a012"><span style="font-size: 10pt">OTHER INFORMATION</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">27</span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td><a href="#a013"><span style="font-size: 10pt">ITEM 6.&#160;</span></a></td>
    <td><a href="#a013"><span style="font-size: 10pt">EXHIBITS</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">29</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: white">
    <td colspan="2"><a href="#a014"><span style="font-size: 10pt"><b>SIGNATURES&#160;</b></span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">30</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a001"></span>PART&#160;I &#8212; FINANCIAL INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a002"></span>ITEM 1. FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 91%; text-align: justify; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font-size: 10pt">Page</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><a href="#b001"><span style="font-size: 10pt"><i>Condensed consolidated balance sheets as of September 30, 2024 and June 30, 2024 (unaudited)</i></span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><i>2</i></span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><a href="#b002"><span style="font-size: 10pt"><i>Condensed consolidated statements of operations and comprehensive loss for the three months ended September 30, 2024 and 2023 (unaudited)</i></span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><i>3</i></span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><a href="#b003"><span style="font-size: 10pt"><i>Condensed consolidated statements of cash flows for the three months ended September 30, 2024 and 2023 (unaudited)&#160;</i></span></a></td>
    <td style="vertical-align: top"/>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><i>4</i></span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><a href="#b004"><span style="font-size: 10pt"><i>Condensed consolidated statements of shareholders&#8217; (deficit) equity&#160;and redeemable noncontrolling interest for the three months ended September 30, 2024 and 2023 (unaudited)</i></span></a></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><i>5</i></span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in"><a href="#b005"><span style="font-size: 10pt"><i>Notes to condensed consolidated financial statements (unaudited)</i></span></a></td>
    <td>&#160;</td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt"><i>6 - 14</i></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b001"></span>Condensed
Consolidated Balance Sheets </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars, except share data) (unaudited)</span></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<table cellpadding="0" cellspacing="0" id="xdx_308_111_pn3n3_zc2wGrIaM5i4" summary="xdx: Statement - Condensed Consolidated Balance Sheets (unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_497_20240930_zXphtKyUEzh8" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20240630_zJXTROB8PXvl" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">September 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">June 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AssetsAbstract_iB_zC7rCdyvrZKj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">ASSETS</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AssetsCurrentAbstract_i01B_ztbaeaaRgU29" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_405_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzJdM_zkigRxJMIErj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-09-30" id="Fact000050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-06-30" id="Fact000051" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross_i02I_maACzJdM_zK2zE6kL3ks6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Deferred share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" contextRef="AsOf2024-09-30" id="Fact000053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0054">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maACzJdM_zlY8eLMrhPC9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Prepaid expenses and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-09-30" id="Fact000056" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">587</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">916</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--AssetsCurrent_i02TI_mtACzJdM_maAzcBc_zafYkKIWIU89" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-09-30" id="Fact000059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,196</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,928</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AssetsNoncurrentAbstract_i01B_zPZyi5wC9twd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DepositsAssets_iI_maAzcBc_zsw6USFx1BQ9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2024-09-30" id="Fact000065" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2024-06-30" id="Fact000066" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--LongTermInvestmentsAndReceivablesNet_iI_maAzcBc_zwq2RnyuC8Ti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Investment in equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermInvestmentsAndReceivablesNet" contextRef="AsOf2024-09-30" id="Fact000068" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermInvestmentsAndReceivablesNet" contextRef="AsOf2024-06-30" id="Fact000069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--FinanceLeaseRightOfUseAsset_iI_maAzcBc_z1IlJ5F4duFk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2024-09-30" id="Fact000071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">167</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000072" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">181</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_maAzcBc_zhO0cM2tAIq" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Land and buildings, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-09-30" id="Fact000074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">836</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30" id="Fact000075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">837</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CapitalizedCostsMineralInterestsInUnprovedProperties_iI_maAzcBc_zKwW5FrnosUe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Mineral properties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties" contextRef="AsOf2024-09-30" id="Fact000077" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,085</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties" contextRef="AsOf2024-06-30" id="Fact000078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,085</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--Assets_iTI_mtAzcBc_zir5RoVcvnCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total assets</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-09-30" id="Fact000080" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,323</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-06-30" id="Fact000081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,070</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--LiabilitiesAbstract_iB_zlDM2PGVfCQi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--LiabilitiesCurrentAbstract_i01B_zcLr1pFG3xe4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-left: 0.125in; text-indent: -0.125in">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableCurrent_iI_maLCzydJ_zUgxKKqvNy76" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-09-30" id="Fact000089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,736</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-06-30" id="Fact000090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,843</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--OtherLiabilitiesCurrent_iI_maLCzydJ_za7AaAOp3Nz1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Warrant liabilities, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0092">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,365</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ConvertibleDebtNoncurrent_iI_maLCzydJ_z5uA3Zm7uT4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2024-09-30" id="Fact000095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,258</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2024-06-30" id="Fact000096" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,660</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--RelatedPartyDepositLiabilities_iI_maLCzydJ_zN2teoALadSg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Related party debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RelatedPartyDepositLiabilities" contextRef="AsOf2024-09-30" id="Fact000098" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0099">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maLCzydJ_zHgbNLvoTUMk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-09-30" id="Fact000101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">97</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--LiabilitiesCurrent_iTI_mtLCzydJ_maLzRB3_z6btUTmBQFfe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact000104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,964</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrentAbstract_iB_z2mUpXpALW04" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OtherLiabilitiesNoncurrent_iI_maLzRB3_zjLeh5SApPva" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Warrant liabilities, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2024-09-30" id="Fact000110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,595</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--EarnoutLiabilityAtFairValue_iI_maLzRB3_zepQEutqF9ua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Earnout liability, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutLiabilityAtFairValue" contextRef="AsOf2024-09-30" id="Fact000113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,633</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutLiabilityAtFairValue" contextRef="AsOf2024-06-30" id="Fact000114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_maLzRB3_zAavrFf3z2Cl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-09-30" id="Fact000116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--Liabilities_iTI_mtLzRB3_maLASEzI6i_zfWfOiGLfeM1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-09-30" id="Fact000119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,439</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-06-30" id="Fact000120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,536</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CommitmentsAndContingencies_iI_zvxGODiduEQi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="color: White; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0122">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--RedeemableNoncontrollingInterestEquityCarryingAmount_iI_maLASEzI6i_zLqwoATJbpV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="AsOf2024-09-30" id="Fact000125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,503</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="AsOf2024-06-30" id="Fact000126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_iB_zi19Kssfrit2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--CommonStockValue_i01I_maSEz9wN_zrklyPQ1cuNk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Common stock, <span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20240930_zvKRgd6j88Ud" title="Common stock, par value (in dollars per share)"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20240630_zgQimk4zVIW8" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact000134" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000136" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares">no</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorizedUnlimited_dxL_c20230701__20240630_zlZLHFx0vgbd" title="Common stock, authorized::XDX::Unlimited"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorizedUnlimited_dxL_c20240701__20240930_zSH8Cxb8F021" title="Common stock, authorized::XDX::Unlimited"><span style="-sec-ix-hidden: xdx2ixbrl0138"><span style="-sec-ix-hidden: xdx2ixbrl0140">unlimited</span></span></span></span> shares authorized; <span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240930_znCZU5h04so3" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-09-30" id="Fact000142" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,720,244</ix:nonFraction></span> and <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630_zb1OoeDvI839" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000144" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,062,647</ix:nonFraction></span> shares outstanding, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-09-30" id="Fact000131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">167,275</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30" id="Fact000132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">163,823</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maSEz9wN_zgTjTQGIh41l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-09-30" id="Fact000146" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">163,983</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000147" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">161,912</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i01I_maSEz9wN_zsDhMubEju4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Accumulated other comprehensive loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-09-30" id="Fact000149" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-06-30" id="Fact000150" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--StockholdersEquity_i01TI_mtSEz9wN_maLASEzI6i_zYD2rX7skmpj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Total shareholders&#8217; equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" id="Fact000152" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,381</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzI6i_zGwGu97u29H9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-09-30" id="Fact000155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,323</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,070</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b002"></span>Condensed
Consolidated Statements of Operations and Comprehensive Loss </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars, except share and per share data) (unaudited)</span></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>
<table cellpadding="0" cellspacing="0" id="xdx_304_113_pn3n3_zmiXlS555py8" summary="xdx: Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20240701__20240930_zqRgciGW8Za6" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_495_20230701__20230930_zSUxiCjxKcy7" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the three months <br/>
ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OperatingExpensesAbstract_iB_zIdikDiYfjzl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--LaborAndRelatedExpense_maOEzFFZ_zExAttDJ4JAg" style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Employee related costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2024-07-01to2024-09-30" id="Fact000161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">330</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2023-07-012023-09-30" id="Fact000162" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">322</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ProfessionalFees_maOEzFFZ_zaIiCDIkvKYh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-07-01to2024-09-30" id="Fact000164" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-07-012023-09-30" id="Fact000165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,187</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--ExplorationExpenditures_maOEzFFZ_zTG4pZSGr2x3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Exploration expenditures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ExplorationExpenditures" contextRef="From2024-07-01to2024-09-30" id="Fact000167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ExplorationExpenditures" contextRef="From2023-07-012023-09-30" id="Fact000168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherGeneralExpense_maOEzFFZ_zNymS0lePtp4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Other operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2024-07-01to2024-09-30" id="Fact000170" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">477</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-07-012023-09-30" id="Fact000171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">834</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingExpenses_iT_mtOEzFFZ_zwSG7ZS2l449" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-07-01to2024-09-30" id="Fact000173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,395</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-07-012023-09-30" id="Fact000174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,443</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--ChangeInFairValueOfEarnoutLiability_iN_di_msILFCOzNir_zaVFPfyz3IT6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Change in fair value of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutLiability" contextRef="From2024-07-01to2024-09-30" id="Fact000176" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">816</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutLiability" contextRef="From2023-07-012023-09-30" id="Fact000177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,093</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_ecustom--ChangeInFairValueOfWarrantLiability_maILFCOzNir_z9xj9AzfBuu4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2024-07-01to2024-09-30" id="Fact000179" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">56</ix:nonFraction></td><td style="text-align: left">)&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiability" contextRef="From2023-07-012023-09-30" id="Fact000180" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--ChangeInFairValueOfConvertibleNotes_iN_di_msILFCOzNir_zrVDR1Burqb7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Change in fair value of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNotes" contextRef="From2024-07-01to2024-09-30" id="Fact000182" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0183">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--InterestExpense_iN_di_msILFCOzNir_zAR0oXAQRBY1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-07-01to2024-09-30" id="Fact000185" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-07-012023-09-30" id="Fact000186" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,075</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_maILFCOzNir_zvqN0XkVNWd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Foreign exchange loss (gain)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2024-07-01to2024-09-30" id="Fact000188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2023-07-012023-09-30" id="Fact000189" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--OtherIncome_maILFCOzNir_zRynGiUll5u7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Other gains</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2024-07-01to2024-09-30" id="Fact000191" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">122</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0192">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_maILFCOzNir_zr7lOCNZTRCl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Loss on equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0194">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2023-07-012023-09-30" id="Fact000195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_iT_mtILFCOzNir_maCINOTz6g1_zPYyD5FVG6xa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" contextRef="From2024-07-01to2024-09-30" id="Fact000197" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,102</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" contextRef="From2023-07-012023-09-30" id="Fact000198" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,488</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCINOTz6g1_zlYzR1lIsvWb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Income tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0200">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012023-09-30" id="Fact000201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCINOTz6g1_maOEMIBzDKR_zCxtawCxF8p6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Net loss and comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2024-07-01to2024-09-30" id="Fact000203" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,102</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-07-012023-09-30" id="Fact000204" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,387</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_msOEMIBzDKR_zcxlN2HOfDHk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Less: Net loss attributable to redeemable noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2024-09-30" id="Fact000206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30" id="Fact000207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_iT_mtOEMIBzDKR_zeVTRgE9Cmid" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Net loss and comprehensive loss attributable to the Company</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2024-07-01to2024-09-30" id="Fact000209" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,071</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2023-07-012023-09-30" id="Fact000210" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,213</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_zVt0E1uHepl3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Loss per common share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2024-07-01to2024-09-30" id="Fact000212" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2023-07-012023-09-30" id="Fact000213" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.09</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40C_ecustom--TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_uShares_zyuVGuaaKFh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Weighted average common shares outstanding, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2024-07-01to2024-09-30" id="Fact000215" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,361,344</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2023-07-012023-09-30" id="Fact000216" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,967,091</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b003"></span>Condensed
Consolidated Statements of Cash Flows </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars) (unaudited)</span></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<table cellpadding="0" cellspacing="0" id="xdx_30C_112_pn3n3_zafiY6b0GCPj" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows (unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_495_20240701__20240930_zrolkNisnc44" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20230701__20230930_ziWQVeEA9Ric" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the three months&#160; <br/>ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zwywMbZFc4w9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--NetIncomeLoss_maNCPBUzZMi_z1kCPMHCEUk" style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left; padding-left: 0.25in; text-indent: -0.125in">Net loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2024-09-30" id="Fact000221" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,102</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact000222" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,387</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zdhymrZPTwrk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Adjustments for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--ChangeInFairValueOfEarnoutShareLiability_i01_maATRNIzPw2_zg5tJSr8oQ4e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Change in valuation of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2024-07-01to2024-09-30" id="Fact000227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">816</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2023-07-012023-09-30" id="Fact000228" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,093</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_ecustom--ChangeInValuationOfWarrantLiabilities_i01_maATRNIzPw2_zlujixdi8ls3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Change in valuation of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2024-07-01to2024-09-30" id="Fact000230" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">56</ix:nonFraction></td><td style="text-align: left">)&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2023-07-012023-09-30" id="Fact000231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--ChangeInFairValueOfConvertibleNote_i01_maATRNIzPw2_zNyypYk7on5h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Change in fair value of convertible note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNote" contextRef="From2024-07-01to2024-09-30" id="Fact000233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0234">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccretionExpense_maATRNIzPw2_zeE3iZpHjHl7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Accretion of convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2024-07-01to2024-09-30" id="Fact000236" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2023-07-012023-09-30" id="Fact000237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,075</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--OtheroperatingGainsLosses_iN_di_msATRNIzPw2_zls1yVp2eU32" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Other gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2024-07-01to2024-09-30" id="Fact000239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0240">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--FairValueOfCommitmentSharesIssued_maATRNIzPw2_z568DSLGzLob" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Yorkville share issuances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2024-07-01to2024-09-30" id="Fact000242" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2023-07-012023-09-30" id="Fact000243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--Depreciation_maATRNIzPw2_zvLEmv9a02ae" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.375in; text-indent: -0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-07-01to2024-09-30" id="Fact000245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-07-012023-09-30" id="Fact000246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--UnrealizedGainLossOnInvestments_iN_di_msATRNIzPw2_zr63WM8anIV7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Unrealized loss on equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0248">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2023-07-012023-09-30" id="Fact000249" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--OperatingLeaseImpairmentLoss_maATRNIzPw2_z6O8z9oJI922" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Non-cash lease activity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2024-07-01to2024-09-30" id="Fact000251" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2023-07-012023-09-30" id="Fact000252" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_iT_mtATRNIzPw2_maNCPBUzZMi_zLA8XPfvOmjg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2024-07-01to2024-09-30" id="Fact000254" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,404</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-012023-09-30" id="Fact000255" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,278</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_iB_z00Ak2FvpDKi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Change in working capital items:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msNCPBUzZMi_zT8lYTLttqRl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.375in; text-indent: -0.125in">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2024-07-01to2024-09-30" id="Fact000260" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">130</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-07-012023-09-30" id="Fact000261" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">417</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_maNCPBUzZMi_zmIWQXAIPs0g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.375in; text-indent: -0.125in">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-07-01to2024-09-30" id="Fact000263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">892</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-07-012023-09-30" id="Fact000264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_maCCERCzBkl_mtNCPBUzZMi_zA3fQsmq15uh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-07-01to2024-09-30" id="Fact000266" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">642</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-012023-09-30" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,737</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zX4P8AuER6sj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in">CASH FLOWS FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfCommonStock_maNCPBUz2Tn_zTwgpMFLMZe3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Proceeds from issuance of capital stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-07-01to2024-09-30" id="Fact000272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">692</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-07-012023-09-30" id="Fact000273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,532</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--ProceedsFromRelatedPartyDebt_maNCPBUz2Tn_zF0TVtVc7HK3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Related party debt draws</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-07-01to2024-09-30" id="Fact000275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0276">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--RepaymentsOfDebt_iN_di_msNCPBUz2Tn_zCx2QPsatN95" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-07-01to2024-09-30" id="Fact000278" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,943</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0279">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_msNCPBUz2Tn_znzWBD9uv9U3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Share issue costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2024-07-01to2024-09-30" id="Fact000281" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-07-012023-09-30" id="Fact000282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtNCPBUz2Tn_maCCERCzBkl_zvcH05iTlCJb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Net cash (used in) provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-07-01to2024-09-30" id="Fact000284" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,220</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-07-012023-09-30" id="Fact000285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,494</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzBkl_zZWjQegGOQ28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Change in cash and cash equivalents during period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-07-01to2024-09-30" id="Fact000287" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,862</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-07-012023-09-30" id="Fact000288" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,243</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zvA96yfLprS7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Cash and cash equivalents, beginning of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zMTNajS4y9O" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Cash and cash equivalents, end of period</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-09-30" id="Fact000293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-09-30" id="Fact000294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,098</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z1yvUFEGT3oh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Supplemental cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ConversionsOfDebtForCommonShares_i01_zJunTJZzOgyc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Conversion of debt for common shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="niobf:ConversionsOfDebtForCommonShares" contextRef="From2024-07-01to2024-09-30" id="Fact000299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="niobf:ConversionsOfDebtForCommonShares" contextRef="From2023-07-012023-09-30" id="Fact000300" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,729</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--ValueOfWarrantsIssued_i01_zV9y0i9jBq8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Value of warrants issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ValueOfWarrantsIssued" contextRef="From2024-07-01to2024-09-30" id="Fact000302" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0303">-</span></td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b004"></span>Condensed
Consolidated Statements of Shareholders&#8217; (Deficit) Equity and Redeemable Noncontrolling Interest </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars, except for share data) (unaudited)</span></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_114_pn3n3_z2PVHEleqyL4" summary="xdx: Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zsHztjH1yDzj" style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zIX00sHSBl91" style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zvKFwiIpC2nk" style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BD_zHkqglb7jFa7" style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--RedeemableNoncontrollingInterestMember_zFjBhqNH2BD9" style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Common Shares Outstanding</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Common<br/>
 Stock</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Accumulated<br/>
 Deficit</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Accumulated<br/>
 Other <br/>
Comprehensive<br/>
 Loss</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Redeemable Noncontrolling Interest</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_435_c20230701__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zOotAvQQRP9k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; font-weight: bold; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2023</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zThp74TT7r5b" title="Beginning balance (in shares)" style="border-bottom: Black 1pt solid; width: 8%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000311" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,202,131</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,421</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000306" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">150,477</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000307" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" id="Fact000308" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,967</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,100</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--PrivatePlacementValue_zqHglFGNrzK6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Private placements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--PrivatePlacementShares_pid_uShares_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKOMUweqxV01" title="Private placement  (in shares)" style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementShares" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000319" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0314">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0315">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:PrivatePlacementValue" contextRef="From2023-07-012023-09-30" id="Fact000316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0317">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--SharesIssuedUnderTheYorkvilleEquityFacility_z4PuzynBe3Ff" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Yorkville equity facility draws</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--SharesIssuedUnderTheYorkvilleEquityFacilityShares_pid_uShares_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3s3cBIRDFF4" title="Shares issued under the Yorkville equity facility (in shares)" style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000327" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">145,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">585</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0322">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0323">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2023-07-012023-09-30" id="Fact000324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">585</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0325">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_z2E3gOnICH6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Debt conversions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziLpUm2DUoua" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000335" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,316,288</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,729</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0330">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0331">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012023-09-30" id="Fact000332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,729</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0333">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_iP3us-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_zqXJHiKDiEUb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000337" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0338">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0339">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012023-09-30" id="Fact000340" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0341">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ProfitLoss_zSa4pUVnolg4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Loss for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0343">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact000344" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,213</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0345">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30" id="Fact000346" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,213</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000347" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_437_c20230701__20230930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zwiip8cEycma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Balance, September 30, 2023</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockSharesOutstanding_iE_pid_uShares_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyL5jeRAOM0j" title="Ending balance (in shares)" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000355" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,913,419</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147,697</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact000350" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">153,690</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000351" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30" id="Fact000352" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,904</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-09-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000353" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,926</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_439_c20240701__20240930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zvIZ14JVrOck" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">Balance, June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDMgV3zs7HJf" title="Beginning balance (in shares)" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000363" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,062,647</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">163,823</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000358" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">161,912</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000359" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--SharesIssuedUnderTheYorkvilleEquityFacility_zsW2JhXApXn2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Yorkville equity facility draws</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--SharesIssuedUnderTheYorkvilleEquityFacilityShares_pid_uShares_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztkUqjzL7JN8" title="Shares issued under the Yorkville equity facility (in shares)" style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000371" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">399,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">691</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:SharesIssuedUnderTheYorkvilleEquityFacility" contextRef="From2024-07-01to2024-09-30" id="Fact000368" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">691</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0369">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zxNTgCzJBD25" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Debt conversions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbkYnapgYvC9" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000379" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">258,347</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0374">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-01to2024-09-30" id="Fact000376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants_iP3us-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_z164ZbNX4IXh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Issuance of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000381" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" contextRef="From2024-07-01to2024-09-30" id="Fact000384" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z1LNALnyz8Ib" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Share issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000387" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0388">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-01to2024-09-30" id="Fact000390" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ProfitLoss_zuJxihM1d468" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Loss for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact000394" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,071</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0395">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-01to2024-09-30" id="Fact000396" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,071</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000397" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_431_c20240701__20240930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zcUG3WcFRFj5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2pt; padding-left: 0.125in; text-indent: -0.125in">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockSharesOutstanding_iE_pid_uShares_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zd10mBuCqlwc" title="Ending balance (in shares)" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000405" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,720,244</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">167,275</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" id="Fact000400" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">163,983</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000401" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30" id="Fact000402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,381</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-09-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000403" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,503</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="b005"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to the Condensed Consolidated Financial Statements &#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->



<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000407" name="us-gaap:NatureOfOperations"><p id="xdx_80F_eus-gaap--NatureOfOperations_zYOu73kDNj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82C_zG0C54Bd2Ow7">DESCRIPTION
    OF BUSINESS</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;NioCorp&#8221; or the &#8220;Company&#8221;)
was incorporated on February 27, 1987, under the laws of the Province of British Columbia and currently operates in <span id="xdx_903_eus-gaap--NumberOfReportableSegments_dxL_uNumber_c20240701__20240930_zMxz1FFDWmP7" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0409">one</span></span> reportable
operating segment consisting of exploration and development of mineral deposits in North America, specifically, the Company&#8217;s
niobium, scandium, and titanium project (the &#8220;Elk Creek Project&#8221;) located in southeastern Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
interim condensed consolidated financial statements have been prepared on a going concern basis that contemplates the realization
of assets and discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These
financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 3, these matters raised substantial doubt about the Company&#8217;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.&#160;</span></p>

</ix:nonNumeric><p id="xdx_816_znuWBoSi4y29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000411" name="us-gaap:BasisOfAccounting"><p id="xdx_80D_eus-gaap--BasisOfAccounting_zysVj0Atdfwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_zmncpzFAIFK6">BASIS
    OF PRESENTATION</span></span></td></tr>
</table>
<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000413" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAS8vA0YxUC9" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zbG62WJMUltc">Basis
    of Presentation and Consolidation</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles of the United States of America (&#8220;U.S. GAAP&#8221;) and the rules and regulations of the Securities and Exchange
Commission (&#8220;SEC&#8221;). The interim condensed consolidated financial statements include the consolidated accounts of the
Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed
in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited
consolidated financial statements for the year ended June 30, 2024. Certain transactions include reference to Canadian dollars
(&#8220;C$&#8221;) where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, all adjustments considered necessary (including normal recurring adjustments) for a fair statement
of the financial position, results of operations, and cash flows at September 30, 2024, and for all periods presented, have been
included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included
in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to appropriate
SEC rules and regulations. These interim condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements for the year ended June 30, 2024. The interim results are not necessarily indicative of results
for the full year ending June 30, 2025, or future operating periods.</span></p>

</ix:nonNumeric><p id="xdx_851_zvMgGNB4otD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000415" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOCmPn7lNNj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_z3UoeJf1dJM6">Recent
    Accounting Standards</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) that are
adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of
recently issued standards did not or will not have a material impact on the Company&#8217;s consolidated financial statements
upon adoption.</span></p>

</ix:nonNumeric><p id="xdx_85A_z3GFShKbKQyh" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000417" name="us-gaap:UseOfEstimates"><p id="xdx_842_eus-gaap--UseOfEstimates_z3SiY5w94AGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_z5OQnemVNJh9">Use
    of Estimates</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements, and the reported amounts of</span></p>

<ix:exclude><p id="xdx_23D_zWQsoFejlgj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>



<ix:exclude><!-- Field: Page; Sequence: 9; Options: NewSection; Value: 6 -->
    <div id="xdx_23A_zf3nrIwSgnc8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div id="xdx_239_zF6PgteGKoMc" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<ix:exclude><p id="xdx_23E_zwCGt4jWO4E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_230_zWHTgKyP3Zxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.&#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zkmkGd1d50X3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to the Condensed Consolidated Financial Statements &#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zeA0n3iuFOJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024&#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z7hilu5WwYwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23F_zWXnHOxWxCZg" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">expenses
during the reporting period. The Company regularly evaluates estimates and assumptions related to the carrying value of
long-term assets, deferred income tax assets and related valuations, liabilities related to the April 2024 Notes, Earnout
Shares, Private Warrants, and Contingent Consent Warrants (each, as defined below), and share-based compensation. The Company
bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be
reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The
actual results experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the
extent there are material differences between estimates and the actual results, future results of operations will be
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company acquired a federal income tax payable of $<span id="xdx_90D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20240701__20240930_zlBtMPIJ1op1" title="Federal income tax payable"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2024-07-01to2024-09-30" id="Fact000426" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">443</ix:nonFraction></span> in connection with the GXII Transaction (as defined below). As a result of post-transaction losses at Elk Creek Resources Corp. (&#8220;ECRC&#8221;), a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable of $<span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20230701__20230930_zPdI1r0unlw8" title="Income tax payable"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012023-09-30" id="Fact000428" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></span> was recorded as an income tax benefit in the condensed consolidated statement of operations and comprehensive loss for the three months ended September 30, 2023. The Company maintains a full valuation allowance against future income tax assets as it is more likely than not that all of the assets will not be realized.

</span></p>

</ix:nonNumeric><p id="xdx_850_zdE5GLaBrof5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000430" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zDPbzauHgqsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_z6q9i4Iyxf9j">Basic
    and Diluted Earnings per Share</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000432" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zsGGon4HYLmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8BF_z4l8xyzsUWA6">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months <br/>Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 0.125in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--NetIncomeLoss1_pn3n3_c20240701__20240930_zXURRH4Zq1Qf" title="Net loss" style="width: 12%; text-align: right">(<ix:nonFraction name="niobf:NetIncomeLoss1" contextRef="From2024-07-01to2024-09-30" id="Fact000434" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,102</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--NetIncomeLoss1_pn3n3_c20230701__20230930_z3Nbict3AAE9" title="Net loss" style="width: 12%; text-align: right">(<ix:nonFraction name="niobf:NetIncomeLoss1" contextRef="From2023-07-012023-09-30" id="Fact000436" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,387</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Less: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20240701__20240930_zFzHDQM6k5Pj" title="Less: Net loss attributable to noncontrolling interest" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2024-09-30" id="Fact000438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230701__20230930_zrbmEO99sj22" title="Less: Net loss attributable to noncontrolling interest" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30" id="Fact000440" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20240930_zO1oS9kkliB7" title="Net loss available to participating securities" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-01to2024-09-30" id="Fact000442" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,071</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20230930_zBwJ4DnmPTml" title="Net loss available to participating securities" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012023-09-30" id="Fact000444" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,213</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Less: Net loss attributable to vested shares of ECRC Class B common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20240701__20240930_zOffFp98jZoe" title="Less: Net loss attributable to vested shares of ECRC Class B common stock" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2024-09-30" id="Fact000446" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">186</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20230930_zbjS9KFiAS9" title="Less: Net loss attributable to vested shares of ECRC Class B common stock" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2023-07-012023-09-30" id="Fact000448" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">257</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20240930_z79TUoCxd7I6" title="Net loss attributable to vested shares of ECRC Class B common stock" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2024-07-01to2024-09-30" id="Fact000450" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,885</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20230930_zU3Yo09f6yFl" title="Net loss attributable to vested shares of ECRC Class B common stock" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2023-07-012023-09-30" id="Fact000452" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,956</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20240930_zCjQCklwt7i1" title="Weighted average shares outstanding basic and diluted" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-01to2024-09-30" id="Fact000454" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,361,344</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20230930_zocTkntBB0de" title="Weighted average shares outstanding basic and diluted" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30" id="Fact000456" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,967,091</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in">Loss per Common Share outstanding &#8211; basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20240701__20240930_zIGXkG54ss4" title="Loss per common share outstanding basic and diluted" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2024-07-01to2024-09-30" id="Fact000458" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.05</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20230930_zfK9460Y3fkb" title="Loss per common share outstanding basic and diluted" style="border-bottom: Black 2pt solid; text-align: right">(<ix:nonFraction name="niobf:EarningsLossPerShareBasicAndDiluted" contextRef="From2023-07-012023-09-30" id="Fact000460" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.09</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zkIsFeClJGA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following common shares, no par value, of the Company (&#8220;Common Shares&#8221;) underlying options to purchase Common Shares
(&#8220;Options&#8221;), Common Share purchase warrants (&#8220;Warrants&#8221;), and outstanding convertible debt were&#160;antidilutive&#160;due
to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three-month
periods indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000462" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_znZLZfAkFCH" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zhUeftbbcOy2" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months <br/>Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Excluded potentially dilutive securities <sup id="xdx_F6F_zIte5Np7FUFf">(1)(2)</sup>:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20240930_fKDEpKDIp_zbrcgLpWgE6d" title="Options" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2024-07-01to2024-09-30" id="Fact000464" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,455,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20230930_fKDEpKDIp_z1MJsWfUsQR" title="Options" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2023-07-012023-09-30" id="Fact000466" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,319,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20240930_fKDEpKDIp_zXvYfHZKQGNi" title="Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2024-07-01to2024-09-30" id="Fact000468" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,932,985</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20230930_fKDEpKDIp_zNG0pUxA0mf7" title="Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2023-07-012023-09-30" id="Fact000470" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,066,304</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20240701__20240930_fKDEpKDIp_zAvLv9qp0eW6" title="Convertible debt" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2024-07-01to2024-09-30" id="Fact000472" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,920,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20230930_fKDEpKDIp_zaVTCGQ29mda" title="Convertible debt" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2023-07-012023-09-30" id="Fact000474" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,448,730</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Total potential dilutive securities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DilutiveSecurities_c20240701__20240930_fKDEpKDIp_zIbOnODh7Mgc" title="Total potential dilutive securities" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2024-07-01to2024-09-30" id="Fact000476" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,308,485</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DilutiveSecurities_c20230701__20230930_fKDEpKDIp_zvnMIq7Frfoj" title="Total potential dilutive securities" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2023-07-012023-09-30" id="Fact000478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,834,034</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.375in">&#160;</td>
    <td style="width: 0.375in; text-align: justify"><span id="xdx_F02_zjAwZAoQHD6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zzr8bMTPhwY9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000479" xml:lang="en-US">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</ix:footnote></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_F0B_zvkAbz8xNUta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zU6ppeYGWiRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000480" xml:lang="en-US">Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.</ix:footnote></span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_z1aDhns6aQ6k" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

</ix:nonNumeric><p id="xdx_85A_zBEmehzoAVh8" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

</ix:nonNumeric><p id="xdx_81E_zFHwSXTJBZu7" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000482" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_807_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z3ot1tQpegTa" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82F_za61ndQ8GZvk">GOING CONCERN</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred a loss of $<span id="xdx_907_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20240701__20240930_zR3aggC3yVq5" title="Net loss::XDX::-2102"><span style="-sec-ix-hidden: xdx2ixbrl0484">2,071</span></span></span> for the three months ended September 30, 2024
(2023 - $<span id="xdx_90A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20230930_zi4eiGAUmh17" title="Net loss::XDX::-3387"><span style="-sec-ix-hidden: xdx2ixbrl0486">3,213</span></span>) and had a working capital deficit of $<span id="xdx_907_eus-gaap--InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward_iI_pn3n3_c20240930_zhDqDUrrZlPc" title="Capital deficit"><ix:nonFraction name="us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward" contextRef="AsOf2024-09-30" id="Fact000488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,928</ix:nonFraction></span> and an accumulated deficit
of $<span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20240930_z12bkB9Yxdla" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-09-30" id="Fact000490" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">163,983</ix:nonFraction></span> as of September 30, 2024. As a development stage issuer, the Company
has not yet commenced its mining operations and accordingly does not generate any revenue. As of September 30, 2024, the Company
had cash of $<span id="xdx_90E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20240930_zPXvz8Fe2rb5" title="Cash"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-09-30" id="Fact000492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></span>, which will not be sufficient to</p>

<ix:exclude><p id="xdx_238_zGDb2RwI6BTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p></ix:exclude>



<ix:exclude><!-- Field: Page; Sequence: 10; Value: 6 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_z0j0z3r4Z1Ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23C_zPYH5ktPtnCf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.&#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zfPlq3c5hpOb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to the Condensed Consolidated Financial Statements &#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zAqD10mxvThg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024&#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zacpp81A1wgl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_234_zAsc3lF0v5B1" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">fund normal operations or the repayment of the April 2024 Notes (as further
discussed in Note 5b) for the next twelve months. These conditions and events raise substantial doubt about the Company&#8217;s
ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In response to these conditions
and events, the Company plans to obtain additional financing. As disclosed in Note 12, in November 2024 the Company closed an underwritten
public offering (the &#8220;November 2024 Registered Offering&#8221;) and a non-brokered private placement (the &#8220;November
2024 Private Offering&#8221;, and together with the November 2024 Registered Offering, the &#8220;November Offerings&#8221;) which
resulted in the receipt of net proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20241101__20241130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zomX2bnvVDck" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfDebt" contextRef="From2024-11-012024-11-30_us-gaap_SubsequentEventMember" id="Fact000501" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,000</ix:nonFraction></span>, after giving effect to certain fees but before estimated underwriting discounts and  offering
expenses. In addition, NioCorp expects to have access to up to $58,577 in net proceeds from the Standby Equity Purchase Agreement,
dated January 26, 2023 (the &#8220;Yorkville Equity Facility Financing Agreement&#8221;), between the Company and YA II PN, Ltd.,
an investment fund managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;), through April 1, 2026. The Company may pursue
additional sources of financing, and while it has been successful in doing so in the past, there can be no assurance it will be
able to do so in the future. Other than the funds received from the November Offerings, and the potential issuance of Common Shares
under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements
for additional financing as of September 30, 2024. The Company&#8217;s plans to obtain additional financing have not been finalized,
are subject to market conditions, and are not within the Company&#8217;s control and therefore cannot be deemed probable. Further,
the Company will be required to raise additional funds for the construction and commencement of operations. As a result, the Company
has concluded that management&#8217;s plans do not alleviate substantial doubt about the Company&#8217;s ability to continue as
a going concern. </p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
interim condensed consolidated financial statements do not include any adjustments related to the recoverability and classification
of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</span></p>

</ix:nonNumeric><p id="xdx_81B_zT7dF8AYB7R5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000503" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zkrkxGif55Lc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82B_z5e1RjR1mCNg">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></span></td></tr>
</table>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000505" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zc59G9He5hEd" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B0_zqwCVXE70PI9" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></p>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_49A_20240930_zplwfu8pkiia" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240630_ziB5bavhMO39" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">June 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zk9amtW1T47i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2024-09-30" id="Fact000507" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,056</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2024-06-30" id="Fact000508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,417</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z52oa7ArvAm9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact000510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">603</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000511" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zRJOO7YReM53" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2024-09-30" id="Fact000513" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2024-06-30" id="Fact000514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zGEuJyfS4n3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Loan origination fees payable to related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact000516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zDoC9z6fm5P2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact000519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,736</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000520" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,843</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zFYbuJRn2mT6" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

</ix:nonNumeric><p id="xdx_81E_zFcRcqK5JkJ6" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000522" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zZ5pfSsOJpyd" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td id="xdx_822_zxcPXBGvzH6b" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>DEBT</span></span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Convertible Debenture</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the remaining
outstanding principal and accrued interest of $<span id="xdx_90C_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20240717__20240719__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zBxJTYCjssz2" title="Principal and accrued interest"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2024-07-172024-07-19_us-gaap_UnsecuredDebtMember" id="Fact000524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">554</ix:nonFraction></span> under the unsecured convertible debentures (the &#8220;Convertible Debentures&#8221;)
issued to Yorkville pursuant to the Securities Purchase Agreement, dated January 26, 2023 (the &#8220;Yorkville Convertible Debt Financing
Agreement&#8221;), into Common Shares in exchange for a $<span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20240717__20240719__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zLK4PEtrT2w7" title="Shares exchange"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span> make-whole payment. The Company recorded a gain on extinguishment of $<span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebentureMember_zw5wPnhgKjy1" title="Gain on extinguishment"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2024-07-012024-09-30_custom_YorkvilleConvertibleDebentureMember" id="Fact000528" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span>
as part other gains in the condensed consolidated statements of operations and comprehensive loss.</span>&#160;</p>

<ix:exclude><p id="xdx_234_zzj7FE3EQo84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>



<ix:exclude><!-- Field: Page; Sequence: 11; Value: 6 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zoSqLaXk8dWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_234_z7fQkFOqG95i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp
Developments Ltd.&#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zMhjEoVPId2d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to the Condensed Consolidated Financial Statements &#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zdaTdhS9QyGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2024&#160;</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zL1xiVm27whc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed
in thousands of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_232_zKQ02nrzjjg4" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000537" name="us-gaap:ConvertibleDebtTableTextBlock"><p id="xdx_896_eus-gaap--ConvertibleDebtTableTextBlock_zS6nsQGSn1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z5wqrivMG86e">The
change in the Convertible Debentures is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; padding-bottom: 1pt">Balance at June 30, 2024</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iS_pn3n3_c20240701__20240930_zkt8cMGNGeCb" title="Balance at June 30, 2024" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-06-30" id="Fact000539" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">571</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20240701__20240930_zjjm9GQdsxd2" title="Accretion expense" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpenseIncludingAssetRetirementObligations" contextRef="From2024-07-01to2024-09-30" id="Fact000541" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Principal and interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_c20240701__20240930_z9tSqczqRNid" title="Principal and interest converted" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:PrincipalAndAccruedInterestConverted" contextRef="From2024-07-01to2024-09-30" id="Fact000543" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">614</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20240930_zqWS7ql9Qxe6" title="Balance, September 30, 2024" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zGnP7n6uRoYf" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000547" name="us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zM25WlNMclH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the components of interest expense associated with the Convertible Debentures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months<br/>
Ended September &#160;30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-left: 0.25in">Component of Interest Expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 0.25in">Contractual&#160;&#160;interest</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ContractualInterest_pn3n3_c20240701__20240930_zdBZCTxVqjbi" title="Contractual interest" style="width: 18%; text-align: right"><ix:nonFraction name="niobf:ContractualInterest" contextRef="From2024-07-01to2024-09-30" id="Fact000549" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ContractualInterest_pn3n3_c20230701__20230930_zEaS59Mdnkjl" title="Contractual interest" style="width: 18%; text-align: right"><ix:nonFraction name="niobf:ContractualInterest" contextRef="From2023-07-012023-09-30" id="Fact000551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">130</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Amortization of discount and issuance costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20240701__20240930_zku8MA5zWO4b" title="Amortization of discount and issuance costs" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2024-07-01to2024-09-30" id="Fact000553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20230701__20230930_zTe3k1Qjtuu7" title="Amortization of discount and issuance costs" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-07-012023-09-30" id="Fact000555" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,945</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AccretionExpense_pn3n3_c20240701__20240930_z3irbjodGS1k" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2024-07-01to2024-09-30" id="Fact000557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20230701__20230930_zN1Qw54oVmAf" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2023-07-012023-09-30" id="Fact000559" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,075</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zdj80LYWzDUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    2024 Notes</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (&#8220;Lind II&#8221;, and together with
Yorkville, the &#8220;April 2024 Purchasers&#8221;) $<span id="xdx_900_eus-gaap--DebtInstrumentRepaidPrincipal_pn6n6_c20240410__20240412__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zGOpWurON7f3" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentRepaidPrincipal" contextRef="From2024-04-102024-04-12_us-gaap_UnsecuredDebtMember" id="Fact000561" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">8.0</ix:nonFraction></span> million aggregate principal amount of unsecured notes (the &#8220;April
2024 Notes&#8221;), pursuant to a securities purchase agreement, dated April 11, 2024 (the &#8220;April 2024 Purchase Agreement&#8221;),
between the Company and each of the April 2024 Purchasers. The Company also issued to the April 2024 Purchasers, in proportion
to the aggregate principal amount of April 2024 Notes issued to each April 2024 Purchaser, Warrants (the &#8220;April 2024 Warrants&#8221;)
to purchase up to <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240410__20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zOYitMs2lr8" title="Number of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-04-102024-04-12_custom_PurchaseAgreementMember" id="Fact000563" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">615,385</ix:nonFraction></span> Common Shares, which are equal to <span id="xdx_90B_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zSvTPALk9PF9" title="Percentage value"><ix:nonFraction name="us-gaap:InvestmentInterestRate" contextRef="AsOf2024-04-12_custom_PurchaseAgreementMember" id="Fact000565" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>% of the aggregate principal amount of April 2024 Notes issued to
the April 2024 Purchasers divided by the exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zd4aJcrb51u1" title="Common share price, per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-04-12_custom_PurchaseAgreementMember" id="Fact000567" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.25</ix:nonFraction></span>, subject to any adjustment to give effect to any stock dividend,
stock split or recapitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000569" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_z4T7CFUp5Rac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zP3ia3mTQTx4">The
change in the April 2024 Notes is presented below:</span></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended September 30, 2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_pn3n3_c20240701__20240930_zrbgGu03Nak8" title="Fair value at June 30, 2024" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FairValueHedgeAssetsAtFairValue" contextRef="AsOf2024-06-30" id="Fact000571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPayment_iN_pn3n3_di_c20240701__20240930_zR38p4UPZYJa" title="Principal payments" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2024-07-01to2024-09-30" id="Fact000573" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,848</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ChangeInFairValue_pn3n3_c20240701__20240930_zXNwEH7byeif" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ChangeInFairValue" contextRef="From2024-07-01to2024-09-30" id="Fact000575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_pn3n3_c20240701__20240930_z2mB5jzrtlmj" title="Fair value at September 30, 2024" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueHedgeAssetsAtFairValue" contextRef="AsOf2024-09-30" id="Fact000577" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,258</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Remaining Principal Balance, September 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td title="Remaining Principal Balance, September 30, 2024" id="xdx_981_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20240701__20240930_zdXlBrzHNPQc" style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalancePrincipalAmount" contextRef="AsOf2024-09-30" id="Fact000579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,280</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zXJmZE5LW0p4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000581" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zjM31nbkrrj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zvbowS805Aka">The
change in the April 2024 Warrant liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended September 30, 2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBoDip8spjwb" title="Fair value at June 30, 2024" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_custom_EarnoutMember" id="Fact000583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">298</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcVmgTLASd83" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-012024-09-30_custom_EarnoutMember" id="Fact000585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">149</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zpZsfpFgI7t1" title="Fair value at September 30, 2024" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_custom_EarnoutMember" id="Fact000587" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">447</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AC_zw9CaRw9KkZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;September Yorkville Consent&#8221;) to the April
2024 Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together
with the Yorkville Consent, the &#8220;September Consents&#8221;) to the April 2024 Notes issued and sold to Lind II pursuant
to the April 2024 Purchase Agreement. The September Consents, among other things, reduced the amounts due to the April 2024 Purchasers
on September 1, 2024 by an aggregate of $<span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20240830__20240901_zkSVTOdGiCk3" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentIssuedPrincipal" contextRef="From2024-08-302024-09-01" id="Fact000589" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1,176</ix:nonFraction></span> to an aggregate of $<span id="xdx_903_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn5n6_c20240830__20240901_zL8itnvPTor7" title="Increased the amounts due"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseDecreaseOtherNet" contextRef="From2024-08-302024-09-01" id="Fact000591" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">336</ix:nonFraction></span>, increased the amounts due to the April 2024 Purchasers
on December 1, 2024 by an aggregate of $<span id="xdx_908_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20241129__20241201_zmFMjZAK2Die" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentIssuedPrincipal" contextRef="From2024-11-292024-12-01" id="Fact000593" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1,176</ix:nonFraction></span>, and prospectively waived any term of the April 2024 Notes that would otherwise
be triggered upon a failure of the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1,
2024. Except as modified by the September Consents and the October Consents (as defined below), as discussed in Note 12, the terms
of the April 2024 Notes as previously disclosed are unchanged.</span></p>

</ix:nonNumeric><p id="xdx_810_zEGSpPNRxPy2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 12; Value: 6 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p id="xdx_23D_ztRopbQsYXo9" style="margin: 0"><b>NioCorp Developments Ltd.</b></p>

<p id="xdx_238_ze3CmXmeQi6k" style="margin: 0"><b>Notes to the Condensed Consolidated Financial Statements</b></p>

<p id="xdx_230_zn8ZjiqdJcCi" style="margin: 0"><b>September 30, 2024</b></p>

<p id="xdx_237_z3LyJ6phvA5f" style="margin: 0">(expressed in thousands
of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</p>

<!-- Field: Rule-Page --><div id="xdx_237_zZg3va0CrI5a" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000600" name="niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock"><p id="xdx_809_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_zScF5kDERuqf" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                                        <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></p></td><td id="xdx_821_z58BJeVrLEn2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLASS
B COMMON STOCK OF ECRC</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000602" name="niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock"><p id="xdx_89A_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zVhx1HrOm4u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Class B common stock of ECRC, an indirect, majority-owned subsidiary
of NioCorp formerly known as GX Acquisition Corp. II (&#8220;GXII&#8221;), include rights under which the holders may exchange
such shares into Common Shares, and certain of such shares are subject to certain vesting conditions (the &#8220;Earnout Shares&#8221;). <span id="xdx_8B4_zxleVNVPRKUk">These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; text-align: justify">Closing Common Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFuPGhTOBKs8" title="Closing common share price" style="width: 15%; text-align: center">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000604" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.18</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgyhhAA1ZVQ5" title="Closing common share price" style="width: 15%; text-align: center">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000606" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember" title="Term (expiry)"><ix:nonNumeric contextRef="From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact000608" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcuZgTLgdxNd" title="Term (expiry)"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact000610" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIbRx34QX4d5" title="Implied volatility of public warrants" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000612" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z9IRMe7Lvndl" title="Implied volatility of public warrants" style="text-align: center"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000614" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65.0</ix:nonFraction>%</td><td style="text-align: left"/></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMKF4ux4RJvi" title="Risk-free rate" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000616" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.74</ix:nonFraction></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlDwrXLgIYP9" title="Risk-free rate" style="text-align: center"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000618" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.35</ix:nonFraction>%</td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zvCMA90fNIE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000620" name="niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock"><p id="xdx_892_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_zRfB1JhYU5M2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zgQyCBHZ4t53">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period
ended September 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_ziKz0TaIDIYc" title="Fair value at June 30, 2024" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2024-06-30_custom_EarnoutMember" id="Fact000622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6r8WZwsTTm7" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAdditions" contextRef="From2024-07-012024-09-30_custom_EarnoutMember" id="Fact000624" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">816</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zORTYqZwaPVe" title="Fair value at September 30, 2024" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2024-09-30_custom_EarnoutMember" id="Fact000626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,633</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_z8eDApJKrGDf" style="margin-top: 0; margin-bottom: 0; font-size: 10pt">&#160;</p>

</ix:nonNumeric><p id="xdx_81D_zfTq6JXJQot4" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000628" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock"><p id="xdx_802_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z3x4D4f79sQh" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_829_zZvwB2hYwkhj">COMMON
SHARES</span></span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000630" name="niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock"><p id="xdx_893_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_zZFBKUMYKyMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z63Atz6HKOr5">The
Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended
September 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Date</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Common Shares Issued</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Gross Funds Received</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Market Value of Shares Issued</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">(Gain)/Loss <br/>on Issuance</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 28, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240828_zE6YmGburBKa" title="Common shares issued" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-08-28" id="Fact000632" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">75,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240826__20240828_z3Xu7SqEIsU6" title="Gross funds received" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-08-262024-08-28" id="Fact000634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockIssued1_c20240826__20240828_zcyBLNQao1Ph" title="Fair value of common shares issued" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2024-08-262024-08-28" id="Fact000636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240826__20240828_zkfOcCJAp957" title="Gross funds received" style="width: 15%; text-align: right">(<ix:nonFraction name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" contextRef="From2024-08-262024-08-28" id="Fact000638" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 3, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240903_zOBtcwwCrJMf" title="Common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-09-03" id="Fact000640" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">71,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240902__20240903_z6mlZYrlMbI2" title="Gross funds received" style="text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-09-022024-09-03" id="Fact000642" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssued1_c20240902__20240903_zV7XJsAvArZh" title="Fair value of common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2024-09-022024-09-03" id="Fact000644" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">123</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240902__20240903_z7MXOIQfnlNi" title="Gross funds received" style="text-align: right">(<ix:nonFraction name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" contextRef="From2024-09-022024-09-03" id="Fact000646" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 6, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240906_zGhd51WzSa43" title="Common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-09-06" id="Fact000648" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">71,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240904__20240906_zQv3aE5FY8Rl" title="Gross funds received" style="text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-09-042024-09-06" id="Fact000650" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssued1_c20240904__20240906_zixMUsNz28mc" title="Fair value of common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2024-09-042024-09-06" id="Fact000652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240904__20240906_zhW8OQ1wWUu9" title="Gross funds received" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0654">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 16, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240916_z5zeFtOqo3n1" title="Common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-09-16" id="Fact000656" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">72,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240914__20240916_zpvPXrV0UqU6" title="Gross funds received" style="text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-09-142024-09-16" id="Fact000658" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssued1_c20240914__20240916_zaQUgyaTOp95" title="Fair value of common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2024-09-142024-09-16" id="Fact000660" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240914__20240916_z1c0TZqHobob" title="Gross funds received" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0662">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 19, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240919_zY7WMZmyTIld" title="Common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-09-19" id="Fact000664" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240918__20240919_zpavCdSPDkAb" title="Gross funds received" style="text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-09-182024-09-19" id="Fact000666" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssued1_c20240918__20240919_zADFG43nCs2l" title="Fair value of common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2024-09-182024-09-19" id="Fact000668" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240918__20240919_z4vO1K4kVYed" title="Gross funds received" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0670">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 25, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240925_zRZZmusJel3j" title="Common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-09-25" id="Fact000672" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240923__20240925_zbREIuEvVnz" title="Gross funds received" style="text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-09-232024-09-25" id="Fact000674" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssued1_c20240923__20240925_zZT86rJ2HWu3" title="Fair value of common shares issued" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2024-09-232024-09-25" id="Fact000676" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240923__20240924_zZ7MwyFKw3kj" title="Gross funds received" style="text-align: right"><ix:nonFraction name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" contextRef="From2024-09-232024-09-24" id="Fact000678" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_z6ioMHfy5DUf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">(Gain)/loss on issuance
represents a non-cash amount equal to the difference between the proceeds received and the fair value of the Common Shares issued
based on the Nasdaq Stock Market LLC (the &#8220;Nasdaq&#8221;) closing price per Common Share on the issuance date and is recorded
in other operating expenses in the condensed consolidated statement of operations and comprehensive loss.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><p id="xdx_23B_zpvlOtZTjRyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 13; Options: NewSection; Value: 10 -->
    <div id="xdx_239_zbTMPS7L6lJl" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div id="xdx_23D_zB0weVlYdwy3" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_234_zePn3BjeFhd9" style="margin: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zLCZTJeKa6ll" style="margin: 0"><b>Notes to the Condensed Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z4rAVE2CJg6d" style="margin: 0"><b>September 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zfWaCukcLAc1" style="margin: 0">(expressed in thousands
of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23A_zSWWR8kD76jb" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->




<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
Options</span></td>
</tr></table>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000686" name="niobf:ScheduleOfStockOptionRollForwardTableTextBlock"><p id="xdx_896_ecustom--ScheduleOfStockOptionRollForwardTableTextBlock_zMbMuSMK0yek" style="display: none; margin-top: 0; margin-bottom: 0; visibility: hidden">&#160;<span id="xdx_8BF_zkjzLBiVNkgb">Schedule of stock option</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of Options</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average <br/>Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate<br/>Intrinsic Value</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br/>Average Remaining Life</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20240930_zKN55L3yTxik" title="Beginning balance" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-06-30" id="Fact000688" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,495,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20240701__20240930_zBMran0dscw8" title="Beginning balance" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-06-30" id="Fact000690" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.78</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20240930_zWLhlpifZTQ5" title="Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zc3qDApeTMv6" title="Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0694">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20240930_z9l2E8nrjI32" title="Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0696">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_z1fFzG6iVfe" title="Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0698">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20240930_zJCiKUx2Sd3b" title="Cancelled/expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2024-07-01to2024-09-30" id="Fact000700" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zBzceKZCe8S7" title="Cancelled/expired" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2024-07-01to2024-09-30" id="Fact000702" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.95</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, September 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20240930_z3otOCN6hc87" title="Ending balance" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-09-30" id="Fact000704" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,455,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20240701__20240930_zcswVa4G4Y3k" title="Beginning balance" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-09-30" id="Fact000706" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.76</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20240930_z2c2YFk6rDbc" title="Aggregate intrinsic value" style="border-bottom: Black 2pt solid; text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0708">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20240701__20240930_zXXc12Xgnri9" title="Weighted average remaining contractual life::XDX::P3Y2M19D"><span style="-sec-ix-hidden: xdx2ixbrl0710">3.22</span></span> Years</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zszTLJlspn3" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
transactions are summarized as follows. Weighted average exercise prices related to Canadian dollar denominated warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000712" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8lmPNryaG88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">&#160;<span id="xdx_8B9_zTE6gwCssKXk">Schedule
of warrant transactions</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20240930_z73Uhv3eLmDj" title="Beginning balance" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30" id="Fact000714" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,563,561</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20240701__20240930_zkF85Xz5gmrh" title="Beginning balance" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30" id="Fact000716" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.53</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20240930_zw0LT0Keyxfi" title="Granted" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightGranted" contextRef="From2024-07-01to2024-09-30" id="Fact000718" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,816,742</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20240930_zc3j9fsutXm4" title="Granted" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceGranted" contextRef="From2024-07-01to2024-09-30" id="Fact000720" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.31</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20240930_zdgaI359Afzb" title="Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0722">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20240930_zvvqp0p8H14j" title="Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20240930_zCaJr1pjYYBg" title="Expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExpired" contextRef="From2024-07-01to2024-09-30" id="Fact000726" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">447,318</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20240930_zoJImAFnjTL7" title="Expired" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExpired" contextRef="From2024-07-01to2024-09-30" id="Fact000728" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.94</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, September 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20240930_zkKpYJzzjipb" title="Ending balance" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30" id="Fact000730" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,932,985</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20240701__20240930_zNwBoIsMvsS3" title="Ending balance" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30" id="Fact000732" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.46</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zImxZqi4Yrg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000734" name="niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zD3G1UZGTpZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zqZVR49RR594">At
September 30, 2024, the Company had outstanding exercisable Warrants, as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">Expiry Date</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zSSH4HKGlsI9" title="Number" style="width: 27%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_ExercisePrice9.70Member" id="Fact000736" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">855,800</ix:nonFraction></td><td style="width: 7%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z96DdCE2pNSb" title="Exercise price" style="width: 30%; text-align: right">C$<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePrice9.70Member" id="Fact000738" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">9.70</ix:nonFraction></span></td><td style="width: 7%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z3qDQfD5uyvf" title="Expiry date" style="width: 26%; text-align: right; padding-left: 5.4pt"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePrice9.70Member" format="ixt:datemonthdayyearen" id="Fact000740" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">February 19, 2025</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdKYVXBP35ig" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_ExercisePrice4.60Member" id="Fact000741" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z3I8a1jjAO31" title="Exercise price" style="text-align: right">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePrice4.60Member" id="Fact000743" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">4.60</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zSIluWBmR1nj" title="Expiry date" style="text-align: right; padding-left: 5.4pt"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePrice4.60Member" format="ixt:datemonthdayyearen" id="Fact000745" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">September 1, 2025</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zDwJjjKLuEX5" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_ExercisePrice3.54Member" id="Fact000746" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">413,432</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zRNDlwyiVKU" style="text-align: right">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePrice3.54Member" id="Fact000747" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">3.54</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zg06YTA9Z3Zj" style="text-align: right; padding-left: 5.4pt"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePrice3.54Member" format="ixt:datemonthdayyearen" id="Fact000748" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">December 22, 2025</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmyxVhES6m55" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_ExercisePrice2.20Member" id="Fact000749" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">315,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZiTM5L9CR9" style="text-align: right">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePrice2.20Member" id="Fact000750" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zisv6jk38da6" style="text-align: right; padding-left: 5.4pt"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePrice2.20Member" format="ixt:datemonthdayyearen" id="Fact000751" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">June 24, 2026</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.35Member_zfjofJn54ZGf" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_ExercisePrice3.35Member" id="Fact000752" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">615,385</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z3x6STfrvH7e" style="text-align: right">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePrice3.25Member" id="Fact000753" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">3.25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zPYjiobUWDY9" style="text-align: right; padding-left: 5.4pt"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePrice3.25Member" format="ixt:datemonthdayyearen" id="Fact000754" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">April 12, 2027</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6ZfccVjwzR2" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_ExercisePrice11.50Member" id="Fact000755" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEr9ouHH2tul" style="text-align: right">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePrice11.50Member" id="Fact000756" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6UUacp3aFDj" style="text-align: right; padding-left: 5.4pt"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePrice11.50Member" format="ixt:datemonthdayyearen" id="Fact000757" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">March 17, 2028</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zzNZxDOiFh6b" title="Number" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_ExercisePrice2.31Member" id="Fact000759" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,816,742</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zJNy4Fn2EVrh" title="Exercise price" style="padding-bottom: 1pt; text-align: right">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ExercisePrice2.31Member" id="Fact000761" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.31</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zB5Cnjq5VNzb" title="Expiry date" style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_ExercisePrice2.31Member" format="ixt:datemonthdayyearen" id="Fact000763" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">September 17, 2028</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930_zthEr47AGJi5" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30" id="Fact000764" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,932,985</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zSwskhowbtXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023, the Company closed a series of transactions (the &#8220;GXII Transaction&#8221;) pursuant to the Business Combination
Agreement, dated as of September 25, 2022, by and among the Company, GXII, and Big Red Merger Sub Ltd. In connection with the
closing of the GXII Transaction (the &#8220;Closing&#8221;), the Company assumed GXII&#8217;s obligations under the agreement
governing the GXII share purchase warrants (the &#8220;GXII Warrants&#8221;), as amended by an assignment, assumption and amendment
agreement (the &#8220;NioCorp Assumed Warrant Agreement&#8221;), and issued an aggregate of <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAIsFIPHJTFj" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_us-gaap_WarrantMember" id="Fact000766" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></span> Warrants (the &#8220;NioCorp
Assumed Warrants&#8221;). The Company issued (a) <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdwYmsdfh5Bg" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-07-012024-09-30_us-gaap_WarrantMember" id="Fact000768" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,999,959</ix:nonFraction></span> public NioCorp Assumed Warrants (the &#8220;Public Warrants&#8221;)
in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20240930__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zvzWjvAbnQvk" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-07-012024-09-30_custom_GXIIPrivateWarrantsMember" id="Fact000770" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,666,667</ix:nonFraction></span> NioCorp Assumed Warrants (the
&#8220;Private Warrants&#8221;) to GX Sponsor II LLC (the &#8220;Sponsor&#8221;).</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 14; Value: 10 -->
    <div id="xdx_236_zTfZ8NWWgC2l" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div id="xdx_231_zk87qeFvS0Ml" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zx6xyV7cam75" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zn6TWKX8uyIj" style="margin: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zXaqubKdexk6" style="margin: 0"><b>Notes to the Condensed Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_ziBbKVic7gB8" style="margin: 0"><b>September 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zIL39KYlEaM7" style="margin: 0">(expressed in thousands
of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><ix:exclude><div id="xdx_234_zjorcLOHRtFh" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_239_zMNBlJAoH7Yf" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zX638s36zuEg" title="Description of warrants"><ix:nonNumeric contextRef="From2024-07-012024-09-30_us-gaap_WarrantMember" id="Fact000779" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">Each
Private Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and
the like).</ix:nonNumeric></span> No fractional shares will be issued upon exercise of any Private Warrants, and fractional shares that would
otherwise be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the
Company be required to net cash settle any Private Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#8217;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any of their permitted transferees
are treated as Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000781" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zKxXK5eB2hJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy as inputs into our pricing model are
based on observable data points. <span id="xdx_8BF_zG8JelBVD2O7">The following observable data points were used in calculating the fair value of the Private Warrants
using a Black Scholes pricing model:</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">September 30,<br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">June 30, <br/>&#160;2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfdQybB2Uyjk" title="Stock price on valuation date" style="width: 17%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact000783" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.18</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMQahFwTLoWh" title="Stock price on valuation date" style="width: 17%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact000785" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6uaYRqmfsT7" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact000787" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zVuUlzysqwtd" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact000789" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfeqUWgK9oP2" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-01-012024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact000791" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zH6AQzfbGZT1" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact000793" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGnIPtuoeprh" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-01-012024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact000795" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.58</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSXKEqPWoSY7" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact000797" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.45</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zub7uRmjb1K8" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-07-012024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact000799" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdG3ykCh1E3e" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact000801" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4byd8V8fZ8g" title="Expected warrant life in years::XDX::P3Y5M30D"><span style="-sec-ix-hidden: xdx2ixbrl0803">3.5</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyUY0S4ai7Zd" title="Expected warrant life in years::XDX::P3Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl0805">3.7</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zF1n5yrcwNtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000807" name="niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zSlc0UIsoLta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zcEEUId4Lp0h">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 42%; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqhb9iCqpaV6" title="Beginning balance" style="width: 15%; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation1" contextRef="AsOf2024-06-30_us-gaap_NoteWarrantMember" id="Fact000809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zRN43KszK6s7" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" contextRef="From2024-07-012024-09-30_us-gaap_NoteWarrantMember" id="Fact000811" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">205</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zorR7P4tzzi1" title="Ending balance" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation1" contextRef="AsOf2024-09-30_us-gaap_NoteWarrantMember" id="Fact000813" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,148</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_z3VG4xq0DWob" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingent
Consent Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20240701__20240930_z4magsa70S5h" title="Contingent consideration description"><ix:nonNumeric contextRef="From2024-07-01to2024-09-30" id="Fact000815" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription">As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#8220;Lind Consent&#8221;), between the Company and Lind Global Asset Management III, LLC (&#8220;Lind III&#8221;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#8220;Contingent Consent Warrants&#8221;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance.</ix:nonNumeric></span> Further, the number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage
of Warrants currently held by Lind III that are exercised, if any, prior to the issuance of any Contingent Consent Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, the Company&#8217;s Common Share price was below the threshold price set forth in the Lind Consent, and accordingly,
the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240915__20240917_z1Z5olcDa9Yg" title="Stock issued, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-09-152024-09-17" id="Fact000817" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,816,742</ix:nonFraction></span> Contingent Consent Warrants to Lind III. Each Contingent Consent Warrant is exercisable for one Common Share
at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zp1dhD6MECb" title="Common share exercise price, per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-17_custom_LindConsentWarrantIssuanceMember" id="Fact000819" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.308</ix:nonFraction></span> and may be exercised at any time prior to their expiration on September 17, 2028. The number of Contingent
Consent Warrants issued was based on $<span id="xdx_90A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20240915__20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zjccZ0Ek9TRg"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2024-09-152024-09-17_custom_LindConsentWarrantIssuanceMember" id="Fact000820" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></span> divided by the five-day volume weighted average price of the Common Shares on September 16,
2024. The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 15; Value: 10 -->
    <div id="xdx_23E_zw4GbbvCCHw8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div id="xdx_239_z5LdUOKUR1c6" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z5h3zZs1SgG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zcxu5VKeGbFa" style="margin: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zESTlr5KelAh" style="margin: 0"><b>Notes to the Condensed Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zPdv11v7xzYb" style="margin: 0"><b>September 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zh20ibQv3XVc" style="margin: 0">(expressed in thousands
of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23D_zn1PYwzFzvm7" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_239_zjETfsKygyc4" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p></ix:exclude>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000829" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zdWof341Pnzg" style="margin: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"> <span id="xdx_8B2_zesmbWpof813">The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 17, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 42%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1XpUJgWPBa" title="Closing common share price" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000831" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.74</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPrzuqE8U4eb" title="Term (years)::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0833">4.0</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z13R0iHC3zFf" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel2Member" id="Fact000835" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67.14</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUbpTPSOfn3k" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel3Member" id="Fact000837" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.44</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_znvUdFHNJesc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized a gain of $103 on the issuance of the Contingent Consent Warrants. This gain was recorded as a part of other
gains in the condensed consolidated statements of operations and comprehensive loss.</span></p>

</ix:nonNumeric><p id="xdx_81F_zE1oJu5CqaQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000839" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zUu0JLuPb4ac" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span><span id="xdx_822_z3M1qLcxwJ48">RELATED PARTY TRANSACTIONS</span></span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On September 11, 2024, the
Company and Mark Smith, Chief Executive Officer, President and Executive Chairman of NioCorp, entered into a loan agreement (the
&#8220;Smith Loan Agreement&#8221;), which provides for a $<span id="xdx_90B_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20240911__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzaqdZ6tI4O8" title="Credit agreement"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2024-09-11_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact000841" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span> non-revolving, multi-draw credit facility (the &#8220;Smith Loan&#8221;). The Smith Loan has an interest rate of <span id="xdx_906_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_z5OM8LPGLPn" title="Interest at a rate"><ix:nonFraction name="us-gaap:RelatedPartyTransactionRate" contextRef="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact000843" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% per annum, calculated monthly in arrears, through the date of repayment of the Smith Loan. The Company can pre-pay
the Smith Loan at any time without notice and without penalty, but any amount of principal or interest repaid by the Company prior
to the earlier of the date of expiration of the Smith Loan Agreement on June 30, 2025 and the occurrence of an event of default
under the Smith Loan Agreement will be subject to an early payment fee of <span id="xdx_90F_ecustom--LineOfCreditFacilityEstablishmentFee_pid_dp_uPure_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzHRABZpZcal" title="Prepayment fee"><ix:nonFraction name="niobf:LineOfCreditFacilityEstablishmentFee" contextRef="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact000845" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></span>% of the value of any such payment. The Smith Loan is secured by all of the Company&#8217;s assets pursuant to a general security agreement  between the Company and Mr. Smith dated September 11, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As of September 30, 2024, the principal amount outstanding under the Smith Loan was $<span id="xdx_905_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zwnLsrtQ7Uia" title="Accounts payable and accrued liabilities"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-09-30_srt_ChiefExecutiveOfficerMember" id="Fact000847" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></span> and accounts payable and accrued liabilities as of September 30, 2024, included $<span id="xdx_901_eus-gaap--ProfessionalFees_pn3n3_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zsWBVuhZKm95" title="Origination fees"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-07-012024-09-30_srt_ChiefExecutiveOfficerMember" id="Fact000849" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29</ix:nonFraction></span> of loan origination fees payable to Mr. Smith. Additional drawdowns totaling $<span id="xdx_908_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zLQxsix6Bkif" title="Additional drawdowns"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2024-09-30_srt_ChiefExecutiveOfficerMember" id="Fact000851" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">471</ix:nonFraction></span> were received subsequent to September 30, 2024. On November 6, 2024, the Company repaid $<span id="xdx_90C_eus-gaap--InterestExpenseOther_pn3n3_c20241101__20241106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zCYw3YEgP7D8" title="Repaid outstanding interest"><ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2024-11-012024-11-06_us-gaap_SubsequentEventMember_srt_ChiefExecutiveOfficerMember" id="Fact000853" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">250</ix:nonFraction></span> of the interest and principal outstanding under the Smith Loan, and $<span id="xdx_90E_eus-gaap--ProfessionalFees_pn3n3_c20241101__20241106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWXMZIhOJ3vk" title="Origination fees"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-11-012024-11-06_us-gaap_SubsequentEventMember_srt_ChiefExecutiveOfficerMember" id="Fact000855" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span> related to the loan origination fees payable.
</p>



</ix:nonNumeric><p id="xdx_81D_zgYH5mtATHOk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000857" name="niobf:ExplorationExpendituresDisclosuresTextBlock"><p id="xdx_804_ecustom--ExplorationExpendituresDisclosuresTextBlock_zvuVvzBSmLja" style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0px"/>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-size: 10pt">9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt; text-transform: uppercase"><span><span><span id="xdx_822_ztBToeqah4O2">EXPLORATION EXPENDITURES</span></span></span></span></td></tr>
</table>


<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000859" name="niobf:ScheduleOfExplorationExpendituresTableTextBlock"><p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zsL7dB5cGwa3" style="margin-top: 0; margin-bottom: 0"><span>&#160;<span id="xdx_8B5_zsdj9jQ4iAsk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Technical studies and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zCypVUoyrM8" style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zlqTAXRCT5zf" style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012023-09-30_custom_TechnicalStudiesAndEngineeringMember" id="Fact000861" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zehYzmGChHga" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012024-09-30_custom_FieldmanagementandotherMember" id="Fact000862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">91</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zeGOggIDLlJk" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012023-09-30_custom_FieldmanagementandotherMember" id="Fact000863" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Metallurgical development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_zzQx5Yq14r13" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012024-09-30_custom_MetallurgicaldevelopmentMember" id="Fact000864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_z9WGaCtLtyTf" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012023-09-30_custom_MetallurgicaldevelopmentMember" id="Fact000865" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">746</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Geologists and field staff</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zY3syMVxeJWb" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zHgvWSGyk4c5" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012023-09-30_custom_GeologistAndFieldStaffMember" id="Fact000867" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20240701__20240930_zNyJD2emNV0j" title="Exploration expenditures" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-01to2024-09-30" id="Fact000869" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20230930_zFNpUJXPw7D4" title="Exploration expenditures" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012023-09-30" id="Fact000871" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,100</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_ziDmdY49fq6j" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_811_zG1ZT8sL3az" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000873" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_80A_eus-gaap--LesseeOperatingLeasesTextBlock_z83dlscUdhfa" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_82B_zAYjmrWj1xEd">LEASES</span></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000875" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_890_eus-gaap--LeaseCostTableTextBlock_zy6ZvhCBSom7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zrtAcrJSBdlk">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_496_20240701__20240930_zuddX0TgWh8" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_492_20230701__20230930_z9ERXRKb3HE8" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_z2EitoeWQAQc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--FixedRentExpense_zAXIEkYb8Vvg" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left; text-indent: 9pt">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2024-07-01to2024-09-30" id="Fact000880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2023-07-012023-09-30" id="Fact000881" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zyPdXj2bZyHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2024-07-01to2024-09-30" id="Fact000883" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2023-07-012023-09-30" id="Fact000884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 9pt">Short-term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2024-07-01to2024-09-30" id="Fact000886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2023-07-012023-09-30" id="Fact000887" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zsAQ1y5nWYS9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Sublease income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2024-07-01to2024-09-30" id="Fact000889" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2023-07-012023-09-30" id="Fact000890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zJtbT4Sa2X7b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net lease cost &#8211; other operating expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2024-07-01to2024-09-30" id="Fact000892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-07-012023-09-30" id="Fact000893" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_z5VAP40ZgmN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000895" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ziGsQjF8hEK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8BA_zsg3t8AIFB44">The
maturities of lease liabilities are as follows at September 30, 2024:</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240930_zveg2pCc2z9l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Future Lease Maturities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zghIBTWYix23" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 82%; text-align: left">Total remaining lease payments</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2024-09-30" id="Fact000897" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">220</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zIpd1zmCGmA8" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less portion of payments representing interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="niobf:LessAmountOfPaymentsRepresentingInterest" contextRef="AsOf2024-09-30" id="Fact000899" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">36</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zcezAec608A1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Present value of lease payments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2024-09-30" id="Fact000901" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zz6LCjdD5GUh" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of lease payments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-09-30" id="Fact000903" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">97</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zrTX1ZjBEPmj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Non-current lease liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-09-30" id="Fact000905" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_zDHbhOOSuBA9" style="margin-top: 0; margin-bottom: 0; font-size: 10pt">&#160;</p>

</ix:nonNumeric><p id="xdx_816_zRx5Q28OkATa" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000907" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock"><p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zsuRNUn7N2o5" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11.</span></td><td id="xdx_822_zmY8XGUQ3n43"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">FAIR
VALUE MEASUREMENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of September 30, 2024, and June 30, 2024, respectively, and indicate the fair value hierarchy of the valuation techniques the
Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted)
in active markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable,
such as quoted prices, interest rates, and yield</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 16; Value: 10 -->
    <div id="xdx_23D_zlSFXSz3FZGh" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zPn3jaK4lbHe" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zQLcsbHKREwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zZIGCQ2Q5lre" style="margin: 0"><b>NioCorp Developments Ltd.</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zFUSttGawoXg" style="margin: 0"><b>Notes to the Condensed Consolidated Financial Statements</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zHDf5jTjhNc2" style="margin: 0"><b>September 30, 2024</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zRhPxGGeIW25" style="margin: 0">(expressed in thousands
of U.S. dollars, except share and per share data or as otherwise stated) (unaudited)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_238_zkfqoAaIDU74" style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_230_zZB3GJcf5MIg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">curves. Fair values determined by Level 3 inputs are unobservable data points
for the financial instrument and include situations where there is little, if any, market activity for the instrument.</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000916" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock"><p id="xdx_895_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zS7Xl6TyuZ56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><span id="xdx_8B8_zHClLontO7H8">Schedule of fair values determined by level 3 inputs are unobservable data</span></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of September 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930_zZME6WgaKGe4" title="Cash and cash equivalents" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact000918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ziFzXAQjvGh2" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="Fact000919" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7mTHS3gEoq9" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzPAdc47U6Zd" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0921">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930_zCBFcNHvSgKi" title="Cash and cash equivalents" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-09-30" id="Fact000923" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zV2XHdki24hk" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="Fact000924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zEu7bx2Dzhyc" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0925">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3BXc5BRhpU2" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240930_zLdcSG65KS9d" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact000928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">154</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdus7P4zxXIk" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="Fact000929" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">154</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGcwFYHReXm6" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0930">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWp5qyswCice" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930_z00RXTHgdzSg" title="Cash and cash equivalents" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30" id="Fact000933" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,258</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1es40GuKkKj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zu51HsKcI149" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zm1UHSIhI4J3" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="Fact000936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,258</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930_zewV8SQqGsO6" title="Cash and cash equivalents" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact000938" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,633</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zxwYTWXrTyDe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0939">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWSh1rRfKlxk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcQBd0TdKWFb" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="Fact000941" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,633</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930_zvwUAM4x6q8f" title="Warrant liabilities" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact000943" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,595</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zP73bx3AXBc6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrqL0I9qpyj" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact000945" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,595</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRidbxwTCoK7" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930_zv2h5v9c6Tuc" title="Cash and cash equivalents" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact000948" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,486</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUEpXKIagtCh" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0949">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKMfCqTjFCca" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact000950" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,595</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJDIFPQyENRk" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="Fact000951" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,891</ix:nonFraction></span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zG6lgkfBSXF2" title="Cash and cash equivalents" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000953" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqmr3MRShjGf" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact000954" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzGXTjIZUcw5" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0955">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zn8FxIJVdBQ8" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zEWoWPE6vcOe" title="Cash and cash equivalents" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30" id="Fact000958" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zViGTku6yLs2" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact000959" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zHSWLOzxYAQk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z589McuW7744" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zR5NmYWeyCIc" title="Total" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000963" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,016</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKBvaK9YBX7e" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact000964" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,016</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zst9o0tMaS91" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd3KuEl7wUQ1" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_c20240630_zKh8qbYc5v3a" title="Cash and cash equivalents" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30" id="Fact000968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhcwih71jPE1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfRLdByz9gQ7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHe9Wj1pYA6d" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact000971" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zQ3nSZ1Juvoa" title="Cash and cash equivalents" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zrX3KNCJE0q4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6XYzzKZaYTl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0975">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3PFRZb4n4N" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact000976" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_z5t3uGONNa0k" title="Warrant liabilities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,016</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zw06mR9kx2h6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqeWLjhrKRrj" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact000980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvl8HxChnie1" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact000981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,365</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_z4JvKiLJMKBa" title="Cash and cash equivalents" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000983" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,922</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoNrYLBvgwKa" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYdGxMedLUie" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact000985" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1uMNXnhfje5" style="border-bottom: Black 2pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact000986" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,271</ix:nonFraction></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_zON0OXAPos8j" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_811_zDA5TSyVUsWb" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2024-09-30" escape="true" id="Fact000988" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_z9F0N3BbS5Od" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12.</span></td><td id="xdx_823_zMxSJCDq22Xa"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SUBSEQUENT EVENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><i>The October Yorkville
Consent</i></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SubsequentEventDescription_c20241002__20241003__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zv44frg4dUG5" title="Subsequent event, description"><ix:nonNumeric contextRef="From2024-10-022024-10-03_us-gaap_SubsequentEventMember" id="Fact000990" name="us-gaap:SubsequentEventDescription">On
October 3, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;October Yorkville Consent&#8221;) to the April 2024
Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with
the October Yorkville Consent, the &#8220;October Consents&#8221;) to the April 2024 Notes issued and sold to Lind II pursuant
to the April 2024 Purchase Agreement. The October Consents, among other things, extended the maturity date to January 31, 2025,
reduced the amounts due to the April 2024 Purchasers on October 1, 2024 by an aggregate of $<span id="xdx_904_eus-gaap--DebtInstrumentIssuedPrincipal_pn3n3_c20240929__20241001_zc89St3CXgHf" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentIssuedPrincipal" contextRef="From2024-09-292024-10-01" id="Fact000992" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,176</ix:nonFraction></span> to an aggregate of $<span id="xdx_907_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn3n3_c20240929__20241001_zVp23XD4E6y5" title="Increased the amounts due"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseDecreaseOtherNet" contextRef="From2024-09-292024-10-01" id="Fact000994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">336</ix:nonFraction></span> and
deferred such amounts due to the April 2024 Purchasers until January 1, 2025, and prospectively waived any term of the April 2024
Notes that would otherwise be triggered upon a failure of the Company to pay to the April 2024 Purchasers the remainder of the
amount due on October 1, 2024. Except as modified by the September Consents, as discussed in Note 5b, and the October Consents,
the terms of the April 2024 Notes as previously disclosed are unchanged.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><i>The November 2024 Offerings</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span id="xdx_90C_eus-gaap--SubsequentEventDescription_c20241102__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQY9JR5z1N9l" title="Subsequent event, description"><ix:nonNumeric contextRef="From2024-11-022024-11-04_us-gaap_SubsequentEventMember" id="Fact000996" name="us-gaap:SubsequentEventDescription">On November 5, 2024, the Company closed the November 2024 Registered Offering, pursuant to the underwriting
agreement, dated November 3, 2024 (the &#8220;Underwriting Agreement&#8221;), with Maxim Group LLC, as underwriter (the &#8220;Underwriter&#8221;),
which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#8220;Series A Public Warrants&#8221;) to purchase up to an
additional 1,672,090 Common Shares and 836,045 Warrants (the &#8220;Series B Public Warrants&#8221; and, together with the Series
A Public Warrants, the &#8220;November Public Warrants&#8221;) to purchase up to an additional 836,045 Common Shares. Each Common
Share was sold together with one Series A Public Warrant and one-half of one Series B Public Warrant at a combined public offering
price of $1.57. The gross proceeds from the November 2024 Registered Offering were approximately $2,500 before deducting underwriting
discounts and offering expenses. The Company entered into a warrant agency agreement with Computershare Inc. and its affiliate,
Computershare Trust Company, N.A., together as warrant agent, setting forth the terms and conditions of the November Public Warrants.
The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will
expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable
beginning six months and one day from the date of issuance, and will expire on November 5, 2029. In addition, pursuant to the Underwriting
Agreement, the Company granted the Underwriter a 45-day over-allotment option to purchase (i) 238,853 additional Common Shares
and (ii) 358,280 Option Warrants (as defined below) to purchase up to an aggregate of 358,280 Common Shares. &#8220;Option Warrant&#8221;
means one Series A Public Warrant combined with one-half of one Series B Public Warrant.</ix:nonNumeric></span> On November 4, 2024, the Underwriter partially
exercised its over-allotment option to purchase <span id="xdx_902_eus-gaap--DebtInstrumentIssuedPrincipal_c20241101__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesAMember_zdbUYVtj9Jf2"><ix:nonFraction name="us-gaap:DebtInstrumentIssuedPrincipal" contextRef="From2024-11-012024-11-04_us-gaap_SubsequentEventMember_custom_PurchaseAgreementSeriesAMember" id="Fact000997" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,734</ix:nonFraction></span> additional Series A Public Warrants and <span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_c20241101__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesBMember_zTr5AGTVdwgl"><ix:nonFraction name="us-gaap:DebtInstrumentIssuedPrincipal" contextRef="From2024-11-012024-11-04_us-gaap_SubsequentEventMember_custom_PurchaseAgreementSeriesBMember" id="Fact000998" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,867</ix:nonFraction></span> additional Series B Public Warrants, which amounts are included in the amounts, discussed above, issued at closing of the November 2024 Registered Offering.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As of September 30, 2024,
the Company had accrued $<span id="xdx_901_ecustom--AccruedCost_iI_pn3n3_c20240930_zHE4AH14fBWb" title="Aggregate principal amount"><ix:nonFraction name="niobf:AccruedCost" contextRef="AsOf2024-09-30" id="Fact001000" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">459</ix:nonFraction></span> of third-party costs related to the November 2024 Registered Offering. These costs were deferred until
the closing of the November 2024 Registered Offering, at which time all costs incurred were charged against the related share capital
account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span id="xdx_90F_eus-gaap--SubsequentEventDescription_c20241110__20241113__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zinDD1rYiPhj" title="Subsequent event, description"><ix:nonNumeric contextRef="From2024-11-102024-11-13_us-gaap_SubsequentEventMember" id="Fact001002" name="us-gaap:SubsequentEventDescription">On November 13, 2024, the Company closed the November 2024 Private Offering, pursuant to binding subscription
agreements with certain accredited investors as part of a non-brokered private placement of 2,199,602 units of the Company (the
&#8220;Units&#8221;). Each Unit consists of one Common Share, one Warrant (collectively, the &#8220;Series A Private Warrants&#8221;)
to purchase one Common Share and one-half of one Warrant to purchase one-half of one Common Share (collectively, the &#8220;Series
B Private Warrants&#8221;). Each Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company purchased
November 2024 Units at a price of $1.7675 per Unit, which price includes $0.125 per Private Warrant and allows such directors and
officers to participate in the November 2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private
Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will expire on November
13, 2026.</ix:nonNumeric></span> The Series B Private Warrants have an exercise price of $<span id="xdx_902_ecustom--StrikePriceOfWarrantsIssued_pid_uUSDPShares_c20241111__20241112__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJeISY7Ku6Li" title="Exercise price"><ix:nonFraction name="niobf:StrikePriceOfWarrantsIssued" contextRef="From2024-11-112024-11-12_us-gaap_SubsequentEventMember" id="Fact001004" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.07</ix:nonFraction></span> per underlying Common Share, are exercisable beginning six months and one day from the date of
issuance, and will expire on November 13, 2029.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">NioCorp currently intends to use the net proceeds from
the November Offerings for working capital and general corporate purposes, including to (i) advance its efforts to launch construction
the Elk Creek Project and move it to commercial operation and (ii) repay the amount outstanding under the Smith Credit Facility. The Smith Loan will continue to be available to the Company following the close of the November Offerings.</p>







</ix:nonNumeric><p id="xdx_817_zDFCvDoLo6ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 17; Value: 10 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-indent: -40.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a003"></span>ITEM
2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-indent: -40.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion and analysis should be read in conjunction with our historical interim condensed consolidated financial statements
and related notes included elsewhere in this Quarterly Report on Form 10-Q and the Annual Report on Form 10-K filed with the Securities
and Exchange Commission (the &#8220;SEC&#8221;) for the year ended June 30, 2024 filed on September 23, 2024 (the &#8220;Annual
Report on Form 10-K&#8221;), which have been prepared in accordance with generally accepted accounting principles in the United
States (&#8220;U.S. GAAP&#8221;).&#160;This discussion and analysis contains forward-looking statements and forward-looking information
that involve risks, uncertainties, and assumptions. Our actual results may differ materially from those anticipated in these forward-looking
statements and information as a result of many factors, including, but not limited to, those set forth elsewhere in this Quarterly
Report on Form 10-Q. See &#8220;Note Regarding Forward-Looking Statements&#8221; below.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>All
currency amounts are stated in <span style="text-decoration: underline">U.S. dollars</span> unless noted otherwise.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>As
used in this Quarterly Report on Form 10-Q, unless the context otherwise indicates, references to &#8220;we,&#8221; &#8220;our,&#8221;
the &#8220;Company,&#8221; &#8220;NioCorp,&#8221; and &#8220;us&#8221; refer to NioCorp Developments Ltd. and its subsidiaries,
collectively. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
Regarding Forward-Looking Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Quarterly Report on Form 10-Q and the exhibits attached hereto contain &#8220;forward-looking statements&#8221; within the meaning
of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and &#8220;forward-looking information&#8221; within the meaning
of applicable Canadian securities legislation (collectively, &#8220;forward-looking statements&#8221;). Such forward-looking statements
concern our anticipated results and developments in the operations of the Company in future periods, planned exploration activities,
the adequacy of the Company&#8217;s financial resources, and other events or conditions that may occur in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements have been based upon our current business and operating plans, as approved by the Company&#8217;s Board of Directors,
and may include statements regarding the anticipated benefits of the transactions (the &#8220;2023 Transactions&#8221;) contemplated
by the previously disclosed Business Combination Agreement, dated September 25, 2022 (the &#8220;Business Combination Agreement&#8221;),
among the Company, GX Acquisition Corp. II and Big Red Merger Sub Ltd, including NioCorp&#8217;s ability to access the full amount
of the expected net proceeds of the Standby Equity Purchase Agreement, dated January 26, 2023 (the &#8220;Yorkville Equity Facility
Financing Agreement&#8221;), between the Company and YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global,
LP (&#8220;Yorkville&#8221;); the anticipated benefits of the November Offerings (as defined below); NioCorp&#8217;s ability to receive a final commitment of financing from the Export-Import Bank of
the United States (&#8220;EXIM&#8221;); anticipated benefits of the listing of the Common Shares, no par value, of the Company
(&#8220;Common Shares&#8221;) on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;); the financial and business performance of
NioCorp; NioCorp&#8217;s anticipated results and developments in the operations of NioCorp in future periods; NioCorp&#8217;s
planned exploration activities; the adequacy of NioCorp&#8217;s financial resources; NioCorp&#8217;s ability to secure sufficient
project financing to complete construction and commence operation of the Company&#8217;s niobium, scandium and titanium project
(the &#8220;Elk Creek Project&#8221;) located in southeastern Nebraska; NioCorp&#8217;s expectation and ability to produce niobium,
scandium, and titanium and the potential to produce rare earth elements at the Elk Creek Project; NioCorp&#8217;s plans to produce
and supply specific products and market demand for those products; the outcome of current recovery process improvement testing
and the evaluation of the benefits and costs of electrifying the mine using Railveyor technology, and NioCorp&#8217;s expectation
that such process and design improvements could lead to greater efficiencies and cost savings in the Elk Creek Project; the Elk
Creek Project&#8217;s ability to produce multiple critical metals; the Elk Creek Project&#8217;s projected ore production and
mining operations over its expected mine life; the completion of technical and economic analyses on the potential addition of
magnetic rare earth oxides to NioCorp&#8217;s planned product suite; NioCorp&#8217;s updating its technical report for the Elk
Creek Project; statements with respect to the estimation of mineral resources and mineral reserves; the exercise of options to
purchase additional land parcels; the execution of contracts with engineering, procurement and construction companies; NioCorp&#8217;s
ongoing evaluation of the impact of inflation, supply chain issues and geopolitical unrest on the Elk Creek Project&#8217;s economic
model; and the creation of full time and contract construction jobs over the construction period of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: -0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are frequently, but not always, identified by words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221;
&#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; and similar expressions, or statements
that events, conditions, or results &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; or &#8220;should&#8221; (or the
negative and grammatical variations of any of these terms) occur</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: -0.75pt">&#160;</p>

<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> or be achieved. Any statements that express or involve discussions
with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, or future events or performance
(often, but not always, using words or phrases such as &#8220;expects&#8221; or &#8220;does not expect,&#8221; &#8220;is expected,&#8221;
&#8220;anticipates&#8221; or &#8220;does not anticipate,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or &#8220;intends,&#8221;
or stating that certain actions, events, or results &#8220;may,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;might,&#8221;
or &#8220;will&#8221; be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements.
Forward-looking statements reflect material expectations and assumptions, including, without limitation, expectations and assumptions
relating to: NioCorp&#8217;s ability to receive sufficient project financing for the construction of the Elk Creek Project on
acceptable terms or at all; NioCorp&#8217;s ability to service its existing debt and meet the payment obligations thereunder;
the future price of metals; the stability of the financial and capital markets; and current estimates and assumptions regarding
the 2023 Transactions and their benefits. Such forward-looking statements reflect the Company&#8217;s current views with respect
to future events and are subject to certain known and unknown risks, uncertainties, and assumptions. Many factors could cause
actual results, performance, or achievements to be materially different from any future results, performance, or achievements
that may be expressed or implied by such forward-looking statements, including, among others, risks related to the following:  NioCorp&#8217;s ability to use the net proceeds of the November Offerings in a manner that will increase the value of shareholders&#8217; investment;
NioCorp&#8217;s ability to operate as a going concern; NioCorp&#8217;s requirement of significant additional capital; NioCorp&#8217;s
ability to receive sufficient project financing for the construction of the Elk Creek Project on acceptable terms or at all; NioCorp&#8217;s
ability to receive a final commitment of financing from EXIM on an acceptable timeline, on acceptable terms, or at all; NioCorp&#8217;s
ability to recognize the anticipated benefits of the 2023 Transactions, including NioCorp&#8217;s ability to access the full amount
of the expected net proceeds under the Yorkville Equity Facility Financing Agreement; NioCorp&#8217;s ability to continue to meet
Nasdaq listing standards; risks relating to the Common Shares, including price volatility, lack of dividend payments and dilution
or the perception of the likelihood of any of the foregoing; the extent to which NioCorp&#8217;s level of indebtedness and/or
the terms contained in agreements governing NioCorp&#8217;s indebtedness or the Yorkville Equity Facility Financing Agreement
may impair NioCorp&#8217;s ability to obtain additional financing; covenants contained in agreements with NioCorp&#8217;s secured
creditors that may affect its assets; NioCorp&#8217;s limited operating history; NioCorp&#8217;s history of losses; the material
weaknesses in NioCorp&#8217;s internal control over financial reporting, NioCorp&#8217;s efforts to remediate such material weaknesses
and the timing of remediation; the possibility that NioCorp may qualify as a &#8220;passive foreign investment company&#8221;
(&#8220;PFIC&#8221;) under the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;); the potential that the 2023
Transactions could result in NioCorp becoming subject to materially adverse U.S. federal income tax consequences as a result of
the application of Section 7874 and related sections of the Code; cost increases for NioCorp&#8217;s exploration and, if warranted,
development projects; a disruption in, or failure of, NioCorp&#8217;s information technology systems, including those related
to cybersecurity; equipment and supply shortages; variations in the market demand for, and prices of, niobium, scandium, titanium
and rare earth products; current and future offtake agreements, joint ventures, and partnerships; NioCorp&#8217;s ability to attract
qualified management; estimates of mineral resources and reserves; mineral exploration and production activities; feasibility
study results; the results of metallurgical testing; the results of technological research; changes in demand for and price of
commodities (such as fuel and electricity) and currencies; competition in the mining industry; changes or disruptions in the securities
markets; legislative, political or economic developments, including changes in federal and/or state laws that may significantly
affect the mining industry; the impacts of climate change, as well as actions taken or required by governments related to strengthening
resilience in the face of potential impacts from climate change; the need to obtain permits and comply with laws and regulations
and other regulatory requirements; the timing and reliability of sampling and assay data; the possibility that actual results
of work may differ from projections/expectations or may not realize the perceived potential of NioCorp&#8217;s projects; risks
of accidents, equipment breakdowns, and labor disputes or other unanticipated difficulties or interruptions; the possibility of
cost overruns or unanticipated expenses in development programs; operating or technical difficulties in connection with exploration,
mining, or development activities; management of the water balance at the Elk Creek Project site; land reclamation requirements
related to the Elk Creek Project; the speculative nature of mineral exploration and development, including the risks of diminishing
quantities of grades of reserves and resources; claims on the title to NioCorp&#8217;s properties; potential future litigation;
and NioCorp&#8217;s lack of insurance covering all of NioCorp&#8217;s operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt 0pt 0.75pt; text-align: justify; text-indent: -0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: -0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may
vary materially from those described herein. This list is not exhaustive of the factors that may affect any of the Company&#8217;s
forward-looking statements. Forward-looking statements are statements about the future and are inherently uncertain, and actual
achievements of the Company or other future events or conditions may differ materially from those reflected in the forward-looking
statements due to a variety of risks, uncertainties, and other factors, including without limitation those discussed under the
heading &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K, as well as other factors described elsewhere in this Quarterly
Report on Form 10-Q and the Company&#8217;s other reports filed with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: -0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: -0.25pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 19; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: -0.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s forward-looking statements contained in this Quarterly Report on Form 10-Q are based on the beliefs, expectations,
and opinions of management as of the date of this Quarterly Report on Form 10-Q. The Company does not assume any obligation to
update forward-looking statements if circumstances or management&#8217;s beliefs, expectations, or opinions should change, except
as required by law. For the reasons set forth above, investors should not attribute undue certainty to, or place undue reliance
on, forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Qualified
Person</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
technical and scientific information that forms the basis for the Elk Creek Project disclosure included in this Quarterly Report
on Form 10-Q has been reviewed and approved by Scott Honan, M.Sc., SME-RM, NioCorp&#8217;s Chief Operating Officer. Mr. Honan
is a &#8220;Qualified Person&#8221; as such term is defined in National Instrument 43-101 &#8211; Standards of Disclosure for
Mineral Projects and subpart 1300 of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
is developing the Elk Creek Project, located in southeast Nebraska. The Elk Creek Project is a development-stage property that
has disclosed niobium, scandium, and titanium reserves and resources and disclosed rare earth mineral resources. The Company is
continuing technical and economic studies around the rare earths contained in the Elk Creek Project&#8217;s mineral resources
in order to determine whether extraction of rare earth elements can be reasonably justified and economically viable after taking
into account all relevant factors. Niobium has developing applications in the formulation of solid-state lithium-ion batteries,
which may reduce charging times and increase battery safety. Niobium is used to produce various superalloys that are extensively
used in high performance aircraft and jet turbines. It also is used in High-Strength, Low-Alloy steel, a stronger steel used in
automobiles, bridges, structural systems, buildings, pipelines, and other applications that generally increases strength and/or
reduces weight, which can result in environmental benefits, including reduced fuel consumption and material usage and fewer air
emissions. Scandium can be combined with aluminum to make high-performance alloys with increased strength and improved corrosion
resistance. Scandium also is a critical component of advanced solid oxide fuel cells, an environmentally preferred technology
for high-reliability, distributed electricity generation. Titanium is a component of various superalloys and other applications
that are used for aerospace applications, weapons systems, protective armor, medical implants, and many others. It also is used
in pigments for paper, paint, and plastics. Rare earths are critical to electrification and decarbonization initiatives and can
be used to manufacture the strongest permanent magnets commercially available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
primary business strategy is to advance our Elk Creek Project to commercial production. We are focused on obtaining additional
funds to carry out our near-term planned work programs associated with securing the project financing necessary to complete mine
development and construction of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Corporate Events</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 5, 2024, the Company closed
the November 2024 Registered Offering, pursuant to the underwriting agreement, dated November 3, 2024 (the &#8220;Underwriting
Agreement&#8221;), with Maxim Group LLC, as underwriter (the &#8220;Underwriter&#8221;), which consisted of 1,592,356 Common Shares,
1,672,090 Warrants (the &#8220;Series A Public Warrants&#8221;) to purchase up to an additional 1,672,090 Common Shares and 836,045
Warrants (the &#8220;Series B Public Warrants&#8221; and, together with the Series A Public Warrants, the &#8220;November Public
Warrants&#8221;) to purchase up to an additional 836,045 Common Shares. Each Common Share was sold together with one Series A Public
Warrant and one-half of one Series B Public Warrant at a combined public offering price of $1.57. The gross proceeds from the November
2024 Registered Offering were approximately $2.5 million before deducting underwriting discounts and offering expenses. The Company
entered into a warrant agency agreement with Computershare Inc. and its affiliate, Computershare Trust Company, N.A., together
as warrant agent, setting forth the terms and conditions of the November Public Warrants. The Series A Public Warrants have an
exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will expire on November 5, 2026. The Series
B Public Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable beginning six months and one day
from the date of issuance, and will expire on November 5, 2029. In addition, pursuant to the Underwriting Agreement, the Company
granted the Underwriter a 45-day over-allotment option to purchase (i) 238,853 additional Common Shares and (ii) 358,280 Option
Warrants (as defined below) to purchase up to an aggregate of 358,280 Common Shares. &#8220;Option Warrant&#8221; means one Series
A Public Warrant combined with one-half of one Series B Public Warrant. On November 4, 2024, Underwriter partially exercised its
over-allotment option to purchase 79,734 additional Series A Public Warrants and 39,867 additional Series B Public Warrants, which
amounts are included in the amounts issued at closing of the November 2024 Registered Offering above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify">On November 13, 2024, the Company
closed a non-brokered private placement (the &#8220;November 2024 Private Offering&#8221; and, together with the November 2024
Registered Offering, the &#8220;November Offerings&#8221;) pursuant to binding subscription agreements with certain accredited
investors (the &#8220;Private Placement Investors&#8221;) as part of a non-brokered private placement of 2,199,602 units of the
Company (the &#8220;Units&#8221;). Each Unit consists of one Common Share, one Warrant (the &#8220;Series A Private
Warrants&#8221;) to purchase up to an additional Common Share, and one-half of one Warrant to purchase up to an additional
one-half of one Common Share (the &#8220;Series B Private Warrants&#8221; and, together with the Series A Private Warrants, the &#8220;November
Private Warrants&#8221;). Each Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private Offering
were approximately $3.5 million before deducting offering expenses. Certain directors and officers of the Company purchased
Units at a price of $1.7675 per Unit, which price includes $0.125 per November Private Warrant and allows such directors and officers
to participate in the November 2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private Warrants
have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will expire on November 13, 2026.
The Series B Private Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable beginning six months
and one day from the date of issuance, and will expire on November 13, 2029.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NioCorp currently intends to use the
net proceeds from the November Offerings for working capital and general corporate purposes, including to (i) advance its
efforts to launch construction of the Elk Creek Project and move it to commercial operation and (ii) repay the amount
outstanding under the Company&#8217;s $2.0 million non-revolving, multiple draw credit facility (the &#8220;Smith
Loan&#8221;) available pursuant to the Loan Agreement, dated September 11, 2024, by and between the Company and its Chief
Executive Officer (&#8220;CEO&#8221;), President, and Executive Chairman, Mark Smith (the &#8220;Smith Loan Agreement&#8221;). The Smith Loan
continues to be available to the Company following the close of the November Offerings.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 20; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Elk
Creek Project Update </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, the Advanced Propulsion Center UK announced that an industry consortium, in which NioCorp is participating,
was awarded funding by the UK Government to support a $8.0 million program to design lightweight aluminum alloys and cast automotive
components made of recycled aluminum strengthened by scandium. The consortium, known as Project PIVOT (&#8220;Performance Integrated
Vehicle Optimisation Technology&#8221;), includes such companies as Aston Martin (LON:AML), Sarginsons Industries (&#8220;Sarginsons&#8221;),
Altair, GESCRAP, and London-based Brunel University. Project PIVOT&#8217;s Steering Committee includes Jaguar Land Rover, Alcon
Industries, Linamar, Shell Re-Charge, and others. Project PIVOT is led by the Coventry, UK-based aluminum foundry company Sarginsons,
and seeks to revolutionize the global casting industry through overhauling the design, weight, carbon intensity, and production
of cast aluminum automotive parts, with a target of 100% recycled content.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 30, 2024, the Company announced that it had completed bench-scale testwork at a demonstration-scale processing plant located
in Trois-Rivieres, Quebec built by the Company and L3 Process Development (&#8220;L3&#8221;) and operated by L3 (the &#8220;Demonstration
Plant&#8221;) that successfully demonstrated that the process developed for extracting and recovering rare earth oxides found
in the ore at the Elk Creek Project can be used to recycle the rare earth content in rare earth permanent magnets. The L3 team
was able to demagnetize and grind up permanent rare earth magnets and then leach the contained rare earth elements from the magnet.
The successful outcome of this testing opens up the possibility of accepting mixed rare earth concentrate from other mines into
the planned Elk Creek plant once it is constructed and operating to supplement the ore expected to be produced from the Elk Creek
mine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended September 30, 2024, the Company commenced negotiations with landowners in Nebraska to extend the current set
of Option to Purchase agreements for land that is needed for project construction and operation and which the Company does not
already own.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other
Activities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
funds become available through the Company&#8217;s fundraising efforts, we expect to undertake the following activities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 97%; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuation
    of the Company&#8217;s efforts to secure federal, state and local operating permits;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued
    evaluation of the potential to produce rare earth products and sell such products under offtake agreements;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negotiation
    and completion of offtake agreements for the remaining uncommitted production of niobium, scandium, and titanium from the
    Elk Creek Project, including the potential sale of titanium as titanium tetrachloride, as well as potential rare earth element
    production;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negotiation
    and completion of engineering, procurement, and construction agreements;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of the final detailed engineering for the underground portion of the Elk Creek Project;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    and completion of the final detailed engineering for surface project facilities;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
    of natural gas and electrical infrastructure under existing agreements to serve the Elk Creek Project site;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of water supply agreements and related infrastructure to deliver fresh water to the Elk Creek Project site;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    of revised mine groundwater investigation and control activities;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    of long-lead equipment procurement activities;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    a follow-on to the Demonstration Plant operations, complete characterization and testing of waste materials to support tailings
    impoundment and paste backfill plant designs; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue
    the engineering and costing of road improvements near the junction of Nebraska state highways 50 and 62, which are intended
    to facilitate access to the Elk Creek Project site and manage increased traffic in the project vicinity.</span></td></tr>
</table>
<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 21; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
and Operating Results</b></span></p>

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no revenues from mining operations. Operating expenses incurred related primarily to costs incurred for the advancement
of the Elk Creek Project and the activities necessary to support corporate and shareholder duties and are detailed in the following
table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; width: 95%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;For
    the Three Months Ended September 30,</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
    expenses</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;($000s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt; width: 72%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee-related
    costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">322</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
    fees</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">450</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,187</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exploration
    expenditures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,100</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    operating expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">477</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">834</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    operating expenses</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,395</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,443</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of Earnout Shares liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">816</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,093</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of warrant liabilities </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair values of convertible notes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,075</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    exchange loss (gain)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    gains</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(122</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on equity securities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    tax benefit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(101</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net  loss and comprehensive loss</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,102</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,387</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Loss
    attributable to noncontrolling interest</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(174</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss attributable to the Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,071</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,213</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three-month
period ended September 30, 2024 compared to the three-month period ended September 30, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
items affecting operating expenses are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
fees</i> decreased for the three-month period in 2024 as compared to 2023, primarily due to higher costs incurred in 2023 related
to the timing of legal services associated with the Company&#8217;s SEC registration statements filed in October 2023, as well
as increased audit fees associated with the Company&#8217;s June 30, 2023 financial statements and increased review fees in connection
with the Company&#8217;s September 30, 2023 financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exploration
expenditures</i> decreased for the three-month period in 2024 as compared to 2023, as 2023 costs included Demonstration Plant
operation costs. Operation of the Demonstration Plant ended during the prior year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
operating expenses </i>include costs related to investor relations, general office expenditures, equity offering and proxy expenditures,
board-related expenditures, and other miscellaneous costs. These costs decreased for the three-month period in 2024 as compared
to 2023 primarily due to a decrease in director and officer insurance expense, as well as declines in scandium development initiatives
and non-cash expenses associated with share issuances under the Yorkville Equity Facility Financing Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
significant items impacting the change in the Company&#8217;s net loss are noted below<i>:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of Earnout Shares liability </i>represents the changes in fair value related to the shares of Class B common stock
of Elk Creek Resource Corporation (&#8220;ECRC&#8221;), an indirect, majority-owned subsidiary of NioCorp formerly known as GX
Acquisition Corp. II, the rights of the holders of which to exchange such shares into Common Shares are subject to certain vesting
conditions (such shares of ECRC Class B common stock, the &#8220;Earnout Shares&#8221;). The increase in costs for 2024 represents
the impact of an increase in the Company&#8217;s Common Share price on the financial modeling used to determine the period end
fair values, whereas 2023 represents the impact of a decline in the Company&#8217;s Common Share price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of warrant liability </i>represents the changes in period-over-period fair values (based primarily on the impacts
of changing closing Common Share prices) related to the change in fair values of (i) the April 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 22; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> Warrants; and (ii) the 5,666,667
Warrants (the &#8220;Private Warrants&#8221;) issued to GX Sponsor II LLC (the &#8220;Sponsor&#8221;) in connection with the assumption by the Company of
GXII&#8217;s obligations under the agreement governing the GXII share purchase warrants, as amended by an assignment, assumption
and amendment agreement, in which the Company issued an aggregate of 15,666,626 Warrants (the &#8220;NioCorp Assumed Warrants&#8221;)
consisting of 9,999,959 public NioCorp Assumed Warrants and the Private Warrants, which are discussed in Note 5b to the interim
condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
expense</i> decreased for the three-month period in 2024 as compared to 2023 as 2023 included accretion expense associated with
the unsecured convertible debentures (the &#8220;Convertible Debentures&#8221;) issued to Yorkville in March 2023. The outstanding balance of the Convertible
Debentures was substantially reduced during fiscal year 2023, resulting in lower accretion during the first quarter of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of convertible debt </i>represents the change in the fair value of the $8.0 million aggregate principal amount of
unsecured notes (the &#8220;April 2024 Notes&#8221;), issued and sold to Yorkville and Lind Global Fund II (together with Yorkville,
the &#8220;April 2024 Purchasers&#8221;) on April 12, 2024, pursuant to a securities purchase agreement, dated April 11, 2024
(the &#8220;April 2024 Purchase Agreement&#8221;), between the Company and each of the April 2024 Purchasers. The Company also
issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of the April 2024 Notes issued to each April
2024 Purchaser, Common Share purchase warrants (&#8220;Warrants&#8221;) to purchase up to 615,385 Common Shares (the &#8220;April
2024 Warrants&#8221;), which are equal to 25% of the aggregate principal amount of April 2024 Notes issued to the April 2024 Purchasers
divided by the exercise price of $3.25, subject to any adjustment to give effect to any stock dividend, stock split or recapitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loss
attributable to noncontrolling interest</i> represents the portion of net loss in ECRC not owned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no revenue generating operations from which we can internally generate funds. To date, our ongoing operations have been financed
by the sale of our equity securities by way of private placements, convertible securities issuances, the exercise of incentive
options to purchase Common Shares (&#8220;Options&#8221;) and Warrants, and related party loans. With respect to currently outstanding
Options and Warrants, we believe that exercise of these instruments, and cash proceeds from such exercises, will not occur unless
and until the market price for our Common Shares equals or exceeds the related exercise price of each instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The November Offerings are expected
to provide near-term access to capital. The sale of the April 2024 Notes has provided, and The Yorkville Equity Facility Financing
Agreement is expected to provide, near-term and longer-term access to capital. The ability of the Company to draw down on the
Yorkville Equity Facility Financing Agreement, at its discretion, is subject to certain limitations and the satisfaction of certain
conditions. When available, the Yorkville Equity Facility Financing Agreement provides an opportunity to actively manage the cash
needs of the Company more closely. Historically, cash has generally been available to the Company through private placements of
equity for which the timing did not always coincide with the Company&#8217;s cash needs. In the near term, the Company intends
to utilize the Yorkville Equity Facility Financing Agreement to offset amounts owed under the April 2024 Notes. The Company may
also utilize the Yorkville Equity Facility Financing Agreement to potentially generate funds at a time when they are in need.
Alternatively, the Company can also utilize the Yorkville Equity Facility Financing Agreement for opportunistic share sales. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the
remaining principal and accrued interest of $553,767 under the Convertible Debenture into Common Shares in exchange for a $95,000
make-whole payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 11, 2024, the Company and
Mark Smith entered into the Smith Loan Agreement, which provides for a $2.0 million non-revolving credit facility. An initial drawdown
under the Smith Loan Agreement of $33,000 was completed on September 11, 2024, and additional drawdowns totaling $471,000 were
received subsequent to September 30, 2024. On November 6, 2024, the Company repaid $250,000 of the interest and principal outstanding under the Smith Loan.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 23; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the securities purchase agreement, dated January 26, 2023, between the Company and Yorkville, on March 17, 2023, Yorkville
advanced a total amount of $15,360 to NioCorp in consideration of the issuance by NioCorp to Yorkville of (i) the Convertible
Debentures and (ii) Warrants, exercisable for up to 1,789,267 Common Shares for cash or, if at any time there is no effective
registration statement registering, or no current prospectus available for, the resale of the underlying Common Shares, on a cashless
basis, at the option of the holder, at a price per Common Share of approximately $8.9422, subject to adjustment to give effect
to any stock dividend, stock split, reverse stock split or similar transaction (the &#8220;Financing Warrants&#8221;). On September
17, 2024, all remaining outstanding Financing Warrants expired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
On September 17, 2024, the Company&#8217;s Common Share price was below the threshold set forth in the Lind Consent, and accordingly,
the Company issued 2,816,742 Contingent Consent Warrants to Lind. Each Contingent Consent Warrant is exercisable for one Common
Share at an exercise price of $2.308 and may be exercised at any time prior to their expiration on September 17, 2028. The number
of Contingent Consent Warrants issued was based on $5.0 million divided by the five-day volume weighted average price of the Common
Shares on September 16, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, the Company
had cash of $0.15 million and a working capital deficit of $6.9 million, compared to cash of $2.0 million and a working capital
deficit of $9.0 million on June 30, 2024.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that the Company will operate at a loss for the foreseeable future. The Company&#8217;s current planned cash needs are
approximately $25.0 million until June 30, 2025, inclusive of any repayments of principal and interest due on the April 2024 Notes.
On September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;September Yorkville Consent&#8221;) to the April
2024 Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together
with the Yorkville Consent, the &#8220;September Consents&#8221;) to the April 2024 Notes issued and sold to Lind II. On October
3, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;October Yorkville Consent&#8221;) to the April 2024 Notes issued
and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with the October Yorkville
Consent, the &#8220;October Consents&#8221;) to the April 2024 Notes issued and sold to Lind II pursuant to the April 2024 Purchase
Agreement. See Note 5b to the interim condensed consolidated financial statements for additional information on the terms of the
September Consents and October Consents. Except as modified by the September Consents and the October Consents, the terms of the
April 2024 Notes as previously disclosed are unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to outstanding accounts payable and short-term liabilities, our average monthly planned expenditures through June 30,
2024 are expected to be approximately $1,915,000 per month where approximately $355,000 is for corporate overhead and estimated
costs related to securing financing necessary for advancement of the Elk Creek Project. This includes general overhead costs,
satisfying outstanding accounts payable, and repayment of the April 2024 Notes and the Smith Loan Agreement. This also includes
anticipated financing costs associated with the Elk Creek Project, including an updated mine plan in connection with the EXIM
application process. The scope of these financing costs remains under discussion with EXIM. Approximately $1,560,000 per month
is planned for expenditures relating to the advancement of the Elk Creek Project by NioCorp&#8217;s majority owned subsidiary,
ECRC. The Company&#8217;s ability to continue operations and fund our current work plan is dependent on management&#8217;s ability
to secure additional financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company anticipates that it does
not have sufficient cash on hand to continue to fund basic operations for the next twelve months, and additional funds totaling
$24.0 million to $25.0 million, net of funds raised from advances under the Yorkville Equity Facility Financing Agreement, borrowings
under the Smith Loan, and funds raised in the November Offerings, are likely to be necessary to continue advancing the
Elk Creek Project in the areas of financing, permitting, and detailed engineering. While the Yorkville Equity Facility Financing
Agreement and the November Offerings may provide the Company with access to additional capital, the Company will likely require
additional capital to meet its cash needs. Management is actively pursuing such additional sources of debt and equity financing,
and while it has been successful in doing so in the past, there can be no assurance it will be able to do so in the future.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek property lease commitments are $13,200 until June 30, 2025. To maintain our currently held properties and fund our currently
anticipated general and administrative costs and planned exploration and development activities at the Elk Creek Project for the
fiscal year ending June 30, 2025, the Company will likely require additional financing during the current fiscal year. Should
such financing not be available in that timeframe, we will be required to reduce our activities and will not be able to carry
out all our presently planned activities at the Elk Creek Project.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 24; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 6, 2023, the Company announced that it had submitted an application to EXIM for debt financing (the &#8220;EXIM Financing&#8221;)
to fund the project costs for the Elk Creek Project, under EXIM&#8217;s &#8220;Make More in America&#8221; initiative. The EXIM
Financing is subject to, among other matters, the satisfactory completion of due diligence, the negotiation and settlement of
final terms, and the negotiation of definitive documentation. There can be no assurance that the EXIM Financing will be completed
on the terms described herein or at all. The Company was informed that its application received approval by the first of three
reviews by the EXIM Transaction Review Committee (the &#8220;TRC&#8221;) on October 2, 2023. During the quarter, EXIM continued
to process the Company&#8217;s application for debt financing under EXIM&#8217;s Make More in America Program. The Company&#8217;s
application sits at TRC in the second step in EXIM&#8217;s four-step approval process. The Company continues to meet with EXIM
as well as providing responses to requests for additional information from EXIM and to the consultants that are conducting due
diligence on the Company&#8217;s application on behalf of EXIM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently unable to estimate how long the application process may take, and there can be no assurances that we will be able
to successfully negotiate a final commitment of debt financing from EXIM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Except for the proceeds
from the November Offerings, potential funding from advances under the Yorkville Equity Facility Financing Agreement, and potential
funding under the Smith Loan Agreement, each as discussed above, and the potential exercise of Options and Warrants, we currently
have no further funding commitments or arrangements for additional financing at this time, and there is no assurance that we will
be able to obtain any such additional financing on acceptable terms, if at all. Pursuant to the Exchange Agreement, dated as of
March 17, 2023 (as amended, supplemented or otherwise modified, the &#8220;Exchange Agreement&#8221;), by and among NioCorp, ECRC
and the Sponsor, NioCorp is restricted from issuing equity or equity-linked securities (other than Common Shares) or any preferred
equity or non-voting equity if such issuance would adversely impact the rights of the holders of the shares of Class B common
stock of ECRC, without the consent of the holders of a majority of the shares of Class B common stock of ECRC. The April 2024
Purchase Agreement also contains certain covenants that, among other things, limit NioCorp&#8217;s ability to use the proceeds
from the April 2024 Purchase Agreement to pay related party debt or to enter into any variable rate transaction, including issuances
of equity or debt securities that are convertible into Common Shares at variable rates and any equity line of credit, at-the-market
agreement or other continuous offering of Common Shares, other than with Yorkville, subject to certain exceptions. Notwithstanding
the restrictions set forth in the Exchange Agreement and the April 2024 Purchase Agreement, there is significant uncertainty that
we would be able to secure any additional financing in the current equity or debt markets. The quantity of funds to be raised
and the terms of any proposed equity or debt financing that may be undertaken will be negotiated by management as opportunities
to raise funds arise. Management may pursue funding sources of both debt and equity financing, including but not limited to the
issuance of equity securities in the form of Common Shares, Warrants, subscription receipts, or any combination thereof in units
of the Company pursuant to private placements to accredited investors or pursuant to public offerings in the form of underwritten/brokered
offerings, registered direct offerings, or other forms of equity financing and public or private issuances of debt securities
including secured and unsecured convertible debt instruments or secured debt project financing. Management does not currently
know the terms pursuant to which such financings may be completed in the future, but any such financings will be negotiated at
arm&#8217;s-length. Future financings involving the issuance of equity securities or derivatives thereof will likely be completed
at a discount to the then-current market price of the Company&#8217;s securities and will likely be dilutive to current shareholders.
In addition, we could raise funds through the sale of interests in our mineral properties, although current market conditions
and other recent worldwide events have substantially reduced the number of potential buyers/acquirers of any such interests. However,
we cannot provide any assurances that we will be able to be successful in raising such funds.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the conditions described within, management has concluded, as supported by the notes that accompany our financial statements
for the year ended June 30, 2024, that substantial doubt exists as to our ability to continue as a going concern. The interim
condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared under the assumption
that we will continue as a going concern. As defined under S-K 1300, we are a development stage issuer and we have incurred losses
since our inception. We may not have sufficient cash, including Option and Warrant exercises subsequent to June 30, 2024, to fund
normal operations and meet debt obligations for the next twelve months without deferring payment on certain current liabilities
and raising additional funds. Uncertainty in capital markets, supply chain disruptions, increased interest rates and inflation,
and the potential for geographic recessions have contributed to general global economic uncertainty. During the three months ended
September 30, 2024, these events continued to create uncertainty with respect to overall project funding and timelines. We believe
that the going concern uncertainty cannot be alleviated with confidence until the Company has entered into a business climate
where funding of its planned ongoing operating activities is secured. Therefore, these factors raise substantial doubt as to our
ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 25; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no exposure to any asset-backed commercial paper. Other than cash held by our subsidiaries for their immediate operating
needs in Colorado and Nebraska, all of our cash reserves are on deposit with major U.S. and Canadian chartered banks. We do not
believe that the credit, liquidity, or market risks with respect thereto have increased as a result of the current market conditions.
However, in order to achieve greater security for the preservation of our capital, we have, of necessity, been required to accept
lower rates of interest, which has also lowered our potential interest income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
Activities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended September 30, 2024, the Company&#8217;s operating activities consumed $0.6 million of cash (2023:
$2.7 million). The cash used in operating activities for the three months ended September 30, 2024, reflects the
Company&#8217;s funding of losses of $2.1 million and increased fair value related to the Earnout Shares liability and other
non-cash transactions. Overall, operational outflows during the three months ended September 30, 2024, decreased from the
corresponding period of 2023 due to costs and expenditures incurred in connection with the Company&#8217;s Demonstration
Plant. Going forward, the Company&#8217;s working capital requirements are expected to increase substantially in connection
with the development of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financing
Activities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
outflows were $1.2 million during the three months ended September 30, 2024 (2023 inflows: $1.5 million), with 2024 inflows reflecting
the gross receipts of $0.7 million from Common Share issuances under the Yorkville Equity Facility Financing Agreement, offset
by $1.9 million of convertible debt repayments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
Flow Considerations </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has historically relied
upon debt and equity financings to finance its activities. Subject to the restrictions set forth in the Exchange Agreement and
the April 2024 Purchase Agreement, the Company may pursue additional debt and/or equity financing in the medium term; however,
there can be no assurance the Company will be able to obtain any required financing in the future on acceptable terms. </p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has limited financial resources compared to its proposed expenditures, no source of operating income, and no assurance
that additional funding will be available to it for current or future projects, although the Company has been successful in the
past in financing its activities through the sale of equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the Company to arrange additional financing in the future will depend, in part, on the prevailing capital market conditions,
and its success in developing the Elk Creek Project. Any quoted market for the Common Shares may be subject to market trends generally,
notwithstanding any potential success of the Company in creating revenue, cash flows, or earnings, and any depression of the trading
price of the Common Shares could impact its ability to obtain equity financing on acceptable terms.</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the Company has used net proceeds from issuances of Common Shares to provide sufficient funds to meet its near-term exploration
and development plans and other contractual obligations when due. However, development and construction of the Elk Creek Project
will require substantial additional capital resources. This includes near-term funding and, ultimately, funding for Elk Creek
Project construction and other costs. See &#8220;<i>Liquidity and Capital Resources</i>&#8221; above for the Company&#8217;s discussion
of arrangements related to possible future financings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Estimates </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no material changes in our critical accounting estimates discussed in &#8220;Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations&#8221; under the heading &#8220;Critical Accounting Estimates and Recent Accounting
Pronouncements&#8221; as of June 30, 2024, in the Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
U.S. Federal Income Tax Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
NioCorp (or a subsidiary) is a PFIC for any taxable year (or portion thereof) that is included in the holding period of a U.S.
holder of Common Shares or other NioCorp securities (as determined under applicable U.S. federal income tax law), then certain
significant adverse tax consequences could apply to such U.S. holder, including requirements to treat any gain realized upon a
disposition of Common Shares (or other securities) as ordinary income, to include certain &#8220;excess</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 26; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">distributions&#8221; on
Common Shares in income, and to pay an interest charge on a portion of any such gain or distribution. NioCorp believes that it
was classified as a PFIC during the taxable years ended June 30, 2024 and 2023, and, based on the current composition of its income
and assets, as well as current business plans and financial expectations, that it may be classified as a PFIC for its current
taxable year or in future taxable years. No opinion of legal counsel or ruling from the Internal Revenue Service (the &#8220;IRS&#8221;)
concerning the PFIC status of NioCorp or any subsidiary has been obtained or is currently planned to be requested. The determination
of whether any corporation was, or will be, a PFIC for a taxable year depends, in part, on the application of complex U.S. federal
income tax rules, which are subject to differing interpretations. In addition, whether any corporation will be a PFIC for any
taxable year depends on the assets and income of such corporation over the course of each such taxable year and, as a result,
cannot be predicted with certainty as of the date of this Quarterly Report on Form 10-Q. In addition, even if NioCorp concluded
that it or any subsidiary was not classified as a PFIC, the IRS could challenge such determination and a court could sustain the
challenge. Accordingly, there can be no assurance that NioCorp or any subsidiary will not be classified as a PFIC for any taxable
year. Each holder of Common Shares or other NioCorp securities should consult its own tax advisors regarding the PFIC status of
NioCorp and each subsidiary thereof and the resulting tax consequences to the holder, as well as any potential to mitigate such
tax consequences through a &#8220;QEF&#8221; or &#8220;mark-to-market&#8221; election. See the &#8220;Risk Factors&#8221; section
of the Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has one class of shares,
being Common Shares. A summary of outstanding shares, Options, Warrants, and convertible debt as of November 13, 2024, is set out
below, on a fully diluted basis.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse; margin-left: 0.25in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; padding-right: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Shares <br/>
Outstanding</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Fully
Diluted)</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,512,202</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    shares of ECRC Class B common stock (1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,282,116</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    (2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,455,500</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    (3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,740,515</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    debt (4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,248,346</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse; margin-left: 0.25in">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    exchangeable into one Common Share at any time, and from time to time, until March 17, 2033.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    exercisable into one Common Share.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 15,666,626 NioCorp Assumed Warrants that are each exercisable into 1.11829212 Common Shares
and 11,073,889 Warrants that are each exercisable into one Common Share.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents Common Shares issuable on conversion of the April 2024 Notes with an outstanding principal
and accrued interest amount of $3.4 million as of November 13, 2024, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
the fixed conversion price of $2.75 per share.</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a004"></span>ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Interest
rate risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s exposure to changes in market interest rates relates primarily to the Company&#8217;s earned interest income on
cash deposits and short-term investments. The Company maintains a balance between the liquidity of cash assets and the interest
rate return thereon. The carrying amount of financial assets, net of any provisions for losses, represents the Company&#8217;s
maximum exposure to credit risk.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign
currency exchange risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurs expenditures in both U.S. dollars and Canadian dollars. Canadian dollar expenditures are primarily related to certain
Common Share-related costs and corporate professional services. As a result, currency exchange fluctuations may impact the costs
of our operating activities. To reduce this risk, we maintain sufficient cash balances in Canadian dollars to fund expected near-term
expenditures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 27; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Commodity
price risk</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is exposed to commodity price risk related to the elements associated with the Elk Creek Project. A significant decrease
in the global demand for these elements may have a material adverse effect on our business. The Elk Creek Project is not in production,
and the Company does not currently hold any commodity derivative positions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a005"></span>ITEM
4. CONTROLS AND PROCEDURES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Disclosure
Controls and Procedures </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of NioCorp Developments Ltd. has evaluated, under the supervision of and with the participation of our management,
including the CEO and the Chief Financial Officer (&#8220;CFO&#8221;), the effectiveness
of the design and operations of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the
Exchange Act) as of September 30, 2024. Based on that evaluation, the CEO and the CFO have concluded that, as of September 30,
2024, our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial
reporting described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the material weaknesses in our internal control over financial reporting, our CEO and CFO have concluded that the interim condensed
consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our
financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Material
Weaknesses in Internal Control over Financial Reporting Existing as of September 30, 2024</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of NioCorp Developments Ltd. is responsible for establishing and maintaining adequate internal control over financial
reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act for the Company. Management assessed the effectiveness
of our internal control over financial reporting as of September 30, 2024. In making this assessment, our management used the
criteria set forth in the Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of
the Treadway Commission (the &#8220;COSO Framework&#8221;). Based on that evaluation, the CEO and the CFO have concluded that,
as of September 30, 2024, our internal control over financial reporting was not effective due to the material weaknesses in internal
control over financial reporting described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Material
Weaknesses </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be
prevented or detected on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
concluded that the material weaknesses disclosed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June
30, 2024, continued to exist as of September 30, 2024. Specifically, management identified deficiencies in the principles associated
with the control environment, risk assessment, control activities, and monitoring components of internal control, based on the
criteria established by the COSO Framework, that constitute material weaknesses, either individually or in the aggregate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Control
                                         Environment</span>: The Company does not have sufficient personnel with the appropriate
                                         levels of knowledge, experience, and training in accounting and internal control over
                                         financial reporting commensurate with the complexity of the Company&#8217;s financing
                                         transactions and associated reporting requirements. This material weakness contributed
                                         to additional material weaknesses further described below.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Risk
                                         Assessment</span>: The Company does not have a formal process to identify, update, and assess
                                         financial reporting risks due to changes in the Company&#8217;s business practices, including
                                         entering into increasingly complex transactions that could significantly impact the design
                                         and operation of the Company&#8217;s control activities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Control
                                         Activities</span>: Management did not maintain effective controls over:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 22.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
                                         and assessing the work of third-party specialists, including the evaluation of the appropriateness
                                         of accounting conclusions, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 28; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 22.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         evaluation of certain inputs and assumptions used to estimate the fair value of instruments
                                         and features associated with complex debt and equity transactions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Monitoring
                                         Activities</span>: Management did not appropriately:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 22.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">select,
                                         develop, and perform ongoing evaluation to ascertain whether the components of internal
                                         controls are present and functioning, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 22.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluate
                                         and communicate internal control deficiencies in a timely manner to those parties responsible
                                         for taking corrective action.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, these material weaknesses resulted in errors that required the restatement of Company&#8217;s consolidated
financial statements as of and for the fiscal years ended June 30, 2022 and 2021, as well as the restatement of the Company&#8217;s
condensed consolidated financial statements as of and for the interim periods ended September 30, 2021, December 31, 2021, March
31, 2022, September 30, 2022 and December 31, 2022. Additionally, these material weaknesses could result in a misstatement of
the account balances or disclosures that would result in a material misstatement to the annual or interim consolidated financial
statements that would not be prevented or timely detected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remediation
Plan for the Material Weaknesses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
address our material weaknesses existing as of September 30, 2024, we have implemented a detailed plan to address each individual
material weakness identified, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         have, and will continue, to engage outside accounting and internal control consultants
                                         with subject matter expertise to supplement our level of knowledge, experience, and training
                                         in accounting and internal control over financial reporting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         plan to develop a formal risk assessment process to ensure that it is robust and frequent
                                         enough for the Company&#8217;s business, including the identification of risks, the level
                                         of detail in our risk assessment, and the clarity of the linkage between risks and internal
                                         controls associated with the material weaknesses. The results of this effort are expected
                                         to enable us to effectively identify, develop, evolve and implement controls and procedures
                                         to address risks.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         plan to develop and provide incremental training to the accounting and financial reporting
                                         team regarding accounting for and valuation of complex financial instruments.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                         will develop a monitoring program to periodically evaluate and assess whether those responsible
                                         for controls are conducting their activities in accordance with their design, such that
                                         there is contemporaneous evidence that the controls are present and functioning and will
                                         communicate internal control deficiencies in a timely manner to those parties responsible
                                         for taking corrective action.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process of designing and maintaining effective internal control over financial reporting is a continuous effort that requires
management to anticipate and react to changes in our business, economic and regulatory environments and to expend significant
resources. As we continue to evaluate our internal control over financial reporting, we may take additional actions to remediate
the material weaknesses or modify the remediation actions described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we continue to devote significant time and attention to these remediation efforts, the material weaknesses will not be considered
remediated until management completes the design and implementation of the actions described above and the controls operate for
a sufficient period of time, and management has concluded, through testing, that these controls are effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in Internal Control over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as discussed above, there has been no change in our internal control over financial reporting during the quarter ended September
30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 29; Value: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a006"></span>PART&#160;II
&#8212; OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 217.7pt; text-indent: -217.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a007"></span>ITEM
1. LEGAL PROCEEDINGS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 217.7pt; text-indent: -217.7pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
know of no material, active, or pending legal proceedings against the Company, nor are we involved as a plaintiff in any material
proceeding or pending litigation. There are no proceedings in which any of our directors, officers, or affiliates, or any registered
or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a008"></span>ITEM
1A. RISK FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no changes to the risk factors set forth under the heading &#8220;Risk Factors&#8221; in the Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a009"></span>ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued and sold the following Common Shares in reliance on exemptions from the registration requirements of the Securities
Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Proceeds (000s)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares Issued</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price/Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 19, 2024<sup>(1)</sup></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">553.8</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 20%; text-align: right">258,347</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">2.1435</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 28, 2024<sup>(2)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.8700</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 3, 2024<sup>(2)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">71,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7473</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 6, 2024<sup>(2)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">71,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6534</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 16, 2024<sup>(2)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7253</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 19, 2024<sup>(2)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.7099</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 25, 2024<sup>(2)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6669</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued
    in reliance on Section 3(a)(9) of the Securities Act, in connection with the voluntary conversion of a portion of the amount
    outstanding under the Convertible Debentures and based upon representations and warranties of Yorkville in connection therewith.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued in reliance
    on Section 4(a)(2) of the Securities Act in connection with the closing of an advance under the Yorkville Equity Facility
    Financing Agreement and based upon representations and warranties of Yorkville in connection therewith.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 217.7pt; text-indent: -217.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 217.7pt; text-indent: -217.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a010"></span>ITEM
3. DEFAULTS UPON SENIOR SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a011"></span>ITEM
4. MINE SAFETY DISCLOSURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 1503(a) of the Dodd-Frank Act, issuers that are operators, or that have a subsidiary that is an operator, of a coal
or other mine in the United States are required to disclose specified information about mine health and safety in their periodic
reports. These reporting requirements are based on the safety and health requirements applicable to mines under the Federal Mine
Safety and Health Act of 1977 (the &#8220;Mine Act&#8221;) which is administered by the U.S. Department of Labor&#8217;s Mine
Safety and Health Administration (&#8220;MSHA&#8221;). During the three-month period ended September 30, 2024, the Company and
its subsidiaries and their properties or operations were not subject to regulation by MSHA under the Mine Act and thus no disclosure
is required under Section 1503(a) of the Dodd-Frank Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a012"></span>ITEM
5. OTHER INFORMATION</b></span></p>

<p style="margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>November
2024 Private Placement</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 13, 2024, the Company closed the November 2024 Private Offering with the Private Placement Investors of an aggregate
of 2,199,602 Units. Each Unit consists of one Common Share, one Series A Private Warrant to purchase one Common Share and one-half
of one Series B Private Warrant to purchase one-half of one Common Share. Each Series A Private Warrant is exercisable for one
Common Share at a price per Common Share of $1.75. The Series A Private Warrants may be exercised at any time on or after the
date of issuance and will expire on November 13, 2026. Each Series B Private Warrant is exercisable for one Common Share at a
price per Common Share of $2.07. The Series B Private Warrants may be exercised at any time beginning six months and one day from
the date of issuance and will expire on November 13, 2029.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
November Private Warrants contain provisions that prohibit the exercise if the holder, together with its affiliates, would beneficially
own more than 4.99% of the number of Common Shares outstanding immediately after giving effect to such exercise. A holder of November
Private Warrants may increase or decrease this percentage to a percentage not in excess of 9.99% by providing notice to the Company,
which increase will not be effective until at least 61 days following such notice. November Private Warrant holders will not have
the rights or privileges of a holder of Common Shares with respect to the Common Shares underlying such November Private Warrants,
including any voting rights, until the holder exercises such November Private Warrants. There is no established trading market
for any of the November Private Warrants and the Company does not expect a market to develop. In addition, the Company does not
intend to apply for the listing of any of the November Private Warrants on any national securities exchange or other trading market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<!-- Field: Page; Sequence: 30; Options: NewSection; Value: 27 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the November 2024 Private Offering, the Company entered into subscription agreements (the &#8220;Subscription
Agreements&#8221;) by and between the Company and the Private Placement Investors. The Subscription Agreements contain the terms
of the Private Placement and typical representations and warranties from the Private Placement Investors to the Company and the
Company to the Private Placement Investors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the Company&#8217;s officers and directors purchased an aggregate of 239,999 Units in the November 2024 Private Offering.
Each officer and director of the Company who purchased Units in the November 2024 Private Offering paid a purchase price of $1.7675
per unit (the &#8220;Insider Unit Price&#8221;), which is equal to the consolidated closing bid price for the Common Shares as
reported by the Nasdaq on November 1, 2024 plus $0.125 per associated November Private Warrant. The remaining investors in the
November 2024 Private Offering, who are not affiliated with the Company (but with whom the Company has a pre-existing relationship),
purchased an aggregate of 1,959,603 Units at a purchase price per Unit of $1.57, which is equal to 90% of the volume weight average
price of the Common Shares on Nasdaq for the five-day period ended November 1, 2024. Gross proceeds to the Company from the November
2024 Private Offering are expected to be approximately $3.5 million.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Subscription Agreements is qualified in its entirety by the full text of the Subscription Agreements,
a copy of which is filed as Exhibit 4.8 to this Report and is incorporated herein by reference. The foregoing descriptions of
the November Private Warrants are qualified in their entirety by the full text of the Form of Series A Private Warrant and Form
of Series B Private Warrant, copies of which are filed as Exhibits 4.9 and 4.10, respectively, to this Report and are incorporated
herein by reference.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Report does not constitute an offer to purchase, nor a solicitation of an offer to sell, the Units or any other securities. The
Units and the underlying securities have not been, and will not be, registered under the Securities Act and may not be offered
or sold in the United States absent registration or an applicable exemption from registration requirements</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Units were issued on a private offering basis to the Private Placement Investors with whom the Company had a pre-existing relationship pursuant to the exemption from the registration requirements of the Securities Act provided by Rule 506(b) of Regulation D thereunder
and Section 4(a)(2) thereof, in each case, pursuant to the representations and covenants the Private Placement Investors made
to the Company in connection with their purchase of the Units.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rule
10b5-1 Trading Arrangements </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended September 30, 2024, no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act)
of the Company adopted or terminated a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement&#8221;
(as each term is defined in Item 408 of Regulation S-K).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"></p>

<!-- Field: Page; Sequence: 31; Options: NewSection; Value: 27 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a013"></span>ITEM
6. EXHIBITS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    No.</span></td>
    <td style="width: 1%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</span></td></tr>


<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(1)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename2.htm">Notice
    of Articles dated April 5, 2016</a></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2(1)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename3.htm">Articles,
    as amended, effective as of January 27, 2015</a></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3(2)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh3-1.htm">Amendment
    to Articles, effective March 17, 2023</a></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1(3)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="https://www.sec.gov/Archives/edgar/data/1512228/000153949724001980/n2574_x219ex4-29.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    and Waiver, dated as of September 4, 2024, between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2(3)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="https://www.sec.gov/Archives/edgar/data/1512228/000153949724001980/n2574_x219ex4-30.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    and Waiver, dated as of September 4, 2024, between NioCorp Developments Ltd. and Lind Global Fund II LP</span></a></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="n2574_x224exh4-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent and Waiver,
    dated as of October 3, 2024, between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="n2574_x224exh4-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent and Waiver,
    dated as of October 3, 2024, between NioCorp Developments Ltd. and Lind Global Fund II LP</span></a></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5(4)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="https://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_1-warrantagency.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agency Agreement,
    dated as of November 5, 2024, by and between NioCorp Developments Ltd., Computershare Inc. and Computershare Trust Company, N.A.</span></a></td></tr>

    <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6(4)</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_2-seriesawarrant.htm">Form of Series A Public Warrant</a></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7(4)</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_3-seriesbwarrant.htm">Form of Series B Public Warrant</a></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x224exh4-8.htm">Form of Subscription Agreement in respect of units issued in November 2024</a></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x224exh4-9.htm">Form of Series A Private Warrant</a></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="n2574_x224exh4-10.htm">Form of Series B Private Warrant</a></span></td></tr>

<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1(5)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-1.htm">Loan
    Agreement, dated as of September 11, 2024, between NioCorp Developments Ltd. and Mark Smith.</a></span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2(5)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-2.htm">Security
    Agreement, dated as of September 11, 2024, between NioCorp Developments Ltd. and Mark Smith.</a></span></td></tr>
    <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3(4)</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 4.3pt"><a href="https://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh1_1-underwriting.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    Agreement, dated as of November 3, 2024, by and between NioCorp Developments Ltd. and Maxim Group LLC</span></a></td></tr>


<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="n2574_x224exh31-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief
    Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley
    Act of 2002</span></a></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="n2574_x224exh31-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief
    Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley
    Act of 2002</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="n2574_x224exh32-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the
    Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><a href="n2574_x224exh32-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the
    Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS(6)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance
    Document</span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH(6)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension- Schema</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL(6)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension &#8211; Calculations</span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF(6)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension &#8211; Definitions</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB(6)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension &#8211; Labels</span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE(6)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension &#8211; Presentations</span></td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive
    Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    compensation plan, arrangement, or agreement.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Draft Registration Statement on Form S-1 (Registration No. 377-01354) submitted to the
    SEC on July 26, 2016, and incorporated herein by reference.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on March 17,
    2023, and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 001-41655) filed with the SEC on September 23, 2024
    and incorporated herein by reference. </span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on November 5, 2024, and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on September 11, 2024,
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Submitted Electronically
    Herewith. Attached as Exhibit 101 to this report are the following formatted in inline XBRL (Extensible Business Reporting
    Language): (i)&#160;the Interim Condensed Consolidated Balance Sheets as of September 30, 2024 and June 30, 2024, (ii)&#160;the
    Interim Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three Months ended September 30, 2024
    and 2023, (iii)&#160;the Interim Condensed Consolidated Statements of Cash Flows for the Three Months ended September 30,
    2024 and 2023, (iv)&#160;the Interim Condensed Consolidated Statements of Shareholders&#8217; (Deficit) Equity and Redeemable
    Noncontrolling Interest &#160;for the Three Months ended September 30, 2024 and 2023 and (v)&#160;the Notes to the Interim
    Condensed Consolidated Financial Statements.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 32; Value: 27 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a014"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NIOCORP
DEVELOPMENTS LTD.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Registrant)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: &#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Mark A. Smith</span></td>
    <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Executive Officer and<br/>
    Executive Chairman</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November 13, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Neal
    Shah</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November 13, 2024</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 33; Value: 27 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->

<p style="margin: 0"></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>n2574_x224exh4-3.htm
<DESCRIPTION>CONSENT AND WAIVER
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Exhibit 4.3<U></U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right"><U></U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><U>CONSENT AND WAIVER</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>THIS CONSENT AND WAIVER </B>(this &#8220;<U>Consent and Waiver</U>&#8221;), dated as of October 3, 2024 to the Note (as defined below) is between <B>NIOCORP DEVELOPMENTS LTD.</B>, a company organized under the laws of the Province of British Columbia, Canada, with principal executive offices located at 7000 South Yosemite Street, Suite 115, Centennial, Colorado 80112 (the &#8220;<U>Company</U>&#8221;),
and <B>YA II PN, LTD.</B>, a Cayman Islands exempt limited partnership (the &#8220;<U>Holder</U>&#8221;). Capitalized terms used herein and not otherwise defined have the meanings set forth for such terms in the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, reference is made to that certain Unsecured Convertible Note, dated as of April 12, 2024 (the &#8220;<U>Note</U>&#8221;), between the Company and the Holder, as modified by the Consent and Waiver, dated September 4, 2024, between the Company and the Holder (the &#8220;<U>September Consent</U>&#8221;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Note was originally issued pursuant to the Securities Purchase Agreement, dated April 11, 2024, between the Company, the Holder and Lind Global Fund II LP;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant to Section (1)(a) of the Note, the term &#8220;Maturity Date&#8221; means December 31, 2024 (the &#8220;<U>Original Maturity Date</U>&#8221;), or such other date as mutually agreed by the parties;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company and the Holder desire to modify the meaning of &#8220;Maturity Date&#8221; from the Original Maturity Date to January 31, 2025 (the &#8220;<U>New Maturity Date</U>&#8221;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant to Section (1)(c) of the Note, any Payment Date and the amount payable to the Holder on any such Payment Date may be modified from time to time upon the mutual written consent of the Company and the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant to the terms of the Note (as unmodified), the Company is obligated to make payment of $1,285,200 (the &#8220;<U>October Payment Amount</U>&#8221;) in respect of the Payment Date on October 1, 2024 (the &#8220;<U>October Payment Date</U>&#8221;) because the Equity Conditions have not been satisfied as of the last Trading Date prior to the October Payment Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company and the Holder desire to modify the Company&#8217;s payment obligation with respect of the October Payment Date by decreasing the amount payable on the October Payment Date and deferring the due date of the remainder of the October Payment Amount until January 1, 2025 (the &#8220;<U>January Payment Date</U>&#8221;) as set forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company and the Holder desire to modify the maximum Offset Amount in respect of the January Payment Date as set forth herein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Holder desires to prospectively waive any term in the Note that would otherwise be triggered upon a failure to pay to the Holder the full October Payment Amount on the October Payment Date, including, but not limited to, (i) the occurrence of an Event of Default under Section (2)(a)(i) of the Note (the &#8220;<U>Event of Default Provision</U>&#8221;), (ii) an increase
to the Interest Rate pursuant to Section (1)(b) of the Note (the &#8220;<U>Interest Rate Provision</U>&#8221;) and (iii) the Holder&#8217;s</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">right to accelerate, at the Holder&#8217;s election, all amounts owing in respect of the Note pursuant to Section (2)(b) of the Note (the &#8220;<U>Acceleration Provision</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Holder hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Pursuant to Section (1)(a) of the Note, the Company and the Holder hereby consent to the modification of the meaning of &#8220;Maturity Date&#8221; from the Original Maturity Date to the New Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Pursuant to Section (1)(c) of the Note, the Company and the Holder hereby consent to the modification of Company&#8217;s payment obligation in respect of the October Payment Date as follows: (i) the amount payable on the October Payment Date is $285,200; and (ii) the remainder
of the October Payment Amount, equal to $1,000,000, will be due and payable on January 1, 2025, which will be due and payable on such date in addition to any payment of Amortization Principal Amount, plus the Payment Premium in respect of such Amortization Principal Amount, plus accrued and unpaid Interest under the Note, if any, as of the Payment Date on January 1, 2025, that the Company may be obligated to make in respect of such Payment Date on January 1, 2025 pursuant to the terms of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The Company and the Holder hereby consent that in respect of the January Payment Date the Offset Amount shall not exceed $2,512,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The Holder hereby prospectively waives any term in the Note that would otherwise be triggered upon a failure to pay to the Holder the remainder of the October Payment Amount, equal to $1,000,000, on the October Payment Date, including, but not limited to, (i) the Event of Default
Provision, (ii) the Interest Rate Provision and (iii) the Acceleration Provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Except as described in Sections 1, 2, 3 and 4 of this Consent and Waiver, the terms of the Note as modified by the September Consent, attached hereto as <U>Exhibit A-1</U> and <U>A-2</U>, respectively, are unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>This Consent and Waiver may be executed in two or more counterparts, each of which shall for all purposes be deemed to be an original and all of which shall constitute the same document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: center; text-indent: -0.05pt"><I>[remainder of page intentionally left blank]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: center; text-indent: -0.05pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: center; text-indent: -0.05pt"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Holder and the Company have caused their respective signature page to this Consent and Waiver to be duly executed as of the date first written above.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">COMPANY:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: left">NIOCORP DEVELOPMENTS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt; width: 45%">/s/ Mark A. Smith</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="text-align: left">Mark A. Smith</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="text-align: left">NioCorp President &amp; CEO</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signature Page to Consent and Waiver to the Unsecured Convertible Note]</I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B></B></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold">HOLDER:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: left">YA II PN, LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2">Yorkville Advisors Global, LP</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Its:</TD>
    <TD COLSPAN="2">Investment Manager</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="text-align: left; width: 40%">Yorkville Advisors Global II, LLC</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Its:</TD>
    <TD STYLE="text-align: left">General Partner</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">/s/ Michael Rosselli</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="text-align: left">Michael Rosselli</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Partner</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signature Page to Consent and Waiver to the Unsecured Convertible Note]</I></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><B>Exhibit A-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><U>Yorkville Note</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><U></U>&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><B>Exhibit A-2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><U>September Consent</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>n2574_x224exh4-4.htm
<DESCRIPTION>CONSENT AND WAIVER
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Exhibit 4.4</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><U>CONSENT AND WAIVER</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>THIS CONSENT AND WAIVER </B>(this &#8220;<U>Consent and Waiver</U>&#8221;), dated as of October 3, 2024 to the Note (as defined below) is between <B>NIOCORP DEVELOPMENTS LTD.</B>, a company organized under the laws of the Province of British Columbia, Canada, with principal executive offices located at 7000 South Yosemite Street, Suite 115, Centennial, Colorado 80112 (the &#8220;<U>Company</U>&#8221;),
and <B>LIND GLOBAL FUND II LP</B>, a Delaware limited partnership (the &#8220;<U>Holder</U>&#8221;). Capitalized terms used herein and not otherwise defined have the meanings set forth for such terms in the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, reference is made to that certain Unsecured Convertible Note, dated as of April 12, 2024 (the &#8220;<U>Note</U>&#8221;), between the Company and the Holder, as modified by the Consent and Waiver, dated September 4, 2024, between the Company and the Holder (the &#8220;<U>September Consent</U>&#8221;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Note was originally issued pursuant to the Securities Purchase Agreement, dated April 11, 2024, between the Company, the Holder and YA II PN, Ltd.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant to Section (1)(a) of the Note, the term &#8220;Maturity Date&#8221; means December 31, 2024 (the &#8220;<U>Original Maturity Date</U>&#8221;), or such other date as mutually agreed by the parties;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company and the Holder desire to modify the meaning of &#8220;Maturity Date&#8221; from the Original Maturity Date to January 31, 2025 (the &#8220;<U>New Maturity Date</U>&#8221;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant to Section (1)(c) of the Note, any Payment Date and the amount payable to the Holder on any such Payment Date may be modified from time to time upon the mutual written consent of the Company and the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, pursuant to the terms of the Note (as unmodified), the Company is obligated to make payment of $226,800 (the &#8220;<U>October Payment Amount</U>&#8221;) in respect of the Payment Date on October 1, 2024 (the &#8220;<U>October Payment Date</U>&#8221;) because the Equity Conditions have not been satisfied as of the last Trading Date prior to the October Payment Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company and the Holder desire to modify the Company&#8217;s payment obligation with respect of the October Payment Date by decreasing the amount payable on the October Payment Date and deferring the due date of the remainder of the October Payment Amount until January 1, 2025 (the &#8220;<U>January Payment Date</U>&#8221;) as set forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company and the Holder desire to modify the maximum Offset Amount in respect of the January Payment Date as set forth herein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Holder desires to prospectively waive any term in the Note that would otherwise be triggered upon a failure to pay to the Holder the full October Payment Amount on the October Payment Date, including, but not limited to, (i) the occurrence of an Event of Default under Section (2)(a)(i) of the Note (the &#8220;<U>Event of Default Provision</U>&#8221;), (ii) an increase
to the Interest Rate pursuant to Section (1)(b) of the Note (the &#8220;<U>Interest Rate Provision</U>&#8221;) and (iii) the Holder&#8217;s</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">right to accelerate, at the Holder&#8217;s election, all amounts owing in respect of the Note pursuant to Section (2)(b) of the Note (the &#8220;<U>Acceleration Provision</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Holder hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Pursuant to Section (1)(a) of the Note, the Company and the Holder hereby consent to the modification of the meaning of &#8220;Maturity Date&#8221; from the Original Maturity Date to the New Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Pursuant to Section (1)(c) of the Note, the Company and the Holder hereby consent to the modification of Company&#8217;s payment obligation in respect of the October Payment Date as follows: (i) the amount payable on the October Payment Date is $50,324; and (ii) the remainder
of the October Payment Amount, equal to $176,476, will be due and payable on January 1, 2025, which will be due and payable on such date in addition to any payment of Amortization Principal Amount, plus the Payment Premium in respect of such Amortization Principal Amount, plus accrued and unpaid Interest under the Note, if any, as of the Payment Date on January 1, 2025, that the Company may be obligated to make in respect of such Payment Date on January 1, 2025 pursuant to the terms of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The Company and the Holder hereby consent that in respect of the January Payment Date the Offset Amount shall not exceed $2,512,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The Holder hereby prospectively waives any term in the Note that would otherwise be triggered upon a failure to pay to the Holder the remainder of the October Payment Amount, equal to $176,476, on the October Payment Date, including, but not limited to, (i) the Event of Default
Provision, (ii) the Interest Rate Provision and (iii) the Acceleration Provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Except as described in Sections 1, 2, 3 and 4 of this Consent and Waiver, the terms of the Note as modified by the September Consent, attached hereto as <U>Exhibit A-1</U> and <U>A-2</U>, respectively, are unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.75in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>This Consent and Waiver may be executed in two or more counterparts, each of which shall for all purposes be deemed to be an original and all of which shall constitute the same document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: center; text-indent: -0.05pt"><I>[remainder of page intentionally left blank]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: center; text-indent: -0.05pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: center; text-indent: -0.05pt"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Holder and the Company have caused their respective signature page to this Consent and Waiver to be duly executed as of the date first written above.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">COMPANY:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: left">NIOCORP DEVELOPMENTS LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt; width: 45%">/s/ Mark A. Smith</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="text-align: left">Mark A. Smith</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="text-align: left">NioCorp President &amp; CEO</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signature Page to Consent and Waiver to the Unsecured Convertible Note]</I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0in"><B></B></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold">HOLDER:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: left">LIND GLOBAL FUND II LP</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2">Lind Global Partners II LLC</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Its:</TD>
    <TD COLSPAN="2">General Partner</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt; width: 40%">/s/ Jeff Easton</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="text-align: left">Jeff Easton</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="text-align: left">Managing Director</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signature Page to Consent and Waiver to the Unsecured Convertible Note]</I></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><B>Exhibit A-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><U>Lind Note</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><B>Exhibit A-2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><U>September Consent</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>4
<FILENAME>n2574_x224exh4-8.htm
<DESCRIPTION>FORM OF SUBSCRIPTION AGREEMENT IN RESPECT OF UNITS ISSUED IN NOVEMBER 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 4.8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES TO WHICH THIS SUBSCRIPTION AGREEMENT RELATES AND THE SECURITIES ISSUABLE UPON EXERCISE THEREOF HAVE NOT BEEN AND WILL
NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;1933 ACT&rdquo;) OR ANY APPLICABLE STATE
SECURITIES LAWS IN THE UNITED STATES AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES (AS SUCH TERM IS DEFINED
IN REGULATION S UNDER THE 1933 ACT) OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, A U.S. PERSON (AS DEFINED IN REGULATION S OF THE
1933 ACT), EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION REQUIREMENTS OF THE 1933 ACT, AND IN ACCORDANCE WITH ANY APPLICABLE STATE
SECURITIES LAWS. HEDGING TRANSACTIONS INVOLVING THE SECURITIES ARE PROHIBITED EXCEPT IN COMPLIANCE WITH THE 1933 ACT. THIS SUBSCRIPTION
AGREEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY OF THE SECURITIES OFFERED HEREBY WITHIN
THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT IN THE LIMITED CIRCUMSTANCES PROVIDED HEREIN PURSUANT
TO TRANSACTIONS EXEMPT FROM REGISTRATION UNDER THE 1933 ACT AND ANY APPLICABLE STATE SECURITIES LAWS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NIOCORP
DEVELOPMENTS LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNIT
SUBSCRIPTION AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NIOCORP
DEVELOPMENTS LTD. (the &ldquo;Issuer&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned (hereinafter referred to as the &ldquo;<B>Subscriber</B>&rdquo;) hereby irrevocably subscribes for and agrees to purchase
from the Issuer the number of units of the Issuer (the &ldquo;<B>Units</B>&rdquo;) set forth below for the aggregate subscription
price set forth below (the &ldquo;<B>Subscription Price</B>&rdquo;), representing a subscription price of US$[1.57][1.7675] per
Unit, upon and subject to the terms and conditions, and the covenants, representations and warranties set forth in this Subscription
Agreement (as defined below), including the attached &ldquo;Terms and Conditions of Subscription&rdquo; (including, without limitation,
the representations, warranties and covenants set forth in the schedules attached hereto). Each Unit is comprised of (i) one common
share in the capital of the Issuer (a &ldquo;<B>Unit Share</B>&rdquo;), (ii) one Series A common share purchase warrant of the
Issuer (a &ldquo;<B>Series A Warrant</B>&rdquo;) and (iii) one-half of one Series B common share purchase warrant of the Issuer
(each whole such Series B common share purchase warrant, a &ldquo;<B>Series B Warrant</B>&rdquo;). Each Series A Warrant will
entitle the holder to acquire one additional common share in the capital of the Issuer (a &ldquo;<B>Series A Warrant Share</B>&rdquo;),
exercisable at any time during a period 24 months following the Closing (as defined below) at an exercise price of US$1.75 per
Series A Warrant Share. Each Series B Warrant will entitle the holder to acquire one additional common share in the capital of
the Issuer (a &ldquo;<B>Series B Warrant Share</B>&rdquo;), exercisable at any time during a period beginning on the date that
is six (6) months and one (1) day following the Closing until 60 months following the Closing at an exercise price of US$2.07
per Series B Warrant Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBSCRIPTION
AND SUBSCRIBER INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
print all information (other than signatures), as applicable, in the space provided below.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Amount
        of Subscription</U></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        Number of Units: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U> x</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">US$[1.57][1.7675]</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
        Subscription Price: US$_________________<BR>
        <BR></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="7" STYLE="width: 48%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Beneficial
        Owner of Subscriber</U></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
        the Subscriber is not an individual, the Subscriber represents and warrants that it <B>has &#9744; / does not have &#9744;
        (check one)</B> a Beneficial Owner (as defined in the Terms and Conditions of Subscription) and, if it has a Beneficial
        Owner, the name and address of the Beneficial Owner is as follows:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        </FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Name of Beneficial Owner</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        </FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Residential Address of Beneficial Owner</I></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD ROWSPAN="7" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Subscriber&rsquo;s
        Information and Signature</U></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 3in"><BR></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 3in"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Name
        of Subscriber &ndash; please print</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3in"><BR></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3in"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
        (of individual or authorized signatory)</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3in"><BR>
</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Official
Capacity or Title (of authorized signatory, if applicable)</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Please
        print name of individual whose signature appears above if different than the name of the Subscriber printed above.</I><BR>
        <BR>
        </FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Subscriber&rsquo;s
        Residential Address</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 3in"><BR></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 3in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Subscriber&rsquo;s
        Telephone Number</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt; border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Principal
        Information</U></B><BR>
        <BR>
        </FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
        the Subscriber is signing as an agent for a principal and is not deemed to be purchasing as principal as set out below,
        the Subscriber hereby represents and warrants that the name and residential address of such principal is as follows:</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 4in"><BR>
</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Name of Principal</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Principal&rsquo;s Residential Address</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Registration
        Instructions</U></B> (if different from the Subscriber&rsquo;s name and address given under Subscriber&rsquo;s Information):</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3in"><BR>
</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Name</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Account reference, if applicable</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><BR>
</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Address (including postal code)</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Telephone
        Number and Contact Name</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt; padding-top: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Delivery
        Instructions</U></B> (if different from the Subscriber&rsquo;s name and address given under Subscriber&rsquo;s Information):</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"><BR></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Name</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><BR>
        <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I><U></U></I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I><U></U></I><BR>
        </FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Account reference, if applicable</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"><BR></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Address (including postal code)</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"><BR></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 3.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Telephone
Number and Contact Name</I></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Present
Ownership of Securities</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber either <B>[check appropriate box]</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="2" STYLE="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
    not currently own directly or indirectly, or exercise control or direction over, any common shares in the capital of the Issuer
    or securities convertible into common shares in the capital of the Issuer; or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">owns
        directly or indirectly, or exercises control or direction over, __________ common shares in the capital of the Issuer,
        and convertible securities (including unexpired warrants) entitling the Subscriber to acquire an additional __________
        common shares in the capital of the Issuer.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Insider
Status</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber either <B>[check appropriate box]</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    an &ldquo;Insider&rdquo; of the Issuer as defined in the <I>Securities Act</I> (British Columbia); or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    not an Insider of the Issuer.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Registrant
Status</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber either <B>[check appropriate box]</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    a &ldquo;Registrant&rdquo; as defined in the <I>Securities Act</I> (British Columbia); or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    not a &ldquo;Registrant&rdquo;.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>U.S.
Purchaser Status</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
The Subscriber either <B>[check appropriate box]</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    a &ldquo;U.S. Purchaser&rdquo; as defined in the Terms and Conditions below; or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
    not a &ldquo;U.S. Purchaser&rdquo;.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCEPTANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer hereby accepts the subscription as set forth above on the terms and conditions contained in this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED
as of ___________________, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NIOCORP
    DEVELOPMENTS LTD.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; width: 3%"><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; width: 47%; border-bottom: Black 1pt solid"><BR></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorized Signatory</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NIOCORP
DEVELOPMENTS LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBSCRIPTION
FOR UNITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INSTRUCTIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To
properly complete this Subscription Agreement, you must:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete
and execute pages ii and iii.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete
                                         and execute <U>Schedule B</U> &ndash; Accredited Investor Status Certificate (Canada).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete
                                         and execute <U>Schedule C</U> &ndash; Accredited Investor Status Certificate (U.S.).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Procedure
and Delivery:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
signed Subscription Agreement, including all required schedules, should be filled out, signed and delivered with payment by no
later than 5:00 p.m. <FONT STYLE="color: Black">(Vancouver time) on Tuesday, November 5, 2024 (or such other time, date or place
as the Subscriber may be advised) to:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7000
South Yosemite Street, Suite 115&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Centennial,
CO 80112&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Neal Shah&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[***]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
for the Subscription Price should be made by a certified cheque, bank draft, money order, or confirmation of wire transfer for
the subscription funds in United States dollars made payable to &ldquo;NioCorp Developments Ltd.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
AND CONDITIONS OF SUBSCRIPTION</B><BR>
<BR>
<B>UNITS OF NIOCORP DEVELOPMENTS LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions
and Interpretation</FONT></TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Subscription Agreement, unless the context required otherwise:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>1933
                                         Act</B>&rdquo; means the United States Securities Act of 1933, as amended;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>B.C.
                                         Act</B>&rdquo; means the <I>Securities Act</I> (British Columbia), the regulations and
                                         rules made thereunder and all administrative policy statements, blanket orders, notices,
                                         directions and rulings issued or adopted by the British Columbia Securities Commission,
                                         all as amended;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Business
                                         Day</B>&rdquo; means a day other than a Saturday, Sunday or a holiday on which principal
                                         chartered banks located in Vancouver, British Columbia are not open for business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing</B>&rdquo;
                                         has the meaning set forth in section 5;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
                                         Date</B>&rdquo; means the date or dates of completion of the sale of Units under the
                                         Offering as may be determined by the Issuer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Closing
                                         Time</B>&rdquo; means 5:00 a.m. (Vancouver time), or such other time as may be determined
                                         by the Issuer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disclosed
                                         Principal</B>&rdquo; means a purchaser that is purchasing the Subscriber&rsquo;s Units
                                         through an agent or trustee for beneficial principal(s);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>International
                                         Jurisdiction</B>&rdquo; has the meaning set forth in section 9(l);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Insider</B>&rdquo;
                                         has the meaning set forth in section 1(1) of the B.C. Act;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer</B>&rdquo;
                                         means NioCorp Developments Ltd.;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>NI
                                         45-106</B>&rdquo; means National Instrument 45-106 <I>Prospectus Exemptions</I> published
                                         by the Canadian Securities Administrators;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Offering</B>&rdquo;
                                         has the meaning set forth in section 3(a);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Nasdaq</B>&rdquo;
                                         means The Nasdaq Stock Market LLC;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Parties</B>&rdquo;
                                         means collectively, the Subscriber and the Issuer and &ldquo;<B>Party</B>&rdquo; means
                                         any one of them, as the context requires;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>person</B>&rdquo;
                                         means any individual (whether acting as an executor, trustee, administrator, legal representative
                                         or otherwise), corporation, firm, partnership, sole proprietorship, syndicate, joint
                                         venture, trustee, trust, fund, unincorporated organization or association and every other
                                         form of legal or business entity of whatsoever nature or kind, and pronouns have a similar
                                         extended meaning;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Personal
                                         Information</B>&rdquo; means any information about a person (whether individual or otherwise)
                                         and includes information contained in this Subscription Agreement, including the Schedules
                                         incorporated by reference herein;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Regulatory
                                         Authorities</B>&rdquo; has the meaning set forth in section 6;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xviii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities</B>&rdquo;
                                         means, collectively, the Unit Shares, the Warrants and the Warrant Shares;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
                                         Laws</B>&rdquo; means the applicable Canadian provincial securities laws and United States
                                         federal and state securities laws and all applicable rules, regulations, notices and
                                         policies promulgated or published thereunder together with all applicable and legally
                                         enforceable published policy statements, policies, rules, blanket orders, rulings and
                                         notice of applicable securities regulatory authorities, as well as the published policies
                                         and rules of Nasdaq;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Series
                                         A Warrant</B>&rdquo; has the meaning set forth on the face page of this Subscription
                                         Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Series
                                         A Warrant Share</B>&rdquo; has the meaning set forth on the face page of this Subscription
                                         Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Series
                                         B Warrant</B>&rdquo; has the meaning set forth on the face page of this Subscription
                                         Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxiii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Series
                                         B Warrant Share</B>&rdquo; has the meaning set forth on the face page of this Subscription
                                         Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxiv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subscriber</B>&rdquo;
                                         means the subscriber for Units as set out on the face page of this Subscription Agreement
                                         and includes, as applicable, the Disclosed Principal unless the context otherwise requires;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subscriber&rsquo;s
                                         Units</B>&rdquo; means those Units that the Subscriber has agreed to purchase under this
                                         Subscription Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxvi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subscription
                                         Agreement</B>&rdquo; or &ldquo;<B>Agreement</B>&rdquo; means this subscription agreement
                                         (including the schedules hereto) and any instrument amending this Subscription Agreement;
                                         &ldquo;hereof&rdquo;, &ldquo;hereto&rdquo;, &ldquo;hereunder&rdquo;, &ldquo;herein&rdquo;
                                         and similar expressions mean and refer to this Subscription Agreement and not to a particular
                                         section or clause; and the expression &ldquo;section&rdquo; or &ldquo;clause&rdquo; followed
                                         by a number or letter means and refers to the specified section or clause of this Subscription
                                         Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxvii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subscription
                                         Price</B>&rdquo; has the meaning set forth on the face page of this Subscription Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxviii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Unit</B>&rdquo;
                                         has the meaning set forth on the face page of this Subscription Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Unit
                                         Share</B>&rdquo; has the meaning set forth on the face page of this Subscription Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxx)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>United
                                         States</B>&rdquo; means the United States of America, its territories and possessions,
                                         any State of the United States and the District of Columbia;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxxi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>U.S.
                                         Person</B>&rdquo; has the meaning set forth in Rule 902(k) of Regulation S promulgated
                                         under the 1933 Act;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxxii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>U.S.
                                         Purchaser</B>&rdquo; is (a) any U.S Person, (b) any person purchasing securities for
                                         the account or benefit of any U.S. Person or person in the United States, (c) any person
                                         who receives or received an offer to acquire the Securities while in the United States,
                                         and (d) any person who is, or whose authorized signatory is, in the United States at
                                         the time such person&rsquo;s buy order was made or this Subscription Agreement was executed
                                         or delivered;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxxiii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>U.S.
                                         SEC</B>&rdquo; means the United States Securities and Exchange Commission.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxxiv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrants</B>&rdquo;
                                         means, together, the Series A Warrants and the Series B Warrants; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxxv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Warrant
                                         Shares</B>&rdquo; means, together, the Series A Warrant Shares and the Series B Warrant
                                         Shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time
                                         is of the essence of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Agreement is to be read with all changes in gender or number as required by the context.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         headings in this Agreement are for convenience of reference only and do not affect the
                                         interpretation of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                         this Agreement, unless otherwise stated, all references to &ldquo;$&rdquo; and &ldquo;US$&rdquo;
                                         are references to United States dollars.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
                                         for Units</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Subscriber hereby confirms its irrevocable subscription for the Units from the Issuer,
                                         on and subject to the terms and conditions set out in this Subscription Agreement, for
                                         the Subscription Price which is payable as described herein. The Subscriber acknowledges
                                         (on its own behalf and including, if applicable, on behalf of each Disclosed Principal)
                                         that upon acceptance by the Issuer of this Subscription Agreement, the Subscription Agreement
                                         will constitute a binding obligation of the Subscriber (including if applicable, each
                                         Disclosed Principal), subject to the terms and subject to the conditions set out in this
                                         Subscription Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Unit Shares and Warrants comprising the Units will be issued and registered in the name
                                         of the Subscriber as per the instructions on the face page of this Subscription Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Offering</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Subscriber acknowledges that this subscription may form part of a larger private placement
                                         offering (the &ldquo;<B>Offering</B>&rdquo;) by the Issuer of up to approximately 2,404,903
                                         Units at a price of US$1.7675 per Unit for officers, directors, employees and consultants
                                         of the Issuer and of US$1.57 per Unit for persons other than officers, directors, employees
                                         and consultants of the Issuer, for aggregate gross proceeds of up to approximately US$3,816,555,
                                         and that the Issuer may increase the size of the Offering in the sole discretion of the
                                         Issuer&rsquo;s board of directors.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Offering is not, and under no circumstance is to be construed as, a public offering of
                                         the Securities. The Offering is not being made, and this subscription does not constitute
                                         an offer to sell or the solicitation of an offer to buy the Units in any jurisdiction
                                         where, or to any person whom, it is unlawful to make such an offer or solicitation.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Subscriber further understands that there is no minimum number of Units that must be
                                         sold pursuant to the Offering and accordingly, the Subscriber may be the sole purchaser
                                         of Units.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Subscriber acknowledges that no fractional Warrants will be issuable under the Offering
                                         and any fractional entitlements will be rounded down to the nearest whole Warrant. As
                                         a result, the Subscriber should purchase only an even number of Units in this Offering
                                         or will otherwise have the amount of associated Series B Warrants rounded down.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Subscriber acknowledges that certain directors and officers of the Issuer have indicated
                                         an interest in purchasing an aggregate of approximately US$350,000 worth of Units in
                                         the Offering at a price of US$1.7675 per Unit. However, such directors and officers are
                                         not obligated to purchase any Units and may determine to purchase fewer or more Units
                                         than they indicated an interest in purchasing. In addition, since no preference shall
                                         be granted to such directors and officers or their affiliates, the Issuer could determine
                                         to sell to such directors and officers or their affiliates fewer Units than they indicated
                                         an interest in purchasing.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Partial
Acceptance or Rejection of Subscription</FONT></TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer may, in its absolute discretion, accept or reject the Subscriber&rsquo;s subscription for Units as set forth in this Subscription
Agreement, in whole or in part, and the Issuer reserves the right to allot to the Subscriber less than the amount of Units subscribed
for under this Subscription Agreement. The Subscriber acknowledges and agrees that the acceptance of this Subscription Agreement
will be conditional upon, among other things, the sale of the Units to the Subscriber being exempt from any prospectus and offering
memorandum requirements of applicable Securities Laws and the equivalent provisions of securities laws of any other applicable
jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Subscription Agreement is rejected in whole, any certified cheque, money order, bank draft or other forms of payment delivered
to the Issuer by the Subscriber on account of the Subscription Price for the Units subscribed for will be promptly returned by
the Issuer to the Subscriber without interest. If this Subscription Agreement is accepted only in part, payment representing the
amount by which the payment delivered by the Subscriber to the Issuer exceeds the Subscription Price of the number of Units sold
to the Subscriber pursuant to a partial acceptance of this Subscription Agreement will be promptly delivered by the Issuer to
the Subscriber without interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
and sale of the Units and payment of the Subscription Price will be completed (the &ldquo;<B>Closing</B>&rdquo;) at the offices
of Blake Cassels &amp; Graydon LLP, 1133 Melville, Suite 3500, The Stack, Vancouver, British Columbia V6E 4E5 at the Closing Time
or at such other place and time as the Issuer may elect on such date or dates to be determined by the Issuer. Closing of the Offering
will only occur if, prior to the Closing Time, the terms and conditions contained in this Subscription Agreement have been complied
with to the satisfaction of the Issuer, or waived by the Issuer, including receipt by the Issuer of all completed Subscription
Agreements and payment of the Subscription Price for all of the Units sold pursuant to the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
prior to the Closing Time, the terms and conditions contained in this Subscription Agreement (other than delivery by the Issuer
to the Subscriber of certificates representing the Unit Shares and Warrants comprising the Units) have not been</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">complied with
to the satisfaction of the Issuer, or waived by the Issuer, the Issuer and the Subscriber will have no further obligations under
this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber acknowledges that the Offering may be completed at one or more partial closings in the discretion of the Issuer and
that the Closing as contemplated in this Subscription Agreement may be effected at one or more of such partial closings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions
                                         of Closing</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Subscription Agreement shall be subject to acceptance by the Issuer and approval, as applicable, by Nasdaq and any other stock
exchange or regulatory authority having jurisdiction with respect to the Issuer (collectively, the &ldquo;<B>Regulatory Authorities</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber acknowledges and agrees that the obligations of the Issuer hereunder are conditional on the accuracy of the representations
and warranties of the Subscriber contained in this Subscription Agreement and in the term sheet appended as Schedule A as of the
date of this Subscription Agreement, and as of the Closing Time as if made at and as of the Closing Time, and the fulfillment
of the following additional conditions as soon as possible and in any event not later than the Closing Time:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber having properly completed, signed and delivered this Subscription Agreement
                                         (with payment) <B><U>by no later than 5:00 p.m. (Vancouver time) on Tuesday, November
                                         5, 2024, to</U></B>:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd.<BR>
7000 South Yosemite Street, Suite 115<BR>
Centennial, CO 80112</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Neal Shah<BR>
Email: [***]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber having properly completed, signed and delivered the Accredited Investor Status
                                         Certificate (Canada) attached as Schedule B hereto and the Accredited Investor Status
                                         Certificate (U.S.) attached as Schedule C hereto;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer having accepted this Subscription Agreement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                         necessary regulatory and conditional approvals from or filings with the applicable Regulatory
                                         Authorities having been obtained or made by the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment
                                         having been made by the Subscriber of the Subscription Price as set out above under the
                                         heading &ldquo;Procedure and Delivery&rdquo; on page vi of this Subscription Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorization
                                         of the Issuer</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber irrevocably authorizes the Issuer, in its discretion, to act as the Subscriber&rsquo;s representative at the Closing,
and hereby appoints the Issuer, with full power of substitution, as its true and lawful attorney with full power and authority
in the Subscriber&rsquo;s place and stead:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         receive certificates representing the Unit Shares and Warrants comprising the Units,
                                         to execute in the Subscriber&rsquo;s name and on its behalf all closing receipts and
                                         required documents, to complete and correct any errors or omissions in any form or document
                                         provided by the Subscriber in connection with the subscription for the Units and to approve
                                         any opinion, certificate or other document addressed to the Subscriber; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                         terminate this Subscription Agreement if any condition precedent is not satisfied, in
                                         such manner and on such terms and conditions as Issuer in their sole discretion may determine.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
power of attorney is irrevocable, is coupled with an interest and has been given for valuable consideration, the receipt and adequacy
of which are acknowledged. This power of attorney and other rights and privileges granted under this section will survive any
legal or mental incapacity, dissolution, bankruptcy or death of the Subscriber (including any Disclosed Principal). This power
of attorney extends to the heirs, executors, administrators, other legal representatives and successors, transferees and assigns
of the Subscriber (including any Disclosed Principal). Any person dealing with the Issuer may conclusively presume and rely upon
the fact that any document, instrument or agreement executed by the Issuer pursuant to this power of attorney is authorized and
binding on the Subscriber (including any Disclosed Principal), without further inquiry. The Subscriber (including any Disclosed
Principal) agrees to be bound by any representations or actions made or taken by the Issuer pursuant to this power of attorney,
and waives any and all defences that may be available to contest, negate or disaffirm any action of the Issuer taken in good faith
under this power of attorney.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">8.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations,
                                         Warranties and Covenants of the Issuer</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer hereby represents and warrants to, and covenants with, the Subscriber as follows and acknowledges that the Subscriber is
relying on such acknowledgements, representations, warranties and covenants in connection with the transactions contemplated herein:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer is a valid and subsisting corporation incorporated and in good standing under
                                         the laws of British Columbia;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer is duly registered and licensed to carry on business in the jurisdictions in which
                                         it carries on business or owns property where required under the laws of that jurisdiction;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                         Subscription Agreement has been or will be by the Closing, duly authorized by all necessary
                                         corporate action on the part of the Issuer, and the Issuer has or will have by the Closing
                                         full corporate power and authority to undertake the Offering;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         common shares of the Issuer are, and will continue to be as of the Closing Date, listed
                                         and posted for trading on Nasdaq;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer will apply to and use commercially reasonable efforts to obtain the listing of
                                         the Unit Shares and Warrant Shares issuable under the Offering on Nasdaq, if and when
                                         such Shares are eligible to be listed on Nasdaq;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer has complied, or will comply, with all applicable corporate and securities laws
                                         and regulations in connection with the offer, sale and issuance of the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         order has been issued and is persisting ceasing or suspending trading in the securities
                                         of the Issuer or prohibiting sale of its securities by the directors, officers or promoters
                                         of the Issuer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer is a &ldquo;reporting issuer&rdquo; in the Provinces of British Columbia, Alberta,
                                         Saskatchewan, Ontario and New Brunswick and is not included on the list of defaulting
                                         reporting issuers issued by the securities regulators in those jurisdictions;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                         their issuance on the Closing Date, the Unit Shares will be validly issued and outstanding
                                         as fully paid and non-assessable common shares in the capital of the Issuer and the Warrants
                                         will be validly issued and the certificates representing such Unit Shares and Warrants
                                         will be validly delivered;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                         exercise of the Warrants in accordance with their respective terms, the Warrant Shares
                                         will be validly issued and outstanding as fully paid and non-assessable common shares
                                         in the capital of the Issuer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         will reserve or set aside sufficient shares in its treasury to issue the Unit Shares
                                         and Warrant Shares;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                         than with respect to the Offering, there is no &ldquo;material fact&rdquo; or &ldquo;material
                                         change&rdquo; (as those terms are defined in applicable Securities Laws) in the affairs
                                         of the Issuer that has not been generally disclosed to the public; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                         Subscription Agreement constitutes a binding and enforceable obligation of the Issuer,
                                         enforceable in accordance with its terms.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">9.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations,
                                         Warranties, Covenants and Acknowledgements of the Subscriber</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
executing this Subscription Agreement, the Subscriber (on its own behalf and, including if applicable, on behalf of each Disclosed
Principal) represents, warrants, covenants and acknowledges to and with the Issuer (and acknowledges that the Issuer is relying
thereon) that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorization
and Effectiveness</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Subscriber is an individual, the Subscriber is of the full age of majority in the
                                         jurisdiction in which this Subscription Agreement is executed and is legally competent
                                         to execute, deliver and be bound by this Subscription Agreement, to perform all of its
                                         obligations hereunder and to undertake all actions required of the Subscriber hereunder;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Subscriber is a corporation, the Subscriber is a valid and subsisting corporation,
                                         has the necessary corporate capacity and authority to enter into and to observe and perform
                                         its covenants and obligations under this Agreement and has taken all necessary corporate
                                         action in respect thereof;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Subscriber is a partnership, syndicate or other unincorporated form of organization,
                                         the Subscriber has the necessary legal capacity and authority to execute and deliver
                                         this Agreement and perform its covenants and obligations hereunder and has obtained all
                                         necessary approvals thereof;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Subscriber is acting as principal, this Subscription Agreement has been duly and
                                         validly authorized, executed and delivered by the Subscriber, and, when accepted by the
                                         Issuer, will constitute a legal, valid and binding obligation enforceable against the
                                         Subscriber in accordance with the terms hereof (subject to bankruptcy, insolvency and
                                         other laws limiting the enforceability of creditors&rsquo; rights and subject to the
                                         qualification that equitable remedies may only be granted in the discretion of a court
                                         of competent jurisdiction);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Subscriber is acting as agent or trustee (including, for greater certainty, a portfolio
                                         manager or comparable adviser) for a principal, the Subscriber is duly authorized to
                                         execute and deliver this Subscription Agreement and all other necessary documents in
                                         connection with such subscription on behalf of such principal, and this Subscription
                                         Agreement has been duly and validly authorized, executed and delivered by or on behalf
                                         of, and, when accepted by the Issuer, will constitute a legal, valid, binding obligation
                                         enforceable in accordance with the terms hereof (subject to bankruptcy, insolvency and
                                         other laws limiting the enforceability of creditors rights and subject to the qualification
                                         that equitable remedies may only be granted in the discretion of a court of competent
                                         jurisdiction) against, such principal;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         execution and delivery of this Subscription Agreement, the performance and compliance
                                         with the terms hereof, the subscription for the Units and the completion of the transactions
                                         contemplated hereby will not result in any material breach of, or be in conflict with
                                         or constitute a material default under, or create a state of facts which, after notice
                                         or lapse of time, or both, would constitute a material default under any term or provision
                                         of the constating documents, by-laws or resolutions of the Subscriber (if not an individual),
                                         the Securities Laws or any other applicable law, any agreement to which the Subscriber
                                         is a party or any applicable regulation, judgment, decree, order or ruling;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber is not one of a combination of shareholders of the Issuer or investors in
                                         the Offering (including by acting jointly or in concert with any such shareholder or
                                         investor) as a consequence of which the issuance of Units to the Subscriber hereunder
                                         (assuming the exercise of any convertible securities of the Issuer currently held by
                                         the Subscriber and any such other shareholders or investors) will result in, or be part
                                         of a transaction that will result in, the creation of a new &ldquo;Insider&rdquo; or
                                         &ldquo;Control Person&rdquo; of the Issuer under the policies or rules of the applicable
                                         Regulatory Authorities and Securities Laws;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Residence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber is a resident of, or is otherwise subject to the laws of, the jurisdiction
                                         disclosed under &ldquo;Subscriber&rsquo;s Residential Address&rdquo; on the face page
                                         of this Subscription Agreement, and that such address is the residence of the Subscriber
                                         or the place of business of the Subscriber at which the Subscriber received and accepted
                                         the offer to acquire the Units and was not created or used solely for the purpose of
                                         acquiring the Units;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
if Purchasing as Agent or Trustee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Subscriber is not subscribing as principal, the Subscriber acknowledges that the
                                         Issuer may be required by law to disclose to applicable securities regulatory authorities
                                         or stock exchanges information concerning the identities of each beneficial purchaser
                                         for whom the Subscriber is acting hereunder;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligibility
to Purchase under Prospectus Exemption</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber (or if applicable, the Disclosed Principal) is eligible to purchase the Units
                                         pursuant to an exemption from the prospectus requirements of the Securities Laws;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber has completed, executed and delivered to the Issuer an Accredited Investor
                                         Status (Canada) Certificate in the form attached hereto as Schedule B, as well as an
                                         Accredited Investor Risk Acknowledgment Form in the form attached as Exhibit A to Schedule
                                         B, indicating that the Subscriber (or if applicable, the Disclosed Principal) fits within
                                         one of the prospectus exemption categories under NI 45-106 as set forth therein and confirms
                                         the truth and accuracy of all representations, warranties and covenants made in such
                                         certificate as of the date of this Subscription Agreement and as of the Closing Time;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>International
Purchasers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Subscriber (or any Disclosed Principal), is resident in or otherwise subject to the
                                         securities laws of any jurisdiction outside of Canada and the United States (each, an
                                         &ldquo;<B>International Jurisdiction</B>&rdquo;), then:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber is knowledgeable of, or has been independently advised as to, the applicable
                                         securities laws of the International Jurisdiction which would apply to this subscription,
                                         if there are any;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber is purchasing the Units pursuant to exemptions from the prospectus and registration
                                         requirements under the applicable securities laws of the International Jurisdiction or,
                                         if such is not applicable, the Subscriber is permitted to purchase the Securities under
                                         the applicable securities laws of such International Jurisdiction without the need to
                                         rely on exemptions;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         applicable securities laws of the International Jurisdiction do not require the Issuer
                                         to prepare and/or file any documents or be subject to ongoing reporting requirements
                                         or seek any approvals of any kind whatsoever in respect of the sale of the Securities
                                         to the Subscriber from any regulatory authority of any kind whatsoever in the International
                                         Jurisdiction;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         purchase of Securities by the Subscriber, and (if applicable) each Disclosed Principal,
                                         does not trigger: (i) any obligation to prepare and file a prospectus, an offering memorandum
                                         or similar document, or any other ongoing reporting requirements with respect to such
                                         purchase or otherwise; (ii) any registration or other obligation on the part of the Issuer;
                                         or (iii) the Issuer becoming subject to regulation in such jurisdiction or require the
                                         Issuer to attorn to the jurisdiction of any governmental authority or regulator in such
                                         jurisdiction or require any translation of documents by the Issuer; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber, and (if applicable) any Disclosed Principal, will not sell or otherwise dispose
                                         of any Securities, except in accordance with applicable Securities Laws;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Prospectus or Undisclosed Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber understands that the sale of the Units is conditional upon such sale being
                                         exempt from the requirements to file and obtain a receipt for a prospectus or to deliver
                                         an offering memorandum, and no prospectus has been filed by the Issuer with any Regulatory
                                         Authority in any jurisdiction in connection with the issuance of the Units. As a result
                                         of acquiring the Units pursuant to such exemptions:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
                                         protections, rights and remedies provided by the Securities Laws, including under the
                                         B.C. Act, including certain statutory rights of rescission or damages and certain statutory
                                         remedies against an issuer, underwriters, auditors, directors and officers that are available
                                         to investors who acquire securities offered by a prospectus or registration statement,
                                         may not be available to the Subscriber;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         common law may not provide investors with an adequate remedy in the event that they suffer
                                         investment losses in connection with securities acquired in a private placement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber may not receive certain information that would otherwise be required to be
                                         given under the Securities Laws, including under the B.C. Act; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer is relieved from certain obligations that would otherwise apply under the Securities
                                         Laws, including under the B.C. Act;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber has not received or been provided with a prospectus or offering memorandum,
                                         within the meaning of the Securities Laws, or any sales or advertising literature in
                                         connection with the Offering. The Subscriber&rsquo;s decision to subscribe for the Units
                                         was not based upon, and the Subscriber has not relied upon, any verbal or written representations
                                         as to fact made by or on behalf of the Issuer and their respective directors, officers,
                                         employees, agents and representatives. The Subscriber&rsquo;s decision to subscribe for
                                         the Units was based solely upon this Subscription Agreement, and information about the
                                         Issuer which is publicly available;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except
                                         for the Subscriber&rsquo;s knowledge regarding the Offering and its subscription for
                                         Units hereunder, the Subscriber has no knowledge of a &ldquo;material fact&rdquo; or
                                         a &ldquo;material change&rdquo; (as those terms are defined in the applicable Securities
                                         Laws) in the affairs of the Issuer that has not been generally disclosed;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investment
Suitability</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber confirms that the Subscriber:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
                                         such knowledge in financial and business affairs as to be capable of evaluating the merits
                                         and risks of its investment in the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         capable of assessing the proposed investment in the Securities as a result of the Subscriber&rsquo;s
                                         own experience or as a result of advice received from a person registered under applicable
                                         Securities Laws;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         aware of the characteristics of the Securities and the risks relating to an investment
                                         therein; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                         able to bear the economic risk of loss of its investment in the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber understands and acknowledges that:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                         securities commission or similar regulatory authority has reviewed or passed on the merits
                                         of the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                         is no government or other insurance covering the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                         are risks associated with the purchase of the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                         are restrictions on the Subscriber&rsquo;s ability to resell the Securities and it is
                                         the responsibility of the Subscriber to find out what those restrictions are and to comply
                                         with them before selling the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Issuer has advised the Subscriber that the Issuer is relying on one or more exemptions
                                         from the requirements to provide the Subscriber with a prospectus and to sell securities
                                         through a person registered to sell securities under Securities Laws and, as a consequence
                                         of acquiring securities pursuant to any such exemption, certain protections, rights and
                                         remedies provided by Securities Laws, including statutory rights of rescission or damages,
                                         will not be available to the Subscriber; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                         it may lose its entire investment in the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Representations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber confirms that none of the Issuer, or any of its directors, employees, officers
                                         or affiliates have made any representations (written or oral) to the Subscriber:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regarding
                                         the future value of the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                         any person will resell or repurchase the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                         any person will refund the purchase price of the Securities other than as provided in
                                         this Subscription Agreement; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                         any of the Issuer&rsquo;s securities will be listed and posted for trading on a stock
                                         exchange or that an application has been made to list and post any of the Issuer&rsquo;s
                                         securities for trading on a stock exchange, other than the Issuer&rsquo;s common shares
                                         on Nasdaq;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitations
on Resale</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber understands and acknowledges that:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Securities will be subject to certain resale and transfer restrictions under applicable
                                         Securities Laws; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 103.5pt"></TD><TD STYLE="width: 54pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Securities may be subject to certain resale and transfer restrictions under the rules
                                         and policies of Nasdaq;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Subscriber acknowledges that it has been advised to consult its own legal advisors with respect to applicable resale and transfer
restrictions, that it is solely responsible for complying with such restrictions and it agrees to comply with the restrictions
referred to in paragraph (s) above and all other applicable resale and transfer restrictions. The Subscriber will comply with
all applicable Securities Laws concerning the subscription, purchase, holding and resale of the Securities and will not resell
any of the Securities except in accordance with the provisions of applicable Securities Laws. In this regard, the Subscriber acknowledges
that the Issuer may be required to put the following legends on any certificates</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">representing the Unit Shares, Warrants and Warrant Shares if issued
                                         prior to the expiry of the applicable hold period:</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE [FOUR MONTHS AND ONE DAY
AFTER THE CLOSING DATE].&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;THE
SECURITIES REPRESENTED HEREBY [FOR WARRANTS INCLUDE: AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF] HAVE NOT BEEN AND WILL
NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;U.S. SECURITIES ACT&rdquo;), OR UNDER
ANY STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING THESE SECURITIES, AGREES FOR THE BENEFIT OF NIOCORP DEVELOPMENTS LTD.
(THE &ldquo;COMPANY&rdquo;), THAT THESE SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY
ONLY (A) TO THE COMPANY, (B) IF THE SECURITIES HAVE BEEN REGISTERED IN COMPLIANCE WITH THE REGISTRATION REQUIREMENTS UNDER THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, (C) IN COMPLIANCE WITH THE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS UNDER THE SECURITIES ACT IN ACCORDANCE WITH RULE 144 THEREUNDER, IF APPLICABLE, AND IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS, OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE
LAWS AND REGULATIONS GOVERNING THE OFFER AND SALE OF SECURITIES, AND, IN EACH CASE, THE HOLDER HAS, PRIOR TO SUCH SALE, FURNISHED
TO THE COMPANY AN OPINION OF COUNSEL OF RECOGNIZED STANDING, OR OTHER EVIDENCE OF EXEMPTION, REASONABLY SATISFACTORY TO THE COMPANY
TO SUCH EFFECT. HEDGING TRANSACTIONS INVOLVING THE SECURITIES ARE PROHIBITED EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[FOR
WARRANTS ONLY: &ldquo;THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED
STATES SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;U.S. SECURITIES ACT&rdquo;). THIS WARRANT MAY NOT BE EXERCISED UNLESS THE
SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND THE APPLICABLE SECURITIES
LEGISLATION OF ANY SUCH STATE OR EXEMPTIONS FROM SUCH REGISTRATION REQUIREMENTS ARE AVAILABLE.&rdquo;]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber acknowledges that it is responsible for obtaining its own legal, investment
                                         and other professional advice with respect to the resale restrictions, &ldquo;hold periods&rdquo;
                                         and legending requirements to which the Securities are or may be subject under the 1933
                                         Act and the rules and regulations of the U.S. SEC. The Subscriber has not relied upon
                                         any statements made by or purporting to have been made on behalf of the Issuer or its
                                         counsel with respect to such matters;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber acknowledges and agrees that the Issuer shall make a notation on its records
                                         or give instructions to the transfer agent of the Subscriber&rsquo;s Units in order to
                                         implement the restrictions on transfer set out in the Subscription Agreement and applicable
                                         Securities Laws;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber acknowledges that there is no market for the Warrants and none is expected
                                         to develop;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>United
States Securities Laws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber acknowledges and agrees that the Subscriber has executed and delivered <U>Schedule
                                         C</U> hereto (Accredited Investor Status Certificate (U.S.)) and hereby is deemed to
                                         have made the representations, warranties and acknowledgments contained therein as if
                                         set forth herein in full;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not
Proceeds of Crime</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         funds representing the Subscription Price which will be advanced by the Subscriber hereunder
                                         will not represent proceeds of crime for the purposes of the <I>Proceeds of Crime (Money
                                         Laundering) and Terrorist Financing Act</I> (Canada) (the &ldquo;<B>PCMLTFA</B>&rdquo;),
                                         the <I>Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept
                                         and Obstruct Terrorism Act</I> (United States) (commonly referred to as the &ldquo;<B>USA
                                         PATRIOT Act</B>&rdquo;) or other similar legislation, and the Subscriber acknowledges
                                         that the Issuer may in the future be required by law to disclose the Subscriber&rsquo;s
                                         name and other information relating to this Subscription Agreement and the Subscriber&rsquo;s
                                         subscription hereunder, on a confidential basis, pursuant to the PCMLTFA. To the best
                                         of its knowledge (i) none of the subscription funds to be provided by the Subscriber
                                         (A) have been or will be derived from or related to any activity that is deemed criminal
                                         under the law of Canada, the United States or any other jurisdiction, or (B) are being
                                         tendered on behalf of a person or entity who has not been identified to the Subscriber,
                                         and (ii) it shall promptly notify the Issuer if the Subscriber discovers that any of
                                         such representations ceases to be true, and to provide the Issuer with appropriate information
                                         in connection therewith;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Financial Assistance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber has not received nor expects to receive any financial assistance from the
                                         Issuer directly or indirectly, in respect of the Subscriber&rsquo;s purchase of the Units;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Future
Financings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber acknowledges that the Issuer may complete additional financings in the future
                                         to develop the business of the Issuer and to fund its ongoing development. There is no
                                         assurance that such financing will be available and if available, on reasonable terms.
                                         Any such future financings may have a dilutive effect on current shareholders, including
                                         the Subscriber;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Advertising</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber has not become aware of any advertisement in printed media of general and
                                         regular paid circulation or on radio, television or other form of telecommunication or
                                         any other form of advertisement (including electronic display on the internet including
                                         but not limited to the Issuer&rsquo;s website) or sales literature with respect to the
                                         distribution of the Units or any seminar or meeting whose attendees have been invited
                                         by general solicitation or general advertising;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Other Fees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         connection with the issue and sale of the Units pursuant to the Offering to Subscribers
                                         outside of the United States, the Issuer may pay or issue either or both of a cash commission
                                         and/or securities pursuant to and in accordance with the policies or rules of Nasdaq
                                         and applicable corporate and Securities Laws;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                         is no person acting or purporting to act on behalf of the Subscriber (including any Disclosed
                                         Principal), if applicable, in connection with the transactions contemplated herein who
                                         is entitled to any brokerage or finder&rsquo;s fee. If any person establishes a claim
                                         that any fee or other compensation is payable in connection with this subscription for
                                         the Units on account of the Subscriber&rsquo;s subscription, the Subscriber covenants
                                         to indemnify and hold harmless the Issuer with respect thereto and with respect to all
                                         costs reasonably incurred in the defence thereof;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Documents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         required by Securities Laws or by any securities commission, stock exchange or other
                                         regulatory authority, the Subscriber will execute, deliver, file and otherwise assist
                                         the Issuer in filing, such reports, undertakings and other documents with respect to
                                         the subscription for and issuance of the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subscriber&rsquo;s
Responsibility for Legal and Financial Advice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber confirms that it is responsible for obtaining its own legal, tax, investment
                                         and other professional advice with respect to the execution, delivery and performance
                                         by it of this Subscription Agreement and the transactions contemplated hereunder including
                                         the suitability of the Securities as an investment for the Subscriber, the tax consequences
                                         of purchasing and dealing with the Securities, and the resale restrictions and &ldquo;hold
                                         periods&rdquo; to which the Securities are or may be subject under Securities Laws. The
                                         Subscriber has not relied upon any statements made by or purporting to have been made
                                         on behalf of the Issuer or its counsel with respect to such matters; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber acknowledges that the Issuer&rsquo;s counsel is acting solely as counsel to
                                         the Issuer and not as counsel to the Subscriber.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">10.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reliance
                                         on Representations, Warranties, Covenants and Acknowledgements</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber acknowledges and agrees that the representations, warranties, covenants and acknowledgements made by the Subscriber
in this Subscription Agreement, including the Schedules hereto, are made with the intention that they may be relied upon by the
Issuer in determining the Subscriber&rsquo;s eligibility (and, if applicable, the eligibility of others for whom the Subscriber
is contracting hereunder) to purchase the Units under Securities Laws. The Subscriber further agrees that by accepting the Units,
the Subscriber will be representing and warranting that such representations, warranties, covenants and acknowledgements are true
as at the Closing Time with the same force and effect for the benefit of the Issuer as if they had been made by the Subscriber
at the Closing Time and that they will survive the purchase by the Subscriber of the Units and will continue in full force and
effect for the benefit of the Issuer notwithstanding any subsequent disposition by the Subscriber of any of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">11.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber acknowledges that the Issuer and its counsel are relying upon the representations, warranties, covenants and acknowledgements
of the Subscriber set forth herein (including the Schedules attached hereto) in determining the eligibility of the Subscriber
(or, if applicable, the eligibility of another on whose behalf the Subscriber is contracting hereunder to subscribe for Units)
to purchase Units under the Offering, and hereby agrees to indemnify the Issuer and its directors, officers, employees, advisers,
affiliates, shareholders and agents (including their legal counsel) against all losses, claims, costs, expenses, damages or liabilities
that they may suffer or incur as a result of or in connection with their reliance on such representations, warranties, acknowledgements
and covenants. The Subscriber undertakes to immediately notify the Issuer of any change in any statement or other information
relating to the Subscriber set forth herein that occurs prior to the Closing Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">12.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscriber&rsquo;s
                                         Costs</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber acknowledges and agrees that all costs incurred by the Subscriber (including any fees and disbursements of any counsel
retained by the Subscriber) relating to the sale of the Units to the Subscriber will be borne by the Subscriber.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">13.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
                                         to the Disclosure of Information</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement and the attachments hereto require the Subscriber to provide certain Personal Information to the Issuer. Such information
is being collected by the Issuer for the purposes of completing the Offering of the Units, which includes, without limitation,
determining the Subscriber&rsquo;s eligibility to purchase the Subscriber&rsquo;s Units under applicable Securities Laws, preparing
and registering any certificates representing the Securities to be issued to the Subscriber, completing filings required by any
stock exchange or securities regulatory authority, indirect collection of information by the applicable stock exchange or Regulatory
Authority under authority granted in applicable securities legislation and the administration and enforcement of the securities
legislation of an applicable jurisdiction by the applicable Regulatory Authority. The Subscriber acknowledges that the Subscriber&rsquo;s
Personal Information, including details of its subscription hereunder, will be disclosed by the Issuer to: (a) stock exchanges
or securities regulatory authorities; (b) the Issuer&rsquo;s registrar and transfer agent; and (c) any of the other agents or
representatives of the Issuer, including legal counsel to the Issuer; and may be disclosed by the Issuer to (d) the Canada Revenue
Agency; and (e) any other person to whom it is required to disclose such information under applicable legislation or authority.
By executing this Subscription Agreement, the Subscriber consents to and authorizes the foregoing collection, use and disclosure
of the Subscriber&rsquo;s Personal Information. The Subscriber also consents to and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">authorizes the filing of copies or originals
of any of this Subscription Agreement (including attachments) below as may be required to be filed with any stock exchange or
securities regulatory authority in connection with the transactions contemplated hereby. In addition, the Subscriber consents
to and authorizes the collection, use and disclosure of all such Personal Information by Nasdaq and other regulatory authorities
in accordance with their requirements, including the provision to third party service providers, from time to time. The contact
information for the officer of the Issuer who can answer questions about this collection of information is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd.<BR>
7000 South Yosemite Street, Suite 115<BR>
Centennial, CO 80112<BR>
Attn: Neal Shah<BR>
<BR>
Tel: 720-940-7826<BR>
email: [***]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Subscribers with questions about the collection of Personal Information by the Ontario Securities Commission, please contact the
Administrative Support Clerk at the Ontario Securities Commission, Suite 1903, Box 55, 20 Queen Street West, Toronto, Ontario,
M5H 3S8, Tel: (416) 593-3684.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">14.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Subscription Agreement and all related agreements between the Parties hereto shall be
                                         governed by and construed in accordance with the laws of the Province of British Columbia,
                                         without reference to its rules governing the choice or conflict of laws. The Parties
                                         hereto irrevocably attorn and submit to the exclusive jurisdiction of the courts of the
                                         Province of British Columbia, sitting in the city of Vancouver, with respect to any dispute
                                         to or arising out of this Subscription Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Subscriber and the Issuer agree that they each will execute or cause to be executed and
                                         delivered all such further and other documents and assurances, and do and cause to be
                                         done all such further acts and things as may be necessary or desirable to give effect
                                         to this Subscription Agreement and without limiting the generality of the foregoing to
                                         do all acts and things, execute and deliver all documents, agreements and writings and
                                         provide such assurances, undertakings, information and investment letters as may be required
                                         from time to time by all applicable Regulatory Authorities or as may be required from
                                         time to time under applicable Securities Laws.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Subscription Agreement, which includes any interest granted or right arising under this
                                         Subscription Agreement, may not be assigned or transferred, without the written consent
                                         of the other Parties.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
                                         as expressly provided in this Subscription Agreement and in the agreements, instruments
                                         and other documents contemplated or provided for herein, this Subscription Agreement
                                         contains the entire agreement between the Parties with respect to the Units and there
                                         are no other terms, conditions, representations or warranties whether expressed, implied,
                                         oral or written, by statute, by common law, by the Issuer, or by anyone else.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                         notice or other communication to be given hereunder shall, in the case of notice to be
                                         given to:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Issuer, be addressed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd.<BR>
7000 South Yosemite Street, Suite 115<BR>
Centennial, CO 80112<BR>
<BR>
Attn: Neal Shah<BR>
Tel: 720-940-7826<BR>
email: [***]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
to such other address, email address or person that the Party designates by notice given in accordance with the foregoing provisions.
Any such notice: (i) if delivered personally or by courier, will be deemed to have been given and received on the date of such
delivery provided that if such day is not a Business Day then it will be deemed to have been given and received on the first Business
Day following such day; and (ii) if transmitted by email or other form of electronic communication, will be deemed to have been
given on the date of transmission if sent before 5:00 p.m. (Vancouver time) on a Business Day or, if not before 5:00 p.m. (Vancouver
time), on the first Business Day following the date of transmission provided that the sender has evidence of a successful transmission
such as a confirmation or electronic delivery receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         representations, warranties, agreements and covenants made or deemed to be made by the
                                         Issuer and the Subscriber herein will survive the execution and delivery, and acceptance,
                                         of this offer and the closing of the issue of the Units contemplated hereby.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms hereof, neither this Subscription Agreement nor any provision hereof shall be modified, changed, discharged or terminated
except by an instrument in writing signed by the Party against whom any waiver, change, discharge or termination is sought.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Subscription Agreement shall enure to the benefit of and be binding upon the Parties
                                         and their respective heirs, executors, administrators and successors but otherwise cannot
                                         be assigned.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                         Subscription Agreement may be executed in any number of counterparts, each of which when
                                         delivered, either in original or PDF or other electronic form, shall be deemed to be
                                         an original and all of which together shall constitute one and the same document. If
                                         less than a complete copy of this Subscription Agreement is delivered to the Issuer by
                                         the Subscriber (other than the execution pages of this Subscription Agreement required
                                         to be executed by the Subscriber), the Issuer and its advisors are entitled to assume,
                                         and the Subscriber shall be deemed to have represented and warranted to the Issuer, that
                                         the Subscriber accepts and agrees to all of the terms and conditions of the pages of
                                         this Subscription Agreement that are not delivered, without any alteration.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Parties hereto confirm their express wish that this Subscription Agreement and all documents
                                         and agreements directly or indirectly relating hereto be drawn up in the English language.
                                         <I>Les Parties reconnaissent leur volont&eacute; expresse que la pr&eacute;sente convention
                                         de souscription&nbsp;ainsi que tous les documents et contrats s&rsquo;y rattachant directement
                                         ou indirectement soient r&eacute;dig&eacute;s en anglais.</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><B>SCHEDULE
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES TO WHICH THIS SUBSCRIPTION AGREEMENT RELATES AND THE SECURITIES ISSUABLE UPON EXERCISE THEREOF HAVE NOT BEEN AND WILL
NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;1933 ACT&rdquo;) OR ANY APPLICABLE STATE
SECURITIES LAWS IN THE UNITED STATES AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES (AS SUCH TERM IS DEFINED
IN REGULATION S UNDER THE 1933 ACT) OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, A U.S. PERSON (AS DEFINED IN REGULATION S OF THE
1933 ACT), EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION REQUIREMENTS OF THE 1933 ACT, AND IN ACCORDANCE WITH ANY APPLICABLE STATE
SECURITIES LAWS. HEDGING TRANSACTIONS INVOLVING THE SECURITIES ARE PROHIBITED EXCEPT IN COMPLIANCE WITH THE 1933 ACT. THIS SUBSCRIPTION
AGREEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY OF THE SECURITIES OFFERED HEREBY WITHIN
THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT IN THE LIMITED CIRCUMSTANCES PROVIDED HEREIN PURSUANT
TO TRANSACTIONS EXEMPT FROM REGISTRATION UNDER THE 1933 ACT AND ANY APPLICABLE STATE SECURITIES LAWS. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding: 0in 0in 4pt; border-bottom: #DDDDDD 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
Sheet</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Private
Placement of Units</B></FONT></P>

</DIV>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%; padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer:</B></FONT></TD>
    <TD STYLE="width: 82%; padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Developments Ltd. (&ldquo;<B>NioCorp</B>&rdquo; or the &ldquo;<B>Issuer</B>&rdquo;).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering:</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
        placement offering (the &ldquo;<B>Offering</B>&rdquo;) of up to approximately 2,404,903 units of the Issuer (the &ldquo;<B>Units</B>&rdquo;).
        Each Unit will consist of (i) one common share of the Issuer (a &ldquo;<B>Common Share</B>&rdquo;), (ii) one Series A
        common share purchase warrant of the Issuer (a &ldquo;<B>Series A Warrant</B>&rdquo;) and (iii) one-half of one Series
        B common share purchase warrant of the Issuer (each whole such Series B common share purchase warrant, a &ldquo;<B>Series
        B Warrant</B>&rdquo; and, together with the Series A Warrants, the &ldquo;<B>Warrants</B>&rdquo;).</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
        directors and officers of the Issuer have indicated an interest in purchasing an aggregate of approximately US$350,000
        worth of Units in the Offering at a price of US$1.7675 per Unit. However, such directors and officers are not obligated
        to purchase any Units and may determine to purchase fewer or more Units than they indicated an interest in purchasing.
        In addition, since no preference shall be granted to such directors and officers or their affiliates, the Issuer could
        determine to sell to such directors and officers or their affiliates fewer Units than they indicated an interest in purchasing.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing:</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$1.7675
        per Unit for officers, directors, employees and consultants of the Issuer and US$1.57 per Unit for persons other than
        officers, directors, employees and consultants of the Issuer.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
        Series A Warrant shall entitle the holder thereof to purchase one additional Common Share (a &ldquo;<B>Series A Warrant
        Share</B>&rdquo;) at an exercise price equal to US$1.75 exercisable at any time during a period 24 months from Closing
        (as defined herein). Each Series B Warrant shall entitle the holder to purchase one additional Common Share (a &ldquo;<B>Series
        B Warrant Share</B>&rdquo; and, together with the Series A Warrant Shares, the &ldquo;<B>Warrant Shares</B>&rdquo;) at
        an exercise price equal to US$2.07 exercisable at any time during a period beginning on the date that is six (6) months
        and one (1) day from Closing until 60 months following the Closing.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
    of Proceeds:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    proceeds of the Offering are expected to be used for working capital and general corporate purposes, including, amongst other
    uses, to (i) advance our efforts to launch our Elk Creek Critical Minerals Project and move it to commercial production and
    (ii) repay all amounts outstanding under our US$2.0 million non-revolving, multiple draw credit facility available pursuant
    to the Loan Agreement, dated September 11, 2024, by and between the Company and Mark Smith.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering
    Jurisdictions:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Offering will take place by way of a private placement to qualified investors in the Provinces of British Columbia, Alberta,
    Saskatchewan, Manitoba, Ontario, New Brunswick, and otherwise in those offshore jurisdictions where the Offering can lawfully
    be made. Subscribers will have a US$5,000 minimum subscription and must be (i) &ldquo;accredited investors&rdquo; (as defined
    in National Instrument 45-106 Prospectus Exemptions (&ldquo;<B>NI 45-106</B>&rdquo;)) and (ii) United States investors must
    be &ldquo;accredited investors&rdquo; as defined in Rule 501(a) under the United States Securities Act of 1933, as amended.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 22; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left; width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hold
    Period:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt; width: 82%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Shares and Warrants issued in connection with the Offering will be subject to an indefinite hold period as required by U.S.
    securities laws, and will also be subject to a four-month and one day hold period (which will run concurrently with the indefinite
    hold period in the United States) as required by Canadian securities laws commencing on the date of the Closing (as defined
    herein) of the Offering and the Warrant Shares issued on exercise of the Warrants will be subject to additional hold periods
    under U.S. securities laws that shall commence on the date the Warrants are exercised, and (if applicable) will also be subject
    to a four-month and one day hold period from Closing (which will run concurrently with the indefinite hold period in the United
    States).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Issuer shall obtain the necessary approvals to list the Common Shares, and Warrant Shares issuable upon exercise of the Warrants,
    where any such exercise occurs, on The Nasdaq Stock Market LLC, if and when such Shares are eligible to be listed on Nasdaq.
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    fee of up to 4.20% to certain finders for proceeds raised from subscribers introduced by such finders. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligibility
    for Investment:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligible
    for RRSPs, RESPs, RRIFs, TFSAs and DPSPs.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Closing:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    or about November 6, 2024 (the &ldquo;<B>Closing</B>&rdquo;), subject to any required regulatory approvals</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; padding-bottom: 3pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&nbsp;A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accredited
Investor Status CERTIFICATE (Canada)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
categories listed herein contain certain specifically defined terms. If you are unsure as to the meanings of those terms or are
unsure as to the applicability of any category below, please contact your broker and/or legal advisor before completing this certificate.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NIOCORP
DEVELOPMENTS LTD.</B> (the &ldquo;<B>Issuer</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used in this Schedule &ldquo;B&rdquo; and defined in the Subscription Agreement to which this Schedule &ldquo;B&rdquo; is
attached have the meanings defined in the Subscription Agreement unless otherwise defined herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the purchase by the undersigned Subscriber of the Units, the Subscriber, on its own behalf or on behalf of each
Disclosed Principal for whom the Subscriber is acting (collectively, the &ldquo;<B>Subscriber</B>&rdquo;), hereby represents,
warrants, covenants and certifies to the Issuer (and acknowledges that the Issuer and its counsel are relying thereon) that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber is purchasing the Units as principal for its own account and not for the benefit
                                         of any other person or is deemed to be purchasing as principal pursuant to NI 45-106;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber is an &ldquo;accredited investor&rdquo; within the meaning of NI 45-106 on
                                         the basis that the Subscriber fits within one of the categories of an &ldquo;accredited
                                         investor&rdquo; reproduced below beside which the Subscriber has indicated the undersigned
                                         belongs to such category;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber was not created or used solely to purchase or hold securities as an accredited
                                         investor as described in paragraph (m) below;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         the Subscriber is an individual purchasing under category (j), (k) or (l) below, it has
                                         completed and signed Exhibit &ldquo;A&rdquo; attached hereto; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                         execution of this Schedule &ldquo;B&rdquo; by the Subscriber, this Schedule &ldquo;B&rdquo;
                                         shall be incorporated into and form a part of the Subscription Agreement to which this
                                         Schedule &ldquo;B&rdquo; is attached.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(PLEASE
CHECK THE BOX OF THE APPLICABLE CATEGORY OF ACCREDITED INVESTOR)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="width: 0.5in; text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
    except in Ontario, a Canadian financial institution, or a Schedule III bank; or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
    in Ontario, a financial institution that is (A) a bank listed in Schedule I, II or III of the <I>Bank Act </I>(Canada); (B)
    an association to which the <I>Cooperative Credit Associations Act </I>(Canada) applies or a central cooperative credit society
    for which an order has been made under subsection 473(1) of that Act; or (C) a loan corporation, trust company, trust corporation,
    insurance company, treasury branch, credit union, caisse populaire, financial services cooperative or credit union league
    or federation that is authorized by a statute of Canada or Ontario to carry on business in Canada or Ontario, as the case
    may be;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Business Development Bank of Canada incorporated under the <I>Business Development Bank of Canada Act </I>(Canada);</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    subsidiary of any person or company referred to in paragraphs (a) or (b), if the person or company owns all of the voting
    securities of the subsidiary, except the voting securities required by law to be owned by directors of that subsidiary;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    person or company registered under the securities legislation of a jurisdiction (province or territory) of Canada as an adviser
    or dealer (or in Ontario, except as otherwise prescribed by the regulations under the <I>Securities Act </I>(Ontario));</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual registered under the securities legislation of a jurisdiction of Canada as a representative of a person referred
    to in paragraph (d);</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e.1)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual formerly registered under the securities legislation of a jurisdiction of Canada, other than an individual formerly
    registered solely as a representative of a limited market dealer under one or both of the <I>Securities Act </I>(Ontario)
    or the <I>Securities Act</I> (Newfoundland and Labrador);</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 24; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Government of Canada or a jurisdiction (province or territory) of Canada, or any crown corporation, agency or wholly owned
    entity of the Government of Canada or a jurisdiction of Canada;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    municipality, public board or commission in Canada and a metropolitan community, school board, the Comit&eacute; de gestion
    de la taxe scolaire de l&rsquo;&icirc;le de Montr&eacute;al or an intermunicipal management board in Qu&eacute;bec;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    national, federal, state, provincial, territorial or municipal government of or in any foreign jurisdiction, or any agency
    of that government;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    pension fund that is regulated by either the Office of the Superintendent of Financial Institutions (Canada), a pension commission
    or similar regulatory authority of a jurisdiction (province or territory) of Canada;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></P></TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an individual who,
    either alone or with a spouse, beneficially owns financial assets having an aggregate realizable value that, before taxes,
    but net of any related liabilities, exceeds CDN$1,000,000;</FONT>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>***
if you qualify as an accredited investor under this category (J), you must complete and execute form 45-109 <I>individiual risk
acknowledgment form</I> attached as exhbit A to this Schedule B </B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j.1)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who beneficially owns financial assets having an aggregate realizable value that, before taxes but net of any related
    liabilities, exceeds CDN$5,000,000;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></P></TD>
    <TD STYLE="padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                     individual whose net income before taxes exceeded CDN$200,000 in each of the two most recent
                                     calendar years or whose net income before taxes combined with that of a spouse exceeded CDN$300,000
                                     in each of the two most recent calendar years and who, in either case, reasonably expects
                                     to exceed that net income level in the current calendar year;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>***
if you qualify as an accredited investor under this category (K), you must complete and execute form 45-109 <I>individiual risk
acknowledgment form</I> attached as exhbit A to this Schedule b</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></P></TD>
    <TD STYLE="padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                     individual who, either alone or with a spouse, has net assets of at least CDN$5,000,000;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>***
if you qualify as an accredited investor under this category (L), you must complete and execute form 45-109 <I>individiual risk
acknowledgment form</I> attached as exhbit A to this Schedule b</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    person, other than an individual or investment fund, that has net assets of at least CDN$5,000,000 as shown on its most recently
    prepared financial statements;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    investment fund that distributes or has distributed its securities only to (i) a person that is or was an accredited investor
    at the time of the distribution, (ii) a person that acquires or acquired securities in the circumstances referred to in sections
    2.10 [<I>Minimum amount investment</I>] or 2.19 [<I>Additional investment in investment funds</I>] of NI 45-106, or (iii)
    a person described in sub-paragraph (i) or (ii) that acquires or acquired securities under section 2.18 [<I>Investment fund
    reinvestment</I>] of NI 45-106;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    investment fund that distributes or has distributed securities under a prospectus in a jurisdiction of Canada for which the
    regulator or, in Qu&eacute;bec, the securities regulatory authority, has issued a receipt;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust company or trust corporation registered or authorized to carry on business under the <I>Trust and Loan Companies Act
    </I>(Canada) or under comparable legislation in a jurisdiction of Canada or a foreign jurisdiction, acting on behalf of a
    fully managed account managed by the trust company or trust corporation, as the case may be;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    person acting on behalf of a fully managed account managed by that person, if that person is registered or authorized to carry
    on business as an adviser or the equivalent under the securities legislation of a jurisdiction of Canada or a foreign jurisdiction;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    registered charity under the <I>Income Tax Act </I>(Canada) that, in regard to the trade, has obtained advice from an eligibility
    adviser or an adviser registered under the securities legislation of the jurisdiction of the registered charity to give advice
    on the securities being traded;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    entity organized in a foreign jurisdiction that is analogous to any of the entities referred to in paragraphs (a) to (d) or
    paragraph (i) in form and function;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    person in respect of which all of the owners of interests, direct, indirect or beneficial, except the voting securities required
    by law to be owned by directors, are persons that are accredited investors;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    investment fund that is advised by a person registered as an adviser or a person that is exempt from registration as an adviser;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    person that is recognized or designated by the securities regulatory authority or, except in Qu&eacute;bec, the regulator
    as an accredited investor;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust established by an accredited investor for the benefit of the accredited investor&rsquo;s family members of which a majority
    of the trustees are accredited investors and all of the beneficiaries are the accredited investor&rsquo;s spouse, a former
    spouse of the accredited investor or a parent, grandparent, brother, sister, child or grandchild of that accredited investor,
    of that accredited investor&rsquo;s spouse or of that accredited investor&rsquo;s former spouse; or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-bottom: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&#9744;</FONT></TD>
    <TD STYLE="padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></P></TD>
    <TD STYLE="padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                     Ontario, such other persons or companies as may be prescribed by the regulations under the
                                     <I>Securities Act</I> (Ontario).</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">***If
checking this category (x), please provide a description of how this requirement is met.&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes hereof, the following definitions are included for convenience:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>bank</B>&rdquo;
                                         means a bank named in Schedule I or II of the <I>Bank Act</I> (Canada);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Canadian
                                         financial institution</B>&rdquo; means (i) an association governed by the <I>Cooperative
                                         Credit Associations Act</I> (Canada) or a central cooperative credit society for which
                                         an order has been made under section 473(1) of that Act, or (ii) a bank, loan corporation,
                                         trust company, trust corporation, insurance company, treasury branch, credit union, caisse
                                         populaire, financial services cooperative, or league that, in each case, is authorized
                                         by an enactment of Canada or a jurisdiction of Canada to carry on business in Canada
                                         or a jurisdiction of Canada;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>company</B>&rdquo;
                                         means any corporation, incorporated association, incorporated syndicate or other incorporated
                                         organization;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>eligibility
                                         adviser</B>&rdquo; means:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                         person that is registered as an investment dealer and authorized to give advice with
                                         respect to the type of security being distributed, and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                         Saskatchewan or Manitoba, also means a lawyer who is a practicing member in good standing
                                         with a law society of a jurisdiction of Canada or a public accountant who is a member
                                         in good standing of an institute or association of chartered accountants, certified general
                                         accountants or certified management accountants in a jurisdiction of Canada provided
                                         that the lawyer or public accountant must not</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
                                                                                                                                              <TD STYLE="text-align: justify; padding-left: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
a professional, business or personal relationship with the issuer, or any of its directors, executive officer, founders, or control
persons, and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have
                                         acted for or been retained personally or otherwise as an employee, executive officer,
                                         director, associate or partner of a person that has acted for or been retained by the
                                         issuer or any of its directors, executive officers, founders or control persons within
                                         the previous 12 months;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>executive
                                         officer</B>&rdquo; means, for an issuer, an individual who is: (i) a chair, vice-chair
                                         or president, (ii) a vice-president in charge of a principal business unit, division
                                         or function including sales, finance or production, or (iii) performing a policy-making
                                         function in respect of the issuer;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>financial
                                         assets</B>&rdquo; means (i) cash, (ii) securities, or (iii) a contract of insurance,
                                         a deposit or an evidence of a deposit that is not a security for the purposes of securities
                                         legislation;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>fully
                                         managed account</B>&rdquo; means an account of a client for which a person makes the
                                         investment decisions if that person has full discretion to trade in securities for the
                                         account without requiring the client&rsquo;s express consent to a transaction;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>investment
                                         fund</B>&rdquo; has the same meaning as in National Instrument 81-106 <I>Investment Fund
                                         Continuous Disclosure</I>;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>person</B>&rdquo;
                                         includes: (i) an individual, (ii) a corporation, (iii) a partnership, trust, fund and
                                         an association, syndicate, organization or other organized group of persons whether incorporated
                                         or not, and (iv) an individual or other person in that person&rsquo;s capacity as a trustee,
                                         executor, administrator or personal or other legal representative.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>related
                                         liabilities</B>&rdquo; means (i) liabilities incurred or assumed for the purpose of financing
                                         the acquisition or ownership of financial assets, or (ii) liabilities that are secured
                                         by financial assets;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Schedule
                                         III bank</B>&rdquo; means an authorized foreign bank named in Schedule III of the <I>Bank
                                         Act</I> (Canada);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>spouse</B>&rdquo;
                                         means, an individual who, (i) is married to another individual and is not living separate
                                         and apart within the meaning of the <I>Divorce Act</I> (Canada), from the other individual,
                                         (ii) is living with another individual in a marriage-like relationship, including a marriage-like
                                         relationship between individuals of the same gender, or (iii) in Alberta, is an individual
                                         referred to in paragraph (i) or (ii), or is an adult interdependent partner within the
                                         meaning of the Adult Interdependent Relationships Act (Alberta); and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>subsidiary</B>&rdquo;
                                         means an issuer that is controlled directly or indirectly by another issuer and includes
                                         a subsidiary of that subsidiary.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
NI 45-106 a person or company is an affiliate of another person or company if one of them is a subsidiary of the other, or if
each of them is controlled by the same person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
NI 45-106 and except in Part 2 Division 4 (Employee, Executive Officer, Director and Consultant Exemption) of NI 45-106, a person
(first person) is considered to control another person (second person) if (a) the first person, beneficially owns or directly
or indirectly exercises control or direction over securities of the second person carrying votes which, if exercised, would entitle
the first person to elect a majority of the directors of the second person, unless that first person holds the voting securities
only to secure an obligation, (b) the second person is a partnership, other than a limited partnership, and the first person holds
more than 50% of the interests of the partnership, or (c) the second person is a limited partnership and the general partner of
the limited partnership is the first person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing representations contained in this Accredited Investor Status Certificate (Canada) are true and accurate as of the date
of this Accredited Investor Status Certificate (Canada) and will be true and accurate as of the Closing Time and the Subscriber
acknowledges that this Accredited Investor Status Certificate (Canada) is incorporated into and forms a part of the Subscription
Agreement to which it is attached. If any such representations shall not be true and accurate prior to the Closing Time, the undersigned
shall give immediate written notice of such fact to the Issuer prior to the Closing Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 95%; border-collapse: collapse; font-size: 10pt; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Dated:&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Witness
(If Subscriber is an Individual)</FONT></P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
the name of Subscriber</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
Name of Witness</FONT></P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Subscriber is a corporation,</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">print name and title of Authorized Signing Officer</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A TO SCHEDULE B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCREDITED
INVESTOR RISK ACKNOWLEDGMENT FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
&ldquo;EXHIBIT A&rdquo; TO SCHEDULE &ldquo;B&rdquo; IS TO BE COMPLETED BY ACCREDITED INVESTORS WHO COMPLETED SCHEDULE &ldquo;B&rdquo;
AND ARE INDIVIDUALS SUBSCRIBING UNDER CATEGORIES (J), (K) OR (L) IN SCHEDULE &ldquo;B&rdquo; TO WHICH THIS EXHIBIT &ldquo;A&rdquo;
IS ATTACHED.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
        <B>WARNING!</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
        investment is risky. Don&rsquo;t invest unless you can afford to lose all the money you pay for this investment.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
    1 TO BE COMPLETED BY THE ISSUER OR SELLING SECURITY HOLDER</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.&nbsp;&nbsp;About
    your investment</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    of securities: <B><I><U>Units (each comprised of one common share, one Series A common share purchase warrant and one-half
    of one Series B common share purchase warrant) </U></I></B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuer:
    <B><I><U>NioCorp Developments Ltd.</U></I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 6pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased
    from: <B><I><U>NioCorp Developments Ltd.</U></I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTIONS
    2 TO 4 TO BE COMPLETED BY THE PURCHASER</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.&nbsp;&nbsp;Risk
    acknowledgement</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    investment is risky. Initial that you understand that:</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Your
    </B><BR>
    <B>Initials</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    of loss</B> - You could lose your entire investment of US$ ____________. <I>[Instruction: Insert the total dollar amount of
    the investment.]</I></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
    risk</B> - You may not be able to sell your investment quickly - or at all.</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lack
    of information</B> - You may receive little or no information about your investment.</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lack
        of advice</B> - You will not receive advice from the salesperson about whether this investment is suitable for you unless
        the salesperson is registered. The salesperson is the person who meets with, or provides information to, you about making
        this investment. To check whether the salesperson is registered, go to <U>www.aretheyregistered.ca</U>.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.&nbsp;&nbsp;Accredited
    investor status</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    must meet at least <B>one</B> of the following criteria to be able to make this investment. Initial the statement that applies
    to you. (You may initial more than one statement.) The person identified in section 6 is responsible for ensuring that you
    meet the definition of accredited investor. That person, or the salesperson identified in section 5, can help you if you have
    questions about whether you meet these criteria.</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Your
    </B><BR>
    <B>initials</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 9pt; padding-left: 0.45in; text-align: left; text-indent: -0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Your net income before taxes was more than CDN$200,000 in each of the 2 most recent calendar years, and you expect it to be
    more than CDN$200,000 in the current calendar year. (You can find your net income before taxes on your personal income tax
    return.)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 9pt; padding-left: 0.45in; text-align: left; text-indent: -0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Your net income before taxes combined with your spouse&rsquo;s was more than CDN$300,000 in each of the 2 most recent calendar
    years, and you expect your combined net income before taxes to be more than CDN$300,000 in the current calendar year.</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 9pt; padding-left: 0.45in; text-align: justify; text-indent: -0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Either alone or with your spouse, you own more than CDN$1 million in cash and securities, after subtracting any debt related
    to the cash and securities.</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 9pt; padding-left: 0.45in; text-align: left; text-indent: -0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Either alone or with your spouse, you have net assets worth more than CDN$5 million. (Your net assets are your total assets
    (including real estate) minus your total debt.)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding: 3pt 5.4pt; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 53%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD COLSPAN="4" STYLE="border: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.&nbsp;&nbsp;Your
    name and signature</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    signing this form, you confirm that you have read this form and you understand the risks of making this investment as identified
    in this form.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    and last name (please print):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 10pt 5.4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 5 TO BE COMPLETED BY THE SALESPERSON </B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.&nbsp;&nbsp;Salesperson
    information</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Instruction:
    The salesperson is the person who meets with, or provides information to, the purchaser with respect to making this investment.
    That could include a representative of the issuer or selling security holder, a registrant or a person who is exempt from
    the registration requirement.]</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    and last name of salesperson (please print): </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of firm (if registered):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 10pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 6 TO BE COMPLETED BY THE ISSUER OR SELLING SECURITY HOLDER</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.&nbsp;&nbsp;For
    more information about this investment</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 1.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>NioCorp
Developments Ltd. </I></B>&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>7000
South Yosemite Street, Suite 115</I></B>&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Centennial,
CO 80112 </I></B>&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Attn:
Neal Shah</I></B>&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Tel:
(720) 940-7826</I></B>&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>email:
[***]</I></B></FONT><BR></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
more information about prospectus exemptions, contact your local securities regulator. You can find contact information at <U>www.securities-administrators.ca</U>.</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B>&nbsp;</FONT></P></TD></TR>
<TR>
    <TD STYLE="width: 53%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Form
instructions:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>1.</I></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
                                         form does not mandate the use of a specific font size or style but the font must be legible.</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>2.</I></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
                                         information in sections 1, 5 and 6 must be completed before the purchaser completes and
                                         signs the form.</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>3.</I></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
                                         purchaser must sign this form. Each of the purchaser and the issuer or selling security
                                         holder must receive a copy of this form signed by the purchaser. The issuer or selling
                                         security holder is required to keep a copy of this form for 8 years after the distribution.</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
<B>ACCREDITED INVESTOR STATUS CERTIFICATE (U.S.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>THE
SECURITIES TO WHICH THIS SUBSCRIPTION AGREEMENT RELATES AND THE SECURITIES ISSUABLE UPON EXERCISE THEREOF HAVE NOT BEEN AND WILL
NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;1933 ACT&rdquo;) OR ANY APPLICABLE STATE
SECURITIES LAWS IN THE UNITED STATES AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES (AS SUCH TERM IS DEFINED
IN REGULATION S UNDER THE 1933 ACT) OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, A U.S. PERSON (AS DEFINED IN REGULATION S OF THE
1933 ACT), EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION REQUIREMENTS OF THE 1933 ACT, AND IN ACCORDANCE WITH ANY APPLICABLE STATE
SECURITIES LAWS. HEDGING TRANSACTIONS INVOLVING THE SECURITIES ARE PROHIBITED EXCEPT IN COMPLIANCE WITH THE 1933 ACT. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the undersigned&rsquo;s (the &ldquo;<B>Subscriber</B>&rdquo;) subscription for Units, by executing this Accredited
Investor Status Certificate (U.S.), the Subscriber represents, warrants and covenants to and with the Issuer as follows (capitalized
terms used herein and not otherwise defined shall have the meaning given in the Subscription Agreement to which this Accredited
Investor Status Certificate (U.S.) is attached):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber understands that the Securities have not been and will not be, prior to distribution,
                                         registered under the United States Securities Act of 1933, as amended (the &ldquo;<B>1933
                                         Act</B>&rdquo;), or the securities laws of any state of the United States and that the
                                         offer and sale of the Offered Units to it will be made in reliance upon an exemption
                                         from registration under Rule 506(b) under Regulation D under the 1933 Act available to
                                         the Issuer for offers and sales to &ldquo;accredited investors&rdquo; as defined in Rule
                                         501(a) of Regulation D under the 1933 Act (&ldquo;<B>Accredited Investors</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber acknowledges that prior to the time of purchase of any Units it has been afforded
                                         the opportunity to ask such questions as it has deemed necessary of, and to receive answers
                                         from, representatives of the Issuer concerning the terms and conditions of the offering
                                         of the Units and to obtain such additional information which the Issuer possesses or
                                         can acquire without unreasonable effort or expense;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber has such knowledge and experience in financial and business matters as to
                                         be capable of evaluating the merits and risks of its investment in the Securities and
                                         is able, without impairing its financial condition, to hold such Securities for an indefinite
                                         period of time and to bear the economic risks of, and withstand a complete loss of, such
                                         investment;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber (and, if the Subscriber is acting on behalf of a beneficial purchaser, such
                                         beneficial purchaser) (i) is an Accredited Investor, (ii) is acquiring the Units for
                                         its own account or for the account of one or more Accredited Investors with respect to
                                         which it exercises sole investment discretion, and in each case not with a view to any
                                         resale, distribution or other disposition of the Securities in violation of United States
                                         federal or state securities laws, and (iii) satisfies (and the beneficial purchaser,
                                         if any, satisfies) the requirements of the paragraphs below to which the Subscriber has
                                         affixed his or her initials</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
line identified as &ldquo;S&rdquo; next to the corresponding paragraph applicable to the Subscriber must be initialed and, if
there is a beneficial purchaser, the line identified as &ldquo;BP&rdquo; next to the corresponding paragraph describing the requirement
satisfied by the beneficial purchaser must be initialed:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(S)&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(BP)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="width: 4%; padding-top: 4pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 76%; padding-top: 4pt; padding-bottom: 4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
bank as defined in Section 3(a)(2) of the 1933 Act or any savings and loan association or other institution as defined in Section
3(a)(5)(A) of the 1933 Act whether acting in its individual or fiduciary capacity; any broker dealer registered pursuant to Section
15 of the <I>Securities Exchange Act of 1934</I>, as amended; any insurance company as defined in Section 2(a)(13) of the 1933
Act; any investment company registered under the <I>Investment Company Act of 1940 </I>or a business </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 30; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 10pt">&nbsp;</TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify">development
    company as defined in Section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small Business
    Administration under Section 301(c) or (d) of the <I>Small Business Investment Act of 1958</I>; any plan established and maintained
    by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the
    benefit of its employees, if such plan has total assets in excess of US$5,000,000; any employee benefit plan within the meaning
    of the <I>Employee Retirement Income Security Act of 1974</I>, if the investment decision is made by a plan fiduciary, as
    defined in Section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered
    investment adviser, or if the employee benefit plan has total assets in excess of US$5,000,000, or, if a self-directed plan,
    with investment decisions made solely by persons that are &ldquo;accredited investors&rdquo; as defined in Rule 501(a) under
    the 1933 Act;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 20%; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(S)&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(BP)&nbsp;</FONT></P></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify; width: 76%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    private business development company as defined in Section 202(a)(22) of the <I>Investments Advisers Act of 1940</I>;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(S)&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(BP)&nbsp;</FONT></P></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, or Massachusetts or similar business
    trust or partnership, not formed for the specific purpose of acquiring the Offered Units offered, with total assets in excess
    of US$5,000,000;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(S)&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(BP)&nbsp;</FONT></P></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    director, executive officer or general partner of the Issuer; or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(S)&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(BP)&nbsp;</FONT></P></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    natural person whose individual net worth, or joint net worth with that person&rsquo;s spouse, at the time of this purchase
    exceeds US$1,000,000; provided, however, that (i) a person&rsquo;s primary residence shall not be included as an asset; (ii)
    indebtedness that is secured by the person&rsquo;s primary residence, up to the estimated fair market value of the primary
    residence at the time of the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness
    outstanding at the time of the sale of securities exceeds the amount outstanding 60 days before such time, other than as a
    result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and (iii)
    indebtedness that is secured by the person&rsquo;s primary residence in excess of the estimated fair market value of the primary
    residence at the time of the sale of securities shall be included as a liability; or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(S)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(BP)&nbsp;</FONT></P></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
natural person who had an individual income in excess of US$200,000 in each of the two most recent years or joint income with
that person's spouse in excess of US$300,000 in each of those years and has a reasonable expectation of reaching the same income
level in the current year; or&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(S)&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(BP)&nbsp;</FONT></P></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    trust with total assets in excess of US$5,000,000, not formed for the specific purpose of acquiring the Offered Units, whose
    purchase is directed by a sophisticated person, being defined as a person who has such knowledge and experience in financial
    and business matters that he or she is capable of evaluating the merits and risks of the prospective investment.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(S)&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________(BP)&nbsp;</FONT></P></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="padding-top: 4pt; padding-bottom: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    entity in which all of the equity owners are accredited investors (if this category is selected, the Subscriber must provide
    certification as to the category under which each equity owner qualifies as an Accredited Investor).</FONT></TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Subscriber acknowledges that it has not purchased the Units as a result of any &ldquo;general solicitation&rdquo; or &ldquo;general
advertising&rdquo; (as those terms are used in Regulation D under the 1933 Act), including any advertisements, articles, notices
or other communications published on the internet or in any newspaper,</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">magazine or similar
                                         media or broadcast over radio, television or the internet, or any seminar or meeting
                                         whose attendees have been invited by general solicitation or general advertising;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber understands and acknowledges that the Securities are &ldquo;restricted securities&rdquo;
                                         within the meaning of Rule 144 under the 1933 Act, and that if in the future it decides
                                         to offer, resell, pledge or otherwise transfer any of such securities, such securities
                                         may be offered, resold, pledged or otherwise transferred, directly or indirectly, only
                                         (a) to the Issuer; (b) pursuant to an effective registration statement under the 1933
                                         Act; (c) in accordance with Rule 144 under the 1933 Act, if available, and, in each case,
                                         in compliance with any applicable securities laws of any state of the United States;
                                         or (d) pursuant to another exemption from the registration requirements under the 1933
                                         Act and any applicable securities laws of any state of the United States, after providing
                                         an opinion of counsel, of recognized standing, in form and substance reasonably satisfactory
                                         to the Issuer, to the effect that the proposed transfer may be effected without registration
                                         under the 1933 Act;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber understands and acknowledges that upon the original issuance of the Securities
                                         and until such time as the same is no longer required under applicable requirements of
                                         the 1933 Act or applicable securities laws of any state of the United States, certificates
                                         representing the Securities and all certificates issued in exchange therefor or in substitution
                                         thereof, shall bear a legend to the following effect:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&ldquo;THE
SECURITIES REPRESENTED HEREBY [For warrants Include: and the securities issuable upon exercise hereof] HAVE NOT BEEN AND WILL
NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;U.S. Securities Act&rdquo;), OR UNDER
ANY STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING THESE securities, AGREES FOR THE BENEFIT OF NIOCORP DEVELOPMENTS LTD.
(THE &ldquo;COmpany&rdquo;), THAT THESE securities MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, directly or indirectly
ONLY (A) TO THE COMPANY, (B) IF THE SECURITIES HAVE BEEN REGISTERED IN COMPLIANCE WITH THE REGISTRATION REQUIREMENTS UNDER THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS (C) IN COMPLIANCE WITH THE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS UNDER THE SECURITIES ACT IN ACCORDANCE WITH RULE 144 THEREUNDER, IF APPLICABLE, AND IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS, OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE
LAWS AND REGULATIONS GOVERNING THE OFFER AND SALE OF SECURITIES, AND, IN EACH CASE, THE HOLDER HAS, PRIOR TO SUCH SALE, FURNISHED
TO THE COMPANY AN OPINION OF COUNSEL OF RECOGNIZED STANDING, OR OTHER EVIDENCE OF EXEMPTION, REASONABLY SATISFACTORY TO THE COMPANY
TO SUCH EFFECT. HEDGING TRANSACTIONS INVOLVING THE SECURITIES ARE PROHIBITED EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Securities are being sold pursuant to clause (C) in the legend above, the legend may be removed by delivery to Computershare
Investor Services Inc., as the Issuer&rsquo;s Canadian registrar and co-transfer agent, or Computershare Trust Company, as the
Issuer&rsquo;s U.S. co-transfer agent, of an opinion of counsel of recognized standing in form and substance satisfactory to the
Issuer, to the effect that the legend is no longer required under applicable requirements of the 1933 Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants may not be exercised unless exemptions are available from the registration requirements of the 1933 Act and the securities
laws of all applicable states of the United States, and the holder has furnished an opinion of counsel of recognized standing
in form and substance reasonably satisfactory to the Issuer to such effect; provided that a holder of warrants (a &ldquo;Warrantholder&rdquo;)
will not be required to deliver an opinion of counsel in connection with its due exercise of the Warrants that comprise part of
the Units purchased pursuant to the Offering, for its own account or for the account of the original beneficial purchaser, if
any, at a time when the Warrantholder and such original beneficial purchaser, if any, are Accredited Investors and its representations
and warranties contained in this Accredited Investor</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 1in"> Status Certificate (U.S.) remain
                                         true and correct with respect to the exercise of the Warrants and the holder represents
                                         to the Issuer as such.</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                         the original issuance of the Warrants and until such time as is no longer required under
                                         applicable requirements of the 1933 Act or applicable state securities laws, all certificates
                                         representing the Warrants sold in the United States and to, or for the account or benefit
                                         of, U.S. Persons, and all certificates issued in exchange therefor or in substitution
                                         thereof, shall bear a legend substantially in the following form:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&ldquo;THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933,
AS AMENDED (THE &ldquo;U.S. SECURITIES ACT&rdquo;). THIS WARRANT MAY NOT BE EXERCISED UNLESS THE SHARES ISSUABLE UPON EXERCISE
OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH STATE
OR EXEMPTIONS FROM SUCH REGISTRATION REQUIREMENTS ARE AVAILABLE.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber consents to the Issuer making a notation on its records or giving instructions
                                         to any transfer agent of the Securities in order to implement the restrictions on transfer
                                         set forth and described herein;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber understands and acknowledges that, except as set forth in the Subscription
                                         Agreement, the Issuer is not obligated to file and has no present intention of filing
                                         with the U.S. SEC or with any state securities commission any registration statement
                                         in respect of resales of the Securities in the United States;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                         required by applicable securities legislation, regulatory policy or order or by any securities
                                         commission, stock exchange or other regulatory authority, the Subscriber will execute,
                                         deliver and file and otherwise assist the Issuer in filing reports, questionnaires, undertakings
                                         and other documents with respect to the issue of the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber (i) acknowledges and understands that (1) there may be material tax consequences
                                         to it of the acquisition, ownership, holding, exercise or disposition of the Securities,
                                         including those relating to the Issuer&rsquo;s potential status as a &ldquo;passive foreign
                                         investment corporation&rdquo; under the Internal Revenue Code of 1986, as amended, and
                                         those relating to the potential tax consequences of the Issuer&rsquo;s combination with
                                         GX Acquisition Corp. II on March 17, 2023 and related transactions, and (2) the Issuer
                                         does not give any opinion or make any representation with respect to the tax consequences
                                         under the United States, state, local or foreign law of the acquisition, ownership, holding,
                                         exercise or disposition of the Securities, and (ii) will consult its own tax advisors
                                         about the United States, state, local and foreign tax consequences of acquiring, owning,
                                         holding, exercising and disposing of the Securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                         acknowledges that it is encouraged to obtain independent legal, income tax and investment
                                         advice with respect to its subscription for the Units and accordingly, has had an opportunity
                                         to acquire an understanding of the meanings of all terms contained herein relevant to
                                         the Subscriber for the purpose of giving the representations, warranties and covenants
                                         contained herein;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber has been independently advised as to the applicable hold period and restrictions
                                         with respect to trading imposed in respect of the Securities by securities legislation
                                         in the jurisdiction in which it resides, and confirms that no representation has been
                                         made respecting the applicable hold periods for such Securities and is aware of the risks
                                         and other characteristics of the Securities and of the fact that the Subscriber may not
                                         be able to resell any of the Securities except in accordance with applicable securities
                                         legislation and regulatory policy; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         Subscriber understands and acknowledges that it is making the representations and warranties
                                         and agreements contained herein with the intent that the they may be relied upon by the
                                         Issuer, in determining its eligibility or (if applicable) the eligibility of others on
                                         whose behalf it is contracting hereunder to purchase the Units.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber undertakes to notify the Issuer immediately at the principal offices of the Issuer of any change in any representation,
warranty or other information relating to the Subscriber set forth herein which takes place prior to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Issuer shall be entitled to rely on delivery of a facsimile or PDF copy of this Accredited Investor Status Certificate (U.S.).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DATED
</B>this________ day of ________________, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
        of Subscriber - please print)</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by:</FONT></P></TD>
    <TD STYLE="width: 47%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Official Capacity or Title - please print)</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>
                    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
Signature</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
print name of individual whose signature appears above if different than the name of the Subscriber printed above.)&nbsp;</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.9
<SEQUENCE>5
<FILENAME>n2574_x224exh4-9.htm
<DESCRIPTION>FORM OF SERIES A PRIVATE WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 4.9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>UNLESS PERMITTED UNDER SECURITIES LEGISLATION,
THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE MARCH 13, 2025.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE SECURITIES REPRESENTED HEREBY AND
THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR UNDER ANY STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING THESE
SECURITIES, AGREES FOR THE BENEFIT OF NIOCORP DEVELOPMENTS LTD. (THE &ldquo;COMPANY&rdquo;), THAT THESE SECURITIES MAY BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY ONLY (A) TO THE COMPANY, (B) IF THE SECURITIES HAVE BEEN REGISTERED
IN COMPLIANCE WITH THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS,
(C) IN COMPLIANCE WITH THE EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES ACT IN ACCORDANCE WITH RULE 144 THEREUNDER,
IF APPLICABLE, AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION
UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE LAWS AND REGULATIONS GOVERNING THE OFFER AND SALE OF SECURITIES, AND, IN EACH
CASE, THE HOLDER HAS, PRIOR TO SUCH SALE, FURNISHED TO THE COMPANY AN OPINION OF COUNSEL OF RECOGNIZED STANDING, OR OTHER EVIDENCE
OF EXEMPTION, REASONABLY SATISFACTORY TO THE COMPANY TO SUCH EFFECT. HEDGING TRANSACTIONS INVOLVING THE SECURITIES ARE PROHIBITED
EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS WARRANT MAY NOT BE EXERCISED UNLESS
THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT AND THE APPLICABLE SECURITIES LEGISLATION
OF ANY SUCH STATE OR EXEMPTIONS FROM SUCH REGISTRATION REQUIREMENTS ARE AVAILABLE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SERIES A COMMON SHARE PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NIOCORP DEVELOPMENTS LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40%">Warrant Shares: [_______]</TD>
<TD STYLE="width: 60%; text-align: right; padding-right: 0.15in">Initial Exercise Date: November 13, 2024</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS SERIES A COMMON
SHARE PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [_____________] or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m.
(New York City time) on November 13, 2026 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and
purchase from NioCorp Developments Ltd., a company incorporated under the laws of the Province of British Columbia (the &ldquo;<U>Company</U>&rdquo;),
up to [______] Common Shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price
of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
Canada or any day on which banking institutions in the State of New York or Province of British Columbia are authorized or required
by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Shares</U>&rdquo; means the common shares of the Company, without par value, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Share Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Other
Securities</U>&rdquo; means the Common Shares and warrants to purchase Common Shares issued in the Public Offering and the Private
Placement, other than this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Private
Placement</U>&rdquo; means the Company&rsquo;s private placement of Common Shares and warrants to purchase Common Shares, including
this Warrant, pursuant to the Subscription Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Offering</U>&rdquo; means the Company&rsquo;s offering of Common Shares and warrants to purchase Common Shares as described in
the preliminary prospectus supplement filed by the Company on November 1, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Agreements</U>&rdquo; means the subscription agreements pursuant to which the Warrants were initially sold by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company
formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Shares are traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
or the New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transactions</U>&rdquo;
means Private Placement and the Public Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare Investor Services Inc., with offices located at 150 Royal Street, Canton, MA 02021 and 100
University Avenue, 8<SUP>th</SUP> Floor, Toronto, Ontario M5J 2Y1, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest
preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Shares are not
then listed or quoted on a Trading Market and are listed or quoted for trading on OTCQB or OTCQX, the volume weighted average price
of the Common Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are
not then listed or quoted for trading on OTCQB or OTCQX, and if prices for the Common Shares are then reported on the Pink Open
Market (or a</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per Common
Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Share purchase warrants of the same series as this Warrant issued by the Company pursuant to
the Subscription Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or
agency of the Company as the Company may designate by notice in writing to the registered Holder at the address of the Holder appearing
on the books of the Company of (i) this Warrant and (ii) a duly executed Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;)). Within one (1) Trading Day following the date of exercise as aforesaid, the Holder shall deliver the
aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank. The Company shall deliver any objection to any Notice of Exercise within one (1) Business
Day of receipt of such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
Price</U>. The exercise price per Warrant Share under this Warrant shall be $1.75, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>[Reserved.]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes
to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of
the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price is received by the Company. Upon
the exercise of this Warrant, including receipt of payment of the aggregate Exercise Price for such exercise, the Company will
credit the account of the Holder in the Direct Registration System (&ldquo;<U>DRS</U>&rdquo;) book entry system maintained by the
Transfer Agent for the Common Shares, within two (2) business days of the exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of the
Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0">Warrant, which new Warrant shall in all
other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the date that is two (2) business days after the delivery of the Exercise Price to the Company, then the Holder will have the
right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>[Reserved]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. If, upon the exercise of this Warrant, the Holder would be entitled to receive a fractional interest in a Warrant
Share, the Company will, upon exercise, round down to the nearest whole number of Warrant Shares to be issued to the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall pay all Transfer Agent fees required for same day processing of any Notice of Exercise, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing
of Books</U>. The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Beneficial
Ownership</U>. Notwithstanding anything to the contrary contained herein, the Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent
that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together
with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s
Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership
Limitation (as defined below). For purposes of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0">the foregoing sentence, the number of Common Shares beneficially owned by the Holder
and its Affiliates and Attribution Parties shall include the number of Common Shares issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (i)
exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution
Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including,
without limitation, any other Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding
sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange
Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e)
applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this
Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group
status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding Common Shares, a Holder may
rely on the number of outstanding Common Shares as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of Common Shares outstanding. Upon the written or oral request of
a Holder, the Company shall within three (3) Trading Days confirm orally and in writing to the Holder the number of Common Shares
then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding Common Shares was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% of the number of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0">Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable
upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Common
Shares outstanding immediately after giving effect to the issuance of Common Shares upon exercise of this Warrant held by the Holder
and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be
effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be
construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained
or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
Limitation</U>. Notwithstanding anything in this Warrant to the contrary, unless approval from the shareholders of the Company
with respect to the Transactions has been obtained, the Holder shall not have the right to exercise any portion of this Warrant
hereunder to the extent that after giving effect to such exercise, the number of Common Shares issued pursuant to such exercise,
together with the number of Common Shares issued pursuant to any prior exercise(s) of this Warrant, plus the number of Other Securities
previously issued in the Transactions, would exceed 19.99% of the Common Shares outstanding immediately prior to November 6, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Share
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise
makes a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable in Common
Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines (including by way of reverse share split)
outstanding Common Shares into a smaller number of shares, or (iv) issues by reclassification of Common Shares any securities of
the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number
of Common Shares (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall
be the number of Common Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this
Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of
a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues
or sells any Common Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record
holders of any class of Common Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder
had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in
abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Pro
Rata Distributions</U>. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Common
Shares (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants
to subscribe for or purchase any security other than the Common Shares, then in each such case the Exercise Price shall be adjusted
by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of shareholders entitled
to receive such distribution by a fraction of which the denominator shall be the VWAP determined as of the record date mentioned
above, and of which the numerator shall be such VWAP on such record date less the then per share fair market value at such record
date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding Common Share as determined
by the Board of Directors in good faith. In either case the adjustments shall be described in a statement provided to the Holder
of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one Common Share.
Such adjustment shall be made whenever any such distribution is made and shall become effective immediately after the record date
mentioned above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger, amalgamation, arrangement or consolidation of the Company with or into another Person, (ii) the
Company and its Subsidiaries, taken as a whole, directly or indirectly, effects any sale, lease, license, assignment, transfer,
conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any,
direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant
to which holders of Common Shares are permitted to sell,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of greater than 50% of the outstanding Common Shares or greater than 50% of the voting power
of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any
reclassification, reorganization or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the
Common Shares are effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger, amalgamation or arrangement) with another Person or group
of Persons whereby such other Person or group acquires greater than 50% of the outstanding Common Shares or greater than 50% of
the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon
such exercise immediately prior to the occurrence of such Fundamental Transaction, the same amount and kind of securities, cash
or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately
prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant
without regard to any limitation in Section 2(e) on the exercise of this Warrant (the &ldquo;<U>Alternate Consideration</U>&rdquo;).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate Consideration. If holders of Common Shares are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to
the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s
option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or,
if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder
by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion
of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the
Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors,
the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid
to the holders of Common Shares of the Company in connection with the Fundamental Transaction, whether that consideration be in
the form of cash, shares or any combination thereof, or whether the holders of Common Shares are given the choice to receive from
among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that
if holders of Common Shares of the Company are not offered or paid any consideration in</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">such Fundamental Transaction, such holders
of Common Shares will be deemed to have received common shares of the Successor Entity (which Successor Entity may be the Company
following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value
of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined
as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility
obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately
following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used
in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of
any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the VWAP immediately preceding the public
announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction,
if earlier), (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental
Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire
transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s
election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of
the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Common
Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the Common Shares pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which
is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0">Company prior thereto and the Successor
Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant with the same
effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given date shall be the
sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to
the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C)
the Company shall authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any
securities of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with
any reclassification of the Common Shares, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party,
any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Shares are
converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to
the Holder at its last email address as it shall appear upon the Warrant Register (as defined below) of the Company, at least ten
(10) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which
a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to
be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or
share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Shares
of record shall be entitled to exchange their Common Shares for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0">or share exchange; provided that the failure to deliver such notice or any defect therein
or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the
extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company
or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice
to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term
of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board
of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in
part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment
of this Warrant substantially in the form attached hereto properly completed and duly executed by the Holder or its agent or attorney
(along with a medallion signature guarantee) and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name
of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly
be cancelled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants
to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial
issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0">Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and
for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer
Restrictions</U>. This Warrant may only be disposed of in compliance with state and U.S. federal securities laws and shall not
be transferred unless the Warrant is (i) registered pursuant to an effective registration statement under the Securities Act and
under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner of sale restrictions or
current public information requirements pursuant to Rule 144 under the Securities Act. In addition, this Warrant may only be transferred
in compliance with applicable Canadian securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for
distributing or reselling this Warrant or such Warrant Shares or any part thereof in violation of the Securities Act or any applicable
state securities laws, except pursuant to sales registered under, or exempt from the registration requirements of, the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except
as expressly set forth in Section 3. Without limiting any rights of a Holder to receive cash payments pursuant to Section 2(d)(i)
and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender and
cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate
of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged
with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be
listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by
the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and
to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions
as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting
the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory
body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without giving effect to conflicts
of law principles that would result in the application of the substantive laws of another jurisdiction. Each party agrees</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0">that
all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant
(whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees
or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for
such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any
provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for
their reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by provincial, state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any
material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses, including, but not limited to, reasonable attorneys&rsquo; fees, excluding those of appellate proceedings, incurred by
the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation,
any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier
service, addressed to the Company, at 7000 South Yosemite Street, Suite 115, Centennial, Colorado, 80112, Attention: Neal Shah,
email address: [***], or such other</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0">email address or address as the Company may specify for such purposes by notice
to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing
and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the
e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries
hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii)
the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address
set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii)
the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)
upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder
constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any Common Shares or as a shareholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand,
and the Holder, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">m)&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)<BR STYLE="clear: both">
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>NIOCORP DEVELOPMENTS LTD.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: NIOCORP
DEVELOPMENTS LTD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&nbsp;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in"> (2) Payment shall take the form of lawful money of the United States.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be credit the
account of the Holder in the DRS book entry system maintained by the Transfer Agent for the Common Shares, if applicable, or delivered
by physical delivery of a certificate to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4)&nbsp;<U>Representations
and Warranties of Holder</U>. The undersigned registered Holder hereby represents, warrants and certifies that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
undersigned is resident in the jurisdiction indicated as its address set forth in this Notice of Exercise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
undersigned acknowledges that the Warrants and Warrant Shares (collectively, the &ldquo;<B>Securities</B>&rdquo;) may not be offered
or sold in the United States or to U.S. Persons (as defined in Rule 902(k) of Regulation S promulgated under the 1933 Act) without
registration under the United States Securities Act of 1933, as amended (the &ldquo;<B>1933 Act</B>&rdquo;), and any applicable
state securities laws, unless an exemption from registration is available;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
undersigned has made reasonable inquiry into the jurisdiction of residence of all persons to whom Warrant Shares are to be issued
hereunder, and, with respect to each such person, <B><U>either </U></B>(A)(i) at the time of this exercise, it is not a U.S. Person
(as defined in Rule 902(k) of Regulation S promulgated under the United States Securities Act of 1933, as amended (the &ldquo;<B>1933
Act</B>&rdquo;)) and did not execute this Notice of Exercise, as applicable, while within the United States, (ii) it is not taking
delivery of any of the Warrant Shares to be issued upon this exercise by or on behalf of any U.S. Person or any person who is within
the United States, and (iii) this exercise</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">in all other respects complies with the terms of Regulation S; <B><U>or</U></B> (B)(i)
it was an original purchaser in NioCorp Developments Ltd.&rsquo;s (the &ldquo;<B>Company</B>&rdquo;) private placement under which
the Warrants were issued, (ii) it is an &ldquo;Accredited Investor&rdquo; as defined in Rule 501(a) under the 1933 Act and (iii)
the representations and warranties made to the Company in connection with the acquisition of the Warrants remain true and correct
on the date of this Notice of Exercise; <B><U>or</U></B> (C) a written opinion of U.S. counsel to the effect that the issuance
of the Warrant Shares upon exercise of the Warrants contemplated hereby has been registered under the 1933 Act, or is exempt from
registration thereunder, is being delivered to the Company, provided that the Holder will not be required to deliver a written
opinion of U.S. counsel in connection with its due exercise of the Warrants, for its own account or for the account of the original
beneficial purchaser, if any, at a time when the Holder and such original beneficial purchaser, if any, are &ldquo;Accredited Investors&rdquo;
as defined in Rule 501(a) under the 1933 Act and its representations and warranties contained in Schedule C to the Subscription
Agreement remain true and correct with respect to the exercise of the Warrants and the Holder represents to the Company as such;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
undersigned does not have any agreement or understanding (written or oral) with any person in the United States or a U.S. Person
respecting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
transfer or assignment of any rights or interest in any of the Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
division of profits, losses, fees, commissions, or any financial stake in connection with any of the Securities; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
voting of the Warrant Shares to be issued hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(5)&nbsp;the
aforesaid Warrant Shares are being acquired for investment and not with a view to, or for resale in connection with, the distribution
thereof, and that the undersigned has no present intention of distributing or reselling such Warrant Shares in connection with
the distribution thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Address of Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>Signature of Holder</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Authorized Signatory of Holder that
is an Entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Title of Authorized Signatory of Holder that
is an Entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE: The signature to this Notice of Exercise
must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever.
If this Notice of Exercise indicates that Warrant Shares are to be issued to a person or persons other than the registered Holder
of the Warrants being exercised, the signature to this Notice of Exercise must be medallion guaranteed by a bank or trust company
and the registered Holder must pay the Company all applicable taxes and other duties. Officers of corporations or other entities
and those acting in a fiduciary or other representative capacity should file proper evidence of authority to exercise the foregoing
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registered holder of a Warrant may
exercise its right to purchase Warrant Shares by completing and surrendering this Notice of Exercise and the Warrant being exercised
to the Company, together with the aggregate amount of the Exercise Price for the Warrant Shares as provided for in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the
foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 80%; font-size: 10pt; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(Please
    Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Dated: </FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">_______________
    __, ______</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE: The signature to this Assignment
Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever,
and must be medallion guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other
representative capacity should file proper evidence of authority to assign the foregoing Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WARRANTS SHALL ONLY BE ASSIGNABLE IN
ACCORDANCE WITH APPLICABLE LAWS, AND THE RESALE OF WARRANTS AND COMMON SHARES ISSUABLE UPON EXERCISE OF WARRANTS MAY BE SUBJECT
TO RESTRICTIONS UNDER SUCH LAWS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPRESENTATIONS AND WARRANTIES OF ASSIGNEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">The undersigned assignee
hereby represents and warrants it is a <I>bona fide </I>resident of the jurisdiction set forth above for its address, and that
<B><U>either </U></B>(A)(i) at the time of this assignment, it is not a U.S. Person (as defined in Rule 902(k) of Regulation S
promulgated under the United States Securities Act of 1933, as amended (the &ldquo;<B>1933 Act</B>&rdquo;)) and did not execute
this Assignment Form while within the United States, (ii) it is not taking assignment of any of the Warrants represented by the
Assignment Form by or on behalf of any U.S. Person or any person who is within the United States, and (iii) this assignment in
all other respects complies with the terms of Regulation S; <B><U>or</U></B> (B)(i) it was an original purchaser in NioCorp Developments
Ltd.&rsquo;s (the &ldquo;<B>Company</B>&rdquo;) private placement under which the Warrants were issued, (ii) it is an &ldquo;Accredited
Investor&rdquo; as defined in Rule 501(a) under the 1933 Act and (iii) the representations and warranties made to the Company in
connection with the acquisition of the Warrants remain true and correct on the date of this Assignment Form; <B><U>or</U></B> (C)
the undersigned assignee is delivering a written</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">opinion of U.S. counsel to the effect that the assignment of the Warrants contemplated
hereby has been registered under the 1933 Act, or is exempt from registration thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature of Assignee</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name (Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.10
<SEQUENCE>6
<FILENAME>n2574_x224exh4-10.htm
<DESCRIPTION>FORM OF SERIES B PRIVATE WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 4.10</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE MARCH 13, 2025.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER
THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR UNDER ANY STATE SECURITIES LAWS. THE
HOLDER HEREOF, BY PURCHASING THESE SECURITIES, AGREES FOR THE BENEFIT OF NIOCORP DEVELOPMENTS LTD. (THE &ldquo;COMPANY&rdquo;),
THAT THESE SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY ONLY (A) TO THE COMPANY,
(B) IF THE SECURITIES HAVE BEEN REGISTERED IN COMPLIANCE WITH THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS, (C) IN COMPLIANCE WITH THE EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES
ACT IN ACCORDANCE WITH RULE 144 THEREUNDER, IF APPLICABLE, AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, OR (D) IN
A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE LAWS AND REGULATIONS GOVERNING
THE OFFER AND SALE OF SECURITIES, AND, IN EACH CASE, THE HOLDER HAS, PRIOR TO SUCH SALE, FURNISHED TO THE COMPANY AN OPINION OF
COUNSEL OF RECOGNIZED STANDING, OR OTHER EVIDENCE OF EXEMPTION, REASONABLY SATISFACTORY TO THE COMPANY TO SUCH EFFECT. HEDGING
TRANSACTIONS INVOLVING THE SECURITIES ARE PROHIBITED EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
WARRANT MAY NOT BE EXERCISED UNLESS THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH STATE OR EXEMPTIONS FROM SUCH REGISTRATION REQUIREMENTS ARE AVAILABLE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
B COMMON SHARE PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NIOCORP
DEVELOPMENTS LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    Shares: [_______]</FONT></TD>
    <TD STYLE="width: 50%; text-align: right; padding-right: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance
    Date: November 13, 2024</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-right: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-right: 0.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: May 14, 2025</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES B COMMON SHARE PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [_____________]
or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after May 14, 2025 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on
or prior to 5:00 p.m. (New York City time) on November 13, 2029 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter,
to subscribe for and purchase from NioCorp Developments Ltd., a company incorporated under the laws of the Province of British
Columbia (the &ldquo;<U>Company</U>&rdquo;), up to [______] Common Shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined
in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. In addition to the
terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
Canada or any day on which banking institutions in the State of New York or Province of British Columbia are authorized or required
by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Shares</U>&rdquo; means the common shares of the Company, without par value, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Share Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other
instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to
receive, Common Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Other
Securities</U>&rdquo; means the Common Shares and warrants to purchase Common Shares issued in the Public Offering and the Private
Placement, other than this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Private
Placement</U>&rdquo; means the Company&rsquo;s private placement of Common Shares and warrants to purchase Common Shares, including
this Warrant, pursuant to the Subscription Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Offering</U>&rdquo; means the Company&rsquo;s offering of Common Shares and warrants to purchase Common Shares as described in
the preliminary prospectus supplement filed by the Company on November 1, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Agreements</U>&rdquo; means the subscription agreements pursuant to which the Warrants were initially sold by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company
formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Shares are traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
or the New York Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transactions</U>&rdquo;
means Private Placement and the Public Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare Investor Services Inc., with offices located at 150 Royal Street, Canton, MA 02021 and 100
University Avenue, 8<SUP>th</SUP> Floor, Toronto, Ontario M5J 2Y1, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest
preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if the Common Shares
are not then listed or quoted on a Trading Market and are listed or quoted for trading on OTCQB or OTCQX, the volume weighted
average price of the Common</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or
quoted for trading on OTCQB or OTCQX, and if prices for the Common Shares are then reported on the Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported,
or (d)&nbsp;in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in
good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Share purchase warrants of the same series as this Warrant issued by the Company pursuant
to the Subscription Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such
other office or agency of the Company as the Company may designate by notice in writing to the registered Holder at the address
of the Holder appearing on the books of the Company of (i) this Warrant and (ii) a duly executed Notice of Exercise in the form
annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;)). Within one (1) Trading Day following the date of exercise as aforesaid,
the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by
wire transfer or cashier&rsquo;s check drawn on a United States bank. The Company shall deliver any objection to any Notice of
Exercise within one (1) Business Day of receipt of such notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Exercise Price</U>. The exercise price per Warrant Share under this Warrant shall be $2.07, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>[Reserved.]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Delivery of Warrant Shares Upon Exercise</U>. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate
purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price is received by the Company.
Upon the exercise of this Warrant, including receipt of payment of the aggregate Exercise Price for such exercise, the Company
will credit the account of the Holder in the Direct Registration System (&ldquo;<U>DRS</U>&rdquo;) book entry system maintained
by the Transfer Agent for the Common Shares, within two (2) business days of the exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of the Holder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all
other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the date that is two (2) business days after the delivery of the Exercise Price to the Company, then the
Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>[Reserved]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. If, upon the exercise of this Warrant, the Holder would be entitled to receive a fractional interest in a Warrant
Share, the Company will, upon exercise, round down to the nearest whole number of Warrant Shares to be issued to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid
by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; <U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same day processing of any Notice
of Exercise, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Closing of Books</U>. The Company will not close its shareholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Holder&rsquo;s Exercise Limitations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Beneficial Ownership</U>. Notwithstanding anything to the contrary contained herein, the Company shall not effect any exercise
of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise,
to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the
Holder (together with the Holder&rsquo;s Affiliates, and any other Persons</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing
sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include
the number of Common Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but
shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of
this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common
Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for
purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and
the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to
the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e)
applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this
Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group
status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding Common Shares, a Holder may
rely on the number of outstanding Common Shares as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written
notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding.&nbsp; Upon the written or oral
request of a Holder, the Company shall within three (3) Trading Days confirm orally and in writing to the Holder the number of
Common Shares then outstanding.&nbsp; In any case, the number of outstanding Common Shares shall be determined after giving effect
to the conversion or exercise of securities of the Company, including</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding Common Shares
was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of Common Shares outstanding
immediately after giving effect to the issuance of Common Shares issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the
Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Common Shares outstanding immediately after giving
effect to the issuance of Common Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e)
shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st </SUP>day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which
may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to
a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Issuance Limitation</U>. Notwithstanding anything in this Warrant to the contrary, unless approval from the shareholders of
the Company with respect to the Transactions has been obtained, the Holder shall not have the right to exercise any portion of
this Warrant hereunder to the extent that after giving effect to such exercise, the number of Common Shares issued pursuant to
such exercise, together with the number of Common Shares issued pursuant to any prior exercise(s) of this Warrant, plus the number
of Other Securities previously issued in the Transactions, would exceed 19.99% of the Common Shares outstanding immediately prior
to November 6, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Share Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or
otherwise makes a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable
in Common Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines (including by way of reverse
share split) outstanding Common Shares into a smaller number of shares, or (iv) issues by reclassification of Common Shares any
securities of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall
be the number of Common Shares (excluding treasury shares, if any) outstanding immediately before such event and of which the
denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares issuable upon
exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately
after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company
grants, issues or sells any Common Share Equivalents or rights to purchase shares, warrants, securities or other property pro
rata to the record holders of any class of Common Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a
record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such
extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Pro Rata Distributions</U>. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders
of Common Shares (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights
or warrants to subscribe for or purchase any security other than the Common Shares, then in each such case the Exercise Price
shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of
shareholders entitled to receive such distribution by a fraction of which the denominator shall be the VWAP determined as of the
record date mentioned above, and of which the numerator shall be such VWAP on such record date less the then per share fair market
value at such record date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding
Common Share as determined by the Board of Directors in good faith. In either case the adjustments shall be described in a statement
provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable
to one Common Share. Such adjustment shall be made whenever any such distribution is made and shall become effective immediately
after the record date mentioned above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;&nbsp;&nbsp;&nbsp;
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger, amalgamation, arrangement or consolidation of the Company with or into another
Person, (ii) the Company and its Subsidiaries, taken as a whole, directly or indirectly, effects any sale, lease, license, assignment,
transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions,
(iii) any, direct or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">indirect,
purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders
of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted
by the holders of greater than 50% of the outstanding Common Shares or greater than 50% of the voting power of the common equity
of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively
converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more
related transactions consummates a share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off, merger, amalgamation or arrangement) with another Person or group of Persons whereby such other Person
or group acquires greater than 50% of the outstanding Common Shares or greater than 50% of the voting power of the common equity
of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction, the same amount and kind of securities, cash or property as it would have been
entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental
Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard to
any limitation in Section 2(e) on the exercise of this Warrant (the &ldquo;<U>Alternate Consideration</U>&rdquo;). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Shares are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to
the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the
Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant
from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>,
that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors,
the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid
to the holders of Common Shares of the Company in connection with the Fundamental Transaction, whether that consideration be in
the form of cash, shares or any combination thereof, or whether the holders of Common Shares are given the choice to receive from
among alternative forms of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consideration
in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Shares of the Company
are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Shares will be deemed to have
received common shares of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction)
in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes
Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the
applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S.
Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility obtained from the HVT function
on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public announcement
of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the
greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if
any, being offered in such Fundamental Transaction and (ii) the VWAP immediately preceding the public announcement of the applicable
contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier), (D) a remaining
option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination
Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available
funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date
of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which
the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Common Shares acquirable and
receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking
into account the relative value of the Common Shares pursuant to such Fundamental Transaction and the value of such shares of
capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added
to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental
Transaction, each and every provision of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to each of the
Company and the Successor Entity or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successor
Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may
exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of
the obligations of the Company prior thereto under this Warrant with the same effect as if the Company and such Successor Entity
or Successor Entities, jointly and severally, had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given
date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the
Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any
resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Shares, (C) the Company shall authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or
purchase any securities of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in
connection with any reclassification of the Common Shares, any consolidation or merger to which the Company (or any of its Subsidiaries)
is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common
Shares are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered
by email to the Holder at its last email address as it shall appear upon the Warrant Register (as defined below) of the Company,
at least ten (10) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the
date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale,
transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the
Common Shares of record shall be entitled to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exchange
their Common Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale,
transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the
Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time
during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate
by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with
a written assignment of this Warrant substantially in the form attached hereto properly completed and duly executed by the Holder
or its agent or attorney (along with a medallion signature guarantee) and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such
instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable
pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;&nbsp;&nbsp;&nbsp;
<U>Transfer Restrictions</U>. This Warrant may only be disposed of in compliance with state and U.S. federal securities laws and
shall not be transferred unless the Warrant is (i) registered pursuant to an effective registration statement under the Securities
Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner of sale restrictions
or current public information requirements pursuant to Rule 144 under the Securities Act. In addition, this Warrant may only be
transferred in compliance with applicable Canadian securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;&nbsp;&nbsp;&nbsp;
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a
view to or for distributing or reselling this Warrant or such Warrant Shares or any part thereof in violation of the Securities
Act or any applicable state securities laws, except pursuant to sales registered under, or exempt from the registration requirements
of, the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>No Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting
rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i),
except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive cash payments pursuant to Section
2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender
and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share
certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;&nbsp;&nbsp;&nbsp;
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next
succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;&nbsp;&nbsp;&nbsp;
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common
Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.
The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights
represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens
and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution,
issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above
the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares
upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions
or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be
necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">York,
without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated
by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners,
members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New
York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is
an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If either party shall commence an action, suit or
proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed
by the other party for their reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
will have restrictions upon resale imposed by provincial, state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting
any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to
cover any costs and expenses, including, but not limited to, reasonable attorneys&rsquo; fees, excluding those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized
overnight courier service, addressed to the</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company,
at 7000 South Yosemite Street, Suite 115, Centennial, Colorado, 80112, Attention: Neal Shah, email address: [***],
or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices
or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by
e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address
of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed
given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at
the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after
the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by
the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability
of the Holder for the purchase price of any Common Shares or as a shareholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not
be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company,
on the one hand, and the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)&nbsp;&nbsp;&nbsp;
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)&nbsp;&nbsp;&nbsp;
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first
above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NIOCORP
                                         DEVELOPMENTS LTD.&nbsp;</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 45%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></P></TD>
    <TD STYLE="width: 52%; border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0in; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.5in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">NIOCORP
                                         DEVELOPMENTS LTD.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;&nbsp;
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;&nbsp;
Payment shall take the form of lawful money of the United States.</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;&nbsp;
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 1.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be credit the account of the Holder in the DRS book entry system maintained by the Transfer Agent for the
Common Shares, if applicable, or delivered by physical delivery of a certificate to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif"><TD STYLE="width: 1.5in; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 20%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)&nbsp;&nbsp;
<U>Representations and Warranties of Holder</U>. The undersigned registered Holder hereby represents, warrants and certifies that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
undersigned is resident in the jurisdiction indicated as its address set forth in this Notice of Exercise;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
undersigned acknowledges that the Warrants and Warrant Shares (collectively, the &ldquo;<B>Securities</B>&rdquo;) may not be offered
or sold in the United States or to U.S. Persons (as defined in Rule 902(k) of Regulation S promulgated under the 1933 Act) without
registration under the United States Securities Act of 1933, as amended (the &ldquo;<B>1933 Act</B>&rdquo;), and any applicable
state securities laws, unless an exemption from registration is available;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
undersigned has made reasonable inquiry into the jurisdiction of residence of all persons to whom Warrant Shares are to be issued
hereunder, and, with respect to each such person, <B><U>either&nbsp;</U></B>(A)(i) at the time of this exercise, it is not a U.S.
Person (as defined in Rule 902(k) of Regulation S promulgated under the United States Securities Act of 1933, as amended (the
&ldquo;<B>1933 Act</B>&rdquo;)) and did not execute this Notice of Exercise, as applicable, while within the United States, (ii)
it is not taking delivery of any of the Warrant Shares to be issued upon this exercise by or on behalf of any U.S. Person or any
person who is within the United States, and (iii) this exercise</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
all other respects complies with the terms of Regulation S;&nbsp;<B><U>or</U></B>&nbsp;(B)(i) it was an original purchaser in
NioCorp Developments Ltd.&rsquo;s (the &ldquo;<B>Company</B>&rdquo;) private placement under which the Warrants were issued, (ii)
it is an &ldquo;Accredited Investor&rdquo; as defined in Rule 501(a) under the 1933 Act and (iii) the representations and warranties
made to the Company in connection with the acquisition of the Warrants remain true and correct on the date of this Notice of Exercise;
<B><U>or</U>&nbsp;</B>(C) a written opinion of U.S. counsel to the effect that the issuance of the Warrant Shares upon exercise
of the Warrants contemplated hereby has been registered under the 1933 Act, or is exempt from registration thereunder, is being
delivered to the Company, provided that the Holder will not be required to deliver a written opinion of U.S. counsel in connection
with its due exercise of the Warrants, for its own account or for the account of the original beneficial purchaser, if any, at
a time when the Holder and such original beneficial purchaser, if any, are &ldquo;Accredited Investors&rdquo; as defined in Rule
501(a) under the 1933 Act and its representations and warranties contained in Schedule C to the Subscription Agreement remain
true and correct with respect to the exercise of the Warrants and the Holder represents to the Company as such;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
undersigned does not have any agreement or understanding (written or oral) with any person in the United States or a U.S. Person
respecting:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
transfer or assignment of any rights or interest in any of the Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
division of profits, losses, fees, commissions, or any financial stake in connection with any of the Securities; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
voting of the Warrant Shares to be issued hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the aforesaid Warrant Shares are being acquired for investment and not with a view to, or for resale in connection with, the distribution
thereof, and that the undersigned has no present intention of distributing or reselling such Warrant Shares in connection with
the distribution thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 1in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
of Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Holder</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory of Holder that is an Entity:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory of Holder that is an Entity:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt; font-family: Times New Roman, Times, Serif"><DIV STYLE="font: 1pt Times New Roman, Times, Serif; border-top: Black 1pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE:
The signature to this Notice of Exercise must correspond with the name as it appears on the face of the Warrant, without alteration
or enlargement or any change whatsoever. If this Notice of Exercise indicates that Warrant Shares are to be issued to a person
or persons other than the registered Holder of the Warrants being exercised, the signature to this Notice of Exercise must be
medallion guaranteed by a bank or trust company and the registered Holder must pay the Company all applicable taxes and other
duties. Officers of corporations or other entities and those acting in a fiduciary or other representative capacity should file
proper evidence of authority to exercise the foregoing Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registered holder of a Warrant may exercise its right to purchase Warrant Shares by completing and surrendering this Notice of
Exercise and the Warrant being exercised to the Company, together with the aggregate amount of the Exercise Price for the Warrant
Shares as provided for in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Name:</FONT></TD>
    <TD STYLE="width: 85%; font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">(Please
    Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
                                         Number:&nbsp;</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Dated:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">_______________
    __, ______</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1pt solid"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration
or enlargement or any change whatsoever, and must be medallion guaranteed by a bank or trust company. Officers of corporations
and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANTS
SHALL ONLY BE ASSIGNABLE IN ACCORDANCE WITH APPLICABLE LAWS, AND THE RESALE OF WARRANTS AND COMMON SHARES ISSUABLE UPON EXERCISE
OF WARRANTS MAY BE SUBJECT TO RESTRICTIONS UNDER SUCH LAWS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES OF ASSIGNEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned assignee hereby represents and warrants it is a&nbsp;<I>bona fide&nbsp;</I>resident of the jurisdiction set forth
above for its address, and that&nbsp;<B><U>either&nbsp;</U></B>(A)(i) at the time of this assignment, it is not a U.S. Person
(as defined in Rule 902(k) of Regulation S promulgated under the United States Securities Act of 1933, as amended (the &ldquo;<B>1933
Act</B>&rdquo;)) and did not execute this Assignment Form while within the United States, (ii) it is not taking assignment of
any of the Warrants represented by the Assignment Form by or on behalf of any U.S. Person or any person who is within the United
States, and (iii) this assignment in all other respects complies with the terms of Regulation S;&nbsp;<B><U>or</U></B>&nbsp;(B)(i)
it was an original purchaser in NioCorp Developments Ltd.&rsquo;s (the &ldquo;<B>Company</B>&rdquo;) private placement under which
the Warrants were issued, (ii) it is an &ldquo;Accredited Investor&rdquo; as defined in Rule 501(a) under the 1933 Act and (iii)
the representations and warranties made to the Company in connection with the acquisition of the Warrants remain true and correct
on the date of this Assignment Form;&nbsp;<B><U>or</U>&nbsp;</B>(C) the undersigned assignee is delivering a written</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">opinion
of U.S. counsel to the effect that the assignment of the Warrants contemplated hereby has been registered under the 1933 Act,
or is exempt from registration thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 55%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 45%; border-top: Black 1pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Signature
    of Assignee</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
    (Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 10.5pt"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>n2574_x224exh31-1.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">I, Mark A. Smith, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">1. I have reviewed this Quarterly Report on Form 10-Q of NioCorp Developments Ltd.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make&nbsp;the&nbsp;statements made, in light of&nbsp;the&nbsp;circumstances under which such statements were made, not misleading with respect to&nbsp;the&nbsp;period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">3. Based on my knowledge,&nbsp;the&nbsp;financial statements, and other financial information included in this report, fairly present in all material respects the&nbsp;financial condition, results of operations and cash flows of&nbsp;the&nbsp;registrant as of, and for,&nbsp;the&nbsp;periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">4.&nbsp;The&nbsp;registrant's other&nbsp;certifying&nbsp;officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for&nbsp;the&nbsp;registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to&nbsp;the&nbsp;registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during&nbsp;the&nbsp;period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding&nbsp;the&nbsp;reliability of financial reporting and&nbsp;the&nbsp;preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(c) Evaluated&nbsp;the&nbsp;effectiveness of&nbsp;the&nbsp;registrant's disclosure controls and procedures and presented in this report our conclusions about&nbsp;the effectiveness of&nbsp;the&nbsp;disclosure controls and procedures, as of&nbsp;the&nbsp;end of&nbsp;the&nbsp;period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(d) Disclosed in this report any change in&nbsp;the&nbsp;registrant's internal control over financial reporting that occurred during&nbsp;the&nbsp;registrant's most recent fiscal quarter (the&nbsp;registrant's fourth fiscal quarter in&nbsp;the&nbsp;case of an annual report) that has materially affected, or is reasonably likely to materially affect,&nbsp;the&nbsp;registrant's internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">5.&nbsp;The&nbsp;registrant's other&nbsp;certifying&nbsp;officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to&nbsp;the&nbsp;registrant's auditors and&nbsp;the&nbsp;audit committee of&nbsp;the&nbsp;registrant's board of directors (or persons performing&nbsp;the&nbsp;equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(a) All significant deficiencies and material weaknesses in&nbsp;the&nbsp;design or operation of internal control over financial reporting which are reasonably likely to adversely affect&nbsp;the&nbsp;registrant's ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in&nbsp;the&nbsp;registrant's internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 13, 2024</P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Mark A. Smith</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Mark A. Smith</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Executive Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>n2574_x224exh31-2.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">I, Neal Shah, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">1. I have reviewed this Quarterly Report on Form 10-Q of NioCorp Developments Ltd.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make&nbsp;the&nbsp;statements made, in light of&nbsp;the&nbsp;circumstances under which such statements were made, not misleading with respect to&nbsp;the&nbsp;period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">3. Based on my knowledge,&nbsp;the&nbsp;financial statements, and other financial information included in this report, fairly present in all material respects the&nbsp;financial condition, results of operations and cash flows of&nbsp;the&nbsp;registrant as of, and for,&nbsp;the&nbsp;periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">4.&nbsp;The&nbsp;registrant's other&nbsp;certifying&nbsp;officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for&nbsp;the&nbsp;registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to&nbsp;the&nbsp;registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during&nbsp;the&nbsp;period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding&nbsp;the&nbsp;reliability of financial reporting and&nbsp;the&nbsp;preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(c) Evaluated&nbsp;the&nbsp;effectiveness of&nbsp;the&nbsp;registrant's disclosure controls and procedures and presented in this report our conclusions about&nbsp;the effectiveness of&nbsp;the&nbsp;disclosure controls and procedures, as of&nbsp;the&nbsp;end of&nbsp;the&nbsp;period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(d) Disclosed in this report any change in&nbsp;the&nbsp;registrant's internal control over financial reporting that occurred during&nbsp;the&nbsp;registrant's most recent fiscal quarter (the&nbsp;registrant's fourth fiscal quarter in&nbsp;the&nbsp;case of an annual report) that has materially affected, or is reasonably likely to materially affect,&nbsp;the&nbsp;registrant's internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">5.&nbsp;The&nbsp;registrant's other&nbsp;certifying&nbsp;officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to&nbsp;the&nbsp;registrant's auditors and&nbsp;the&nbsp;audit committee of&nbsp;the&nbsp;registrant's board of directors (or persons performing&nbsp;the&nbsp;equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(a) All significant deficiencies and material weaknesses in&nbsp;the&nbsp;design or operation of internal control over financial reporting which are reasonably likely to adversely affect&nbsp;the&nbsp;registrant's ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in&nbsp;the&nbsp;registrant's internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 13, 2024</P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Neal Shah</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Neal Shah</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial and Accounting Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>n2574_x224exh32-1.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In connection with the Quarterly Report on Form 10-Q of NioCorp Developments Ltd. (the &quot;Company&quot;), for the period ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &quot;Report&quot;), I, Mark Smith, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 13, 2024</P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Mark A. Smith</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Mark A. Smith</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Executive Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>n2574_x224exh32-2.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In connection with the Quarterly Report on Form 10-Q of NioCorp Developments Ltd. (the &quot;Company&quot;), for the period ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &quot;Report&quot;), I, Neal Shah, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 13, 2024</P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Neal&nbsp;&nbsp;Shah</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Neal Shah</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial and Accounting Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-family: Arial, Helvetica, Sans-Serif; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>niobf-20240930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9aM5s7xRiXhun8uCaHNMOamOCbPtxpd9GelBvm16bfnq/yop8dKtnyRI4/5mEdQA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:niobf="http://niocorp.com/20240930" elementFormDefault="qualified" targetNamespace="http://niocorp.com/20240930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://niocorp.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" id="StatementsOfOperationsAndComprehensiveLoss">
          <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000005 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" id="StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest">
          <link:definition>00000006 - Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
          <link:definition>00000007 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPresentation" id="BasisOfPresentation">
          <link:definition>00000008 - Disclosure - BASIS OF PRESENTATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GoingConcern" id="GoingConcern">
          <link:definition>00000009 - Disclosure - GOING CONCERN</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
          <link:definition>00000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/Debt" id="Debt">
          <link:definition>00000011 - Disclosure - DEBT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" id="ClassBCommonStockOfEcrc">
          <link:definition>00000012 - Disclosure - CLASS B COMMON STOCK OF ECRC</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonShares" id="CommonShares">
          <link:definition>00000013 - Disclosure - COMMON SHARES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>00000014 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ExplorationExpenditures" id="ExplorationExpenditures">
          <link:definition>00000015 - Disclosure - EXPLORATION EXPENDITURES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/Leases" id="Leases">
          <link:definition>00000016 - Disclosure - LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>00000017 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000018 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPresentationPolicies" id="BasisOfPresentationPolicies">
          <link:definition>00000019 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPresentationTables" id="BasisOfPresentationTables">
          <link:definition>00000020 - Disclosure - BASIS OF PRESENTATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
          <link:definition>00000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DebtTables" id="DebtTables">
          <link:definition>00000022 - Disclosure - DEBT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" id="ClassBCommonStockOfEcrcTables">
          <link:definition>00000023 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesTables" id="CommonSharesTables">
          <link:definition>00000024 - Disclosure - COMMON SHARES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ExplorationExpendituresTables" id="ExplorationExpendituresTables">
          <link:definition>00000025 - Disclosure - EXPLORATION EXPENDITURES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LeasesTables" id="LeasesTables">
          <link:definition>00000026 - Disclosure - LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>00000027 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" id="DescriptionOfBusinessDetailsNarrative">
          <link:definition>00000028 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" id="FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails">
          <link:definition>00000029 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" id="ScheduleOfExcludedFromDilutiveSecuritiesDetails">
          <link:definition>00000030 - Disclosure - Schedule of excluded from the dilutive securities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPresentationDetailsNarrative" id="BasisOfPresentationDetailsNarrative">
          <link:definition>00000031 - Disclosure - BASIS OF PRESENTATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GoingConcernDetailsNarrative" id="GoingConcernDetailsNarrative">
          <link:definition>00000032 - Disclosure - GOING CONCERN (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" id="ScheduleOfAccountPayableAndAccruedLiabilitiesDetails">
          <link:definition>00000033 - Disclosure - Schedule of account payable and accrued liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails" id="ChangeInConvertibleDebenturesIsPresentedBelowDetails">
          <link:definition>00000034 - Disclosure - The change in the Convertible Debentures is presented below: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" id="FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details">
          <link:definition>00000035 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails" id="ChangeInApril2024NotesIsPresentedBelowDetails">
          <link:definition>00000036 - Disclosure - The change in the April 2024 Notes is presented below: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" id="ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails">
          <link:definition>00000037 - Disclosure - The change in the April 2024 Warrant liability is presented below: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DebtDetailsNarrative" id="DebtDetailsNarrative">
          <link:definition>00000038 - Disclosure - DEBT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" id="TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails">
          <link:definition>00000039 - Disclosure - These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" id="FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details">
          <link:definition>00000040 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" id="CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details">
          <link:definition>00000041 - Disclosure - The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" id="ScheduleOfStockOptionDetails">
          <link:definition>00000042 - Disclosure - Schedule of stock option (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails" id="ScheduleOfWarrantTransactionsDetails">
          <link:definition>00000043 - Disclosure - Schedule of warrant transactions (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" id="AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails">
          <link:definition>00000044 - Disclosure - At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" id="FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails">
          <link:definition>00000045 - Disclosure - The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" id="ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails">
          <link:definition>00000046 - Disclosure - The change in the Private Warrants liability is presented below: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" id="CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails">
          <link:definition>00000047 - Disclosure - The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" id="CommonSharesDetailsNarrative">
          <link:definition>00000048 - Disclosure - COMMON SHARES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" id="ScheduleOfExplorationExpendituresDetails">
          <link:definition>00000050 - Disclosure - Schedule of exploration expenditures (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" id="CompanyIncurredLeaseCostsAsFollowsDetails">
          <link:definition>00000051 - Disclosure - The Company incurred lease costs as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" id="MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details">
          <link:definition>00000052 - Disclosure - The maturities of lease liabilities are as follows at September 30, 2024: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" id="ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails">
          <link:definition>00000053 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000054 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20240930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20240930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20240930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20240930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="niobf_CommonSharesWithoutParValueMember" name="CommonSharesWithoutParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" name="WarrantsEachExercisableFor1.11829212CommonSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterestMember" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" name="YorkvilleConvertibleDebtFinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleConvertibleDebentureMember" name="YorkvilleConvertibleDebentureMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PurchaseAgreementMember" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutMember" name="EarnoutMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice9.70Member" name="ExercisePrice9.70Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice4.60Member" name="ExercisePrice4.60Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice3.54Member" name="ExercisePrice3.54Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.20Member" name="ExercisePrice2.20Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice3.35Member" name="ExercisePrice3.35Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice3.25Member" name="ExercisePrice3.25Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice11.50Member" name="ExercisePrice11.50Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.31Member" name="ExercisePrice2.31Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIPrivateWarrantsMember" name="GXIIPrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LindConsentWarrantIssuanceMember" name="LindConsentWarrantIssuanceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NonRevolvingCreditFacilityAgreementMember" name="NonRevolvingCreditFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GeneralSecurityAgreementMember" name="GeneralSecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TechnicalStudiesAndEngineeringMember" name="TechnicalStudiesAndEngineeringMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FieldmanagementandotherMember" name="FieldmanagementandotherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MetallurgicaldevelopmentMember" name="MetallurgicaldevelopmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GeologistAndFieldStaffMember" name="GeologistAndFieldStaffMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PurchaseAgreementSeriesAMember" name="PurchaseAgreementSeriesAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PurchaseAgreementSeriesBMember" name="PurchaseAgreementSeriesBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutLiabilityAtFairValue" name="EarnoutLiabilityAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpenditures" name="ExplorationExpenditures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutLiability" name="ChangeInFairValueOfEarnoutLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfWarrantLiability" name="ChangeInFairValueOfWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfConvertibleNotes" name="ChangeInFairValueOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarningsLossPerShareBasicAndDiluted" name="EarningsLossPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" name="TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutShareLiability" name="ChangeInFairValueOfEarnoutShareLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInValuationOfWarrantLiabilities" name="ChangeInValuationOfWarrantLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfConvertibleNote" name="ChangeInFairValueOfConvertibleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OtheroperatingGainsLosses" name="OtheroperatingGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueOfCommitmentSharesIssued" name="FairValueOfCommitmentSharesIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConversionsOfDebtForCommonShares" name="ConversionsOfDebtForCommonShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ValueOfWarrantsIssued" name="ValueOfWarrantsIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivatePlacementValue" name="PrivatePlacementValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivatePlacementShares" name="PrivatePlacementShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" name="SharesIssuedUnderTheYorkvilleEquityFacility" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" name="SharesIssuedUnderTheYorkvilleEquityFacilityShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" name="StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureClassBCommonStockOfEcrcAbstract" name="DisclosureClassBCommonStockOfEcrcAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" name="ScheduleOfClassBCommonStockOfECRCTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureExplorationExpendituresAbstract" name="DisclosureExplorationExpendituresAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpendituresDisclosuresTextBlock" name="ExplorationExpendituresDisclosuresTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" name="ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" name="ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" name="ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfStockOptionRollForwardTableTextBlock" name="ScheduleOfStockOptionRollForwardTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" name="ScheduleOfOutstandingExercisableWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" name="ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfExplorationExpendituresTableTextBlock" name="ScheduleOfExplorationExpendituresTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NetIncomeLoss1" name="NetIncomeLoss1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrincipalAndAccruedInterestConverted" name="PrincipalAndAccruedInterestConverted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ContractualInterest" name="ContractualInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValue" name="ChangeInFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightGranted" name="ClassOfWarrantOrRightGranted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceGranted" name="ClassOfWarrantOrRightExercisePriceGranted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercised" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceExercised" name="ClassOfWarrantOrRightExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExpired" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceExpired" name="ClassOfWarrantOrRightExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangesInFairValueOfInitialValuation1" name="ChangesInFairValueOfInitialValuation1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LineOfCreditFacilityEstablishmentFee" name="LineOfCreditFacilityEstablishmentFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CostCentreAxis" name="CostCentreAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="niobf_CostCentreDomain" name="CostCentreDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FixedRentExpense" name="FixedRentExpense" nillable="true" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LessAmountOfPaymentsRepresentingInterest" name="LessAmountOfPaymentsRepresentingInterest" nillable="true" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" name="AvailableForSaleSecuritiesEquitySecuritiesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AccruedCost" name="AccruedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StrikePriceOfWarrantsIssued" name="StrikePriceOfWarrantsIssued" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice11.00Member" name="ExercisePrice11.00Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangesInFairValueOfInitialValuation" name="ChangesInFairValueOfInitialValuation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AccruedCosts" name="AccruedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LineOfCreditFacilityPrepaymentFee" name="LineOfCreditFacilityPrepaymentFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AmountPaidToRelatedParty" name="AmountPaidToRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NonRevolvingAmountOutstanding" name="NonRevolvingAmountOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MarkSmithMember" name="MarkSmithMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>niobf-20240930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20240930.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:href="niobf-20240930.xsd#StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentation" xlink:href="niobf-20240930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcern" xlink:href="niobf-20240930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20240930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Debt" xlink:href="niobf-20240930.xsd#Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20240930.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20240930.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactions" xlink:href="niobf-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20240930.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20240930.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationPolicies" xlink:href="niobf-20240930.xsd#BasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationTables" xlink:href="niobf-20240930.xsd#BasisOfPresentationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20240930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DebtTables" xlink:href="niobf-20240930.xsd#DebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20240930.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20240930.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20240930.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20240930.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:href="niobf-20240930.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20240930.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationDetailsNarrative" xlink:href="niobf-20240930.xsd#BasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernDetailsNarrative" xlink:href="niobf-20240930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20240930.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:href="niobf-20240930.xsd#FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInApril2024NotesIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DebtDetailsNarrative" xlink:href="niobf-20240930.xsd#DebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:href="niobf-20240930.xsd#TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:href="niobf-20240930.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:href="niobf-20240930.xsd#CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20240930.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails" xlink:href="niobf-20240930.xsd#ScheduleOfWarrantTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20240930.xsd#AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:href="niobf-20240930.xsd#FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:href="niobf-20240930.xsd#CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20240930.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="niobf-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20240930.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20240930.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:href="niobf-20240930.xsd#MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20240930.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" xlink:label="loc_us-gaapDeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="loc_us-gaapLongTermInvestmentsAndReceivablesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapLongTermInvestmentsAndReceivablesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="loc_us-gaapRelatedPartyDepositLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapRelatedPartyDepositLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="loc_niobfEarnoutLiabilityAtFairValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_niobfEarnoutLiabilityAtFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExplorationExpenditures" xlink:label="loc_niobfExplorationExpenditures" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_niobfExplorationExpenditures" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutLiability" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_niobfChangeInFairValueOfEarnoutLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="loc_niobfChangeInFairValueOfWarrantLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_niobfChangeInFairValueOfWarrantLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfConvertibleNotes" xlink:label="loc_niobfChangeInFairValueOfConvertibleNotes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_niobfChangeInFairValueOfConvertibleNotes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutShareLiability" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="loc_niobfChangeInValuationOfWarrantLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfConvertibleNote" xlink:label="loc_niobfChangeInFairValueOfConvertibleNote" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfChangeInFairValueOfConvertibleNote" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_OtheroperatingGainsLosses" xlink:label="loc_niobfOtheroperatingGainsLosses" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="loc_niobfFairValueOfCommitmentSharesIssued" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_niobfFairValueOfCommitmentSharesIssued" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Shareholders&apos; (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentation" xlink:title="00000008 - Disclosure - BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcern" xlink:title="00000009 - Disclosure - GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Debt" xlink:title="00000011 - Disclosure - DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000012 - Disclosure - CLASS B COMMON STOCK OF ECRC" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000013 - Disclosure - COMMON SHARES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactions" xlink:title="00000014 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000015 - Disclosure - EXPLORATION EXPENDITURES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000016 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000017 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationPolicies" xlink:title="00000019 - Disclosure - BASIS OF PRESENTATION (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationTables" xlink:title="00000020 - Disclosure - BASIS OF PRESENTATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DebtTables" xlink:title="00000022 - Disclosure - DEBT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000023 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000024 - Disclosure - COMMON SHARES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000025 - Disclosure - EXPLORATION EXPENDITURES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000026 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000027 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="00000029 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000030 - Disclosure - Schedule of excluded from the dilutive securities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationDetailsNarrative" xlink:title="00000031 - Disclosure - BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernDetailsNarrative" xlink:title="00000032 - Disclosure - GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000033 - Disclosure - Schedule of account payable and accrued liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:title="00000034 - Disclosure - The change in the Convertible Debentures is presented below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:title="00000035 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails" xlink:title="00000036 - Disclosure - The change in the April 2024 Notes is presented below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:title="00000037 - Disclosure - The change in the April 2024 Warrant liability is presented below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DebtDetailsNarrative" xlink:title="00000038 - Disclosure - DEBT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:title="00000039 - Disclosure - These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:title="00000040 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:title="00000041 - Disclosure - The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000042 - Disclosure - Schedule of stock option (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails" xlink:title="00000043 - Disclosure - Schedule of warrant transactions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000044 - Disclosure - At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:title="00000045 - Disclosure - The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000046 - Disclosure - The change in the Private Warrants liability is presented below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:title="00000047 - Disclosure - The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000048 - Disclosure - COMMON SHARES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000050 - Disclosure - Schedule of exploration expenditures (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000051 - Disclosure - The Company incurred lease costs as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:title="00000052 - Disclosure - The maturities of lease liabilities are as follows at September 30, 2024: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000053 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000054 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>niobf-20240930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20240930.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:href="niobf-20240930.xsd#StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentation" xlink:href="niobf-20240930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcern" xlink:href="niobf-20240930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20240930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Debt" xlink:href="niobf-20240930.xsd#Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20240930.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20240930.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactions" xlink:href="niobf-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20240930.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20240930.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationPolicies" xlink:href="niobf-20240930.xsd#BasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationTables" xlink:href="niobf-20240930.xsd#BasisOfPresentationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20240930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DebtTables" xlink:href="niobf-20240930.xsd#DebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20240930.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20240930.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20240930.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20240930.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:href="niobf-20240930.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20240930.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationDetailsNarrative" xlink:href="niobf-20240930.xsd#BasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernDetailsNarrative" xlink:href="niobf-20240930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20240930.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:href="niobf-20240930.xsd#FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInApril2024NotesIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DebtDetailsNarrative" xlink:href="niobf-20240930.xsd#DebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:href="niobf-20240930.xsd#TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:href="niobf-20240930.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:href="niobf-20240930.xsd#CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20240930.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails" xlink:href="niobf-20240930.xsd#ScheduleOfWarrantTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20240930.xsd#AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:href="niobf-20240930.xsd#FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:href="niobf-20240930.xsd#CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20240930.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="niobf-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20240930.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20240930.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:href="niobf-20240930.xsd#MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20240930.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="loc_niobfCommonSharesWithoutParValueMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfCommonSharesWithoutParValueMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Shareholders&apos; (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="loc_niobfRedeemableNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfRedeemableNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PrivatePlacementValue" xlink:label="loc_niobfPrivatePlacementValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementValue_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PrivatePlacementShares" xlink:label="loc_niobfPrivatePlacementShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementShares_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" xlink:label="loc_niobfStockIssuedDuringPeriodValueIssuanceOfFinancingWarrants_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueIssuanceOfFinancingWarrants_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_60" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentation" xlink:title="00000008 - Disclosure - BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcern" xlink:title="00000009 - Disclosure - GOING CONCERN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Debt" xlink:title="00000011 - Disclosure - DEBT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000012 - Disclosure - CLASS B COMMON STOCK OF ECRC" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000013 - Disclosure - COMMON SHARES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactions" xlink:title="00000014 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000015 - Disclosure - EXPLORATION EXPENDITURES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000016 - Disclosure - LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000017 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationPolicies" xlink:title="00000019 - Disclosure - BASIS OF PRESENTATION (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationTables" xlink:title="00000020 - Disclosure - BASIS OF PRESENTATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DebtTables" xlink:title="00000022 - Disclosure - DEBT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000023 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000024 - Disclosure - COMMON SHARES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000025 - Disclosure - EXPLORATION EXPENDITURES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000026 - Disclosure - LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000027 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="00000029 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000030 - Disclosure - Schedule of excluded from the dilutive securities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationDetailsNarrative" xlink:title="00000031 - Disclosure - BASIS OF PRESENTATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernDetailsNarrative" xlink:title="00000032 - Disclosure - GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward" xlink:label="loc_us-gaapInvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapInvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromRepaymentsOfDebt_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000033 - Disclosure - Schedule of account payable and accrued liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:title="00000034 - Disclosure - The change in the Convertible Debentures is presented below: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:title="00000035 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails" xlink:title="00000036 - Disclosure - The change in the April 2024 Notes is presented below: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:title="00000037 - Disclosure - The change in the April 2024 Warrant liability is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DebtDetailsNarrative" xlink:title="00000038 - Disclosure - DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_YorkvilleConvertibleDebentureMember" xlink:label="loc_niobfYorkvilleConvertibleDebentureMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfYorkvilleConvertibleDebentureMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementMember" xlink:label="loc_niobfPurchaseAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="loc_us-gaapDebtInstrumentRepaidPrincipal_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentRepaidPrincipal_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRate" xlink:label="loc_us-gaapInvestmentInterestRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInvestmentInterestRate_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="loc_us-gaapDebtInstrumentIssuedPrincipal_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuedPrincipal_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:label="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet_90" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:title="00000039 - Disclosure - These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:title="00000040 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAdditions_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAdditions_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:title="00000041 - Disclosure - The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000042 - Disclosure - Schedule of stock option (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails" xlink:title="00000043 - Disclosure - Schedule of warrant transactions (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000044 - Disclosure - At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice9.70Member" xlink:label="loc_niobfExercisePrice9.70Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice9.70Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice4.60Member" xlink:label="loc_niobfExercisePrice4.60Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice4.60Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.54Member" xlink:label="loc_niobfExercisePrice3.54Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.54Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice2.20Member" xlink:label="loc_niobfExercisePrice2.20Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.20Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.35Member" xlink:label="loc_niobfExercisePrice3.35Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.35Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.25Member" xlink:label="loc_niobfExercisePrice3.25Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.25Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice11.50Member" xlink:label="loc_niobfExercisePrice11.50Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.50Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice2.31Member" xlink:label="loc_niobfExercisePrice2.31Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.31Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_100" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:title="00000045 - Disclosure - The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharePrice_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000046 - Disclosure - The change in the Private Warrants liability is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="loc_niobfChangesInFairValueOfInitialValuation1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation1_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:title="00000047 - Disclosure - The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000048 - Disclosure - COMMON SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="loc_niobfGXIIPrivateWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPrivateWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="loc_niobfLindConsentWarrantIssuanceMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLindConsentWarrantIssuanceMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_80" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfNonRevolvingCreditFacilityAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfNonRevolvingCreditFacilityAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="loc_niobfGeneralSecurityAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfGeneralSecurityAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLongTermLineOfCredit_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaapRelatedPartyTransactionRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionRate_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LineOfCreditFacilityEstablishmentFee" xlink:label="loc_niobfLineOfCreditFacilityEstablishmentFee_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfLineOfCreditFacilityEstablishmentFee_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProfessionalFees_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLinesOfCreditCurrent_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapInterestExpenseOther_60" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000050 - Disclosure - Schedule of exploration expenditures (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CostCentreAxis" xlink:label="loc_niobfCostCentreAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_niobfCostCentreAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_TechnicalStudiesAndEngineeringMember" xlink:label="loc_niobfTechnicalStudiesAndEngineeringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfTechnicalStudiesAndEngineeringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_FieldmanagementandotherMember" xlink:label="loc_niobfFieldmanagementandotherMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFieldmanagementandotherMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_MetallurgicaldevelopmentMember" xlink:label="loc_niobfMetallurgicaldevelopmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfMetallurgicaldevelopmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GeologistAndFieldStaffMember" xlink:label="loc_niobfGeologistAndFieldStaffMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfGeologistAndFieldStaffMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExplorationExpense_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000051 - Disclosure - The Company incurred lease costs as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:title="00000052 - Disclosure - The maturities of lease liabilities are as follows at September 30, 2024: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000053 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapNotesPayable_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000054 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementSeriesAMember" xlink:label="loc_niobfPurchaseAgreementSeriesAMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementSeriesAMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementSeriesBMember" xlink:label="loc_niobfPurchaseAgreementSeriesBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementSeriesBMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventDescription_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="loc_us-gaapDebtInstrumentIssuedPrincipal_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuedPrincipal_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:label="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_AccruedCost" xlink:label="loc_niobfAccruedCost_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_niobfAccruedCost_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_StrikePriceOfWarrantsIssued" xlink:label="loc_niobfStrikePriceOfWarrantsIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_niobfStrikePriceOfWarrantsIssued_90" xlink:type="arc" order="4" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>niobf-20240930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="niobf_CommonSharesWithoutParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesWithoutParValueMember" xlink:to="niobf_CommonSharesWithoutParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonSharesWithoutParValueMember_lbl" xml:lang="en-US">Common Shares Without Par Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:to="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_lbl" xml:lang="en-US">Warrants Each Exercisable For1.11829212 Common Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="niobf_RedeemableNoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestMember" xlink:to="niobf_RedeemableNoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterestMember_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember" xlink:label="us-gaap_UnsecuredDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebtMember" xlink:to="us-gaap_UnsecuredDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebtMember_lbl" xml:lang="en-US">Unsecured Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:to="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_lbl" xml:lang="en-US">Yorkville Convertible Debt Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_YorkvilleConvertibleDebentureMember" xlink:label="niobf_YorkvilleConvertibleDebentureMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebentureMember" xlink:to="niobf_YorkvilleConvertibleDebentureMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleConvertibleDebentureMember_lbl" xml:lang="en-US">Yorkville Convertible Debenture [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementMember" xlink:label="niobf_PurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementMember" xlink:to="niobf_PurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PurchaseAgreementMember_lbl" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="niobf_EarnoutMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutMember" xlink:to="niobf_EarnoutMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutMember_lbl" xml:lang="en-US">Earnout [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice9.70Member" xlink:label="niobf_ExercisePrice9.70Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice9.70Member" xlink:to="niobf_ExercisePrice9.70Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice9.70Member_lbl" xml:lang="en-US">Exercise Price9.70 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice4.60Member" xlink:label="niobf_ExercisePrice4.60Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice4.60Member" xlink:to="niobf_ExercisePrice4.60Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice4.60Member_lbl" xml:lang="en-US">Exercise Price4.60 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.54Member" xlink:label="niobf_ExercisePrice3.54Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.54Member" xlink:to="niobf_ExercisePrice3.54Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice3.54Member_lbl" xml:lang="en-US">Exercise Price3.54 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice2.20Member" xlink:label="niobf_ExercisePrice2.20Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.20Member" xlink:to="niobf_ExercisePrice2.20Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.20Member_lbl" xml:lang="en-US">Exercise Price2.20 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.35Member" xlink:label="niobf_ExercisePrice3.35Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.35Member" xlink:to="niobf_ExercisePrice3.35Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice3.35Member_lbl" xml:lang="en-US">Exercise Price3.35 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.25Member" xlink:label="niobf_ExercisePrice3.25Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.25Member" xlink:to="niobf_ExercisePrice3.25Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice3.25Member_lbl" xml:lang="en-US">Exercise Price3.25 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice11.50Member" xlink:label="niobf_ExercisePrice11.50Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.50Member" xlink:to="niobf_ExercisePrice11.50Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice11.50Member_lbl" xml:lang="en-US">Exercise Price11.50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice2.31Member" xlink:label="niobf_ExercisePrice2.31Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.31Member" xlink:to="niobf_ExercisePrice2.31Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.31Member_lbl" xml:lang="en-US">Exercise Price2.31 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="niobf_GXIIPrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPrivateWarrantsMember" xlink:to="niobf_GXIIPrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIPrivateWarrantsMember_lbl" xml:lang="en-US">GXII Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="niobf_LindConsentWarrantIssuanceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindConsentWarrantIssuanceMember" xlink:to="niobf_LindConsentWarrantIssuanceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LindConsentWarrantIssuanceMember_lbl" xml:lang="en-US">Lind Consent Warrant Issuance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoteWarrantMember" xlink:label="us-gaap_NoteWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoteWarrantMember" xlink:to="us-gaap_NoteWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoteWarrantMember_lbl" xml:lang="en-US">Note Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_NonRevolvingCreditFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember_lbl" xml:lang="en-US">Non Revolving Credit Facility Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="niobf_GeneralSecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeneralSecurityAgreementMember" xlink:to="niobf_GeneralSecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GeneralSecurityAgreementMember_lbl" xml:lang="en-US">General Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CostCentreAxis" xlink:label="niobf_CostCentreAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CostCentreAxis" xlink:to="niobf_CostCentreAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CostCentreAxis_lbl" xml:lang="en-US">Cost Centre [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_TechnicalStudiesAndEngineeringMember" xlink:label="niobf_TechnicalStudiesAndEngineeringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TechnicalStudiesAndEngineeringMember" xlink:to="niobf_TechnicalStudiesAndEngineeringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_TechnicalStudiesAndEngineeringMember_lbl" xml:lang="en-US">Technical Studies And Engineering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_FieldmanagementandotherMember" xlink:label="niobf_FieldmanagementandotherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FieldmanagementandotherMember" xlink:to="niobf_FieldmanagementandotherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FieldmanagementandotherMember_lbl" xml:lang="en-US">Fieldmanagementandother [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_MetallurgicaldevelopmentMember" xlink:label="niobf_MetallurgicaldevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MetallurgicaldevelopmentMember" xlink:to="niobf_MetallurgicaldevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MetallurgicaldevelopmentMember_lbl" xml:lang="en-US">Metallurgicaldevelopment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GeologistAndFieldStaffMember" xlink:label="niobf_GeologistAndFieldStaffMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeologistAndFieldStaffMember" xlink:to="niobf_GeologistAndFieldStaffMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GeologistAndFieldStaffMember_lbl" xml:lang="en-US">Geologist And Field Staff [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementSeriesAMember" xlink:label="niobf_PurchaseAgreementSeriesAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementSeriesAMember" xlink:to="niobf_PurchaseAgreementSeriesAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PurchaseAgreementSeriesAMember_lbl" xml:lang="en-US">Purchase Agreement Series A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementSeriesBMember" xlink:label="niobf_PurchaseAgreementSeriesBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementSeriesBMember" xlink:to="niobf_PurchaseAgreementSeriesBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PurchaseAgreementSeriesBMember_lbl" xml:lang="en-US">Purchase Agreement Series B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" xlink:to="us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross_lbl" xml:lang="en-US">Deferred share issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssets" xlink:label="us-gaap_DepositsAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssets" xlink:to="us-gaap_DepositsAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssets_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="us-gaap_LongTermInvestmentsAndReceivablesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:to="us-gaap_LongTermInvestmentsAndReceivablesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermInvestmentsAndReceivablesNet_lbl" xml:lang="en-US">Investment in equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Land and buildings, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:to="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties_lbl" xml:lang="en-US">Mineral properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Warrant liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="us-gaap_RelatedPartyDepositLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDepositLiabilities" xlink:to="us-gaap_RelatedPartyDepositLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDepositLiabilities_lbl" xml:lang="en-US">Related party debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Warrant liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="niobf_EarnoutLiabilityAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutLiabilityAtFairValue" xlink:to="niobf_EarnoutLiabilityAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutLiabilityAtFairValue_lbl" xml:lang="en-US">Earnout liability, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, no par value, unlimited shares authorized; 38,720,244 and 38,062,647 shares outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:to="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Employee related costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExplorationExpenditures" xlink:label="niobf_ExplorationExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenditures" xlink:to="niobf_ExplorationExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExplorationExpenditures_lbl" xml:lang="en-US">Exploration expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralExpense" xlink:label="us-gaap_OtherGeneralExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralExpense_lbl" xml:lang="en-US">Other operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_lbl" xml:lang="en-US">Change in fair value of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="niobf_ChangeInFairValueOfWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfConvertibleNotes" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotes" xlink:to="niobf_ChangeInFairValueOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes_lbl" xml:lang="en-US">Change in fair value of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign exchange loss (gain)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other gains</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xml:lang="en-US">Loss on equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Net loss and comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Net loss attributable to redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_lbl" xml:lang="en-US">Net loss and comprehensive loss attributable to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common share, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average common shares outstanding, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments for:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_lbl" xml:lang="en-US">Change in valuation of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_lbl" xml:lang="en-US">Change in valuation of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfConvertibleNote" xlink:label="niobf_ChangeInFairValueOfConvertibleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNote" xlink:to="niobf_ChangeInFairValueOfConvertibleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfConvertibleNote_lbl" xml:lang="en-US">Change in fair value of convertible note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionExpense" xlink:label="us-gaap_AccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpense_lbl" xml:lang="en-US">Accretion of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_OtheroperatingGainsLosses" xlink:label="niobf_OtheroperatingGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_OtheroperatingGainsLosses_lbl" xml:lang="en-US">Other gain</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="niobf_FairValueOfCommitmentSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfCommitmentSharesIssued" xlink:to="niobf_FairValueOfCommitmentSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueOfCommitmentSharesIssued_lbl" xml:lang="en-US">Yorkville share issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Unrealized loss on equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US">Non-cash lease activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in working capital items:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of capital stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Related party debt draws</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Debt repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Share issue costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash and cash equivalents during period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ConversionsOfDebtForCommonShares" xlink:label="niobf_ConversionsOfDebtForCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConversionsOfDebtForCommonShares" xlink:to="niobf_ConversionsOfDebtForCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConversionsOfDebtForCommonShares_lbl" xml:lang="en-US">Conversion of debt for common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ValueOfWarrantsIssued" xlink:label="niobf_ValueOfWarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ValueOfWarrantsIssued" xlink:to="niobf_ValueOfWarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ValueOfWarrantsIssued_lbl" xml:lang="en-US">Value of warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Beginning balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PrivatePlacementValue" xlink:label="niobf_PrivatePlacementValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementValue" xlink:to="niobf_PrivatePlacementValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivatePlacementValue_lbl" xml:lang="en-US">Private placements</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PrivatePlacementShares" xlink:label="niobf_PrivatePlacementShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementShares" xlink:to="niobf_PrivatePlacementShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivatePlacementShares_lbl" xml:lang="en-US">Private placement (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_lbl" xml:lang="en-US">Yorkville equity facility draws</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_lbl" xml:lang="en-US">Shares issued under the Yorkville equity facility (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xml:lang="en-US">Debt conversions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Debt conversions (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" xlink:label="niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" xlink:to="niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants_lbl" xml:lang="en-US">Issuance of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Share issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Loss for the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Ending balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">GOING CONCERN</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="niobf_DisclosureClassBCommonStockOfEcrcAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:to="niobf_DisclosureClassBCommonStockOfEcrcAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureClassBCommonStockOfEcrcAbstract_lbl" xml:lang="en-US">Class B Common Stock Of Ecrc</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:to="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_lbl" xml:lang="en-US">CLASS B COMMON STOCK OF ECRC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">COMMON SHARES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="niobf_DisclosureExplorationExpendituresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureExplorationExpendituresAbstract" xlink:to="niobf_DisclosureExplorationExpendituresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureExplorationExpendituresAbstract_lbl" xml:lang="en-US">Exploration Expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:to="niobf_ExplorationExpendituresDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock_lbl" xml:lang="en-US">EXPLORATION EXPENDITURES</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureLeasesAbstract" xlink:label="niobf_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Earnings per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_lbl" xml:lang="en-US">Schedule of excluded from the dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of account payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">The change in the Convertible Debentures is presented below:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_lbl" xml:lang="en-US">The following table discloses the components of interest expense associated with the Convertible Debentures.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl" xml:lang="en-US">The change in the April 2024 Notes is presented below:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US">The change in the April 2024 Warrant liability is presented below:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:to="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_lbl" xml:lang="en-US">These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_lbl" xml:lang="en-US">The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:label="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:to="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_lbl" xml:lang="en-US">The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfStockOptionRollForwardTableTextBlock" xlink:label="niobf_ScheduleOfStockOptionRollForwardTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfStockOptionRollForwardTableTextBlock" xlink:to="niobf_ScheduleOfStockOptionRollForwardTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfStockOptionRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of warrant transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_lbl" xml:lang="en-US">At September 30, 2024, the Company had outstanding exercisable Warrants, as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_lbl" xml:lang="en-US">The change in the Private Warrants liability is presented below:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:to="niobf_ScheduleOfExplorationExpendituresTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock_lbl" xml:lang="en-US">Schedule of exploration expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">The Company incurred lease costs as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">The maturities of lease liabilities are as follows at September 30, 2024:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xml:lang="en-US">Schedule of fair values determined by level 3 inputs are unobservable data</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of reportable segments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_NetIncomeLoss1" xlink:label="niobf_NetIncomeLoss1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NetIncomeLoss1" xlink:to="niobf_NetIncomeLoss1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NetIncomeLoss1_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Less: Net loss attributable to noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss available to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Net loss attributable to vested shares of ECRC Class B common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_lbl" xml:lang="en-US">Net loss attributable to vested shares of ECRC Class B common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_2_lbl" xml:lang="en-US">Loss per common share outstanding basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:label="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:to="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions_lbl" xml:lang="en-US">Options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecurities" xlink:label="us-gaap_DilutiveSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecurities" xlink:to="us-gaap_DilutiveSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DilutiveSecurities_lbl" xml:lang="en-US">Total potential dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal income tax payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward" xlink:label="us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward" xlink:to="us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward_lbl" xml:lang="en-US">Capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Accounts payable, trade</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Trade payable accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Environmental accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Loan origination fees payable to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Balance at June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="us-gaap_AccretionExpenseIncludingAssetRetirementObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:to="us-gaap_AccretionExpenseIncludingAssetRetirementObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpenseIncludingAssetRetirementObligations_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="niobf_PrincipalAndAccruedInterestConverted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrincipalAndAccruedInterestConverted_lbl" xml:lang="en-US">Principal and interest converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ConvertibleDebt_2_lbl" xml:lang="en-US">Balance, September 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ContractualInterest" xlink:label="niobf_ContractualInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ContractualInterest" xlink:to="niobf_ContractualInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ContractualInterest_lbl" xml:lang="en-US">Contractual interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of discount and issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccretionExpense_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_lbl" xml:lang="en-US">Fair value at June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Principal payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValue" xlink:label="niobf_ChangeInFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValue" xlink:to="niobf_ChangeInFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValue_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_2_lbl" xml:lang="en-US">Fair value at September 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount_lbl" xml:lang="en-US">Remaining Principal Balance, September 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Fair value at June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_2_lbl" xml:lang="en-US">Fair value at September 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Shares exchange</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRepaidPrincipal" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal_lbl" xml:lang="en-US">Aggregate principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRate" xlink:label="us-gaap_InvestmentInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Percentage value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Common share price, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_lbl" xml:lang="en-US">Aggregate principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:to="us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_lbl" xml:lang="en-US">Increased the amounts due</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Closing common share price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xml:lang="en-US">Term (expiry)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Implied volatility of public warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_lbl" xml:lang="en-US">Fair value at June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="us-gaap_ServicingLiabilityAtFairValueAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:to="us-gaap_ServicingLiabilityAtFairValueAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAdditions_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_2_lbl" xml:lang="en-US">Fair value at September 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Gross funds received</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Fair value of common shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:label="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:to="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_lbl" xml:lang="en-US">Gross funds received</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Cancelled/expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled/expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightGranted" xlink:label="niobf_ClassOfWarrantOrRightGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightGranted" xlink:to="niobf_ClassOfWarrantOrRightGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightGranted_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExercised" xlink:label="niobf_ClassOfWarrantOrRightExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExpired" xlink:label="niobf_ClassOfWarrantOrRightExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExpired_lbl" xml:lang="en-US">Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US">Expiry date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="srt_PlatformOperatorCryptoAssetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetTable" xlink:to="srt_PlatformOperatorCryptoAssetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetTable_lbl" xml:lang="en-US">Platform Operator, Crypto Asset [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="srt_PlatformOperatorCryptoAssetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetLineItems" xlink:to="srt_PlatformOperatorCryptoAssetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetLineItems_lbl" xml:lang="en-US">Platform Operator, Crypto Asset [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Stock price on valuation date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Strike price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected warrant life in years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="niobf_ChangesInFairValueOfInitialValuation1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation1" xlink:to="niobf_ChangesInFairValueOfInitialValuation1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation1_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation1" xlink:to="niobf_ChangesInFairValueOfInitialValuation1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation1_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Term (years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xml:lang="en-US">Historic equity volatility</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_4_lbl" xml:lang="en-US">Warrants traded prior to the closing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Warrants traded prior to the closing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xml:lang="en-US">Description of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription_lbl" xml:lang="en-US">Contingent consideration description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock issued, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5_lbl" xml:lang="en-US">Common share exercise price, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US">Credit agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="us-gaap_RelatedPartyTransactionRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionRate" xlink:to="us-gaap_RelatedPartyTransactionRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionRate_lbl" xml:lang="en-US">Interest at a rate</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LineOfCreditFacilityEstablishmentFee" xlink:label="niobf_LineOfCreditFacilityEstablishmentFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityEstablishmentFee" xlink:to="niobf_LineOfCreditFacilityEstablishmentFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LineOfCreditFacilityEstablishmentFee_lbl" xml:lang="en-US">Prepayment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfessionalFees_2_lbl" xml:lang="en-US">Origination fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xml:lang="en-US">Additional drawdowns</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseOther" xlink:label="us-gaap_InterestExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseOther_lbl" xml:lang="en-US">Repaid outstanding interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExplorationExpense" xlink:label="us-gaap_ExplorationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationExpense" xlink:to="us-gaap_ExplorationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExplorationExpense_lbl" xml:lang="en-US">Exploration expenditures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Company Incurred Lease Costs As Follows</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US">Operating Lease Cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_FixedRentExpense" xlink:label="niobf_FixedRentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FixedRentExpense" xlink:to="niobf_FixedRentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FixedRentExpense_lbl" xml:lang="en-US">Fixed rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US">Variable rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">Short-term lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SubleaseIncome_lbl" xml:lang="en-US">Sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Net lease cost &#8211; other operating expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="niobf_DisclosureLeasesAbstract_3_lbl" xml:lang="en-US">Maturities Of Lease Liabilities Are As Follows At September 30 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total remaining lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LessAmountOfPaymentsRepresentingInterest" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_lbl" xml:lang="en-US">Less portion of payments representing interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Less current portion of lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Non-current lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_3_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xml:lang="en-US">Warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventDescription" xlink:label="us-gaap_SubsequentEventDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventDescription" xlink:to="us-gaap_SubsequentEventDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventDescription_lbl" xml:lang="en-US">Subsequent event, description</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_AccruedCost" xlink:label="niobf_AccruedCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AccruedCost" xlink:to="niobf_AccruedCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_AccruedCost_lbl" xml:lang="en-US">Aggregate principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_StrikePriceOfWarrantsIssued" xlink:label="niobf_StrikePriceOfWarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StrikePriceOfWarrantsIssued" xlink:to="niobf_StrikePriceOfWarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StrikePriceOfWarrantsIssued_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:to="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember_doc" xml:lang="en-US">The element represents warrants each exercisable for1.11829212 common shares member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesWithoutParValueMember" xlink:to="niobf_CommonSharesWithoutParValueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonSharesWithoutParValueMember_doc" xml:lang="en-US">The element represents common shares without par value member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_doc" xml:lang="en-US">The element represents earnings loss per share basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:to="niobf_ExplorationExpendituresDisclosuresTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock_doc" xml:lang="en-US">The element represents exploration expenditures disclosures text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:to="niobf_ScheduleOfExplorationExpendituresTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock_doc" xml:lang="en-US">The element represents schedule of exploration expenditures table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CostCentreAxis" xlink:to="niobf_CostCentreAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CostCentreAxis_doc" xml:lang="en-US">The element represents cost centre axis.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TechnicalStudiesAndEngineeringMember" xlink:to="niobf_TechnicalStudiesAndEngineeringMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TechnicalStudiesAndEngineeringMember_doc" xml:lang="en-US">The element represents technical studies and engineering member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FieldmanagementandotherMember" xlink:to="niobf_FieldmanagementandotherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FieldmanagementandotherMember_doc" xml:lang="en-US">The element represents fieldmanagementandother member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MetallurgicaldevelopmentMember" xlink:to="niobf_MetallurgicaldevelopmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MetallurgicaldevelopmentMember_doc" xml:lang="en-US">The element represents metallurgicaldevelopment member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeologistAndFieldStaffMember" xlink:to="niobf_GeologistAndFieldStaffMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GeologistAndFieldStaffMember_doc" xml:lang="en-US">The element represents geologist and field staff member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FixedRentExpense" xlink:to="niobf_FixedRentExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FixedRentExpense_doc" xml:lang="en-US">The element represents fixed rent expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_doc" xml:lang="en-US">The element represents less amount of payments representing interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NetIncomeLoss1" xlink:to="niobf_NetIncomeLoss1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NetIncomeLoss1_doc" xml:lang="en-US">The element represents net income loss1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrincipalAndAccruedInterestConverted_doc" xml:lang="en-US">The element represents principal and accrued interest converted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValue" xlink:to="niobf_ChangeInFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValue_doc" xml:lang="en-US">The element represents change in fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutMember" xlink:to="niobf_EarnoutMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutMember_doc" xml:lang="en-US">The element represents earnout member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:to="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of primary inputs into the monte carlo models table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_doc" xml:lang="en-US">The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_doc" xml:lang="en-US">The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:to="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_doc" xml:lang="en-US">The element represents schedule common shares under facility financing agreement table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:to="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock_doc" xml:lang="en-US">The element represents schedule of class b common stock of e c r c table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfStockOptionRollForwardTableTextBlock" xlink:to="niobf_ScheduleOfStockOptionRollForwardTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfStockOptionRollForwardTableTextBlock_doc" xml:lang="en-US">The element represents schedule of stock option roll forward table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightGranted" xlink:to="niobf_ClassOfWarrantOrRightGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightGranted_doc" xml:lang="en-US">The element represents class of warrant or right granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercised_doc" xml:lang="en-US">The element represents class of warrant or right exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExpired_doc" xml:lang="en-US">The element represents class of warrant or right expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of outstanding exercisable warrants table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted_doc" xml:lang="en-US">The element represents class of warrant or right exercise price granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_doc" xml:lang="en-US">The element represents class of warrant or right exercise price exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_doc" xml:lang="en-US">The element represents class of warrant or right exercise price expired.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice11.00Member" xlink:label="niobf_ExercisePrice11.00Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.00Member" xlink:to="niobf_ExercisePrice11.00Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice11.00Member_doc" xml:lang="en-US">The element represents exercise price11.00 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice9.70Member" xlink:to="niobf_ExercisePrice9.70Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice9.70Member_doc" xml:lang="en-US">The element represents exercise price9.70 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice4.60Member" xlink:to="niobf_ExercisePrice4.60Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice4.60Member_doc" xml:lang="en-US">The element represents exercise price4.60 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.54Member" xlink:to="niobf_ExercisePrice3.54Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice3.54Member_doc" xml:lang="en-US">The element represents exercise price3.54 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.20Member" xlink:to="niobf_ExercisePrice2.20Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice2.20Member_doc" xml:lang="en-US">The element represents exercise price2.20 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.35Member" xlink:to="niobf_ExercisePrice3.35Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice3.35Member_doc" xml:lang="en-US">The element represents exercise price3.35 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.50Member" xlink:to="niobf_ExercisePrice11.50Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice11.50Member_doc" xml:lang="en-US">The element represents exercise price11.50 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.31Member" xlink:to="niobf_ExercisePrice2.31Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice2.31Member_doc" xml:lang="en-US">The element represents exercise price2.31 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.25Member" xlink:to="niobf_ExercisePrice3.25Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice3.25Member_doc" xml:lang="en-US">The element represents exercise price3.25 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPrivateWarrantsMember" xlink:to="niobf_GXIIPrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIPrivateWarrantsMember_doc" xml:lang="en-US">The element represents g x i i private warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in the fair value of the private warrants table text block.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="niobf_ChangesInFairValueOfInitialValuation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangesInFairValueOfInitialValuation_doc" xml:lang="en-US">The element represents changes in fair value of initial valuation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation1" xlink:to="niobf_ChangesInFairValueOfInitialValuation1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangesInFairValueOfInitialValuation1_doc" xml:lang="en-US">The element represents changes in fair value of initial valuation1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_doc" xml:lang="en-US">The element represents available for sale securities equity securities other.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_AccruedCosts" xlink:label="niobf_AccruedCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AccruedCosts" xlink:to="niobf_AccruedCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AccruedCosts_doc" xml:lang="en-US">The element represents accrued costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AccruedCost" xlink:to="niobf_AccruedCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AccruedCost_doc" xml:lang="en-US">The element represents accrued cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindConsentWarrantIssuanceMember" xlink:to="niobf_LindConsentWarrantIssuanceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LindConsentWarrantIssuanceMember_doc" xml:lang="en-US">The element represents lind consent warrant issuance member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:to="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1_doc" xml:lang="en-US">The element represents share based compensation arrangement by share based payment award options outstanding weighted average exercise price1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutLiabilityAtFairValue" xlink:to="niobf_EarnoutLiabilityAtFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutLiabilityAtFairValue_doc" xml:lang="en-US">The element represents earnout liability at fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenditures" xlink:to="niobf_ExplorationExpenditures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpenditures_doc" xml:lang="en-US">The element represents exploration expenditures.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_doc" xml:lang="en-US">The element represents change in fair value of earnout liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotes" xlink:to="niobf_ChangeInFairValueOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes_doc" xml:lang="en-US">The element represents change in fair value of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_doc" xml:lang="en-US">The element represents change in fair value of warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_doc" xml:lang="en-US">The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_doc" xml:lang="en-US">The element represents total weighted average number of share outstanding basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_doc" xml:lang="en-US">The element represents change in fair value of earnout share liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_doc" xml:lang="en-US">The element represents change in valuation of warrant liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNote" xlink:to="niobf_ChangeInFairValueOfConvertibleNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfConvertibleNote_doc" xml:lang="en-US">The element represents change in fair value of convertible note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OtheroperatingGainsLosses_doc" xml:lang="en-US">The element represents otheroperating gains losses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfCommitmentSharesIssued" xlink:to="niobf_FairValueOfCommitmentSharesIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueOfCommitmentSharesIssued_doc" xml:lang="en-US">The element represents fair value of commitment shares issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConversionsOfDebtForCommonShares" xlink:to="niobf_ConversionsOfDebtForCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConversionsOfDebtForCommonShares_doc" xml:lang="en-US">The element represents conversions of debt for common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ValueOfWarrantsIssued" xlink:to="niobf_ValueOfWarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ValueOfWarrantsIssued_doc" xml:lang="en-US">The element represents value of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementValue" xlink:to="niobf_PrivatePlacementValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivatePlacementValue_doc" xml:lang="en-US">The element represents private placement value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacility_doc" xml:lang="en-US">The element represents shares issued under the yorkville equity facility.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:to="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares_doc" xml:lang="en-US">The element represents shares issued under the yorkville equity facility shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivatePlacementShares" xlink:to="niobf_PrivatePlacementShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivatePlacementShares_doc" xml:lang="en-US">The element represents private placement shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" xlink:to="niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants_doc" xml:lang="en-US">The element represents stock issued during period value issuance of financing warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:to="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_doc" xml:lang="en-US">The element represents yorkville convertible debt financing agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebentureMember" xlink:to="niobf_YorkvilleConvertibleDebentureMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleConvertibleDebentureMember_doc" xml:lang="en-US">The element represents yorkville convertible debenture.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementMember" xlink:to="niobf_PurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PurchaseAgreementMember_doc" xml:lang="en-US">The element represents purchase agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeneralSecurityAgreementMember" xlink:to="niobf_GeneralSecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GeneralSecurityAgreementMember_doc" xml:lang="en-US">The element represents general security agreement member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LineOfCreditFacilityPrepaymentFee" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityPrepaymentFee" xlink:to="niobf_LineOfCreditFacilityPrepaymentFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee_doc" xml:lang="en-US">The element represents line of credit facility prepayment fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_NonRevolvingCreditFacilityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember_doc" xml:lang="en-US">The element represents non revolving credit facility agreement member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_AmountPaidToRelatedParty" xlink:label="niobf_AmountPaidToRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AmountPaidToRelatedParty" xlink:to="niobf_AmountPaidToRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AmountPaidToRelatedParty_doc" xml:lang="en-US">The element represents amount paid to related party.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_NonRevolvingAmountOutstanding" xlink:label="niobf_NonRevolvingAmountOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingAmountOutstanding" xlink:to="niobf_NonRevolvingAmountOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NonRevolvingAmountOutstanding_doc" xml:lang="en-US">The element represents non revolving amount outstanding.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_MarkSmithMember" xlink:label="niobf_MarkSmithMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MarkSmithMember" xlink:to="niobf_MarkSmithMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MarkSmithMember_doc" xml:lang="en-US">The element represents mark smith.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementSeriesAMember" xlink:to="niobf_PurchaseAgreementSeriesAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PurchaseAgreementSeriesAMember_doc" xml:lang="en-US">The element represents purchase agreement series a.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementSeriesBMember" xlink:to="niobf_PurchaseAgreementSeriesBMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PurchaseAgreementSeriesBMember_doc" xml:lang="en-US">The element represents purchase agreement series b.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StrikePriceOfWarrantsIssued" xlink:to="niobf_StrikePriceOfWarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StrikePriceOfWarrantsIssued_doc" xml:lang="en-US">The element represents strike price of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ContractualInterest" xlink:to="niobf_ContractualInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ContractualInterest_doc" xml:lang="en-US">The element represents contractual interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfEarnoutLiability_3_lbl" xml:lang="en-US">Change In Fair Value Of Earnout Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotes" xlink:to="niobf_ChangeInFairValueOfConvertibleNotes_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes_3_lbl" xml:lang="en-US">Change In Fair Value Of Convertible Notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense, Operating and Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_3_lbl" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling InterestOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_2_lbl" xml:lang="en-US">OCI, Equity Method Investment, before Tax, Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OtheroperatingGainsLosses_3_lbl" xml:lang="en-US">Otheroperating Gains Losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_2_lbl" xml:lang="en-US">Repayments of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_3_lbl" xml:lang="en-US">Convertible Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_3_lbl" xml:lang="en-US">Fair Value Hedge Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_2_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="us-gaap_InvestmentOwnedBalancePrincipalAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalancePrincipalAmount_2_lbl" xml:lang="en-US">Investment Owned, Balance, Principal Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_4_lbl" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_2_lbl" xml:lang="en-US">Debt Instrument, Issued, Principal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_3_lbl" xml:lang="en-US">Servicing Liability at Fair Value, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:to="us-gaap_ServicingLiabilityAtFairValueAdditions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiabilityAtFairValueAdditions_2_lbl" xml:lang="en-US">Servicing Liability at Fair Value, Additions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:to="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_2_lbl" xml:lang="en-US">Nonmonetary Transaction, Gain (Loss) Recognized on Transfer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightGranted" xlink:to="niobf_ClassOfWarrantOrRightGranted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightGranted_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceGranted_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Exercise Price Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercised_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Exercise Price Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Exercise Price Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation1" xlink:to="niobf_ChangesInFairValueOfInitialValuation1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangesInFairValueOfInitialValuation1_4_lbl" xml:lang="en-US">Changes In Fair Value Of Initial ValuationOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_2_lbl" xml:lang="en-US">Servicing Asset at Fair Value, Changes in Fair Value Resulting from Changes in Valuation Inputs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationExpense" xlink:to="us-gaap_ExplorationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExplorationExpense_2_lbl" xml:lang="en-US">Exploration Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubleaseIncome_2_lbl" xml:lang="en-US">Sublease Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_3_lbl" xml:lang="en-US">Available For Sale Securities Equity Securities Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_2_lbl" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AccruedCost" xlink:to="niobf_AccruedCost_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AccruedCost_3_lbl" xml:lang="en-US">Accrued Cost</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>niobf-20240930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://niocorp.com/role/Cover" xlink:href="niobf-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheets" xlink:href="niobf-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:href="niobf-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="niobf-20240930.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfCashFlows" xlink:href="niobf-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:href="niobf-20240930.xsd#StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusiness" xlink:href="niobf-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentation" xlink:href="niobf-20240930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcern" xlink:href="niobf-20240930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="niobf-20240930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Debt" xlink:href="niobf-20240930.xsd#Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:href="niobf-20240930.xsd#ClassBCommonStockOfEcrc" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonShares" xlink:href="niobf-20240930.xsd#CommonShares" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactions" xlink:href="niobf-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpenditures" xlink:href="niobf-20240930.xsd#ExplorationExpenditures" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/Leases" xlink:href="niobf-20240930.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurements" xlink:href="niobf-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEvents" xlink:href="niobf-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationPolicies" xlink:href="niobf-20240930.xsd#BasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationTables" xlink:href="niobf-20240930.xsd#BasisOfPresentationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="niobf-20240930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DebtTables" xlink:href="niobf-20240930.xsd#DebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:href="niobf-20240930.xsd#ClassBCommonStockOfEcrcTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesTables" xlink:href="niobf-20240930.xsd#CommonSharesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ExplorationExpendituresTables" xlink:href="niobf-20240930.xsd#ExplorationExpendituresTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/LeasesTables" xlink:href="niobf-20240930.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FairValueMeasurementsTables" xlink:href="niobf-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="niobf-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:href="niobf-20240930.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:href="niobf-20240930.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/BasisOfPresentationDetailsNarrative" xlink:href="niobf-20240930.xsd#BasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/GoingConcernDetailsNarrative" xlink:href="niobf-20240930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:href="niobf-20240930.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:href="niobf-20240930.xsd#FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInApril2024NotesIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/DebtDetailsNarrative" xlink:href="niobf-20240930.xsd#DebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:href="niobf-20240930.xsd#TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:href="niobf-20240930.xsd#FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:href="niobf-20240930.xsd#CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:href="niobf-20240930.xsd#ScheduleOfStockOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails" xlink:href="niobf-20240930.xsd#ScheduleOfWarrantTransactionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:href="niobf-20240930.xsd#AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:href="niobf-20240930.xsd#FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:href="niobf-20240930.xsd#ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:href="niobf-20240930.xsd#CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:href="niobf-20240930.xsd#CommonSharesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="niobf-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:href="niobf-20240930.xsd#ScheduleOfExplorationExpendituresDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:href="niobf-20240930.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:href="niobf-20240930.xsd#MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:href="niobf-20240930.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="niobf-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="loc_niobfCommonSharesWithoutParValueMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfCommonSharesWithoutParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:label="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfWarrantsEachExercisableFor1.11829212CommonSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" xlink:label="loc_us-gaapDeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="loc_us-gaapLongTermInvestmentsAndReceivablesNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLongTermInvestmentsAndReceivablesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="loc_us-gaapRelatedPartyDepositLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapRelatedPartyDepositLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="loc_niobfEarnoutLiabilityAtFairValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_niobfEarnoutLiabilityAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="loc_us-gaapCommonStockSharesAuthorizedUnlimited" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorizedUnlimited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExplorationExpenditures" xlink:label="loc_niobfExplorationExpenditures" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfExplorationExpenditures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfEarnoutLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfChangeInFairValueOfEarnoutLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="loc_niobfChangeInFairValueOfWarrantLiability" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfChangeInFairValueOfWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfConvertibleNotes" xlink:label="loc_niobfChangeInFairValueOfConvertibleNotes" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfChangeInFairValueOfConvertibleNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="loc_niobfEarningsLossPerShareBasicAndDiluted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfEarningsLossPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_niobfTotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfTotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutShareLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="loc_niobfChangeInValuationOfWarrantLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValueOfConvertibleNote" xlink:label="loc_niobfChangeInFairValueOfConvertibleNote" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInFairValueOfConvertibleNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_OtheroperatingGainsLosses" xlink:label="loc_niobfOtheroperatingGainsLosses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="loc_niobfFairValueOfCommitmentSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_niobfFairValueOfCommitmentSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ConversionsOfDebtForCommonShares" xlink:label="loc_niobfConversionsOfDebtForCommonShares" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_niobfConversionsOfDebtForCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ValueOfWarrantsIssued" xlink:label="loc_niobfValueOfWarrantsIssued" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_niobfValueOfWarrantsIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Shareholders&apos; (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="loc_niobfRedeemableNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_niobfRedeemableNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PrivatePlacementValue" xlink:label="loc_niobfPrivatePlacementValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PrivatePlacementShares" xlink:label="loc_niobfPrivatePlacementShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfPrivatePlacementShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacility" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacility" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:label="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfSharesIssuedUnderTheYorkvilleEquityFacilityShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" xlink:label="loc_niobfStockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueIssuanceOfFinancingWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentation" xlink:title="00000008 - Disclosure - BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccounting" xlink:label="loc_us-gaapBasisOfAccounting" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccounting" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcern" xlink:title="00000009 - Disclosure - GOING CONCERN">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Debt" xlink:title="00000011 - Disclosure - DEBT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="00000012 - Disclosure - CLASS B COMMON STOCK OF ECRC">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:label="loc_niobfScheduleOfClassBCommonStockOfECRCTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfClassBCommonStockOfECRCTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="00000013 - Disclosure - COMMON SHARES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactions" xlink:title="00000014 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="00000015 - Disclosure - EXPLORATION EXPENDITURES">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:label="loc_niobfExplorationExpendituresDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_niobfExplorationExpendituresDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="00000016 - Disclosure - LEASES">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="00000017 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationPolicies" xlink:title="00000019 - Disclosure - BASIS OF PRESENTATION (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationTables" xlink:title="00000020 - Disclosure - BASIS OF PRESENTATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DebtTables" xlink:title="00000022 - Disclosure - DEBT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="loc_us-gaapConvertibleDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:label="loc_us-gaapScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="00000023 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:label="loc_niobfScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:label="loc_niobfScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="00000024 - Disclosure - COMMON SHARES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:label="loc_niobfScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfStockOptionRollForwardTableTextBlock" xlink:label="loc_niobfScheduleOfStockOptionRollForwardTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfScheduleOfStockOptionRollForwardTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="00000025 - Disclosure - EXPLORATION EXPENDITURES (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:label="loc_niobfScheduleOfExplorationExpendituresTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_niobfScheduleOfExplorationExpendituresTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="00000026 - Disclosure - LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="00000027 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaapNumberOfReportableSegments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNumberOfReportableSegments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="00000029 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_NetIncomeLoss1" xlink:label="loc_niobfNetIncomeLoss1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_niobfNetIncomeLoss1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:label="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="loc_niobfEarningsLossPerShareBasicAndDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_niobfEarningsLossPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="00000030 - Disclosure - Schedule of excluded from the dilutive securities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToWrittenPutOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToWrittenPutOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecurities" xlink:label="loc_us-gaapDilutiveSecurities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapDilutiveSecurities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPresentationDetailsNarrative" xlink:title="00000031 - Disclosure - BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernDetailsNarrative" xlink:title="00000032 - Disclosure - GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward" xlink:label="loc_us-gaapInvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapInvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromRepaymentsOfDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="00000033 - Disclosure - Schedule of account payable and accrued liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails" xlink:title="00000034 - Disclosure - The change in the Convertible Debentures is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="loc_niobfPrincipalAndAccruedInterestConverted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfPrincipalAndAccruedInterestConverted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebt_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details" xlink:title="00000035 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ContractualInterest" xlink:label="loc_niobfContractualInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfContractualInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails" xlink:title="00000036 - Disclosure - The change in the April 2024 Notes is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="loc_us-gaapFairValueHedgeAssetsAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueHedgeAssetsAtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangeInFairValue" xlink:label="loc_niobfChangeInFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfChangeInFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="loc_us-gaapFairValueHedgeAssetsAtFairValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueHedgeAssetsAtFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:label="loc_us-gaapInvestmentOwnedBalancePrincipalAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapInvestmentOwnedBalancePrincipalAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails" xlink:title="00000037 - Disclosure - The change in the April 2024 Warrant liability is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DebtDetailsNarrative" xlink:title="00000038 - Disclosure - DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_YorkvilleConvertibleDebentureMember" xlink:label="loc_niobfYorkvilleConvertibleDebentureMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfYorkvilleConvertibleDebentureMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementMember" xlink:label="loc_niobfPurchaseAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="loc_us-gaapDebtInstrumentRepaidPrincipal" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentRepaidPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRate" xlink:label="loc_us-gaapInvestmentInterestRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInvestmentInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="loc_us-gaapDebtInstrumentIssuedPrincipal" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuedPrincipal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:label="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails" xlink:title="00000039 - Disclosure - These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details" xlink:title="00000040 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingLiabilityAtFairValueAdditions" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAdditions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details" xlink:title="00000041 - Disclosure - The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:label="loc_us-gaapNonmonetaryTransactionGainLossRecognizedOnTransfer" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapNonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfStockOptionDetails" xlink:title="00000042 - Disclosure - Schedule of stock option (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails" xlink:title="00000043 - Disclosure - Schedule of warrant transactions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightGranted" xlink:label="loc_niobfClassOfWarrantOrRightGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightGranted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceGranted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExercised" xlink:label="loc_niobfClassOfWarrantOrRightExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExpired" xlink:label="loc_niobfClassOfWarrantOrRightExpired" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceExpired" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails" xlink:title="00000044 - Disclosure - At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice9.70Member" xlink:label="loc_niobfExercisePrice9.70Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice9.70Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice4.60Member" xlink:label="loc_niobfExercisePrice4.60Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice4.60Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.54Member" xlink:label="loc_niobfExercisePrice3.54Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.54Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice2.20Member" xlink:label="loc_niobfExercisePrice2.20Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.20Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.35Member" xlink:label="loc_niobfExercisePrice3.35Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.35Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice3.25Member" xlink:label="loc_niobfExercisePrice3.25Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.25Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice11.50Member" xlink:label="loc_niobfExercisePrice11.50Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.50Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ExercisePrice2.31Member" xlink:label="loc_niobfExercisePrice2.31Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.31Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails" xlink:title="00000045 - Disclosure - The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_srtPlatformOperatorCryptoAssetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails" xlink:title="00000046 - Disclosure - The change in the Private Warrants liability is presented below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="loc_niobfChangesInFairValueOfInitialValuation1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="loc_niobfChangesInFairValueOfInitialValuation1_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails" xlink:title="00000047 - Disclosure - The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="00000048 - Disclosure - COMMON SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="loc_niobfGXIIPrivateWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="loc_niobfLindConsentWarrantIssuanceMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLindConsentWarrantIssuanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfNonRevolvingCreditFacilityAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfNonRevolvingCreditFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="loc_niobfGeneralSecurityAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfGeneralSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLongTermLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaapRelatedPartyTransactionRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LineOfCreditFacilityEstablishmentFee" xlink:label="loc_niobfLineOfCreditFacilityEstablishmentFee" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfLineOfCreditFacilityEstablishmentFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="00000050 - Disclosure - Schedule of exploration expenditures (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CostCentreAxis" xlink:label="loc_niobfCostCentreAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_niobfCostCentreAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_TechnicalStudiesAndEngineeringMember" xlink:label="loc_niobfTechnicalStudiesAndEngineeringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfTechnicalStudiesAndEngineeringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_FieldmanagementandotherMember" xlink:label="loc_niobfFieldmanagementandotherMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFieldmanagementandotherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_MetallurgicaldevelopmentMember" xlink:label="loc_niobfMetallurgicaldevelopmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfMetallurgicaldevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_GeologistAndFieldStaffMember" xlink:label="loc_niobfGeologistAndFieldStaffMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfGeologistAndFieldStaffMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExplorationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="00000051 - Disclosure - The Company incurred lease costs as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaapLeaseCostAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_FixedRentExpense" xlink:label="loc_niobfFixedRentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfFixedRentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaapVariableLeaseCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapVariableLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaapShortTermLeaseCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapShortTermLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details" xlink:title="00000052 - Disclosure - The maturities of lease liabilities are as follows at September 30, 2024: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_LessAmountOfPaymentsRepresentingInterest" xlink:label="loc_niobfLessAmountOfPaymentsRepresentingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfLessAmountOfPaymentsRepresentingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="00000053 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000054 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementSeriesAMember" xlink:label="loc_niobfPurchaseAgreementSeriesAMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementSeriesAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_PurchaseAgreementSeriesBMember" xlink:label="loc_niobfPurchaseAgreementSeriesBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementSeriesBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="loc_us-gaapDebtInstrumentIssuedPrincipal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuedPrincipal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:label="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseDecreaseOtherNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_AccruedCost" xlink:label="loc_niobfAccruedCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_niobfAccruedCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20240930.xsd#niobf_StrikePriceOfWarrantsIssued" xlink:label="loc_niobfStrikePriceOfWarrantsIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_niobfStrikePriceOfWarrantsIssued" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>n257410qimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410qimg001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 1P"< P$1  (1 0,1 ?_$ +    $% 0$!
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M4;=7'YY\E)VAH^G'FLG[23;:8F"*4)2>LD"X 'Y**F[&3J=Y*%OP :U>Y/\
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4"-NJM.>%-*WM5:ODJ(E1$J(O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963145637136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Nov. 13, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NioCorp
Developments Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001512228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1262185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 South Yosemite Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
        115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Centennial<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">334-7066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,512,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember', window );">Common Shares Without Par Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, without par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember', window );">Warrants Each Exercisable For1.11829212 Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each exercisable for 1.11829212 Common Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NIOBW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963147299744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 2,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross', window );">Deferred share issuance costs</a></td>
<td class="nump">459<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">587<span></span>
</td>
<td class="nump">916<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAndReceivablesNet', window );">Investment in equity securities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Land and buildings, net</a></td>
<td class="nump">836<span></span>
</td>
<td class="nump">837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties', window );">Mineral properties</a></td>
<td class="nump">16,085<span></span>
</td>
<td class="nump">16,085<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">18,323<span></span>
</td>
<td class="nump">20,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">2,736<span></span>
</td>
<td class="nump">1,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible debt</a></td>
<td class="nump">5,258<span></span>
</td>
<td class="nump">7,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyDepositLiabilities', window );">Related party debt</a></td>
<td class="nump">33<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,124<span></span>
</td>
<td class="nump">11,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="nump">1,595<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutLiabilityAtFairValue', window );">Earnout liability, at fair value</a></td>
<td class="nump">4,633<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,439<span></span>
</td>
<td class="nump">17,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">1,503<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value, unlimited shares authorized; 38,720,244 and 38,062,647 shares outstanding, respectively</a></td>
<td class="nump">167,275<span></span>
</td>
<td class="nump">163,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(163,983)<span></span>
</td>
<td class="num">(161,912)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(911)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">2,381<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity</a></td>
<td class="nump">$ 18,323<span></span>
</td>
<td class="nump">$ 20,070<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout liability at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation, depletion, amortization, and valuation allowance, of capitalized cost for mineral interest in unproved property in oil- and gas-producing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-15<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-13<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance costs recognized in a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, before deduction of accumulated amortization or effects of subsequent adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestmentsAndReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestmentsAndReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (12)(c)<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (16)(c)<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (15)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (14)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyDepositLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deposits held by the entity for a related party (entity, shareholder, employee).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyDepositLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963148291360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorizedUnlimited', window );">Common stock, authorized</a></td>
<td class="text">Unlimited<span></span>
</td>
<td class="text">Unlimited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">38,720,244<span></span>
</td>
<td class="nump">38,062,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorizedUnlimited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether number of common shares permitted to be issued is unlimited. Acceptable value is "Unlimited".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorizedUnlimited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:authorizedUnlimitedItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963143698768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Employee related costs</a></td>
<td class="nump">$ 330<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">1,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExplorationExpenditures', window );">Exploration expenditures</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expenses</a></td>
<td class="nump">477<span></span>
</td>
<td class="nump">834<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfEarnoutLiability', window );">Change in fair value of earnout shares liability</a></td>
<td class="nump">816<span></span>
</td>
<td class="num">(2,093)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfWarrantLiability', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="nump">17<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange loss (gain)</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other gains</a></td>
<td class="num">(122)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Loss on equity securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1', window );">Loss before income taxes</a></td>
<td class="num">(2,102)<span></span>
</td>
<td class="num">(3,488)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net loss and comprehensive loss</a></td>
<td class="num">(2,102)<span></span>
</td>
<td class="num">(3,387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to redeemable noncontrolling interest</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent', window );">Net loss and comprehensive loss attributable to the Company</a></td>
<td class="num">$ (2,071)<span></span>
</td>
<td class="num">$ (3,213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share, basic and diluted</a></td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding, basic and diluted</a></td>
<td class="nump">38,361,344<span></span>
</td>
<td class="nump">31,967,091<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfEarnoutLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of earnout liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfEarnoutLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarningsLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnings loss per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarningsLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExplorationExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exploration expenditures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExplorationExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents total weighted average number of share outstanding basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481725/323-10-35-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963147156544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="num">$ (2,102)<span></span>
</td>
<td class="num">$ (3,387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfEarnoutShareLiability', window );">Change in valuation of earnout shares liability</a></td>
<td class="nump">816<span></span>
</td>
<td class="num">(2,093)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInValuationOfWarrantLiabilities', window );">Change in valuation of warrant liabilities</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfConvertibleNote', window );">Change in fair value of convertible note</a></td>
<td class="nump">17<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion of convertible debt</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_OtheroperatingGainsLosses', window );">Other gain</a></td>
<td class="num">(122)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueOfCommitmentSharesIssued', window );">Yorkville share issuances</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on equity securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Non-cash lease activity</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">&#160;</a></td>
<td class="num">(1,404)<span></span>
</td>
<td class="num">(3,278)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in working capital items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(130)<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">892<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(642)<span></span>
</td>
<td class="num">(2,737)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of capital stock</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">1,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Related party debt draws</a></td>
<td class="nump">33<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="num">(1,943)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(1,220)<span></span>
</td>
<td class="nump">1,494<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents during period</a></td>
<td class="num">(1,862)<span></span>
</td>
<td class="num">(1,243)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">2,012<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ConversionsOfDebtForCommonShares', window );">Conversion of debt for common shares</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">5,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ValueOfWarrantsIssued', window );">Value of warrants issued</a></td>
<td class="nump">$ 2,262<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfEarnoutShareLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of earnout share liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfEarnoutShareLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInValuationOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in valuation of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInValuationOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ConversionsOfDebtForCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents conversions of debt for common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ConversionsOfDebtForCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueOfCommitmentSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value of commitment shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueOfCommitmentSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_OtheroperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents otheroperating gains losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_OtheroperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ValueOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ValueOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481639/420-10-35-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963143811856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Redeemable Noncontrolling Interest [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2023</a></td>
<td class="nump">$ 140,421<span></span>
</td>
<td class="num">$ (150,477)<span></span>
</td>
<td class="num">$ (911)<span></span>
</td>
<td class="num">$ (10,967)<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">31,202,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivatePlacementValue', window );">Private placements</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivatePlacementShares', window );">Private placement (in shares)</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacility', window );">Yorkville equity facility draws</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">585<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares', window );">Shares issued under the Yorkville equity facility (in shares)</a></td>
<td class="nump">145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 5,729<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,729<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Debt conversions (in shares)</a></td>
<td class="nump">1,316,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">$ (38)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the period</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(3,213)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,213)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2023</a></td>
<td class="nump">$ 147,697<span></span>
</td>
<td class="num">(153,690)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
<td class="num">(6,904)<span></span>
</td>
<td class="nump">1,926<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="nump">32,913,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2024</a></td>
<td class="nump">$ 163,823<span></span>
</td>
<td class="num">(161,912)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2024</a></td>
<td class="nump">38,062,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,062,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacility', window );">Yorkville equity facility draws</a></td>
<td class="nump">$ 691<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 691<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares', window );">Shares issued under the Yorkville equity facility (in shares)</a></td>
<td class="nump">399,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 501<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Debt conversions (in shares)</a></td>
<td class="nump">258,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants', window );">Issuance of warrants</a></td>
<td class="nump">$ 2,262<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,262<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the period</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,071)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,071)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2024</a></td>
<td class="nump">$ 167,275<span></span>
</td>
<td class="num">$ (163,983)<span></span>
</td>
<td class="num">$ (911)<span></span>
</td>
<td class="nump">$ 2,381<span></span>
</td>
<td class="nump">$ 1,503<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2024</a></td>
<td class="nump">38,720,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,720,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrivatePlacementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents private placement shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrivatePlacementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrivatePlacementValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents private placement value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrivatePlacementValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents shares issued under the yorkville equity facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharesIssuedUnderTheYorkvilleEquityFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents shares issued under the yorkville equity facility shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value issuance of financing warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963151734560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--NatureOfOperations_zYOu73kDNj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82C_zG0C54Bd2Ow7">DESCRIPTION
    OF BUSINESS</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;NioCorp&#8221; or the &#8220;Company&#8221;)
was incorporated on February 27, 1987, under the laws of the Province of British Columbia and currently operates in <span id="xdx_903_eus-gaap--NumberOfReportableSegments_dxL_uNumber_c20240701__20240930_zMxz1FFDWmP7" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0409">one</span></span> reportable
operating segment consisting of exploration and development of mineral deposits in North America, specifically, the Company&#8217;s
niobium, scandium, and titanium project (the &#8220;Elk Creek Project&#8221;) located in southeastern Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
interim condensed consolidated financial statements have been prepared on a going concern basis that contemplates the realization
of assets and discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These
financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 3, these matters raised substantial doubt about the Company&#8217;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963142900128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BasisOfAccounting_zysVj0Atdfwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_827_zmncpzFAIFK6">BASIS
    OF PRESENTATION</span></span></td></tr>
</table>
<p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAS8vA0YxUC9" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zbG62WJMUltc">Basis
    of Presentation and Consolidation</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles of the United States of America (&#8220;U.S. GAAP&#8221;) and the rules and regulations of the Securities and Exchange
Commission (&#8220;SEC&#8221;). The interim condensed consolidated financial statements include the consolidated accounts of the
Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed
in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited
consolidated financial statements for the year ended June 30, 2024. Certain transactions include reference to Canadian dollars
(&#8220;C$&#8221;) where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, all adjustments considered necessary (including normal recurring adjustments) for a fair statement
of the financial position, results of operations, and cash flows at September 30, 2024, and for all periods presented, have been
included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included
in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to appropriate
SEC rules and regulations. These interim condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements for the year ended June 30, 2024. The interim results are not necessarily indicative of results
for the full year ending June 30, 2025, or future operating periods.</span></p>

<p id="xdx_851_zvMgGNB4otD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOCmPn7lNNj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_z3UoeJf1dJM6">Recent
    Accounting Standards</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) that are
adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of
recently issued standards did not or will not have a material impact on the Company&#8217;s consolidated financial statements
upon adoption.</span></p>

<p id="xdx_85A_z3GFShKbKQyh" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--UseOfEstimates_z3SiY5w94AGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_z5OQnemVNJh9">Use
    of Estimates</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements, and the reported amounts of</span></p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">expenses
during the reporting period. The Company regularly evaluates estimates and assumptions related to the carrying value of
long-term assets, deferred income tax assets and related valuations, liabilities related to the April 2024 Notes, Earnout
Shares, Private Warrants, and Contingent Consent Warrants (each, as defined below), and share-based compensation. The Company
bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be
reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The
actual results experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the
extent there are material differences between estimates and the actual results, future results of operations will be
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company acquired a federal income tax payable of $<span id="xdx_90D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20240701__20240930_zlBtMPIJ1op1" title="Federal income tax payable">443</span> in connection with the GXII Transaction (as defined below). As a result of post-transaction losses at Elk Creek Resources Corp. (&#8220;ECRC&#8221;), a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable of $<span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20230701__20230930_zPdI1r0unlw8" title="Income tax payable">101</span> was recorded as an income tax benefit in the condensed consolidated statement of operations and comprehensive loss for the three months ended September 30, 2023. The Company maintains a full valuation allowance against future income tax assets as it is more likely than not that all of the assets will not be realized.

</span></p>

<p id="xdx_850_zdE5GLaBrof5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zDPbzauHgqsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_z6q9i4Iyxf9j">Basic
    and Diluted Earnings per Share</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zsGGon4HYLmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8BF_z4l8xyzsUWA6">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months <br/>Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 0.125in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--NetIncomeLoss1_pn3n3_c20240701__20240930_zXURRH4Zq1Qf" style="width: 12%; text-align: right" title="Net loss">(2,102</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--NetIncomeLoss1_pn3n3_c20230701__20230930_z3Nbict3AAE9" style="width: 12%; text-align: right" title="Net loss">(3,387</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Less: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20240701__20240930_zFzHDQM6k5Pj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest">(31</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230701__20230930_zrbmEO99sj22" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest">(174</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20240930_zO1oS9kkliB7" style="text-align: right" title="Net loss available to participating securities">(2,071</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20230930_zBwJ4DnmPTml" style="text-align: right" title="Net loss available to participating securities">(3,213</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Less: Net loss attributable to vested shares of ECRC Class B common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20240701__20240930_zOffFp98jZoe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock">(186</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20230930_zbjS9KFiAS9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock">(257</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20240930_z79TUoCxd7I6" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(1,885</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20230930_zU3Yo09f6yFl" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(2,956</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20240930_zCjQCklwt7i1" style="text-align: right" title="Weighted average shares outstanding basic and diluted">38,361,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20230930_zocTkntBB0de" style="text-align: right" title="Weighted average shares outstanding basic and diluted">31,967,091</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in">Loss per Common Share outstanding &#8211; basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20240701__20240930_zIGXkG54ss4" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">(0.05</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20230930_zfK9460Y3fkb" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">(0.09</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
</table>

<p id="xdx_8AA_zkIsFeClJGA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following common shares, no par value, of the Company (&#8220;Common Shares&#8221;) underlying options to purchase Common Shares
(&#8220;Options&#8221;), Common Share purchase warrants (&#8220;Warrants&#8221;), and outstanding convertible debt were&#160;antidilutive&#160;due
to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three-month
periods indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_znZLZfAkFCH" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zhUeftbbcOy2" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months <br/>Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Excluded potentially dilutive securities <sup id="xdx_F6F_zIte5Np7FUFf">(1)(2)</sup>:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20240930_fKDEpKDIp_zbrcgLpWgE6d" style="width: 12%; text-align: right" title="Options">2,455,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20230930_fKDEpKDIp_z1MJsWfUsQR" style="width: 12%; text-align: right" title="Options">1,319,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20240930_fKDEpKDIp_zXvYfHZKQGNi" style="text-align: right" title="Warrants">20,932,985</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20230930_fKDEpKDIp_zNG0pUxA0mf7" style="text-align: right" title="Warrants">19,066,304</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20240701__20240930_fKDEpKDIp_zAvLv9qp0eW6" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">1,920,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20230930_fKDEpKDIp_zaVTCGQ29mda" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,448,730</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Total potential dilutive securities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DilutiveSecurities_c20240701__20240930_fKDEpKDIp_zIbOnODh7Mgc" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities">25,308,485</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DilutiveSecurities_c20230701__20230930_fKDEpKDIp_zvnMIq7Frfoj" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities">22,834,034</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.375in">&#160;</td>
    <td style="width: 0.375in; text-align: justify"><span id="xdx_F02_zjAwZAoQHD6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zzr8bMTPhwY9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_F0B_zvkAbz8xNUta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zU6ppeYGWiRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.</span></td></tr>
</table>

<p id="xdx_8AE_z1aDhns6aQ6k" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

<p id="xdx_85A_zBEmehzoAVh8" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150485632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">GOING CONCERN</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z3ot1tQpegTa" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82F_za61ndQ8GZvk">GOING CONCERN</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred a loss of $<span id="xdx_907_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20240701__20240930_zR3aggC3yVq5" title="Net loss::XDX::-2102"><span style="-sec-ix-hidden: xdx2ixbrl0484">2,071</span></span></span> for the three months ended September 30, 2024
(2023 - $<span id="xdx_90A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20230930_zi4eiGAUmh17" title="Net loss::XDX::-3387"><span style="-sec-ix-hidden: xdx2ixbrl0486">3,213</span></span>) and had a working capital deficit of $<span id="xdx_907_eus-gaap--InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward_iI_pn3n3_c20240930_zhDqDUrrZlPc" title="Capital deficit">6,928</span> and an accumulated deficit
of $<span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20240930_z12bkB9Yxdla" title="Accumulated deficit">163,983</span> as of September 30, 2024. As a development stage issuer, the Company
has not yet commenced its mining operations and accordingly does not generate any revenue. As of September 30, 2024, the Company
had cash of $<span id="xdx_90E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20240930_zPXvz8Fe2rb5" title="Cash">150</span>, which will not be sufficient to</p>




















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">fund normal operations or the repayment of the April 2024 Notes (as further
discussed in Note 5b) for the next twelve months. These conditions and events raise substantial doubt about the Company&#8217;s
ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In response to these conditions
and events, the Company plans to obtain additional financing. As disclosed in Note 12, in November 2024 the Company closed an underwritten
public offering (the &#8220;November 2024 Registered Offering&#8221;) and a non-brokered private placement (the &#8220;November
2024 Private Offering&#8221;, and together with the November 2024 Registered Offering, the &#8220;November Offerings&#8221;) which
resulted in the receipt of net proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20241101__20241130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zomX2bnvVDck" title="Net proceeds">6,000</span>, after giving effect to certain fees but before estimated underwriting discounts and  offering
expenses. In addition, NioCorp expects to have access to up to $58,577 in net proceeds from the Standby Equity Purchase Agreement,
dated January 26, 2023 (the &#8220;Yorkville Equity Facility Financing Agreement&#8221;), between the Company and YA II PN, Ltd.,
an investment fund managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;), through April 1, 2026. The Company may pursue
additional sources of financing, and while it has been successful in doing so in the past, there can be no assurance it will be
able to do so in the future. Other than the funds received from the November Offerings, and the potential issuance of Common Shares
under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements
for additional financing as of September 30, 2024. The Company&#8217;s plans to obtain additional financing have not been finalized,
are subject to market conditions, and are not within the Company&#8217;s control and therefore cannot be deemed probable. Further,
the Company will be required to raise additional funds for the construction and commencement of operations. As a result, the Company
has concluded that management&#8217;s plans do not alleviate substantial doubt about the Company&#8217;s ability to continue as
a going concern. </p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
interim condensed consolidated financial statements do not include any adjustments related to the recoverability and classification
of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963151734304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zkrkxGif55Lc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82B_z5e1RjR1mCNg">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</span></span></td></tr>
</table>

<p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zc59G9He5hEd" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B0_zqwCVXE70PI9" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></p>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_49A_20240930_zplwfu8pkiia" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240630_ziB5bavhMO39" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">June 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zk9amtW1T47i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,056</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,417</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z52oa7ArvAm9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">603</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zRJOO7YReM53" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zGEuJyfS4n3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Loan origination fees payable to related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">29</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zDoC9z6fm5P2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">2,736</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">1,843</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zFYbuJRn2mT6" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150676928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">DEBT</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zZ5pfSsOJpyd" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">

    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td id="xdx_822_zxcPXBGvzH6b" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>DEBT</span></span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
    Convertible Debenture</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the remaining
outstanding principal and accrued interest of $<span id="xdx_90C_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20240717__20240719__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zBxJTYCjssz2" title="Principal and accrued interest">554</span> under the unsecured convertible debentures (the &#8220;Convertible Debentures&#8221;)
issued to Yorkville pursuant to the Securities Purchase Agreement, dated January 26, 2023 (the &#8220;Yorkville Convertible Debt Financing
Agreement&#8221;), into Common Shares in exchange for a $<span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20240717__20240719__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zLK4PEtrT2w7" title="Shares exchange">95</span> make-whole payment. The Company recorded a gain on extinguishment of $<span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebentureMember_zw5wPnhgKjy1" title="Gain on extinguishment">19</span>
as part other gains in the condensed consolidated statements of operations and comprehensive loss.</span>&#160;</p>




















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ConvertibleDebtTableTextBlock_zS6nsQGSn1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z5wqrivMG86e">The
change in the Convertible Debentures is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; padding-bottom: 1pt">Balance at June 30, 2024</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iS_pn3n3_c20240701__20240930_zkt8cMGNGeCb" style="width: 13%; text-align: right" title="Balance at June 30, 2024">571</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20240701__20240930_zjjm9GQdsxd2" style="text-align: right" title="Accretion expense">43</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Principal and interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_c20240701__20240930_z9tSqczqRNid" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted">(614</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20240930_zqWS7ql9Qxe6" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, September 30, 2024"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zGnP7n6uRoYf" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p id="xdx_892_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zM25WlNMclH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the components of interest expense associated with the Convertible Debentures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months<br/>
Ended September &#160;30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-left: 0.25in">Component of Interest Expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 0.25in">Contractual&#160;&#160;interest</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ContractualInterest_pn3n3_c20240701__20240930_zdBZCTxVqjbi" style="width: 18%; text-align: right" title="Contractual interest">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ContractualInterest_pn3n3_c20230701__20230930_zEaS59Mdnkjl" style="width: 18%; text-align: right" title="Contractual interest">130</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Amortization of discount and issuance costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20240701__20240930_zku8MA5zWO4b" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs">43</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20230701__20230930_zTe3k1Qjtuu7" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs">1,945</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AccretionExpense_pn3n3_c20240701__20240930_z3irbjodGS1k" style="border-bottom: Black 2pt solid; text-align: right" title="Total">44</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20230701__20230930_zN1Qw54oVmAf" style="border-bottom: Black 2pt solid; text-align: right" title="Total">2,075</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zdj80LYWzDUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    2024 Notes</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (&#8220;Lind II&#8221;, and together with
Yorkville, the &#8220;April 2024 Purchasers&#8221;) $<span id="xdx_900_eus-gaap--DebtInstrumentRepaidPrincipal_pn6n6_c20240410__20240412__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zGOpWurON7f3" title="Aggregate principal amount">8.0</span> million aggregate principal amount of unsecured notes (the &#8220;April
2024 Notes&#8221;), pursuant to a securities purchase agreement, dated April 11, 2024 (the &#8220;April 2024 Purchase Agreement&#8221;),
between the Company and each of the April 2024 Purchasers. The Company also issued to the April 2024 Purchasers, in proportion
to the aggregate principal amount of April 2024 Notes issued to each April 2024 Purchaser, Warrants (the &#8220;April 2024 Warrants&#8221;)
to purchase up to <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240410__20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zOYitMs2lr8" title="Number of shares">615,385</span> Common Shares, which are equal to <span id="xdx_90B_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zSvTPALk9PF9" title="Percentage value">25</span>% of the aggregate principal amount of April 2024 Notes issued to
the April 2024 Purchasers divided by the exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zd4aJcrb51u1" title="Common share price, per share">3.25</span>, subject to any adjustment to give effect to any stock dividend,
stock split or recapitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_z4T7CFUp5Rac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zP3ia3mTQTx4">The
change in the April 2024 Notes is presented below:</span></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended September 30, 2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_pn3n3_c20240701__20240930_zrbgGu03Nak8" style="width: 10%; text-align: right" title="Fair value at June 30, 2024">7,089</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPayment_iN_pn3n3_di_c20240701__20240930_zR38p4UPZYJa" style="text-align: right" title="Principal payments">(1,848</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ChangeInFairValue_pn3n3_c20240701__20240930_zXNwEH7byeif" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_pn3n3_c20240701__20240930_z2mB5jzrtlmj" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024">5,258</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Remaining Principal Balance, September 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20240701__20240930_zdXlBrzHNPQc" style="text-align: right" title="Remaining Principal Balance, September 30, 2024">5,280</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A6_zXJmZE5LW0p4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p id="xdx_89E_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zjM31nbkrrj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zvbowS805Aka">The
change in the April 2024 Warrant liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended September 30, 2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBoDip8spjwb" style="width: 10%; text-align: right" title="Fair value at June 30, 2024">298</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcVmgTLASd83" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">149</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zpZsfpFgI7t1" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024">447</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AC_zw9CaRw9KkZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;September Yorkville Consent&#8221;) to the April
2024 Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together
with the Yorkville Consent, the &#8220;September Consents&#8221;) to the April 2024 Notes issued and sold to Lind II pursuant
to the April 2024 Purchase Agreement. The September Consents, among other things, reduced the amounts due to the April 2024 Purchasers
on September 1, 2024 by an aggregate of $<span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20240830__20240901_zkSVTOdGiCk3" title="Aggregate principal amount">1,176</span> to an aggregate of $<span id="xdx_903_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn5n6_c20240830__20240901_zL8itnvPTor7" title="Increased the amounts due">336</span>, increased the amounts due to the April 2024 Purchasers
on December 1, 2024 by an aggregate of $<span id="xdx_908_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20241129__20241201_zmFMjZAK2Die" title="Aggregate principal amount">1,176</span>, and prospectively waived any term of the April 2024 Notes that would otherwise
be triggered upon a failure of the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1,
2024. Except as modified by the September Consents and the October Consents (as defined below), as discussed in Note 12, the terms
of the April 2024 Notes as previously disclosed are unchanged.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963146695824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract', window );"><strong>Class B Common Stock Of Ecrc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock', window );">CLASS B COMMON STOCK OF ECRC</a></td>
<td class="text"><p id="xdx_809_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_zScF5kDERuqf" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                                        <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></p></td><td id="xdx_821_z58BJeVrLEn2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLASS
B COMMON STOCK OF ECRC</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_89A_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zVhx1HrOm4u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Class B common stock of ECRC, an indirect, majority-owned subsidiary
of NioCorp formerly known as GX Acquisition Corp. II (&#8220;GXII&#8221;), include rights under which the holders may exchange
such shares into Common Shares, and certain of such shares are subject to certain vesting conditions (the &#8220;Earnout Shares&#8221;). <span id="xdx_8B4_zxleVNVPRKUk">These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; text-align: justify">Closing Common Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFuPGhTOBKs8" style="width: 15%; text-align: center" title="Closing common share price">$2.18</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgyhhAA1ZVQ5" style="width: 15%; text-align: center" title="Closing common share price">$1.73</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcuZgTLgdxNd" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIbRx34QX4d5" style="text-align: center" title="Implied volatility of public warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z9IRMe7Lvndl" style="text-align: center" title="Implied volatility of public warrants">65.0%</td><td style="text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMKF4ux4RJvi" style="text-align: center" title="Risk-free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.74</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlDwrXLgIYP9" style="text-align: center" title="Risk-free rate">4.35%</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zvCMA90fNIE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_892_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_zRfB1JhYU5M2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zgQyCBHZ4t53">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period
ended September 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_ziKz0TaIDIYc" style="width: 15%; text-align: right" title="Fair value at June 30, 2024">3,817</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6r8WZwsTTm7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">816</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zORTYqZwaPVe" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024">4,633</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_z8eDApJKrGDf" style="margin-top: 0; margin-bottom: 0; font-size: 10pt">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureClassBCommonStockOfEcrcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of class b common stock of e c r c table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150512192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">COMMON SHARES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z3x4D4f79sQh" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_829_zZvwB2hYwkhj">COMMON
SHARES</span></span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<p id="xdx_893_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_zZFBKUMYKyMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z63Atz6HKOr5">The
Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended
September 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Date</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Common Shares Issued</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Gross Funds Received</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Market Value of Shares Issued</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">(Gain)/Loss <br/>on Issuance</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 28, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240828_zE6YmGburBKa" style="width: 15%; text-align: right" title="Common shares issued">75,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240826__20240828_z3Xu7SqEIsU6" style="width: 15%; text-align: right" title="Gross funds received">140</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockIssued1_c20240826__20240828_zcyBLNQao1Ph" style="width: 15%; text-align: right" title="Fair value of common shares issued">133</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240826__20240828_zkfOcCJAp957" style="width: 15%; text-align: right" title="Gross funds received">(7</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 3, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240903_zOBtcwwCrJMf" style="text-align: right" title="Common shares issued">71,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240902__20240903_z6mlZYrlMbI2" style="text-align: right" title="Gross funds received">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssued1_c20240902__20240903_zV7XJsAvArZh" style="text-align: right" title="Fair value of common shares issued">123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240902__20240903_z7MXOIQfnlNi" style="text-align: right" title="Gross funds received">(1</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 6, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240906_zGhd51WzSa43" style="text-align: right" title="Common shares issued">71,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240904__20240906_zQv3aE5FY8Rl" style="text-align: right" title="Gross funds received">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssued1_c20240904__20240906_zixMUsNz28mc" style="text-align: right" title="Fair value of common shares issued">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240904__20240906_zhW8OQ1wWUu9" style="text-align: right" title="Gross funds received"><span style="-sec-ix-hidden: xdx2ixbrl0654">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 16, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240916_z5zeFtOqo3n1" style="text-align: right" title="Common shares issued">72,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240914__20240916_zpvPXrV0UqU6" style="text-align: right" title="Gross funds received">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssued1_c20240914__20240916_zaQUgyaTOp95" style="text-align: right" title="Fair value of common shares issued">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240914__20240916_z1c0TZqHobob" style="text-align: right" title="Gross funds received"><span style="-sec-ix-hidden: xdx2ixbrl0662">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 19, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240919_zY7WMZmyTIld" style="text-align: right" title="Common shares issued">49,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240918__20240919_zpavCdSPDkAb" style="text-align: right" title="Gross funds received">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssued1_c20240918__20240919_zADFG43nCs2l" style="text-align: right" title="Fair value of common shares issued">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240918__20240919_z4vO1K4kVYed" style="text-align: right" title="Gross funds received"><span style="-sec-ix-hidden: xdx2ixbrl0670">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 25, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240925_zRZZmusJel3j" style="text-align: right" title="Common shares issued">60,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240923__20240925_zbREIuEvVnz" style="text-align: right" title="Gross funds received">101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssued1_c20240923__20240925_zZT86rJ2HWu3" style="text-align: right" title="Fair value of common shares issued">108</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240923__20240924_zZ7MwyFKw3kj" style="text-align: right" title="Gross funds received">7</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AD_z6ioMHfy5DUf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">(Gain)/loss on issuance
represents a non-cash amount equal to the difference between the proceeds received and the fair value of the Common Shares issued
based on the Nasdaq Stock Market LLC (the &#8220;Nasdaq&#8221;) closing price per Common Share on the issuance date and is recorded
in other operating expenses in the condensed consolidated statement of operations and comprehensive loss.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>














<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
Options</span></td>
</tr></table>

<p id="xdx_896_ecustom--ScheduleOfStockOptionRollForwardTableTextBlock_zMbMuSMK0yek" style="display: none; margin-top: 0; margin-bottom: 0; visibility: hidden">&#160;<span id="xdx_8BF_zkjzLBiVNkgb">Schedule of stock option</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of Options</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average <br/>Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate<br/>Intrinsic Value</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br/>Average Remaining Life</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20240930_zKN55L3yTxik" style="width: 15%; text-align: right" title="Beginning balance">2,495,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20240701__20240930_zBMran0dscw8" style="width: 15%; text-align: right" title="Beginning balance">4.78</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20240930_zWLhlpifZTQ5" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl0692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zc3qDApeTMv6" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl0694">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20240930_z9l2E8nrjI32" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0696">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_z1fFzG6iVfe" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0698">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20240930_zJCiKUx2Sd3b" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">(40,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zBzceKZCe8S7" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">6.95</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, September 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20240930_z3otOCN6hc87" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">2,455,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20240701__20240930_zcswVa4G4Y3k" style="border-bottom: Black 2pt solid; text-align: right" title="Beginning balance">4.76</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20240930_z2c2YFk6rDbc" style="border-bottom: Black 2pt solid; text-align: right" title="Aggregate intrinsic value">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0708">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20240701__20240930_zXXc12Xgnri9" title="Weighted average remaining contractual life::XDX::P3Y2M19D"><span style="-sec-ix-hidden: xdx2ixbrl0710">3.22</span></span> Years</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zszTLJlspn3" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
transactions are summarized as follows. Weighted average exercise prices related to Canadian dollar denominated warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8lmPNryaG88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">&#160;<span id="xdx_8B9_zTE6gwCssKXk">Schedule
of warrant transactions</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20240930_z73Uhv3eLmDj" style="width: 15%; text-align: right" title="Beginning balance">18,563,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20240701__20240930_zkF85Xz5gmrh" style="width: 15%; text-align: right" title="Beginning balance">10.53</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20240930_zw0LT0Keyxfi" style="text-align: right" title="Granted">2,816,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20240930_zc3j9fsutXm4" style="text-align: right" title="Granted">2.31</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20240930_zdgaI359Afzb" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0722">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20240930_zvvqp0p8H14j" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20240930_zCaJr1pjYYBg" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">(447,318</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20240930_zoJImAFnjTL7" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">8.94</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, September 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20240930_zkKpYJzzjipb" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">20,932,985</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20240701__20240930_zNwBoIsMvsS3" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">9.46</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zImxZqi4Yrg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p id="xdx_891_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zD3G1UZGTpZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zqZVR49RR594">At
September 30, 2024, the Company had outstanding exercisable Warrants, as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">Expiry Date</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zSSH4HKGlsI9" style="width: 27%; text-align: right" title="Number">855,800</td><td style="width: 7%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z96DdCE2pNSb" style="width: 30%; text-align: right" title="Exercise price">C$<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.70</span></td><td style="width: 7%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z3qDQfD5uyvf" style="width: 26%; text-align: right; padding-left: 5.4pt" title="Expiry date">February 19, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdKYVXBP35ig" style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z3I8a1jjAO31" style="text-align: right" title="Exercise price">$4.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zSIluWBmR1nj" style="text-align: right; padding-left: 5.4pt" title="Expiry date">September 1, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zDwJjjKLuEX5" style="text-align: right">413,432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zRNDlwyiVKU" style="text-align: right">$3.54</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zg06YTA9Z3Zj" style="text-align: right; padding-left: 5.4pt">December 22, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmyxVhES6m55" style="text-align: right">315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZiTM5L9CR9" style="text-align: right">$2.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zisv6jk38da6" style="text-align: right; padding-left: 5.4pt">June 24, 2026</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.35Member_zfjofJn54ZGf" style="text-align: right">615,385</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z3x6STfrvH7e" style="text-align: right">$3.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zPYjiobUWDY9" style="text-align: right; padding-left: 5.4pt">April 12, 2027</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6ZfccVjwzR2" style="text-align: right">15,666,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEr9ouHH2tul" style="text-align: right">$11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6UUacp3aFDj" style="text-align: right; padding-left: 5.4pt">March 17, 2028</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zzNZxDOiFh6b" style="border-bottom: Black 1pt solid; text-align: right" title="Number">2,816,742</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zJNy4Fn2EVrh" style="padding-bottom: 1pt; text-align: right" title="Exercise price">$2.31</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zB5Cnjq5VNzb" style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt" title="Expiry date">September 17, 2028</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930_zthEr47AGJi5" style="border-bottom: Black 2pt solid; text-align: right">20,932,985</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td></tr>
</table>

<p id="xdx_8A6_zSwskhowbtXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 17, 2023, the Company closed a series of transactions (the &#8220;GXII Transaction&#8221;) pursuant to the Business Combination
Agreement, dated as of September 25, 2022, by and among the Company, GXII, and Big Red Merger Sub Ltd. In connection with the
closing of the GXII Transaction (the &#8220;Closing&#8221;), the Company assumed GXII&#8217;s obligations under the agreement
governing the GXII share purchase warrants (the &#8220;GXII Warrants&#8221;), as amended by an assignment, assumption and amendment
agreement (the &#8220;NioCorp Assumed Warrant Agreement&#8221;), and issued an aggregate of <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAIsFIPHJTFj" title="Warrants traded prior to the closing">15,666,626</span> Warrants (the &#8220;NioCorp
Assumed Warrants&#8221;). The Company issued (a) <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdwYmsdfh5Bg" title="Warrants traded prior to the closing">9,999,959</span> public NioCorp Assumed Warrants (the &#8220;Public Warrants&#8221;)
in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20240930__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zvzWjvAbnQvk" title="Warrants traded prior to the closing">5,666,667</span> NioCorp Assumed Warrants (the
&#8220;Private Warrants&#8221;) to GX Sponsor II LLC (the &#8220;Sponsor&#8221;).</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>













<div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"></div>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zX638s36zuEg" title="Description of warrants">Each
Private Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and
the like).</span> No fractional shares will be issued upon exercise of any Private Warrants, and fractional shares that would
otherwise be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the
Company be required to net cash settle any Private Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#8217;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any of their permitted transferees
are treated as Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zKxXK5eB2hJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy as inputs into our pricing model are
based on observable data points. <span id="xdx_8BF_zG8JelBVD2O7">The following observable data points were used in calculating the fair value of the Private Warrants
using a Black Scholes pricing model:</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">September 30,<br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">June 30, <br/>&#160;2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfdQybB2Uyjk" style="width: 17%; text-align: right" title="Stock price on valuation date">2.18</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMQahFwTLoWh" style="width: 17%; text-align: right" title="Stock price on valuation date">1.73</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6uaYRqmfsT7" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zVuUlzysqwtd" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfeqUWgK9oP2" title="Implied volatility of public warrants">60</span></span></td><td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zH6AQzfbGZT1" title="Implied volatility of public warrants">69.0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGnIPtuoeprh" title="Risk free rate">3.58</span></span></td><td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSXKEqPWoSY7" title="Risk free rate">4.45</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zub7uRmjb1K8" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdG3ykCh1E3e" title="Dividend yield">0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4byd8V8fZ8g" title="Expected warrant life in years::XDX::P3Y5M30D"><span style="-sec-ix-hidden: xdx2ixbrl0803">3.5</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyUY0S4ai7Zd" title="Expected warrant life in years::XDX::P3Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl0805">3.7</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zF1n5yrcwNtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zSlc0UIsoLta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zcEEUId4Lp0h">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 42%; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqhb9iCqpaV6" style="width: 15%; text-align: right" title="Beginning balance">1,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zRN43KszK6s7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">(205</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zorR7P4tzzi1" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">1,148</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AB_z3VG4xq0DWob" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingent
Consent Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20240701__20240930_z4magsa70S5h" title="Contingent consideration description">As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#8220;Lind Consent&#8221;), between the Company and Lind Global Asset Management III, LLC (&#8220;Lind III&#8221;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#8220;Contingent Consent Warrants&#8221;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance.</span> Further, the number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage
of Warrants currently held by Lind III that are exercised, if any, prior to the issuance of any Contingent Consent Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, the Company&#8217;s Common Share price was below the threshold price set forth in the Lind Consent, and accordingly,
the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240915__20240917_z1Z5olcDa9Yg" title="Stock issued, shares">2,816,742</span> Contingent Consent Warrants to Lind III. Each Contingent Consent Warrant is exercisable for one Common Share
at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zp1dhD6MECb" title="Common share exercise price, per share">2.308</span> and may be exercised at any time prior to their expiration on September 17, 2028. The number of Contingent
Consent Warrants issued was based on $<span id="xdx_90A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20240915__20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zjccZ0Ek9TRg">5,000</span> divided by the five-day volume weighted average price of the Common Shares on September 16,
2024. The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

















<p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zdWof341Pnzg" style="margin: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"> <span id="xdx_8B2_zesmbWpof813">The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 17, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 42%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1XpUJgWPBa" style="width: 15%; text-align: right" title="Closing common share price">1.74</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPrzuqE8U4eb" title="Term (years)::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0833">4.0</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z13R0iHC3zFf" title="Historic equity volatility">67.14</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUbpTPSOfn3k" title="Risk-free rate">3.44</span></td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8AE_znvUdFHNJesc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized a gain of $103 on the issuance of the Contingent Consent Warrants. This gain was recorded as a part of other
gains in the condensed consolidated statements of operations and comprehensive loss.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963146467184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zUu0JLuPb4ac" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span><span id="xdx_822_z3M1qLcxwJ48">RELATED PARTY TRANSACTIONS</span></span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On September 11, 2024, the
Company and Mark Smith, Chief Executive Officer, President and Executive Chairman of NioCorp, entered into a loan agreement (the
&#8220;Smith Loan Agreement&#8221;), which provides for a $<span id="xdx_90B_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20240911__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzaqdZ6tI4O8" title="Credit agreement">2,000</span> non-revolving, multi-draw credit facility (the &#8220;Smith Loan&#8221;). The Smith Loan has an interest rate of <span id="xdx_906_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_z5OM8LPGLPn" title="Interest at a rate">10</span>% per annum, calculated monthly in arrears, through the date of repayment of the Smith Loan. The Company can pre-pay
the Smith Loan at any time without notice and without penalty, but any amount of principal or interest repaid by the Company prior
to the earlier of the date of expiration of the Smith Loan Agreement on June 30, 2025 and the occurrence of an event of default
under the Smith Loan Agreement will be subject to an early payment fee of <span id="xdx_90F_ecustom--LineOfCreditFacilityEstablishmentFee_pid_dp_uPure_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzHRABZpZcal" title="Prepayment fee">2.5</span>% of the value of any such payment. The Smith Loan is secured by all of the Company&#8217;s assets pursuant to a general security agreement  between the Company and Mr. Smith dated September 11, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As of September 30, 2024, the principal amount outstanding under the Smith Loan was $<span id="xdx_905_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zwnLsrtQ7Uia" title="Accounts payable and accrued liabilities">33</span> and accounts payable and accrued liabilities as of September 30, 2024, included $<span id="xdx_901_eus-gaap--ProfessionalFees_pn3n3_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zsWBVuhZKm95" title="Origination fees">29</span> of loan origination fees payable to Mr. Smith. Additional drawdowns totaling $<span id="xdx_908_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zLQxsix6Bkif" title="Additional drawdowns">471</span> were received subsequent to September 30, 2024. On November 6, 2024, the Company repaid $<span id="xdx_90C_eus-gaap--InterestExpenseOther_pn3n3_c20241101__20241106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zCYw3YEgP7D8" title="Repaid outstanding interest">250</span> of the interest and principal outstanding under the Smith Loan, and $<span id="xdx_90E_eus-gaap--ProfessionalFees_pn3n3_c20241101__20241106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWXMZIhOJ3vk" title="Origination fees">28</span> related to the loan origination fees payable.
</p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963256372128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EXPLORATION EXPENDITURES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureExplorationExpendituresAbstract', window );"><strong>Exploration Expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExplorationExpendituresDisclosuresTextBlock', window );">EXPLORATION EXPENDITURES</a></td>
<td class="text"><p id="xdx_804_ecustom--ExplorationExpendituresDisclosuresTextBlock_zvuVvzBSmLja" style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0px"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-size: 10pt">9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt; text-transform: uppercase"><span><span><span id="xdx_822_ztBToeqah4O2">EXPLORATION EXPENDITURES</span></span></span></span></td></tr>
</table>


<p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zsL7dB5cGwa3" style="margin-top: 0; margin-bottom: 0"><span>&#160;<span id="xdx_8B5_zsdj9jQ4iAsk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Technical studies and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zCypVUoyrM8" style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zlqTAXRCT5zf" style="width: 15%; text-align: right">200</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zehYzmGChHga" style="text-align: right">91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zeGOggIDLlJk" style="text-align: right">135</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Metallurgical development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_zzQx5Yq14r13" style="text-align: right">47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_z9WGaCtLtyTf" style="text-align: right">746</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Geologists and field staff</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zY3syMVxeJWb" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zHgvWSGyk4c5" style="border-bottom: Black 1pt solid; text-align: right">19</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20240701__20240930_zNyJD2emNV0j" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures">138</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20230930_zFNpUJXPw7D4" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures">1,100</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_ziDmdY49fq6j" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureExplorationExpendituresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureExplorationExpendituresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExplorationExpendituresDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exploration expenditures disclosures text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExplorationExpendituresDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963148298128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--LesseeOperatingLeasesTextBlock_z83dlscUdhfa" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_82B_zAYjmrWj1xEd">LEASES</span></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p id="xdx_890_eus-gaap--LeaseCostTableTextBlock_zy6ZvhCBSom7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zrtAcrJSBdlk">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_496_20240701__20240930_zuddX0TgWh8" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_492_20230701__20230930_z9ERXRKb3HE8" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_z2EitoeWQAQc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--FixedRentExpense_zAXIEkYb8Vvg" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left; text-indent: 9pt">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">23</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">23</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zyPdXj2bZyHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 9pt">Short-term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zsAQ1y5nWYS9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Sublease income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zJtbT4Sa2X7b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net lease cost &#8211; other operating expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">20</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">22</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AB_z5VAP40ZgmN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ziGsQjF8hEK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8BA_zsg3t8AIFB44">The
maturities of lease liabilities are as follows at September 30, 2024:</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240930_zveg2pCc2z9l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Future Lease Maturities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zghIBTWYix23" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 82%; text-align: left">Total remaining lease payments</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right">220</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zIpd1zmCGmA8" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less portion of payments representing interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(36</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zcezAec608A1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Present value of lease payments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zz6LCjdD5GUh" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of lease payments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(97</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zrTX1ZjBEPmj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Non-current lease liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">87</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A2_zDHbhOOSuBA9" style="margin-top: 0; margin-bottom: 0; font-size: 10pt">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150533552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zsuRNUn7N2o5" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11.</span></td><td id="xdx_822_zmY8XGUQ3n43"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">FAIR
VALUE MEASUREMENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of September 30, 2024, and June 30, 2024, respectively, and indicate the fair value hierarchy of the valuation techniques the
Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted)
in active markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable,
such as quoted prices, interest rates, and yield</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">curves. Fair values determined by Level 3 inputs are unobservable data points
for the financial instrument and include situations where there is little, if any, market activity for the instrument.</span></p>

<p id="xdx_895_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zS7Xl6TyuZ56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><span id="xdx_8B8_zHClLontO7H8">Schedule of fair values determined by level 3 inputs are unobservable data</span></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of September 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930_zZME6WgaKGe4" style="width: 12%; text-align: right" title="Cash and cash equivalents">150</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ziFzXAQjvGh2" style="width: 12%; text-align: right">150</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7mTHS3gEoq9" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzPAdc47U6Zd" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0921">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930_zCBFcNHvSgKi" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zV2XHdki24hk" style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zEu7bx2Dzhyc" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0925">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3BXc5BRhpU2" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240930_zLdcSG65KS9d" style="border-bottom: Black 2pt solid; text-align: right" title="Total">154</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdus7P4zxXIk" style="border-bottom: Black 2pt solid; text-align: right">154</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGcwFYHReXm6" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0930">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWp5qyswCice" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930_z00RXTHgdzSg" style="text-align: right" title="Cash and cash equivalents">5,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1es40GuKkKj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zu51HsKcI149" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zm1UHSIhI4J3" style="text-align: right">5,258</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930_zewV8SQqGsO6" style="text-align: right" title="Cash and cash equivalents">4,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zxwYTWXrTyDe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0939">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWSh1rRfKlxk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcQBd0TdKWFb" style="text-align: right">4,633</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930_zvwUAM4x6q8f" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zP73bx3AXBc6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrqL0I9qpyj" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRidbxwTCoK7" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930_zv2h5v9c6Tuc" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,486</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUEpXKIagtCh" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0949">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKMfCqTjFCca" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJDIFPQyENRk" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,891</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zG6lgkfBSXF2" style="width: 12%; text-align: right" title="Cash and cash equivalents">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqmr3MRShjGf" style="width: 12%; text-align: right">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzGXTjIZUcw5" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0955">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zn8FxIJVdBQ8" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zEWoWPE6vcOe" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zViGTku6yLs2" style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zHSWLOzxYAQk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z589McuW7744" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zR5NmYWeyCIc" style="border-bottom: Black 2pt solid; text-align: right" title="Total">2,016</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKBvaK9YBX7e" style="border-bottom: Black 2pt solid; text-align: right">2,016</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zst9o0tMaS91" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd3KuEl7wUQ1" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_c20240630_zKh8qbYc5v3a" style="text-align: right" title="Cash and cash equivalents">7,089</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhcwih71jPE1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfRLdByz9gQ7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHe9Wj1pYA6d" style="text-align: right">7,089</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zQ3nSZ1Juvoa" style="text-align: right" title="Cash and cash equivalents">3,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zrX3KNCJE0q4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6XYzzKZaYTl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0975">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3PFRZb4n4N" style="text-align: right">3,817</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_z5t3uGONNa0k" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities">4,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zw06mR9kx2h6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqeWLjhrKRrj" style="border-bottom: Black 1pt solid; text-align: right">1,651</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvl8HxChnie1" style="border-bottom: Black 1pt solid; text-align: right">2,365</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_z4JvKiLJMKBa" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents">14,922</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoNrYLBvgwKa" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYdGxMedLUie" style="border-bottom: Black 2pt solid; text-align: right">1,651</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1uMNXnhfje5" style="border-bottom: Black 2pt solid; text-align: right">13,271</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AB_zON0OXAPos8j" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963247966304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_z9F0N3BbS5Od" style="margin-top: 0; margin-bottom: 0; font-size: 1pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12.</span></td><td id="xdx_823_zMxSJCDq22Xa"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SUBSEQUENT EVENTS</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><i>The October Yorkville
Consent</i></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SubsequentEventDescription_c20241002__20241003__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zv44frg4dUG5" title="Subsequent event, description">On
October 3, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;October Yorkville Consent&#8221;) to the April 2024
Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with
the October Yorkville Consent, the &#8220;October Consents&#8221;) to the April 2024 Notes issued and sold to Lind II pursuant
to the April 2024 Purchase Agreement. The October Consents, among other things, extended the maturity date to January 31, 2025,
reduced the amounts due to the April 2024 Purchasers on October 1, 2024 by an aggregate of $<span id="xdx_904_eus-gaap--DebtInstrumentIssuedPrincipal_pn3n3_c20240929__20241001_zc89St3CXgHf" title="Aggregate principal amount">1,176</span> to an aggregate of $<span id="xdx_907_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn3n3_c20240929__20241001_zVp23XD4E6y5" title="Increased the amounts due">336</span> and
deferred such amounts due to the April 2024 Purchasers until January 1, 2025, and prospectively waived any term of the April 2024
Notes that would otherwise be triggered upon a failure of the Company to pay to the April 2024 Purchasers the remainder of the
amount due on October 1, 2024. Except as modified by the September Consents, as discussed in Note 5b, and the October Consents,
the terms of the April 2024 Notes as previously disclosed are unchanged.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><i>The November 2024 Offerings</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span id="xdx_90C_eus-gaap--SubsequentEventDescription_c20241102__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQY9JR5z1N9l" title="Subsequent event, description">On November 5, 2024, the Company closed the November 2024 Registered Offering, pursuant to the underwriting
agreement, dated November 3, 2024 (the &#8220;Underwriting Agreement&#8221;), with Maxim Group LLC, as underwriter (the &#8220;Underwriter&#8221;),
which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#8220;Series A Public Warrants&#8221;) to purchase up to an
additional 1,672,090 Common Shares and 836,045 Warrants (the &#8220;Series B Public Warrants&#8221; and, together with the Series
A Public Warrants, the &#8220;November Public Warrants&#8221;) to purchase up to an additional 836,045 Common Shares. Each Common
Share was sold together with one Series A Public Warrant and one-half of one Series B Public Warrant at a combined public offering
price of $1.57. The gross proceeds from the November 2024 Registered Offering were approximately $2,500 before deducting underwriting
discounts and offering expenses. The Company entered into a warrant agency agreement with Computershare Inc. and its affiliate,
Computershare Trust Company, N.A., together as warrant agent, setting forth the terms and conditions of the November Public Warrants.
The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will
expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable
beginning six months and one day from the date of issuance, and will expire on November 5, 2029. In addition, pursuant to the Underwriting
Agreement, the Company granted the Underwriter a 45-day over-allotment option to purchase (i) 238,853 additional Common Shares
and (ii) 358,280 Option Warrants (as defined below) to purchase up to an aggregate of 358,280 Common Shares. &#8220;Option Warrant&#8221;
means one Series A Public Warrant combined with one-half of one Series B Public Warrant.</span> On November 4, 2024, the Underwriter partially
exercised its over-allotment option to purchase <span id="xdx_902_eus-gaap--DebtInstrumentIssuedPrincipal_c20241101__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesAMember_zdbUYVtj9Jf2">79,734</span> additional Series A Public Warrants and <span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_c20241101__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesBMember_zTr5AGTVdwgl">39,867</span> additional Series B Public Warrants, which amounts are included in the amounts, discussed above, issued at closing of the November 2024 Registered Offering.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As of September 30, 2024,
the Company had accrued $<span id="xdx_901_ecustom--AccruedCost_iI_pn3n3_c20240930_zHE4AH14fBWb" title="Aggregate principal amount">459</span> of third-party costs related to the November 2024 Registered Offering. These costs were deferred until
the closing of the November 2024 Registered Offering, at which time all costs incurred were charged against the related share capital
account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span id="xdx_90F_eus-gaap--SubsequentEventDescription_c20241110__20241113__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zinDD1rYiPhj" title="Subsequent event, description">On November 13, 2024, the Company closed the November 2024 Private Offering, pursuant to binding subscription
agreements with certain accredited investors as part of a non-brokered private placement of 2,199,602 units of the Company (the
&#8220;Units&#8221;). Each Unit consists of one Common Share, one Warrant (collectively, the &#8220;Series A Private Warrants&#8221;)
to purchase one Common Share and one-half of one Warrant to purchase one-half of one Common Share (collectively, the &#8220;Series
B Private Warrants&#8221;). Each Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company purchased
November 2024 Units at a price of $1.7675 per Unit, which price includes $0.125 per Private Warrant and allows such directors and
officers to participate in the November 2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private
Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will expire on November
13, 2026.</span> The Series B Private Warrants have an exercise price of $<span id="xdx_902_ecustom--StrikePriceOfWarrantsIssued_pid_uUSDPShares_c20241111__20241112__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJeISY7Ku6Li" title="Exercise price">2.07</span> per underlying Common Share, are exercisable beginning six months and one day from the date of
issuance, and will expire on November 13, 2029.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify">NioCorp currently intends to use the net proceeds from
the November Offerings for working capital and general corporate purposes, including to (i) advance its efforts to launch construction
the Elk Creek Project and move it to commercial operation and (ii) repay the amount outstanding under the Smith Credit Facility. The Smith Loan will continue to be available to the Company following the close of the November Offerings.</p>







<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963145635472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text"><p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAS8vA0YxUC9" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zbG62WJMUltc">Basis
    of Presentation and Consolidation</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles of the United States of America (&#8220;U.S. GAAP&#8221;) and the rules and regulations of the Securities and Exchange
Commission (&#8220;SEC&#8221;). The interim condensed consolidated financial statements include the consolidated accounts of the
Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed
in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited
consolidated financial statements for the year ended June 30, 2024. Certain transactions include reference to Canadian dollars
(&#8220;C$&#8221;) where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, all adjustments considered necessary (including normal recurring adjustments) for a fair statement
of the financial position, results of operations, and cash flows at September 30, 2024, and for all periods presented, have been
included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included
in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to appropriate
SEC rules and regulations. These interim condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements for the year ended June 30, 2024. The interim results are not necessarily indicative of results
for the full year ending June 30, 2025, or future operating periods.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOCmPn7lNNj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_z3UoeJf1dJM6">Recent
    Accounting Standards</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) that are
adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of
recently issued standards did not or will not have a material impact on the Company&#8217;s consolidated financial statements
upon adoption.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_842_eus-gaap--UseOfEstimates_z3SiY5w94AGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_z5OQnemVNJh9">Use
    of Estimates</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements, and the reported amounts of</span></p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">expenses
during the reporting period. The Company regularly evaluates estimates and assumptions related to the carrying value of
long-term assets, deferred income tax assets and related valuations, liabilities related to the April 2024 Notes, Earnout
Shares, Private Warrants, and Contingent Consent Warrants (each, as defined below), and share-based compensation. The Company
bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be
reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The
actual results experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the
extent there are material differences between estimates and the actual results, future results of operations will be
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company acquired a federal income tax payable of $<span id="xdx_90D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20240701__20240930_zlBtMPIJ1op1" title="Federal income tax payable">443</span> in connection with the GXII Transaction (as defined below). As a result of post-transaction losses at Elk Creek Resources Corp. (&#8220;ECRC&#8221;), a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable of $<span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20230701__20230930_zPdI1r0unlw8" title="Income tax payable">101</span> was recorded as an income tax benefit in the condensed consolidated statement of operations and comprehensive loss for the three months ended September 30, 2023. The Company maintains a full valuation allowance against future income tax assets as it is more likely than not that all of the assets will not be realized.

</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Earnings per Share</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zDPbzauHgqsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_z6q9i4Iyxf9j">Basic
    and Diluted Earnings per Share</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zsGGon4HYLmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8BF_z4l8xyzsUWA6">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months <br/>Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 0.125in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--NetIncomeLoss1_pn3n3_c20240701__20240930_zXURRH4Zq1Qf" style="width: 12%; text-align: right" title="Net loss">(2,102</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--NetIncomeLoss1_pn3n3_c20230701__20230930_z3Nbict3AAE9" style="width: 12%; text-align: right" title="Net loss">(3,387</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Less: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20240701__20240930_zFzHDQM6k5Pj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest">(31</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230701__20230930_zrbmEO99sj22" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest">(174</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20240930_zO1oS9kkliB7" style="text-align: right" title="Net loss available to participating securities">(2,071</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20230930_zBwJ4DnmPTml" style="text-align: right" title="Net loss available to participating securities">(3,213</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Less: Net loss attributable to vested shares of ECRC Class B common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20240701__20240930_zOffFp98jZoe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock">(186</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20230930_zbjS9KFiAS9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock">(257</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20240930_z79TUoCxd7I6" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(1,885</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20230930_zU3Yo09f6yFl" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(2,956</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20240930_zCjQCklwt7i1" style="text-align: right" title="Weighted average shares outstanding basic and diluted">38,361,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20230930_zocTkntBB0de" style="text-align: right" title="Weighted average shares outstanding basic and diluted">31,967,091</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in">Loss per Common Share outstanding &#8211; basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20240701__20240930_zIGXkG54ss4" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">(0.05</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20230930_zfK9460Y3fkb" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">(0.09</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
</table>

<p id="xdx_8AA_zkIsFeClJGA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following common shares, no par value, of the Company (&#8220;Common Shares&#8221;) underlying options to purchase Common Shares
(&#8220;Options&#8221;), Common Share purchase warrants (&#8220;Warrants&#8221;), and outstanding convertible debt were&#160;antidilutive&#160;due
to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three-month
periods indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_znZLZfAkFCH" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zhUeftbbcOy2" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months <br/>Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Excluded potentially dilutive securities <sup id="xdx_F6F_zIte5Np7FUFf">(1)(2)</sup>:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20240930_fKDEpKDIp_zbrcgLpWgE6d" style="width: 12%; text-align: right" title="Options">2,455,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20230930_fKDEpKDIp_z1MJsWfUsQR" style="width: 12%; text-align: right" title="Options">1,319,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20240930_fKDEpKDIp_zXvYfHZKQGNi" style="text-align: right" title="Warrants">20,932,985</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20230930_fKDEpKDIp_zNG0pUxA0mf7" style="text-align: right" title="Warrants">19,066,304</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20240701__20240930_fKDEpKDIp_zAvLv9qp0eW6" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">1,920,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20230930_fKDEpKDIp_zaVTCGQ29mda" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,448,730</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Total potential dilutive securities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DilutiveSecurities_c20240701__20240930_fKDEpKDIp_zIbOnODh7Mgc" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities">25,308,485</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DilutiveSecurities_c20230701__20230930_fKDEpKDIp_zvnMIq7Frfoj" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities">22,834,034</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.375in">&#160;</td>
    <td style="width: 0.375in; text-align: justify"><span id="xdx_F02_zjAwZAoQHD6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zzr8bMTPhwY9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_F0B_zvkAbz8xNUta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zU6ppeYGWiRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.</span></td></tr>
</table>

<p id="xdx_8AE_z1aDhns6aQ6k" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963247878656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders:</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zsGGon4HYLmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8BF_z4l8xyzsUWA6">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months <br/>Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify; padding-left: 0.125in">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--NetIncomeLoss1_pn3n3_c20240701__20240930_zXURRH4Zq1Qf" style="width: 12%; text-align: right" title="Net loss">(2,102</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--NetIncomeLoss1_pn3n3_c20230701__20230930_z3Nbict3AAE9" style="width: 12%; text-align: right" title="Net loss">(3,387</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Less: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20240701__20240930_zFzHDQM6k5Pj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest">(31</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230701__20230930_zrbmEO99sj22" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest">(174</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20240930_zO1oS9kkliB7" style="text-align: right" title="Net loss available to participating securities">(2,071</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20230930_zBwJ4DnmPTml" style="text-align: right" title="Net loss available to participating securities">(3,213</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Less: Net loss attributable to vested shares of ECRC Class B common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20240701__20240930_zOffFp98jZoe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock">(186</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20230930_zbjS9KFiAS9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock">(257</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20240930_z79TUoCxd7I6" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(1,885</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20230930_zU3Yo09f6yFl" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(2,956</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20240930_zCjQCklwt7i1" style="text-align: right" title="Weighted average shares outstanding basic and diluted">38,361,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20230930_zocTkntBB0de" style="text-align: right" title="Weighted average shares outstanding basic and diluted">31,967,091</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in">Loss per Common Share outstanding &#8211; basic and diluted</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20240701__20240930_zIGXkG54ss4" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">(0.05</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20230930_zfK9460Y3fkb" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">(0.09</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Schedule of excluded from the dilutive securities</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_znZLZfAkFCH" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8BC_zhUeftbbcOy2" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months <br/>Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Excluded potentially dilutive securities <sup id="xdx_F6F_zIte5Np7FUFf">(1)(2)</sup>:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20240930_fKDEpKDIp_zbrcgLpWgE6d" style="width: 12%; text-align: right" title="Options">2,455,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20230930_fKDEpKDIp_z1MJsWfUsQR" style="width: 12%; text-align: right" title="Options">1,319,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20240930_fKDEpKDIp_zXvYfHZKQGNi" style="text-align: right" title="Warrants">20,932,985</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20230930_fKDEpKDIp_zNG0pUxA0mf7" style="text-align: right" title="Warrants">19,066,304</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20240701__20240930_fKDEpKDIp_zAvLv9qp0eW6" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">1,920,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20230930_fKDEpKDIp_zaVTCGQ29mda" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,448,730</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2pt">Total potential dilutive securities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--DilutiveSecurities_c20240701__20240930_fKDEpKDIp_zIbOnODh7Mgc" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities">25,308,485</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--DilutiveSecurities_c20230701__20230930_fKDEpKDIp_zvnMIq7Frfoj" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities">22,834,034</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.375in">&#160;</td>
    <td style="width: 0.375in; text-align: justify"><span id="xdx_F02_zjAwZAoQHD6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zzr8bMTPhwY9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span id="xdx_F0B_zvkAbz8xNUta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_zU6ppeYGWiRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963250605856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of account payable and accrued liabilities</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zc59G9He5hEd" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B0_zqwCVXE70PI9" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></p>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td id="xdx_49A_20240930_zplwfu8pkiia" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240630_ziB5bavhMO39" style="text-align: center"><span style="font-size: 1pt">&#160;</span></td><td><span style="font-size: 1pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30,</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">June 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zk9amtW1T47i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,056</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,417</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z52oa7ArvAm9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">603</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zRJOO7YReM53" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zGEuJyfS4n3e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Loan origination fees payable to related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">29</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zDoC9z6fm5P2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">2,736</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">1,843</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963148395760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">The change in the Convertible Debentures is presented below:</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ConvertibleDebtTableTextBlock_zS6nsQGSn1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_z5wqrivMG86e">The
change in the Convertible Debentures is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; padding-bottom: 1pt">Balance at June 30, 2024</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iS_pn3n3_c20240701__20240930_zkt8cMGNGeCb" style="width: 13%; text-align: right" title="Balance at June 30, 2024">571</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20240701__20240930_zjjm9GQdsxd2" style="text-align: right" title="Accretion expense">43</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Principal and interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_c20240701__20240930_z9tSqczqRNid" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted">(614</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20240930_zqWS7ql9Qxe6" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, September 30, 2024"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock', window );">The following table discloses the components of interest expense associated with the Convertible Debentures.</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zM25WlNMclH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the components of interest expense associated with the Convertible Debentures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months<br/>
Ended September &#160;30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify; padding-left: 0.25in">Component of Interest Expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 0.25in">Contractual&#160;&#160;interest</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ContractualInterest_pn3n3_c20240701__20240930_zdBZCTxVqjbi" style="width: 18%; text-align: right" title="Contractual interest">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ContractualInterest_pn3n3_c20230701__20230930_zEaS59Mdnkjl" style="width: 18%; text-align: right" title="Contractual interest">130</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Amortization of discount and issuance costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20240701__20240930_zku8MA5zWO4b" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs">43</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20230701__20230930_zTe3k1Qjtuu7" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs">1,945</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt; padding-left: 0.25in">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AccretionExpense_pn3n3_c20240701__20240930_z3irbjodGS1k" style="border-bottom: Black 2pt solid; text-align: right" title="Total">44</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20230701__20230930_zN1Qw54oVmAf" style="border-bottom: Black 2pt solid; text-align: right" title="Total">2,075</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">The change in the April 2024 Notes is presented below:</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_z4T7CFUp5Rac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zP3ia3mTQTx4">The
change in the April 2024 Notes is presented below:</span></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended September 30, 2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_pn3n3_c20240701__20240930_zrbgGu03Nak8" style="width: 10%; text-align: right" title="Fair value at June 30, 2024">7,089</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPayment_iN_pn3n3_di_c20240701__20240930_zR38p4UPZYJa" style="text-align: right" title="Principal payments">(1,848</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ChangeInFairValue_pn3n3_c20240701__20240930_zXNwEH7byeif" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_pn3n3_c20240701__20240930_z2mB5jzrtlmj" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024">5,258</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Remaining Principal Balance, September 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20240701__20240930_zdXlBrzHNPQc" style="text-align: right" title="Remaining Principal Balance, September 30, 2024">5,280</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">The change in the April 2024 Warrant liability is presented below:</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zjM31nbkrrj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zvbowS805Aka">The
change in the April 2024 Warrant liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Three Months Ended September 30, 2024</span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBoDip8spjwb" style="width: 10%; text-align: right" title="Fair value at June 30, 2024">298</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcVmgTLASd83" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">149</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Balance, September 30, 2024</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zpZsfpFgI7t1" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024">447</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (b)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the detailed components of other nonoperating expenses. This disclosure may include methodology, assumptions and amounts for : (a) losses on securities (net of profits) and (b) miscellaneous income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150511696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract', window );"><strong>Class B Common Stock Of Ecrc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock', window );">These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs:</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zVhx1HrOm4u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Class B common stock of ECRC, an indirect, majority-owned subsidiary
of NioCorp formerly known as GX Acquisition Corp. II (&#8220;GXII&#8221;), include rights under which the holders may exchange
such shares into Common Shares, and certain of such shares are subject to certain vesting conditions (the &#8220;Earnout Shares&#8221;). <span id="xdx_8B4_zxleVNVPRKUk">These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; text-align: justify">Closing Common Share price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFuPGhTOBKs8" style="width: 15%; text-align: center" title="Closing common share price">$2.18</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgyhhAA1ZVQ5" style="width: 15%; text-align: center" title="Closing common share price">$1.73</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcuZgTLgdxNd" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIbRx34QX4d5" style="text-align: center" title="Implied volatility of public warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z9IRMe7Lvndl" style="text-align: center" title="Implied volatility of public warrants">65.0%</td><td style="text-align: left"></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMKF4ux4RJvi" style="text-align: center" title="Risk-free rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.74</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlDwrXLgIYP9" style="text-align: center" title="Risk-free rate">4.35%</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock', window );">The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024:</a></td>
<td class="text"><p id="xdx_892_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_zRfB1JhYU5M2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zgQyCBHZ4t53">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period
ended September 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_ziKz0TaIDIYc" style="width: 15%; text-align: right" title="Fair value at June 30, 2024">3,817</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6r8WZwsTTm7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">816</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zORTYqZwaPVe" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024">4,633</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureClassBCommonStockOfEcrcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of primary inputs into the monte carlo models table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150323872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock', window );">The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024:</a></td>
<td class="text"><p id="xdx_893_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_zZFBKUMYKyMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z63Atz6HKOr5">The
Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended
September 30, 2024:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Date</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Common Shares Issued</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Gross Funds Received</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Market Value of Shares Issued</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">(Gain)/Loss <br/>on Issuance</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 28, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240828_zE6YmGburBKa" style="width: 15%; text-align: right" title="Common shares issued">75,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240826__20240828_z3Xu7SqEIsU6" style="width: 15%; text-align: right" title="Gross funds received">140</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockIssued1_c20240826__20240828_zcyBLNQao1Ph" style="width: 15%; text-align: right" title="Fair value of common shares issued">133</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240826__20240828_zkfOcCJAp957" style="width: 15%; text-align: right" title="Gross funds received">(7</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 3, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240903_zOBtcwwCrJMf" style="text-align: right" title="Common shares issued">71,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240902__20240903_z6mlZYrlMbI2" style="text-align: right" title="Gross funds received">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssued1_c20240902__20240903_zV7XJsAvArZh" style="text-align: right" title="Fair value of common shares issued">123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240902__20240903_z7MXOIQfnlNi" style="text-align: right" title="Gross funds received">(1</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 6, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240906_zGhd51WzSa43" style="text-align: right" title="Common shares issued">71,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240904__20240906_zQv3aE5FY8Rl" style="text-align: right" title="Gross funds received">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssued1_c20240904__20240906_zixMUsNz28mc" style="text-align: right" title="Fair value of common shares issued">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240904__20240906_zhW8OQ1wWUu9" style="text-align: right" title="Gross funds received"><span style="-sec-ix-hidden: xdx2ixbrl0654">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 16, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240916_z5zeFtOqo3n1" style="text-align: right" title="Common shares issued">72,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240914__20240916_zpvPXrV0UqU6" style="text-align: right" title="Gross funds received">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssued1_c20240914__20240916_zaQUgyaTOp95" style="text-align: right" title="Fair value of common shares issued">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240914__20240916_z1c0TZqHobob" style="text-align: right" title="Gross funds received"><span style="-sec-ix-hidden: xdx2ixbrl0662">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 19, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240919_zY7WMZmyTIld" style="text-align: right" title="Common shares issued">49,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240918__20240919_zpavCdSPDkAb" style="text-align: right" title="Gross funds received">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssued1_c20240918__20240919_zADFG43nCs2l" style="text-align: right" title="Fair value of common shares issued">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240918__20240919_z4vO1K4kVYed" style="text-align: right" title="Gross funds received"><span style="-sec-ix-hidden: xdx2ixbrl0670">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 25, 2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240925_zRZZmusJel3j" style="text-align: right" title="Common shares issued">60,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240923__20240925_zbREIuEvVnz" style="text-align: right" title="Gross funds received">101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssued1_c20240923__20240925_zZT86rJ2HWu3" style="text-align: right" title="Fair value of common shares issued">108</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240923__20240924_zZ7MwyFKw3kj" style="text-align: right" title="Gross funds received">7</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfStockOptionRollForwardTableTextBlock', window );">Schedule of stock option</a></td>
<td class="text"><p id="xdx_896_ecustom--ScheduleOfStockOptionRollForwardTableTextBlock_zMbMuSMK0yek" style="display: none; margin-top: 0; margin-bottom: 0; visibility: hidden">&#160;<span id="xdx_8BF_zkjzLBiVNkgb">Schedule of stock option</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number of Options</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average <br/>Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate<br/>Intrinsic Value</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted <br/>Average Remaining Life</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20240930_zKN55L3yTxik" style="width: 15%; text-align: right" title="Beginning balance">2,495,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20240701__20240930_zBMran0dscw8" style="width: 15%; text-align: right" title="Beginning balance">4.78</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20240930_zWLhlpifZTQ5" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl0692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zc3qDApeTMv6" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl0694">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20240930_z9l2E8nrjI32" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0696">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_z1fFzG6iVfe" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0698">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20240930_zJCiKUx2Sd3b" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">(40,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zBzceKZCe8S7" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired">6.95</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, September 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20240930_z3otOCN6hc87" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">2,455,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20240701__20240930_zcswVa4G4Y3k" style="border-bottom: Black 2pt solid; text-align: right" title="Beginning balance">4.76</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20240930_z2c2YFk6rDbc" style="border-bottom: Black 2pt solid; text-align: right" title="Aggregate intrinsic value">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0708">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20240701__20240930_zXXc12Xgnri9" title="Weighted average remaining contractual life::XDX::P3Y2M19D"><span style="-sec-ix-hidden: xdx2ixbrl0710">3.22</span></span> Years</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of warrant transactions</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8lmPNryaG88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden">&#160;<span id="xdx_8B9_zTE6gwCssKXk">Schedule
of warrant transactions</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 63%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20240930_z73Uhv3eLmDj" style="width: 15%; text-align: right" title="Beginning balance">18,563,561</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20240701__20240930_zkF85Xz5gmrh" style="width: 15%; text-align: right" title="Beginning balance">10.53</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20240930_zw0LT0Keyxfi" style="text-align: right" title="Granted">2,816,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20240930_zc3j9fsutXm4" style="text-align: right" title="Granted">2.31</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20240930_zdgaI359Afzb" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0722">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20240930_zvvqp0p8H14j" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20240930_zCaJr1pjYYBg" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">(447,318</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20240930_zoJImAFnjTL7" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">8.94</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, September 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20240930_zkKpYJzzjipb" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">20,932,985</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20240701__20240930_zNwBoIsMvsS3" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">9.46</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock', window );">At September 30, 2024, the Company had outstanding exercisable Warrants, as follows:</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zD3G1UZGTpZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zqZVR49RR594">At
September 30, 2024, the Company had outstanding exercisable Warrants, as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">Expiry Date</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zSSH4HKGlsI9" style="width: 27%; text-align: right" title="Number">855,800</td><td style="width: 7%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z96DdCE2pNSb" style="width: 30%; text-align: right" title="Exercise price">C$<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.70</span></td><td style="width: 7%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z3qDQfD5uyvf" style="width: 26%; text-align: right; padding-left: 5.4pt" title="Expiry date">February 19, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdKYVXBP35ig" style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z3I8a1jjAO31" style="text-align: right" title="Exercise price">$4.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zSIluWBmR1nj" style="text-align: right; padding-left: 5.4pt" title="Expiry date">September 1, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zDwJjjKLuEX5" style="text-align: right">413,432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zRNDlwyiVKU" style="text-align: right">$3.54</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zg06YTA9Z3Zj" style="text-align: right; padding-left: 5.4pt">December 22, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmyxVhES6m55" style="text-align: right">315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZiTM5L9CR9" style="text-align: right">$2.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zisv6jk38da6" style="text-align: right; padding-left: 5.4pt">June 24, 2026</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.35Member_zfjofJn54ZGf" style="text-align: right">615,385</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z3x6STfrvH7e" style="text-align: right">$3.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zPYjiobUWDY9" style="text-align: right; padding-left: 5.4pt">April 12, 2027</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6ZfccVjwzR2" style="text-align: right">15,666,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEr9ouHH2tul" style="text-align: right">$11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6UUacp3aFDj" style="text-align: right; padding-left: 5.4pt">March 17, 2028</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zzNZxDOiFh6b" style="border-bottom: Black 1pt solid; text-align: right" title="Number">2,816,742</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zJNy4Fn2EVrh" style="padding-bottom: 1pt; text-align: right" title="Exercise price">$2.31</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zB5Cnjq5VNzb" style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt" title="Expiry date">September 17, 2028</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930_zthEr47AGJi5" style="border-bottom: Black 2pt solid; text-align: right">20,932,985</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model:</a></td>
<td class="text"><p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zKxXK5eB2hJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy as inputs into our pricing model are
based on observable data points. <span id="xdx_8BF_zG8JelBVD2O7">The following observable data points were used in calculating the fair value of the Private Warrants
using a Black Scholes pricing model:</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">September 30,<br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">June 30, <br/>&#160;2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfdQybB2Uyjk" style="width: 17%; text-align: right" title="Stock price on valuation date">2.18</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMQahFwTLoWh" style="width: 17%; text-align: right" title="Stock price on valuation date">1.73</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6uaYRqmfsT7" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zVuUlzysqwtd" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfeqUWgK9oP2" title="Implied volatility of public warrants">60</span></span></td><td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zH6AQzfbGZT1" title="Implied volatility of public warrants">69.0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGnIPtuoeprh" title="Risk free rate">3.58</span></span></td><td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">%</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSXKEqPWoSY7" title="Risk free rate">4.45</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zub7uRmjb1K8" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdG3ykCh1E3e" title="Dividend yield">0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4byd8V8fZ8g" title="Expected warrant life in years::XDX::P3Y5M30D"><span style="-sec-ix-hidden: xdx2ixbrl0803">3.5</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyUY0S4ai7Zd" title="Expected warrant life in years::XDX::P3Y8M12D"><span style="-sec-ix-hidden: xdx2ixbrl0805">3.7</span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock', window );">The change in the Private Warrants liability is presented below:</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zSlc0UIsoLta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zcEEUId4Lp0h">The
change in the Private Warrants liability is presented below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 42%; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqhb9iCqpaV6" style="width: 15%; text-align: right" title="Beginning balance">1,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zRN43KszK6s7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">(205</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Fair value at September 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zorR7P4tzzi1" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance">1,148</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zdWof341Pnzg" style="margin: 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"> <span id="xdx_8B2_zesmbWpof813">The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 17, <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 42%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1XpUJgWPBa" style="width: 15%; text-align: right" title="Closing common share price">1.74</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPrzuqE8U4eb" title="Term (years)::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0833">4.0</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z13R0iHC3zFf" title="Historic equity volatility">67.14</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUbpTPSOfn3k" title="Risk-free rate">3.44</span></td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule common shares under facility financing agreement table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in the fair value of the private warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of outstanding exercisable warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfStockOptionRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of stock option roll forward table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfStockOptionRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963248010560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EXPLORATION EXPENDITURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureExplorationExpendituresAbstract', window );"><strong>Exploration Expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfExplorationExpendituresTableTextBlock', window );">Schedule of exploration expenditures</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zsL7dB5cGwa3" style="margin-top: 0; margin-bottom: 0"><span>&#160;<span id="xdx_8B5_zsdj9jQ4iAsk" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Technical studies and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zCypVUoyrM8" style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zlqTAXRCT5zf" style="width: 15%; text-align: right">200</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zehYzmGChHga" style="text-align: right">91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zeGOggIDLlJk" style="text-align: right">135</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Metallurgical development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_zzQx5Yq14r13" style="text-align: right">47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_z9WGaCtLtyTf" style="text-align: right">746</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Geologists and field staff</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zY3syMVxeJWb" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zHgvWSGyk4c5" style="border-bottom: Black 1pt solid; text-align: right">19</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20240701__20240930_zNyJD2emNV0j" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures">138</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20230930_zFNpUJXPw7D4" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures">1,100</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureExplorationExpendituresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureExplorationExpendituresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfExplorationExpendituresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of exploration expenditures table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfExplorationExpendituresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963247834144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">The Company incurred lease costs as follows:</a></td>
<td class="text"><p id="xdx_890_eus-gaap--LeaseCostTableTextBlock_zy6ZvhCBSom7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zrtAcrJSBdlk">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td id="xdx_496_20240701__20240930_zuddX0TgWh8" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_492_20230701__20230930_z9ERXRKb3HE8" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the Three Months Ended September 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_z2EitoeWQAQc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating Lease Cost:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--FixedRentExpense_zAXIEkYb8Vvg" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left; text-indent: 9pt">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">23</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">23</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--VariableLeaseCost_zyPdXj2bZyHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 9pt">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 9pt">Short-term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zsAQ1y5nWYS9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Sublease income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zJtbT4Sa2X7b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net lease cost &#8211; other operating expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">20</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td style="border-bottom: Black 2pt solid; text-align: right">22</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">The maturities of lease liabilities are as follows at September 30, 2024:</a></td>
<td class="text"><p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ziGsQjF8hEK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8BA_zsg3t8AIFB44">The
maturities of lease liabilities are as follows at September 30, 2024:</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240930_zveg2pCc2z9l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Future Lease Maturities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zghIBTWYix23" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 82%; text-align: left">Total remaining lease payments</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 15%; font-size: 10pt; text-align: right">220</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zIpd1zmCGmA8" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less portion of payments representing interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(36</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zcezAec608A1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Present value of lease payments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zz6LCjdD5GUh" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of lease payments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(97</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zrTX1ZjBEPmj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Non-current lease liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">87</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150644000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of fair values determined by level 3 inputs are unobservable data</a></td>
<td class="text"><p id="xdx_895_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zS7Xl6TyuZ56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"><span id="xdx_8B8_zHClLontO7H8">Schedule of fair values determined by level 3 inputs are unobservable data</span></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of September 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930_zZME6WgaKGe4" style="width: 12%; text-align: right" title="Cash and cash equivalents">150</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ziFzXAQjvGh2" style="width: 12%; text-align: right">150</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7mTHS3gEoq9" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzPAdc47U6Zd" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0921">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930_zCBFcNHvSgKi" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zV2XHdki24hk" style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zEu7bx2Dzhyc" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0925">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3BXc5BRhpU2" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240930_zLdcSG65KS9d" style="border-bottom: Black 2pt solid; text-align: right" title="Total">154</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdus7P4zxXIk" style="border-bottom: Black 2pt solid; text-align: right">154</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGcwFYHReXm6" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0930">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWp5qyswCice" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930_z00RXTHgdzSg" style="text-align: right" title="Cash and cash equivalents">5,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1es40GuKkKj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zu51HsKcI149" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zm1UHSIhI4J3" style="text-align: right">5,258</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930_zewV8SQqGsO6" style="text-align: right" title="Cash and cash equivalents">4,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zxwYTWXrTyDe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0939">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWSh1rRfKlxk" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0940">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcQBd0TdKWFb" style="text-align: right">4,633</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930_zvwUAM4x6q8f" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zP73bx3AXBc6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrqL0I9qpyj" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRidbxwTCoK7" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930_zv2h5v9c6Tuc" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,486</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUEpXKIagtCh" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0949">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKMfCqTjFCca" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJDIFPQyENRk" style="border-bottom: Black 2pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,891</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zG6lgkfBSXF2" style="width: 12%; text-align: right" title="Cash and cash equivalents">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqmr3MRShjGf" style="width: 12%; text-align: right">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzGXTjIZUcw5" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0955">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zn8FxIJVdBQ8" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zEWoWPE6vcOe" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zViGTku6yLs2" style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zHSWLOzxYAQk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z589McuW7744" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zR5NmYWeyCIc" style="border-bottom: Black 2pt solid; text-align: right" title="Total">2,016</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKBvaK9YBX7e" style="border-bottom: Black 2pt solid; text-align: right">2,016</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zst9o0tMaS91" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd3KuEl7wUQ1" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_c20240630_zKh8qbYc5v3a" style="text-align: right" title="Cash and cash equivalents">7,089</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhcwih71jPE1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfRLdByz9gQ7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHe9Wj1pYA6d" style="text-align: right">7,089</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zQ3nSZ1Juvoa" style="text-align: right" title="Cash and cash equivalents">3,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zrX3KNCJE0q4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6XYzzKZaYTl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0975">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3PFRZb4n4N" style="text-align: right">3,817</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_z5t3uGONNa0k" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities">4,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zw06mR9kx2h6" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqeWLjhrKRrj" style="border-bottom: Black 1pt solid; text-align: right">1,651</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvl8HxChnie1" style="border-bottom: Black 1pt solid; text-align: right">2,365</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2pt">Total</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_z4JvKiLJMKBa" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents">14,922</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoNrYLBvgwKa" style="border-bottom: Black 2pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">-</span></td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYdGxMedLUie" style="border-bottom: Black 2pt solid; text-align: right">1,651</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1uMNXnhfje5" style="border-bottom: Black 2pt solid; text-align: right">13,271</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150541616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>N</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963143376240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_NetIncomeLoss1', window );">Net loss</a></td>
<td class="num">$ (2,102)<span></span>
</td>
<td class="num">$ (3,387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to noncontrolling interest</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to participating securities</a></td>
<td class="num">(2,071)<span></span>
</td>
<td class="num">(3,213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to vested shares of ECRC Class B common stock</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net loss attributable to vested shares of ECRC Class B common stock</a></td>
<td class="num">$ (1,885)<span></span>
</td>
<td class="num">$ (2,956)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding basic and diluted</a></td>
<td class="nump">38,361,344<span></span>
</td>
<td class="nump">31,967,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarningsLossPerShareBasicAndDiluted', window );">Loss per common share outstanding basic and diluted</a></td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarningsLossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnings loss per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarningsLossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_NetIncomeLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents net income loss1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_NetIncomeLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963147175840">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of excluded from the dilutive securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions', window );">Options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">2,455,500<span></span>
</td>
<td class="nump">1,319,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">20,932,985<span></span>
</td>
<td class="nump">19,066,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">1,920,000<span></span>
</td>
<td class="nump">2,448,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Total potential dilutive securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 25,308,485<span></span>
</td>
<td class="nump">$ 22,834,034<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 35<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-35<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-36<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150692080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal income tax payable</a></td>
<td class="nump">$ 443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150486912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,102)<span></span>
</td>
<td class="num">$ (3,387)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward', window );">Capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfDebt', window );">Net proceeds</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed deficit from capital loss carryforward of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963145134288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of account payable and accrued liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade</a></td>
<td class="nump">$ 2,056<span></span>
</td>
<td class="nump">$ 1,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Trade payable accruals</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Environmental accruals</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure', window );">Loan origination fees payable to related party</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 2,736<span></span>
</td>
<td class="nump">$ 1,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of trade and related party payables and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150829776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The change in the Convertible Debentures is presented below: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance at June 30, 2024</a></td>
<td class="nump">$ 571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpenseIncludingAssetRetirementObligations', window );">Accretion expense</a></td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrincipalAndAccruedInterestConverted', window );">Principal and interest converted</a></td>
<td class="num">(614)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance, September 30, 2024</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrincipalAndAccruedInterestConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents principal and accrued interest converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrincipalAndAccruedInterestConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpenseIncludingAssetRetirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481879/410-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpenseIncludingAssetRetirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963148399728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table discloses the components of interest expense associated with the Convertible Debentures. (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ContractualInterest', window );">Contractual interest</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of discount and issuance costs</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Total</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 2,075<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ContractualInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents contractual interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ContractualInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481639/420-10-35-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150532816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The change in the April 2024 Notes is presented below: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Fair value at June 30, 2024</a></td>
<td class="nump">$ 7,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Principal payments</a></td>
<td class="num">(1,848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValue', window );">Change in fair value</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Fair value at September 30, 2024</a></td>
<td class="nump">5,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalancePrincipalAmount', window );">Remaining Principal Balance, September 30, 2024</a></td>
<td class="nump">$ 5,280<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative assets designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalancePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of investment owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalancePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150365136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The change in the April 2024 Warrant liability is presented below: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Fair value at June 30, 2024</a></td>
<td class="nump">$ 3,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Fair value at September 30, 2024</a></td>
<td class="nump">4,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember', window );">Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Fair value at June 30, 2024</a></td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value</a></td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Fair value at September 30, 2024</a></td>
<td class="nump">$ 447<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963147289200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 01, 2024</div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
<th class="th"><div>Sep. 17, 2024</div></th>
<th class="th"><div>Sep. 01, 2024</div></th>
<th class="th"><div>Jul. 19, 2024</div></th>
<th class="th"><div>Apr. 12, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,816,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share price, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.46<span></span>
</td>
<td class="nump">$ 10.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Aggregate principal amount</a></td>
<td class="nump">$ 1,176,000<span></span>
</td>
<td class="nump">$ 1,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,176,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet', window );">Increased the amounts due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Shares exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebentureMember', window );">Yorkville Convertible Debenture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementMember', window );">Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Percentage value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share price, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Shares exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepaidPrincipal', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in debt instruments, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseDecreaseOtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepaidPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt repaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepaidPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150494240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details) - Measurement Input, Exercise Price [Member] - Valuation Technique, Option Pricing Model [Member] - Earnout [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 17, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 1.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">Term (expiry)</a></td>
<td class="text">Mar. 17,  2033<span></span>
</td>
<td class="text">Mar. 17,  2033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">3.74%<span></span>
</td>
<td class="nump">4.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150807728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details) - Earnout [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAmount', window );">Fair value at June 30, 2024</a></td>
<td class="nump">$ 3,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAdditions', window );">Change in fair value</a></td>
<td class="nump">816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAmount', window );">Fair value at September 30, 2024</a></td>
<td class="nump">$ 4,633<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiabilityAtFairValueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of new servicing liabilities, that are subsequently measured at fair value, acquired or created during the current period through assumptions of servicing obligations and servicing obligations that result from transfers of financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481229/860-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiabilityAtFairValueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiabilityAtFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of a liability representing servicing arrangements under which the estimated future revenue from contractually specified servicing fees, late charges, and other ancillary revenues are not expected to adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481229/860-50-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481260/860-50-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481260/860-50-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481260/860-50-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiabilityAtFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963147357920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 25, 2024</div></th>
<th class="th"><div>Sep. 24, 2024</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
<th class="th"><div>Sep. 16, 2024</div></th>
<th class="th"><div>Sep. 06, 2024</div></th>
<th class="th"><div>Sep. 03, 2024</div></th>
<th class="th"><div>Aug. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares issued</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,750<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">71,500<span></span>
</td>
<td class="nump">71,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross funds received</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Fair value of common shares issued</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer', window );">Gross funds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the difference in values (gain (loss)) between the nonmonetary assets or liabilities exchanged with another entity inclusive of boot (small monetary consideration).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 845<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482864/845-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 845<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482864/845-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963311607504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of stock option (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance | shares</a></td>
<td class="nump">2,495,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance | $ / shares</a></td>
<td class="nump">$ 4.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled/expired | shares</a></td>
<td class="num">(40,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled/expired | $ / shares</a></td>
<td class="nump">$ 6.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance | shares</a></td>
<td class="nump">2,455,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance | $ / shares</a></td>
<td class="nump">$ 4.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life</a></td>
<td class="text">3 years 2 months 19 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963146183856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of warrant transactions (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance</a></td>
<td class="nump">18,563,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Beginning balance | $ / shares</a></td>
<td class="nump">$ 10.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightGranted', window );">Granted</a></td>
<td class="nump">2,816,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceGranted', window );">Granted | $ / shares</a></td>
<td class="nump">$ 2.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercised', window );">Exercised</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceExercised', window );">Exercised</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExpired', window );">Expired</a></td>
<td class="num">(447,318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceExpired', window );">Expired | $ / shares</a></td>
<td class="nump">$ 8.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance</a></td>
<td class="nump">20,932,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Ending balance | $ / shares</a></td>
<td class="nump">$ 9.46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963147269696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">20,932,985<span></span>
</td>
<td class="nump">20,932,985<span></span>
</td>
<td class="nump">18,563,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 9.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member', window );">Exercise Price9.70 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">855,800<span></span>
</td>
<td class="nump">855,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Feb. 19,  2025<span></span>
</td>
<td class="text">Feb. 19,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member', window );">Exercise Price4.60 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member', window );">Exercise Price3.54 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">413,432<span></span>
</td>
<td class="nump">413,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Dec. 22,  2025<span></span>
</td>
<td class="text">Dec. 22,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member', window );">Exercise Price2.20 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">315,000<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Jun. 24,  2026<span></span>
</td>
<td class="text">Jun. 24,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.35Member', window );">Exercise Price3.35 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">615,385<span></span>
</td>
<td class="nump">615,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member', window );">Exercise Price3.25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Apr. 12,  2027<span></span>
</td>
<td class="text">Apr. 12,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member', window );">Exercise Price11.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">15,666,626<span></span>
</td>
<td class="nump">15,666,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Mar. 17,  2028<span></span>
</td>
<td class="text">Mar. 17,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.31Member', window );">Exercise Price2.31 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number | shares</a></td>
<td class="nump">2,816,742<span></span>
</td>
<td class="nump">2,816,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="text">Sep. 17,  2028<span></span>
</td>
<td class="text">Sep. 17,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice9.70Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.35Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.35Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.31Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.31Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963146427008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details) - Fair Value, Inputs, Level 2 [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 17, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Stock price on valuation date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="nump">67.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.58%<span></span>
</td>
<td class="nump">4.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected warrant life in years</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">3 years 5 months 30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PlatformOperatorCryptoAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.FF.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476188/405-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PlatformOperatorCryptoAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963247979584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The change in the Private Warrants liability is presented below: (Details) - Note Warrant [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation1', window );">Beginning balance</a></td>
<td class="nump">$ 1,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs', window );">Change in fair value</a></td>
<td class="num">(205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation1', window );">Ending balance</a></td>
<td class="nump">$ 1,148<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangesInFairValueOfInitialValuation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents changes in fair value of initial valuation1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangesInFairValueOfInitialValuation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value from changes in the inputs used to calculate the fair value of contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(4)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481229/860-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963146383728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 17, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">3 years 5 months 30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Historic equity volatility</a></td>
<td class="nump">67.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.58%<span></span>
</td>
<td class="nump">4.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="nump">3.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Valuation Technique, Option Pricing Model [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 1.74<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Historic equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963146241312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 17, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 17, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,932,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,563,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription', window );">Contingent consideration description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#8220;Lind Consent&#8221;), between the Company and Lind Global Asset Management III, LLC (&#8220;Lind III&#8221;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#8220;Contingent Consent Warrants&#8221;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued, shares</a></td>
<td class="nump">2,816,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share exercise price, per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember', window );">GXII Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_LindConsentWarrantIssuanceMember', window );">Lind Consent Warrant Issuance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share exercise price, per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | $</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,666,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,999,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
Private Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and
the like).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents a description of such arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for issuing warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_LindConsentWarrantIssuanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_LindConsentWarrantIssuanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963148441792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 06, 2024</div></th>
<th class="th"><div>Sep. 11, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Origination fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="nump">$ 1,187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Origination fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Additional drawdowns</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Origination fees</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Repaid outstanding interest</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember', window );">Non Revolving Credit Facility Agreement [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember', window );">General Security Agreement [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Interest at a rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LineOfCreditFacilityEstablishmentFee', window );">Prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LineOfCreditFacilityEstablishmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LineOfCreditFacilityEstablishmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150697536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of exploration expenditures (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_TechnicalStudiesAndEngineeringMember', window );">Technical Studies And Engineering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_FieldmanagementandotherMember', window );">Fieldmanagementandother [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_MetallurgicaldevelopmentMember', window );">Metallurgicaldevelopment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_GeologistAndFieldStaffMember', window );">Geologist And Field Staff [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExplorationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&amp;G" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExplorationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_TechnicalStudiesAndEngineeringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_TechnicalStudiesAndEngineeringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_FieldmanagementandotherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_FieldmanagementandotherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_MetallurgicaldevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_MetallurgicaldevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_GeologistAndFieldStaffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_GeologistAndFieldStaffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963151698688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company incurred lease costs as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating Lease Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FixedRentExpense', window );">Fixed rent expense</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable rent expense</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost &#8211; other operating expense</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FixedRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fixed rent expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FixedRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963148289456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The maturities of lease liabilities are as follows at September 30, 2024: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total remaining lease payments</a></td>
<td class="nump">$ 220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LessAmountOfPaymentsRepresentingInterest', window );">Less portion of payments representing interest</a></td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease payments</a></td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less current portion of lease payments</a></td>
<td class="num">(97)<span></span>
</td>
<td class="num">$ (96)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease liability</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LessAmountOfPaymentsRepresentingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents less amount of payments representing interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LessAmountOfPaymentsRepresentingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150493104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of fair values determined by level 3 inputs are unobservable data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 2,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Cash and cash equivalents</a></td>
<td class="nump">5,258<span></span>
</td>
<td class="nump">7,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,633<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">1,595<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">11,486<span></span>
</td>
<td class="nump">14,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">2,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">1,595<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">1,595<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Cash and cash equivalents</a></td>
<td class="nump">5,258<span></span>
</td>
<td class="nump">7,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,633<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,891<span></span>
</td>
<td class="nump">$ 13,271<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents available for sale securities equity securities other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AvailableForSaleSecuritiesEquitySecuritiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963150490016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 01, 2024</div></th>
<th class="th"><div>Nov. 13, 2024</div></th>
<th class="th"><div>Nov. 12, 2024</div></th>
<th class="th"><div>Nov. 04, 2024</div></th>
<th class="th"><div>Nov. 04, 2024</div></th>
<th class="th"><div>Oct. 03, 2024</div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
<th class="th"><div>Sep. 01, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Aggregate principal amount</a></td>
<td class="nump">$ 1,176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,176,000<span></span>
</td>
<td class="nump">$ 1,176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet', window );">Increased the amounts due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336,000<span></span>
</td>
<td class="nump">$ 336,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AccruedCost', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 459,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent event, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On November 13, 2024, the Company closed the November 2024 Private Offering, pursuant to binding subscription
agreements with certain accredited investors as part of a non-brokered private placement of 2,199,602 units of the Company (the
&#8220;Units&#8221;). Each Unit consists of one Common Share, one Warrant (collectively, the &#8220;Series A Private Warrants&#8221;)
to purchase one Common Share and one-half of one Warrant to purchase one-half of one Common Share (collectively, the &#8220;Series
B Private Warrants&#8221;). Each Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company purchased
November 2024 Units at a price of $1.7675 per Unit, which price includes $0.125 per Private Warrant and allows such directors and
officers to participate in the November 2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private
Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will expire on November
13, 2026.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On November 5, 2024, the Company closed the November 2024 Registered Offering, pursuant to the underwriting
agreement, dated November 3, 2024 (the &#8220;Underwriting Agreement&#8221;), with Maxim Group LLC, as underwriter (the &#8220;Underwriter&#8221;),
which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#8220;Series A Public Warrants&#8221;) to purchase up to an
additional 1,672,090 Common Shares and 836,045 Warrants (the &#8220;Series B Public Warrants&#8221; and, together with the Series
A Public Warrants, the &#8220;November Public Warrants&#8221;) to purchase up to an additional 836,045 Common Shares. Each Common
Share was sold together with one Series A Public Warrant and one-half of one Series B Public Warrant at a combined public offering
price of $1.57. The gross proceeds from the November 2024 Registered Offering were approximately $2,500 before deducting underwriting
discounts and offering expenses. The Company entered into a warrant agency agreement with Computershare Inc. and its affiliate,
Computershare Trust Company, N.A., together as warrant agent, setting forth the terms and conditions of the November Public Warrants.
The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will
expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable
beginning six months and one day from the date of issuance, and will expire on November 5, 2029. In addition, pursuant to the Underwriting
Agreement, the Company granted the Underwriter a 45-day over-allotment option to purchase (i) 238,853 additional Common Shares
and (ii) 358,280 Option Warrants (as defined below) to purchase up to an aggregate of 358,280 Common Shares. &#8220;Option Warrant&#8221;
means one Series A Public Warrant combined with one-half of one Series B Public Warrant.<span></span>
</td>
<td class="text">On
October 3, 2024, NioCorp entered into (i) a consent and waiver (the &#8220;October Yorkville Consent&#8221;) to the April 2024
Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with
the October Yorkville Consent, the &#8220;October Consents&#8221;) to the April 2024 Notes issued and sold to Lind II pursuant
to the April 2024 Purchase Agreement. The October Consents, among other things, extended the maturity date to January 31, 2025,
reduced the amounts due to the April 2024 Purchasers on October 1, 2024 by an aggregate of $1,176 to an aggregate of $336 and
deferred such amounts due to the April 2024 Purchasers until January 1, 2025, and prospectively waived any term of the April 2024
Notes that would otherwise be triggered upon a failure of the Company to pay to the April 2024 Purchasers the remainder of the
amount due on October 1, 2024. Except as modified by the September Consents, as discussed in Note 5b, and the October Consents,
the terms of the April 2024 Notes as previously disclosed are unchanged.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StrikePriceOfWarrantsIssued', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Purchase Agreement Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Purchase Agreement Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AccruedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents accrued cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AccruedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StrikePriceOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents strike price of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StrikePriceOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in debt instruments, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseDecreaseOtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>72
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY*&Q17WA5O^CS/O41RH*32A0$PI4V9OTA:+DG.32YD>MZ-L5=:6]$06.R?E
ME9(@?$L&\Q?/8."]M7EU(F,'/OJ-C[[+^GR!Q0:HU0*QOB"_2KK%J7+:NGJU
MJ: RI=O!=@XGWFRTW7?&E$$>1(W0 <AQ W+L!'E!UD0M10+$!G,"J!!EE8PQ
M$W:@M;GQ'HCQ9-H!ZGRE/>K $?!)X\O$Z<L5)P6F"2"_"UUFH@H^DQO";8Y,
M#$<F4=AQQ)29PL >\* !&3A!?F,2IZK;5/D/L!#$'N? >#6$TZ"#SQ1"4Q39
M 88-P-!9FG^R_"SN+\_PE.5Y(F,'?D:-G]&1S"^8H/;@1T9<_4DG]$Z1 T#3
M!M#4">A3OB5"9CHM5*_7_4+> 4'46E!)B17GU"S&#DR7Q %*Z+4LYCEQ5N/'
M&5N?E8(X$GAGY2"#@VZ!V80BV(-PCV>A$^%G7?CZWZJD:4+S&S$$.;&F\\[2
M/H#([Y:952CL0=E2('2RS_R+NN>J%Q1<#8J\;XEW1@[#Z$7==#PJ=@BRY3#H
M)K&Z73E6V;<LH(_\+CQ33 V_H=<#KV4O.'[J' &?P$+]G>I4U@[];)D-NJGM
M71RS4HT.H,!W>)62*KMQ'/-247=*\8JFO4T"FBR&0C/'32D8C?V>!6K9#KKI
M[@?F'*N.MH=Q"+ $:TPY4/-02:R0G48?-$'LO+(PI!_T545+D=#)3'J2W^J2
MU2N1D)4]_T)SP$"3J!MV4RH,@KZZ:+D-NLGMFJ35WJ+ 7)%(+T0+B1F5ZWS1
MXX<YV-(A=//A5]45L53=&Z1$;1Z;%+JSNF(2W=0@&XM,SS2'6C9$;C8\G.>.
ME"(RZ2Z"J,O9%BD]^_40-VII$<'_,]DA)ZD^>N=U(FN'ON[M+]WD^K2^@RPL
M.IEVN=8F%4QZIA;44BUR4^TEYCDK6\AW#P%L\NHX,&K8(N5'L&> 02WY(O?>
M\5$%BLR-H['=LLA KR_M6^Y$;NZL*_1895KH;SSVNSM;FU@X\?NZ2$N3R$V3
M"Y9EM)K]ZUUKS'(=6)+'?7A/Q9!/,72\3ELF16XFO28)(5DUTN0LUVYSEJ8Z
MIV@NB7JCO569K DGGI'V-BF_+Y]:;D61LXTN/[Z[OOSX]?/%Y?7RQ;,(P? M
MN/SK^Z=O_UBA/H$_'5WU1-8.76\I&;DI6:<IRX&0+/ZIME1,SQ=U<QJ"4DEG
M^MBR/DI2>5S*#>/T7Y*\!7XT#)$W1.-QE=[JU@O0,!B']\*J\0FI'JF5'P+U
M0T&J,^?4WDM,(E=;2Q0:C=HFYT>H9ZKU6]+WW:2OQO$R*^L1*R%K&E-KFOHF
MD9\I -.HFZEV03CM.]WS6\[WW5OA?:3549AJ+9G*C8W^.K!5/9L)^WFDN>4]
MFT+8Q7U$ZA!T2]Z^F[SKCEUEQH:E">'BOL[J4Q$K8).4D1\9@"W4[7D]X[:_
M=]+[D%WRP:S!CS:V854*C_32<DYLV6Y;Q&S;[='>MPS](>D+YC<T%XK.UTK/
M>QVJ%LCK;S/UC61%]7ECQ:1D676Y(5A!UP+J^9HQ>7^COY@T7\CF_P%02P,$
M%     @ %H!M66I/P2S( @  B@<  !@   !X;"]W;W)K<VAE971S+W-H965T
M,RYX;6RM56UOTS 0_BNG@- FC25-VG2,-M):F !I4K5J\ 'QP4VNC37'#K;3
M#GX]YZ0-[916&N)+XI=['M]SYSN/-DH_FAS1PE,AI!E[N;7EM>^;-,>"F4M5
MHJ2=I=(%LS35*]^4&EE6@PKAAT$0^P7CTDM&]=I,)R-56<$ESC28JBB8_C5!
MH39CK^?M%N[Y*K=NP4]&)5OA'.U#.=,T\UN6C!<H#5<2-"['WDWO>AH[^]K@
M*\>-V1N#4[)0ZM%-/F=C+W .H<#4.@9&OS5.40A'1&[\W')Z[9$.N#_>L=_6
MVDG+@AF<*O&-9S8?>U<>9+ADE;#W:O,)MWH&CB]5PM1?V#2VPW<>I)6QJMB"
MR8."R^;/GK9QV ,03S<@W +"YX#X""#: J)::.-9+>L#LRP9:;4![:R)S0WJ
MV-1H4L.ER^+<:MKEA+/)5,F,<H(9T,@HP3-F:3)A@LD48>Z(#9Q5DE49IYUS
M.)LQC=+F:'G*Q#F\A=?@@\EIU8Q\2SXY9C_=GC]IS@^/G!_!G2(R Q_)CZP#
M/SV-[X4G"'P*1AN1<!>127B2<8[E)43!!81!V.]RZ#3\2R6/P0_<B=H$137?
MX)@[EA)"96-!+>&62TH+9P)FRO"Z#K[?+(S55 T_NH+?<$?=W*Y#7)N2I3CV
MJ 48U&OTDC>O>G'PODOX?R(["$._#4/_%#O=TZ(@M50/Z>,%E$S#FHD*X8Q+
MR)003!LH43?W\+PK% U_7/.[WK9.@I&_WM=WRN+ Z4'K]. %3K/*YDKSWYW7
M?'*:Z8%6"E=_77GY)^B!H+@5%+] 4%/S0&^#L4QF7*ZZA#6,_;VH1E=#5QS]
M9^'O,@SB,.X/GV7!WVMW!>I5_0H82%4E;=/YVM7VH;FI^ZO_U[QYI>Z87G%I
M0."2H,'ED&*IF\[?3*PJZ^:Y4)9:<3W,Z;%$[0QH?ZF4W4W< >WSF_P!4$L#
M!!0    ( !: ;5D7TO->!@4  ,L2   8    >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&ULK5AA;]LV$/TKA%8,+=!$HB1;=N88:-P6"]"N0=.NGVF)MH5*I$M2
M=O+O=Z04R98H+@OV)9:4N^-[1_+>D8LC%S_ECE*%'LJ"R6MOI]3^RO=ENJ,E
MD9=\3QG\9\-%212\BJTO]X*2S#B5A1\&P=0O2<Z\Y<)\NQ/+!:]4D3-Z)Y"L
MRI*(QQM:\..UA[VG#U_S[4[I#_YRL2=;>D_5]_V=@#>_C9+E)64RYPP)NKGV
MWN&K51AJ!V/Q=TZ/\N09:2IKSG_JE]OLV@LT(EK05.D0!'X.=$6+0D<"'+^:
MH%X[IG8\?7Z*_M&0!S)K(NF*%S_R3.VNO9F',KHA5:&^\N.?M"$TT?%27DCS
M%QT;V\!#:245+QMG0%#FK/XE#TTB3AP@CMTA;!S"OD,\XA U#I$A6B,SM-X3
M198+P8](:&N(IA],;HPWL,F9GL9[)>"_.?BIY8JS#":%9@B>)"_RC"AXN5?P
M [.E).(;]&5/!=%9EX@P;5G"DMGIN3Q0](E+B5Y7C%19#JYOT 7Z?O\>O7[U
M!KU".4/?=KR2X"87O@+ >E@_;<#=U.#"$7 1^LR9VDGT 4!FY_X^$&W9AD]L
M;T)GP'NZOT11\!:%01A;\*R>[QXYX$1M\B,3;S(2K\DKVR+ZL->S8,U1'2.R
MQ]#;_$KN24JO/9@42<6!>LO??\/3X \;P?\IV!G=N*4;NZ(O/Y3[@C]2"MN_
M,*LLY5)9*==QIB:.+D2'910%"_]PRL1B$X:MS1G 20MPX@1X)_B&2EVA2($V
MU#X==8CX9-QXTL<VM,%XEMC!35MP4W?V'B![]3:LEPMLMTK8,4Z'XT>S'D:+
M#0X".\:DQ9@X,7Y1.RH0?]:R3H9Y3)(>QJ'-+(KM$&<MQ)D3XC>N8'*?!W%F
M2>-\TL,X-(KB.+*#G+<@YTZ0JQUA6ZJKYX;D AU(45%=B"D1#+08R1V!F4=%
M3M9YD:M'&_CY,'=XVL,^M+D(@_D(>!QTFA*\"/Z1"$&8:G'G]K0WT<]@3?K0
M+4;)&/ 3,<0O IYR=J!"Y>N"(L;5"&P\7"[]!>T>WUY_D:/TXK"C%CJIW3)%
M(:1Z6O!6!N%P3\9]!D.;,$@F(YGOE! [E6<)/1ET7+JRI?4<%*:MV$(C^L8*
M-1HN[S[2H<D%QB- .PW#;A&K2YS&95\$L670$UUJH#G'>,$RZ!0.NR7.=&M:
M07Y54#>0I&DEQC>B,]:S8#9\+8(X,A&='&*W'AHF:PHG&;UA4UY2I,C#")&A
MV%V$.!A,B\4LBF>S$:B=*F*W+-ZV\  PHYM<64$Z@_R7; ]E\P('8PGOA!.[
ME?,O.%2:7:G/ .G9&4!_ME(:BJ,U[Q:S*!IKF'"GHM@MHY^@F;M"'6ZE1+ZN
M%-%E7'%H0S,*A^*ZJ,,4,25X4>BF(&^*I963130CW&=D,<+)2.L2=L(:NH7U
M7Z9@P!!JE3FM$69M$9K1IN?ZG_3)V,RB$(^H;=BI;>A66[.#H1'33$JH2::K
M>:M/Y7EJ&&9Y4:G^P:^!7H=.3C$%ET&_.1LQFX] []0T=*OI#W,] $<8 GT!
M ;DZI0 %ME)2 0-82\_E,Y35:!9-<3008)LEGD^38-[?X?[)M4!)Q=;<EDB
M6C%5GYG;K^V-S#MS#]'[?H.O5O6]2A>FON;Y3,06E! 5= ,A@\L$"KVH;T[J
M%\7WYO)AS97BI7G<49)1H0W@_QL.[53SH@=H[Z^6_P!02P,$%     @ %H!M
M6<P20>H_!@  1AH  !@   !X;"]W;W)K<VAE971S+W-H965T-2YX;6RM66UO
MVS80_BN$5PPMT-02);]EB0'':=8 :Q+$:8M]I"7:YBJ)*DG;S7[]CI0BV1;%
M))V_Q))R/#T/>;SGCCK;<O%=KBA5Z&>:9/*\LU(J/^UV9;2B*9$?>$XS^,^"
MBY0HN!7+KLP%);$9E"9=['G];DI8UAF?F6=W8GS&URIA&;T32*[3E(C'"YKP
M[7G'[SP]N&?+E=(/NN.SG"SIC*HO^9V NV[E)68IS23C&1)T<=Z9^*?3P PP
M%E\9W<J=:Z2IS#G_KF^NX_..IQ'1A$9*NR#PLZ%3FB3:$^#X43KM5._4 W>O
MG[Q?&?) 9DXDG?+D&XO5ZKPS[*"8+L@Z4?=\^XF6A'K:7\03:?ZB;6GK=5"T
MEHJGY6! D+*L^"4_RXG8&0!^[ -P.0 ?#@A;!@3E@, 0+9 96I=$D?&9X%LD
MM#5XTQ=F;LQH8,,RO8PS)>"_#,:I\91G,2P*C1%<29ZPF"BXF2GX@=52$O$%
MFA*Y0E>PXA*]76=D'3.P>8=.T)?9)7K[YAUZ@UB&'E9\+4D6R[.N F3:?S<J
M45P4*' +B@!]YIE:2?01T,3[X[O J**%GVA=8*?#&<T_H,![C["'0PN>Z<N'
M!PXX037+@?'7:YOER>P3NOKK]ML,7=W??D:W=Q_O)P_7-W^BR?3A^NOUP_7'
MF6W6"J^!W:O>X:<R)Q$][\ 6EE1L:&?\^V]^W_O#1OE(SO8F(*PF('1Y']]
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MT)RP&-&?N>X)['O"HIY^X!TN4=,J]%NJ,[]64-\MH2 V?*V+LYP\$BTRT&U
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MBI*8"FT _U]PKIYN] NJ3T?C_P!02P,$%     @ %H!M67C$D]M9!@  HB@
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MWBG=+%A?\O7$VRI>K*GU=$W'84'_18"\@=;7EIK93#A ^Z<U^PY02P,$%
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M'HH$IB\3X*(Z=:TH<)ZT_)9=8[)X^V9RE)Z]8M[!SKR#U]"_'[[7U:<C>((
MO]0X6)JF%?H!I"XZ:[$$ <HXQ][Y ;)A>CR!Z3";3.%H^"$[@<G1=/CA9 J3
MPQ2JCERJN5H44-^PP:VD:<'72#7<B@?V*$/QP7EKI0J1ABOCT<$[X0C#TIT=
ME-)1_CMZ7^IP#8?Y>ZAZ+(WW'OP&U1JA"2DX8O(.H3"ZE/%=#C"N0PBMD'3G
M.@JDT)[C6YHN]R!RZE0!L3?[[9N3;')\Y@8BETKZ!_"&(;W4'0+1$[ R4J_X
MK$"K1W#)S<FU]!ZRK']&8O!(8KC_#K1*$$72,+FGY@FBC!I$K8I)J%<C.'?
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MQKD:-]ZT89;EQM-D#,N:/D70L@#=5X;JH]_P [N/F\6_4$L#!!0    ( !:
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MV0=H?2'I5;0#FZ#[23'Y#U!+ P04    "  6@&U9 "<JY@P$  "E"   &0
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MC9,Y1&U8EE&4\**WE 1 X<+XW*XG81# OL+Y.WU5H<K=]-"0R$:8ML6ZW6Y
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M-%320EW<I^C1^/AH<BPZKJB#(R;Q[/0T/AV-!, Y?A:/1J.H[6XFH_C9%,F
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M=V]R:W-H965T<R]S:&5E=#(P+GAM;+U676_;-A1]UZ\@W*%( ,V6)3NVT\1
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MN#_?H7_VVDG+G!F\5N('S^VJ%W0"R''!UL+>J\T7W.II.[Q,">/_85/YMN,
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MSB_I?>NJ"56&5:4O_+FRU$;\=$5]&[5SH/V%4G9GN 3UEZ#_#U!+ P04
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M-%CYQX(F6=3N .VO%;7-?N$2-+/Q]!]02P,$%     @ %H!M6=[>/=\A!
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M!!$30H6Q8P1!OR<<H5(,1#1^K#"#S9+LN-U>HU][[:1E*BR.M/HJ$Y<.@K,
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MHN3,OH^B,"3[*A7L=%0-JG1S0Y-,ML)TS=7O]J/ILNO(O^[=7+NE*%=HPJ%
M:'@\Q&NINEG1+8QL7'^NI,%N=V:%XQ64=<#S0DJS7=@ _<!._P!02P,$%
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M:'S2)4%U=5U4"ZL*/Z(GRM+ ]Y\9W;"HG0/9YTK9S<(EJ._LX6]02P,$%
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M^!\?6J&]VOB@=AJ?)<RPN81A= %Q%(]@<89QV-<_](Q7;S ^ZI))_H>Y%KF
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M,S.<Y(8_KOKNJ#\F)4^3'.XH8F668?KW"E*RF1BV\=AQGZQB+CM,?US@%3P
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M$/XK)U9-K=050MY8EB US:IM4J>H:;</TSXX< E6C<ULD[3_?C90-UL)VKZ
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M$I4SL/M;*<UQX@YHVM/9WU!+ P04    "  6@&U9(CJ\H=,"  !Z!@  &0
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MA5)8D4VNKOGN&S0!!88OX;FLWFA7]_4]"R4;J7C1@+6#@K+Z2^Z:@>@ /'P
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MF;[G@# =]/\5YVI?,0+MS2G^!U!+ P04    "  6@&U9XZXDJR &  #U,P
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M%@2X(@E3KWS_.^;QM V?SYE,_V&?VSH6^(E4/,S!VH.01MF3O.4ZG ":K0J
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MK2[A\.!H#^]X.,NQXYV^Q]NFBN;4O.UC6!&&( I8:9$]P<-W$PI7&FOUN.L
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M2@/Q?D$(?[Z1#30_0LS_ U!+ P04    "  6@&U9+,&9AB@'  #;(P  &0
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MI4K[M2J=0'0"K9%8(H^!V_M$A3I(6CX1'J>)NCZDTEK44U5:+^*-:%1%@XH
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M'QSWW>N@6/;>88I5^#LJM!>4)(:Y1CH7E[J/B6)AN]A1?)6OW,ZX4CS)-Y=
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M@+ ,"*W0@IF5=8<5'@T$7R-A=FLT,["YL=%:#6'&QID2^BW1<6HTT_^+.*>
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M1'?.(,P&_7[!N=I,S %5+S[Z!U!+ P04    "  6@&U9 (OU[-<"   T"
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MD94=(W-W%TREP9O%-5.\^T'9"?A^(:79=.SU4O^;2/X"4$L#!!0    ( !:
M;5G/;839 @4   PA   9    >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;,U:
MVV[;.!#]%4);+%H@C432DNVL;:!)4&P6R2)(>GDH]H&VZ5BH+BY)V>W?+RDK
MHF511%3S(2^Q),\<G1E=SLG0DUW.OO,UI0+\3).,3[VU$)L+W^>+-4T)/\\W
M-)/?K'*6$B%WV9//-XR299F4)CX*@LA/29QYLTEY[)[-)GDADCBC]PSP(DT)
M^W5)DWPW]:#W?. A?EH+=<"?33;DB3Y2\7ESS^2>7Z,LXY1F/,XSP.AJZGV
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ML<QW(S#>UJ<#->O50@T=*K4=JT^]IP,UZ]62#^V:_T(UM:/TJ?1TH&:EVC9
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M4[*D3 7([U=Y+IYWU()X_0.(V?]02P,$%     @ %H!M66%[Q.YU"@  I4
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M8A@O=:CG@5W7*G0/@:KNJ0)H&N51WT4LHTR=23[7'^H%&L%L%55"4DL6:9?
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  6@&U97L;\)00%  #C(P
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MSN6T2_G:\[W&Y_\GU>5\;[H^_K+\/CEZ>R\X!_B3X/$+4$L#!!0    ( !:
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !: ;5G8$TOW:@8  ,@C   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  6@&U9S2CVL3$&   M&P  &               @(&M#@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ %H!M66I/P2S( @  B@<
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M965T-RYX;6Q02P$"% ,4    "  6@&U92=DW26(*  ! &@  &
M    @('H+@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M%H!M6<*R,EX>!   Z @  !@              ("!@#D  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( !: ;5F,Q/NIN@(  "T&   9
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M970Q-"YX;6Q02P$"% ,4    "  6@&U9U'1/T)P"  #"!0  &0
M    @(%P6   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M !: ;5G :TY#! ,  ,@&   9              " @4-;  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ %H!M685M*,-S!   QPH  !D
M             ("!?EX  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    "  6@&U9Z%<Z]\D'   \%0  &0              @($H8P  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( !: ;5DU3JV7H H
M .\;   9              " @2AK  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ %H!M68]UQV0$!0  Z@L  !D              ("!
M_W4  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  6@&U9
MD']@SKT"   5!@  &0              @($Z>P  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( !: ;5EW'DM2F0,  "<+   9
M      " @2Y^  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ %H!M6=[>/=\A!   #@H  !D              ("!_H$  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  6@&U99XTG3HL&  !!$P
M&0              @(%6A@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( !: ;5E?[R[)H0(  +P%   9              " @1B-  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ %H!M6?)N\TP@
M P  OP<  !D              ("!\(\  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    "  6@&U9T=]C8$0#  #K!P  &0
M@(%'DP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( !:
M;5F)8HC:3P(  -<$   9              " @<*6  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ %H!M68N^6<_& P  $PL  !D
M         ("!2)D  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    "  6@&U9HXF>XA<$   L"P  &0              @(%%G0  >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( !: ;5F S4B%HP(  ,X&
M   9              " @9.A  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ %H!M67;C1$5I P  /!   !D              ("!;:0
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  6@&U9\#Y=
M',D"  #6!P  &0              @($-J   >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( !: ;5E.%&4_HP(  '0&   9
M  " @0VK  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M%H!M6;9K!.35 @  .@<  !D              ("!YZT  'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    "  6@&U9^35X:[<"  #A!@  &0
M            @('SL   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( !: ;5GJVU43Z0(  )$(   9              " @>&S  !X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ %H!M62EBF24K!@
M0SP  !D              ("! ;<  'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    "  6@&U9(=T-U7@#  "J"@  &0              @(%C
MO0  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( !: ;5DB
M.KRATP(  'H&   9              " @1+!  !X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ %H!M627PA%R( P  ]PX  !D
M     ("!',0  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !: ;5DXW"[JCP(  .,%   9              "
M@?;8  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ %H!M
M6<)90?J6!   D!@  !D              ("!O-L  'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    "  6@&U9+,&9AB@'  #;(P  &0
M        @(&)X   >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( !: ;5D-8/>#YP0  &H@   9              " @>CG  !X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ %H!M691*RBLA P  EPL
M !D              ("!!NT  'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    "  6@&U9 (OU[-<"   T"   &0              @(%>\
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( !: ;5G\!*)%
MPP(  %D(   9              " @6SS  !X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ %H!M6<]MA-D"!0  #"$  !D
M ("!9O8  'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    "  6
M@&U987O$[G4*  "E0   &0              @(&?^P  >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( !: ;5D<,E20, ,  $H2   -
M          "  4L& 0!X;"]S='EL97,N>&UL4$L! A0#%     @ %H!M69>*
MNQS     $P(   L              ( !I@D! %]R96QS+RYR96QS4$L! A0#
M%     @ %H!M65[&_"4$!0  XR,   \              ( !CPH! 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( !: ;5D/E%1(V@$  %D@   :
M      "  < / 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( !: ;5DA7:<FS0$  "0@   3              "  =(1 0!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     ^ #X Z1   - 3 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>112</ContextCount>
  <ElementCount>247</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DescriptionOfBusiness</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPresentation</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - GOING CONCERN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GoingConcern</Role>
      <ShortName>GOING CONCERN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Debt</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - CLASS B COMMON STOCK OF ECRC</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrc</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - COMMON SHARES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonShares</Role>
      <ShortName>COMMON SHARES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - EXPLORATION EXPENDITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ExplorationExpenditures</Role>
      <ShortName>EXPLORATION EXPENDITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPresentationPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - BASIS OF PRESENTATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPresentationTables</Role>
      <ShortName>BASIS OF PRESENTATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/BasisOfPresentation</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DebtTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/Debt</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrc</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - COMMON SHARES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesTables</Role>
      <ShortName>COMMON SHARES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonShares</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - EXPLORATION EXPENDITURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ExplorationExpendituresTables</Role>
      <ShortName>EXPLORATION EXPENDITURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ExplorationExpenditures</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/Leases</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/FairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/DescriptionOfBusiness</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - The following table sets forth the computation of the Company???s basic and diluted net loss per share attributable to common shareholders: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails</Role>
      <ShortName>The following table sets forth the computation of the Company???s basic and diluted net loss per share attributable to common shareholders: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Schedule of excluded from the dilutive securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails</Role>
      <ShortName>Schedule of excluded from the dilutive securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPresentationDetailsNarrative</Role>
      <ShortName>BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/BasisOfPresentationTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - GOING CONCERN (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GoingConcernDetailsNarrative</Role>
      <ShortName>GOING CONCERN (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/GoingConcern</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Schedule of account payable and accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Schedule of account payable and accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - The change in the Convertible Debentures is presented below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails</Role>
      <ShortName>The change in the Convertible Debentures is presented below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details</Role>
      <ShortName>The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - The change in the April 2024 Notes is presented below: (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails</Role>
      <ShortName>The change in the April 2024 Notes is presented below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - The change in the April 2024 Warrant liability is presented below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails</Role>
      <ShortName>The change in the April 2024 Warrant liability is presented below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - DEBT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DebtDetailsNarrative</Role>
      <ShortName>DEBT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/DebtTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails</Role>
      <ShortName>These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details</Role>
      <ShortName>The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details</Role>
      <ShortName>The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Schedule of stock option (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfStockOptionDetails</Role>
      <ShortName>Schedule of stock option (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Schedule of warrant transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails</Role>
      <ShortName>Schedule of warrant transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails</Role>
      <ShortName>At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails</Role>
      <ShortName>The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - The change in the Private Warrants liability is presented below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails</Role>
      <ShortName>The change in the Private Warrants liability is presented below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails</Role>
      <ShortName>The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - COMMON SHARES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetailsNarrative</Role>
      <ShortName>COMMON SHARES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/RelatedPartyTransactions</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Schedule of exploration expenditures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails</Role>
      <ShortName>Schedule of exploration expenditures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - The Company incurred lease costs as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails</Role>
      <ShortName>The Company incurred lease costs as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - The maturities of lease liabilities are as follows at September 30, 2024: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details</Role>
      <ShortName>The maturities of lease liabilities are as follows at September 30, 2024: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails</Role>
      <ShortName>Schedule of fair values determined by level 3 inputs are unobservable data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="n2574_x224-10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/SubsequentEvents</ParentRole>
      <Position>54</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="n2574_x224-10q.htm">n2574_x224-10q.htm</File>
    <File>niobf-20240930.xsd</File>
    <File>niobf-20240930_cal.xml</File>
    <File>niobf-20240930_def.xml</File>
    <File>niobf-20240930_lab.xml</File>
    <File>niobf-20240930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>n257410qimg001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="439">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="33">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "n2574_x224-10q.htm": {
   "nsprefix": "niobf",
   "nsuri": "http://niocorp.com/20240930",
   "dts": {
    "inline": {
     "local": [
      "n2574_x224-10q.htm"
     ]
    },
    "schema": {
     "local": [
      "niobf-20240930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "niobf-20240930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "niobf-20240930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "niobf-20240930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "niobf-20240930_pre.xml"
     ]
    }
   },
   "keyStandard": 200,
   "keyCustom": 47,
   "axisStandard": 13,
   "axisCustom": 1,
   "memberStandard": 13,
   "memberCustom": 25,
   "hidden": {
    "total": 95,
    "http://fasb.org/us-gaap/2024": 67,
    "http://niocorp.com/20240930": 22,
    "http://xbrl.sec.gov/dei/2024": 6
   },
   "contextCount": 112,
   "entityCount": 1,
   "segmentCount": 38,
   "elementCount": 392,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 439,
    "http://xbrl.sec.gov/dei/2024": 33
   },
   "report": {
    "R1": {
     "role": "http://niocorp.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://niocorp.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://niocorp.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://niocorp.com/role/StatementsOfCashFlows",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ChangeInFairValueOfEarnoutShareLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ChangeInFairValueOfEarnoutShareLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest",
     "longName": "00000006 - Statement - Condensed Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)",
     "shortName": "Condensed Consolidated Statements of Shareholders' (Deficit) Equity and Redeemable Noncontrolling Interest (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://niocorp.com/role/DescriptionOfBusiness",
     "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://niocorp.com/role/BasisOfPresentation",
     "longName": "00000008 - Disclosure - BASIS OF PRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:BasisOfAccounting",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:BasisOfAccounting",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://niocorp.com/role/GoingConcern",
     "longName": "00000009 - Disclosure - GOING CONCERN",
     "shortName": "GOING CONCERN",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://niocorp.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "00000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://niocorp.com/role/Debt",
     "longName": "00000011 - Disclosure - DEBT",
     "shortName": "DEBT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrc",
     "longName": "00000012 - Disclosure - CLASS B COMMON STOCK OF ECRC",
     "shortName": "CLASS B COMMON STOCK OF ECRC",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://niocorp.com/role/CommonShares",
     "longName": "00000013 - Disclosure - COMMON SHARES",
     "shortName": "COMMON SHARES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://niocorp.com/role/RelatedPartyTransactions",
     "longName": "00000014 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://niocorp.com/role/ExplorationExpenditures",
     "longName": "00000015 - Disclosure - EXPLORATION EXPENDITURES",
     "shortName": "EXPLORATION EXPENDITURES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ExplorationExpendituresDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ExplorationExpendituresDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://niocorp.com/role/Leases",
     "longName": "00000016 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://niocorp.com/role/FairValueMeasurements",
     "longName": "00000017 - Disclosure - FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://niocorp.com/role/SubsequentEvents",
     "longName": "00000018 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://niocorp.com/role/BasisOfPresentationPolicies",
     "longName": "00000019 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://niocorp.com/role/BasisOfPresentationTables",
     "longName": "00000020 - Disclosure - BASIS OF PRESENTATION (Tables)",
     "shortName": "BASIS OF PRESENTATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "longName": "00000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://niocorp.com/role/DebtTables",
     "longName": "00000022 - Disclosure - DEBT (Tables)",
     "shortName": "DEBT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcTables",
     "longName": "00000023 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://niocorp.com/role/CommonSharesTables",
     "longName": "00000024 - Disclosure - COMMON SHARES (Tables)",
     "shortName": "COMMON SHARES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://niocorp.com/role/ExplorationExpendituresTables",
     "longName": "00000025 - Disclosure - EXPLORATION EXPENDITURES (Tables)",
     "shortName": "EXPLORATION EXPENDITURES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://niocorp.com/role/LeasesTables",
     "longName": "00000026 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://niocorp.com/role/FairValueMeasurementsTables",
     "longName": "00000027 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative",
     "longName": "00000028 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R29": {
     "role": "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
     "longName": "00000029 - Disclosure - The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders: (Details)",
     "shortName": "The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:NetIncomeLoss1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:NetIncomeLoss1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails",
     "longName": "00000030 - Disclosure - Schedule of excluded from the dilutive securities (Details)",
     "shortName": "Schedule of excluded from the dilutive securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://niocorp.com/role/BasisOfPresentationDetailsNarrative",
     "longName": "00000031 - Disclosure - BASIS OF PRESENTATION (Details Narrative)",
     "shortName": "BASIS OF PRESENTATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:UseOfEstimates",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:UseOfEstimates",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://niocorp.com/role/GoingConcernDetailsNarrative",
     "longName": "00000032 - Disclosure - GOING CONCERN (Details Narrative)",
     "shortName": "GOING CONCERN (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails",
     "longName": "00000033 - Disclosure - Schedule of account payable and accrued liabilities (Details)",
     "shortName": "Schedule of account payable and accrued liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails",
     "longName": "00000034 - Disclosure - The change in the Convertible Debentures is presented below: (Details)",
     "shortName": "The change in the Convertible Debentures is presented below: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details",
     "longName": "00000035 - Disclosure - The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)",
     "shortName": "The following table discloses the components of interest expense associated with the Convertible Debentures. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ContractualInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ContractualInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails",
     "longName": "00000036 - Disclosure - The change in the April 2024 Notes is presented below: (Details)",
     "shortName": "The change in the April 2024 Notes is presented below: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:FairValueHedgeAssetsAtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:FairValueHedgeAssetsAtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails",
     "longName": "00000037 - Disclosure - The change in the April 2024 Warrant liability is presented below: (Details)",
     "shortName": "The change in the April 2024 Warrant liability is presented below: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OtherLiabilitiesFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_custom_EarnoutMember",
      "name": "us-gaap:OtherLiabilitiesFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://niocorp.com/role/DebtDetailsNarrative",
     "longName": "00000038 - Disclosure - DEBT (Details Narrative)",
     "shortName": "DEBT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-09-152024-09-17",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember",
      "name": "us-gaap:DebtInstrumentIncreaseAccruedInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails",
     "longName": "00000039 - Disclosure - These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details)",
     "shortName": "These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember",
      "name": "niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details",
     "longName": "00000040 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details)",
     "shortName": "The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_custom_EarnoutMember",
      "name": "us-gaap:ServicingLiabilityAtFairValueAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_custom_EarnoutMember",
      "name": "us-gaap:ServicingLiabilityAtFairValueAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
       "niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details",
     "longName": "00000041 - Disclosure - The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details)",
     "shortName": "The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-25",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-25",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://niocorp.com/role/ScheduleOfStockOptionDetails",
     "longName": "00000042 - Disclosure - Schedule of stock option (Details)",
     "shortName": "Schedule of stock option (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfStockOptionRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfStockOptionRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails",
     "longName": "00000043 - Disclosure - Schedule of warrant transactions (Details)",
     "shortName": "Schedule of warrant transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:ClassOfWarrantOrRightGranted",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails",
     "longName": "00000044 - Disclosure - At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)",
     "shortName": "At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_custom_ExercisePrice9.70Member",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "CADPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails",
     "longName": "00000045 - Disclosure - The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details)",
     "shortName": "The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails",
     "longName": "00000046 - Disclosure - The change in the Private Warrants liability is presented below: (Details)",
     "shortName": "The change in the Private Warrants liability is presented below: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_NoteWarrantMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_NoteWarrantMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
     "longName": "00000047 - Disclosure - The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details)",
     "shortName": "The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-152024-09-17_us-gaap_FairValueInputsLevel3Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://niocorp.com/role/CommonSharesDetailsNarrative",
     "longName": "00000048 - Disclosure - COMMON SHARES (Details Narrative)",
     "shortName": "COMMON SHARES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ProfessionalFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_srt_ChiefExecutiveOfficerMember",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
     "longName": "00000050 - Disclosure - Schedule of exploration expenditures (Details)",
     "shortName": "Schedule of exploration expenditures (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ExplorationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "us-gaap:ExplorationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails",
     "longName": "00000051 - Disclosure - The Company incurred lease costs as follows: (Details)",
     "shortName": "The Company incurred lease costs as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:FixedRentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2024-09-30",
      "name": "niobf:FixedRentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details",
     "longName": "00000052 - Disclosure - The maturities of lease liabilities are as follows at September 30, 2024: (Details)",
     "shortName": "The maturities of lease liabilities are as follows at September 30, 2024: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails",
     "longName": "00000053 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)",
     "shortName": "Schedule of fair values determined by level 3 inputs are unobservable data (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://niocorp.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000054 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2024-11-292024-12-01",
      "name": "us-gaap:DebtInstrumentIssuedPrincipal",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "niobf:AccruedCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x224-10q.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Accounts Payable and Accrued Liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r59",
      "r62",
      "r632"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan origination fees payable to related party",
        "documentation": "Fair value portion of trade and related party payables and accrued expenses."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r638",
      "r642"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r553"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable, trade",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r57"
     ]
    },
    "us-gaap_AccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccretionExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of convertible debt",
        "verboseLabel": "Total",
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r629"
     ]
    },
    "us-gaap_AccretionExpenseIncludingAssetRetirementObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccretionExpenseIncludingAssetRetirementObligations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion expense",
        "documentation": "Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "niobf_AccruedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "AccruedCost",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Aggregate principal amount",
        "documentation": "The element represents accrued cost.",
        "label": "Accrued Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r71",
      "r124",
      "r394",
      "r413",
      "r414"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r7",
      "r12",
      "r298",
      "r301",
      "r342",
      "r409",
      "r410",
      "r597",
      "r598",
      "r599",
      "r608",
      "r609",
      "r610",
      "r611"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities",
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of discount and issuance costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r250",
      "r602",
      "r647"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r103",
      "r120",
      "r142",
      "r171",
      "r175",
      "r179",
      "r180",
      "r213",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r290",
      "r295",
      "r316",
      "r390",
      "r461",
      "r526",
      "r527",
      "r553",
      "r565",
      "r630",
      "r631",
      "r653"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r125",
      "r142",
      "r213",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r290",
      "r295",
      "r316",
      "r553",
      "r630",
      "r631",
      "r653"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r542"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "niobf_AvailableForSaleSecuritiesEquitySecuritiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "AvailableForSaleSecuritiesEquitySecuritiesOther",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "The element represents available for sale securities equity securities other.",
        "label": "Available For Sale Securities Equity Securities Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccounting": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccounting",
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BASIS OF PRESENTATION",
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation and Consolidation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsDescription",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration description",
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents a description of such arrangements."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedCostsMineralInterestsInUnprovedProperties",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral properties",
        "documentation": "Amount, before accumulated depreciation, depletion, amortization, and valuation allowance, of capitalized cost for mineral interest in unproved property in oil- and gas-producing activities."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r656",
      "r657",
      "r658"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "verboseLabel": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r118",
      "r520"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r638"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r76",
      "r141"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in cash and cash equivalents during period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r76"
     ]
    },
    "niobf_ChangeInFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ChangeInFairValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value",
        "documentation": "The element represents change in fair value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ChangeInFairValueOfConvertibleNote",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of convertible note",
        "documentation": "The element represents change in fair value of convertible note."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ChangeInFairValueOfConvertibleNotes",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of convertible notes",
        "documentation": "The element represents change in fair value of convertible notes.",
        "label": "Change In Fair Value Of Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfEarnoutLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ChangeInFairValueOfEarnoutLiability",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of earnout shares liability",
        "documentation": "The element represents change in fair value of earnout liability.",
        "label": "Change In Fair Value Of Earnout Liability"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfEarnoutShareLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ChangeInFairValueOfEarnoutShareLiability",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation of earnout shares liability",
        "documentation": "The element represents change in fair value of earnout share liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ChangeInFairValueOfWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of warrant liabilities",
        "documentation": "The element represents change in fair value of warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInValuationOfWarrantLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ChangeInValuationOfWarrantLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation of warrant liabilities",
        "documentation": "The element represents change in valuation of warrant liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangesInFairValueOfInitialValuation1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ChangesInFairValueOfInitialValuation1",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "documentation": "The element represents changes in fair value of initial valuation1.",
        "label": "Changes In Fair Value Of Initial ValuationOne"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r121",
      "r122",
      "r123",
      "r142",
      "r159",
      "r163",
      "r168",
      "r169",
      "r173",
      "r174",
      "r213",
      "r226",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r316",
      "r416",
      "r417",
      "r418",
      "r419",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r449",
      "r470",
      "r494",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r586",
      "r603",
      "r613"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercisePriceExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ClassOfWarrantOrRightExercisePriceExercised",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercised",
        "documentation": "The element represents class of warrant or right exercise price exercised.",
        "label": "Class Of Warrant Or Right Exercise Price Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceExpired": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ClassOfWarrantOrRightExercisePriceExpired",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expired",
        "documentation": "The element represents class of warrant or right exercise price expired.",
        "label": "Class Of Warrant Or Right Exercise Price Expired"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ClassOfWarrantOrRightExercisePriceGranted",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted",
        "documentation": "The element represents class of warrant or right exercise price granted.",
        "label": "Class Of Warrant Or Right Exercise Price Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/DebtDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common share price, per share",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "verboseLabel": "Exercise price",
        "terseLabel": "Common share exercise price, per share",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ClassOfWarrantOrRightExercised",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercised",
        "documentation": "The element represents class of warrant or right exercised.",
        "label": "Class Of Warrant Or Right Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExpired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ClassOfWarrantOrRightExpired",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expired",
        "documentation": "The element represents class of warrant or right expired."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ClassOfWarrantOrRightGranted",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted",
        "documentation": "The element represents class of warrant or right granted.",
        "label": "Class Of Warrant Or Right Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ScheduleOfWarrantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Number",
        "verboseLabel": "Warrants traded prior to the closing",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of warrants",
        "documentation": "Description of reason for issuing warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r100",
      "r392",
      "r448"
     ]
    },
    "niobf_CommonSharesWithoutParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "CommonSharesWithoutParValueMember",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Without Par Value [Member]",
        "documentation": "The element represents common shares without par value member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r608",
      "r609",
      "r611",
      "r635",
      "r662",
      "r665"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_CommonStockSharesAuthorizedUnlimited": {
     "xbrltype": "authorizedUnlimitedItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorizedUnlimited",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, authorized",
        "documentation": "Indicates whether number of common shares permitted to be issued is unlimited. Acceptable value is \"Unlimited\"."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r66",
      "r449",
      "r467",
      "r665",
      "r666"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, no par value, unlimited shares authorized; 38,720,244 and 38,062,647 shares outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r393",
      "r553"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OciEquityMethodInvestmentBeforeTaxParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss and comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r130",
      "r132",
      "r137",
      "r388",
      "r404",
      "r406"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Net loss attributable to vested shares of ECRC Class B common stock",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r46",
      "r49",
      "r130",
      "r132",
      "r136",
      "r387",
      "r404",
      "r405"
     ]
    },
    "niobf_ContractualInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ContractualInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableDisclosesComponentsOfInterestExpenseAssociatedWithConvertibleDebentures.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual interest",
        "documentation": "The element represents contractual interest."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ConversionsOfDebtForCommonShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ConversionsOfDebtForCommonShares",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of debt for common shares",
        "documentation": "The element represents conversions of debt for common shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at June 30, 2024",
        "periodEndLabel": "Balance, September 30, 2024",
        "label": "Convertible Debt",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r99",
      "r660"
     ]
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible debt",
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The change in the Convertible Debentures is presented below:",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CostCentreAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "CostCentreAxis",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Centre [Axis]",
        "documentation": "The element represents cost centre axis."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CostCentreDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "CostCentreDomain",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares exchange",
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_DebtInstrumentIncreaseDecreaseOtherNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentIncreaseDecreaseOtherNet",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increased the amounts due",
        "documentation": "Amount of increase (decrease) in debt instruments, classified as other."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_DebtInstrumentIssuedPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentIssuedPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Aggregate principal amount",
        "label": "Debt Instrument, Issued, Principal",
        "documentation": "Amount of principal of debt issued."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r551",
      "r604",
      "r646",
      "r648"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payments",
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r55"
     ]
    },
    "us-gaap_DebtInstrumentRepaidPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRepaidPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate principal amount",
        "documentation": "Amount of principal of debt repaid."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r37",
      "r38",
      "r54",
      "r86",
      "r87",
      "r143",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r551",
      "r604",
      "r646",
      "r648"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal income tax payable",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r633",
      "r634"
     ]
    },
    "us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred share issuance costs",
        "documentation": "Amount of issuance costs recognized in a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, before deduction of accumulated amortization or effects of subsequent adjustments."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_DepositsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositsAssets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r28"
     ]
    },
    "us-gaap_DilutiveSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DilutiveSecurities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total potential dilutive securities",
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "niobf_DisclosureClassBCommonStockOfEcrcAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "DisclosureClassBCommonStockOfEcrcAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Stock Of Ecrc"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DisclosureExplorationExpendituresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "DisclosureExplorationExpendituresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration Expenditures"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DisclosureLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "DisclosureLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "verboseLabel": "Company Incurred Lease Costs As Follows",
        "terseLabel": "Maturities Of Lease Liabilities Are As Follows At September 30 2024"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r577",
      "r579",
      "r580"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "niobf_EarningsLossPerShareBasicAndDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "EarningsLossPerShareBasicAndDiluted",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share, basic and diluted",
        "verboseLabel": "Loss per common share outstanding basic and diluted",
        "documentation": "The element represents earnings loss per share basic and diluted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Earnings per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r170"
     ]
    },
    "niobf_EarnoutLiabilityAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "EarnoutLiabilityAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout liability, at fair value",
        "documentation": "The element represents earnout liability at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "EarnoutMember",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout [Member]",
        "documentation": "The element represents earnout member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r113",
      "r133",
      "r134",
      "r135",
      "r144",
      "r145",
      "r146",
      "r148",
      "r153",
      "r154",
      "r156",
      "r172",
      "r214",
      "r215",
      "r224",
      "r259",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r287",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r329",
      "r332",
      "r342",
      "r402",
      "r409",
      "r410",
      "r411",
      "r427",
      "r494"
     ]
    },
    "niobf_ExercisePrice11.50Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExercisePrice11.50Member",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price11.50 [Member]",
        "documentation": "The element represents exercise price11.50 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.20Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExercisePrice2.20Member",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price2.20 [Member]",
        "documentation": "The element represents exercise price2.20 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.31Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExercisePrice2.31Member",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price2.31 [Member]",
        "documentation": "The element represents exercise price2.31 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice3.25Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExercisePrice3.25Member",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price3.25 [Member]",
        "documentation": "The element represents exercise price3.25 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice3.35Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExercisePrice3.35Member",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price3.35 [Member]",
        "documentation": "The element represents exercise price3.35 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice3.54Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExercisePrice3.54Member",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price3.54 [Member]",
        "documentation": "The element represents exercise price3.54 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice4.60Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExercisePrice4.60Member",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price4.60 [Member]",
        "documentation": "The element represents exercise price4.60 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice9.70Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExercisePrice9.70Member",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price9.70 [Member]",
        "documentation": "The element represents exercise price9.70 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExplorationExpenditures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExplorationExpenditures",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration expenditures",
        "documentation": "The element represents exploration expenditures."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExplorationExpendituresDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ExplorationExpendituresDisclosuresTextBlock",
     "presentation": [
      "http://niocorp.com/role/ExplorationExpenditures"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EXPLORATION EXPENDITURES",
        "documentation": "The element represents exploration expenditures disclosures text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExplorationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ExplorationExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exploration expenditures",
        "label": "Exploration Expense",
        "documentation": "Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or \"G&amp;G\" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r6"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r313",
      "r542"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r313",
      "r542"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:",
        "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r542",
      "r637",
      "r638",
      "r643"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r544"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r544"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model:",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r544"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://niocorp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values determined by level 3 inputs are unobservable data",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r355",
      "r356",
      "r357",
      "r532",
      "r533",
      "r536",
      "r537",
      "r538",
      "r542",
      "r544"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueHedgeAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueHedgeAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value at June 30, 2024",
        "periodEndLabel": "Fair value at September 30, 2024",
        "label": "Fair Value Hedge Assets",
        "documentation": "Fair value of all derivative assets designated as fair value hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r260",
      "r265",
      "r308",
      "r313",
      "r355",
      "r536",
      "r537",
      "r538",
      "r542"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r260",
      "r265",
      "r308",
      "r309",
      "r313",
      "r356",
      "r532",
      "r533",
      "r536",
      "r537",
      "r538",
      "r542"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r357",
      "r532",
      "r533",
      "r536",
      "r537",
      "r538",
      "r542",
      "r544"
     ]
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE MEASUREMENTS",
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r355",
      "r356",
      "r357",
      "r532",
      "r533",
      "r536",
      "r537",
      "r538",
      "r542",
      "r544"
     ]
    },
    "niobf_FairValueOfCommitmentSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "FairValueOfCommitmentSharesIssued",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville share issuances",
        "documentation": "The element represents fair value of commitment shares issued."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FieldmanagementandotherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "FieldmanagementandotherMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fieldmanagementandother [Member]",
        "documentation": "The element represents fieldmanagementandother member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r251",
      "r256",
      "r303",
      "r315",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r403",
      "r529",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r554",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r619",
      "r620",
      "r621",
      "r622",
      "r636",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644"
     ]
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Financial Liabilities Fair Value Disclosure",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r638",
      "r642"
     ]
    },
    "niobf_FixedRentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "FixedRentExpense",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed rent expense",
        "documentation": "The element represents fixed rent expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign exchange loss (gain)",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r491"
     ]
    },
    "niobf_GXIIPrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "GXIIPrivateWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GXII Private Warrants [Member]",
        "documentation": "The element represents g x i i private warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on extinguishment",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r33",
      "r34"
     ]
    },
    "niobf_GeneralSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "GeneralSecurityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Security Agreement [Member]",
        "documentation": "The element represents general security agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GeologistAndFieldStaffMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "GeologistAndFieldStaffMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geologist And Field Staff [Member]",
        "documentation": "The element represents geologist and field staff member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "documentation": "The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest1.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling InterestOne"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentationDetailsNarrative",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax benefit",
        "label": "Income tax payable",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r110",
      "r155",
      "r156",
      "r171",
      "r177",
      "r180",
      "r276",
      "r277",
      "r280",
      "r408",
      "r539"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in working capital items:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r169"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible debt",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r169"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToWrittenPutOptions",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r169",
      "r522",
      "r523"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Operating and Nonoperating",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r175",
      "r176",
      "r178",
      "r180",
      "r328",
      "r526",
      "r527"
     ]
    },
    "us-gaap_InterestExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseOther",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repaid outstanding interest",
        "documentation": "Amount of interest expense classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital deficit",
        "documentation": "Amount of accumulated undistributed deficit from capital loss carryforward of investment company."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_InvestmentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentInterestRate",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage value",
        "documentation": "Rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r501",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r557",
      "r617",
      "r618"
     ]
    },
    "us-gaap_InvestmentOwnedBalancePrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentOwnedBalancePrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024NotesIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Remaining Principal Balance, September 30, 2024",
        "label": "Investment Owned, Balance, Principal Amount",
        "documentation": "Amount of principal of investment owned."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r502",
      "r507",
      "r510",
      "r557"
     ]
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee related costs",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net lease cost \u2013 other operating expense",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r552"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Cost:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company incurred lease costs as follows:",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "niobf_LessAmountOfPaymentsRepresentingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "LessAmountOfPaymentsRepresentingInterest",
     "presentation": [
      "http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less portion of payments representing interest",
        "documentation": "The element represents less amount of payments representing interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The maturities of lease liabilities are as follows at September 30, 2024:",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total remaining lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://niocorp.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r142",
      "r213",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r291",
      "r295",
      "r296",
      "r316",
      "r447",
      "r524",
      "r565",
      "r630",
      "r653",
      "r654"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, redeemable noncontrolling interest, and shareholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r101",
      "r396",
      "r553",
      "r605",
      "r623",
      "r645"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r117",
      "r142",
      "r213",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r291",
      "r295",
      "r296",
      "r316",
      "r553",
      "r630",
      "r653",
      "r654"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LindConsentWarrantIssuanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "LindConsentWarrantIssuanceMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lind Consent Warrant Issuance [Member]",
        "documentation": "The element represents lind consent warrant issuance member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LineOfCreditFacilityEstablishmentFee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "LineOfCreditFacilityEstablishmentFee",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayment fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional drawdowns",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r96"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://niocorp.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DEBT",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_LongTermInvestmentsAndReceivablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermInvestmentsAndReceivablesNet",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in equity securities",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_LongTermLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermLineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit agreement",
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r29",
      "r30"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r625",
      "r626",
      "r627"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r31",
      "r625",
      "r626",
      "r627"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r639",
      "r640",
      "r641"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r544"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r544"
     ]
    },
    "niobf_MetallurgicaldevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "MetallurgicaldevelopmentMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Metallurgicaldevelopment [Member]",
        "documentation": "The element represents metallurgicaldevelopment member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://niocorp.com/role/DescriptionOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r111"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r78"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/GoingConcernDetailsNarrative",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss for the period",
        "verboseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r78",
      "r102",
      "r115",
      "r129",
      "r131",
      "r135",
      "r142",
      "r147",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r155",
      "r156",
      "r166",
      "r213",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r284",
      "r287",
      "r305",
      "r316",
      "r401",
      "r469",
      "r492",
      "r493",
      "r563",
      "r630"
     ]
    },
    "niobf_NetIncomeLoss1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "NetIncomeLoss1",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss",
        "documentation": "The element represents net income loss1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OciEquityMethodInvestmentBeforeTaxParent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Net loss attributable to redeemable noncontrolling interest",
        "negatedTerseLabel": "Less: Net loss attributable to noncontrolling interest",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r92",
      "r129",
      "r131",
      "r153",
      "r155",
      "r156",
      "r400",
      "r599"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss available to participating securities",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r149",
      "r150",
      "r151",
      "r152",
      "r157",
      "r158",
      "r167",
      "r169",
      "r287"
     ]
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributable to vested shares of ECRC Class B common stock",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r169"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_NonRevolvingCreditFacilityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "NonRevolvingCreditFacilityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Revolving Credit Facility Agreement [Member]",
        "documentation": "The element represents non revolving credit facility agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonmonetaryTransactionGainLossRecognizedOnTransfer",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gross funds received",
        "label": "Nonmonetary Transaction, Gain (Loss) Recognized on Transfer",
        "documentation": "Disclosure of the difference in values (gain (loss)) between the nonmonetary assets or liabilities exchanged with another entity inclusive of boot (small monetary consideration)."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r341"
     ]
    },
    "us-gaap_NoteWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoteWarrantMember",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Warrant [Member]",
        "documentation": "A note that entitles the holder to buy stock of the company at a specified price, which is much higher than the stock price at the time of issue."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Notes Payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r99",
      "r660",
      "r661"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r528",
      "r615"
     ]
    },
    "us-gaap_OciEquityMethodInvestmentBeforeTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OciEquityMethodInvestmentBeforeTaxParent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss and comprehensive loss attributable to the Company",
        "label": "OCI, Equity Method Investment, before Tax, Parent",
        "documentation": "Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r289",
      "r294"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash lease activity",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value of lease payments",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability",
        "negatedLabel": "Less current portion of lease payments",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/MaturitiesOfLeaseLiabilitiesAreAsFollowsAtSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liability",
        "label": "Non-current lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payable accruals",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on equity securities",
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r402"
     ]
    },
    "us-gaap_OtherGeneralExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherGeneralExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other operating expenses",
        "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r526"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other gains",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r471",
      "r511",
      "r512",
      "r513"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities, at fair value",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r553"
     ]
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value at June 30, 2024",
        "periodEndLabel": "Fair value at September 30, 2024",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Other Liabilities, Fair Value Disclosure",
        "documentation": "Fair value portion of other liabilities."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r638",
      "r642"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrant liabilities, at fair value",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "niobf_OtheroperatingGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "OtheroperatingGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other gain",
        "documentation": "The element represents otheroperating gains losses.",
        "label": "Otheroperating Gains Losses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issue costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "srt_PlatformOperatorCryptoAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "PlatformOperatorCryptoAssetLineItems",
     "presentation": [
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "srt_PlatformOperatorCryptoAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "PlatformOperatorCryptoAssetTable",
     "presentation": [
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Table]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "niobf_PrincipalAndAccruedInterestConverted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "PrincipalAndAccruedInterestConverted",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInConvertibleDebenturesIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal and interest converted",
        "documentation": "The element represents principal and accrued interest converted."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PrivatePlacementShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "PrivatePlacementShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placement (in shares)",
        "documentation": "The element represents private placement shares."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PrivatePlacementValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "PrivatePlacementValue",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placements",
        "documentation": "The element represents private placement value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of capital stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party debt draws",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds",
        "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees",
        "verboseLabel": "Origination fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r563",
      "r663",
      "r664"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss for the period",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r129",
      "r131",
      "r139",
      "r142",
      "r147",
      "r153",
      "r155",
      "r156",
      "r213",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r284",
      "r287",
      "r289",
      "r292",
      "r293",
      "r305",
      "r316",
      "r389",
      "r399",
      "r426",
      "r469",
      "r492",
      "r493",
      "r540",
      "r541",
      "r564",
      "r599",
      "r630"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land and buildings, net",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r119",
      "r398"
     ]
    },
    "niobf_PurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "PurchaseAgreementMember",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement [Member]",
        "documentation": "The element represents purchase agreement."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PurchaseAgreementSeriesAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "PurchaseAgreementSeriesAMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement Series A [Member]",
        "documentation": "The element represents purchase agreement series a."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PurchaseAgreementSeriesBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "PurchaseAgreementSeriesBMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement Series B [Member]",
        "documentation": "The element represents purchase agreement series b."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable noncontrolling interest",
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r83",
      "r84"
     ]
    },
    "niobf_RedeemableNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "RedeemableNoncontrollingInterestMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Noncontrolling Interest [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDepositLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDepositLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party debt",
        "documentation": "Amount of deposits held by the entity for a related party (entity, shareholder, employee)."
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r266",
      "r346",
      "r347",
      "r391",
      "r397",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r466",
      "r468",
      "r499"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r474",
      "r475",
      "r478"
     ]
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionRate",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest at a rate",
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r266",
      "r346",
      "r347",
      "r391",
      "r397",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r466",
      "r468",
      "r499",
      "r652"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r347",
      "r348",
      "r422",
      "r423",
      "r424",
      "r476",
      "r477",
      "r478",
      "r497",
      "r498"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Debt repayments",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/GoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r88",
      "r395",
      "r412",
      "r414",
      "r420",
      "r450",
      "r553"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r144",
      "r145",
      "r146",
      "r148",
      "r153",
      "r154",
      "r156",
      "r214",
      "r215",
      "r224",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r287",
      "r297",
      "r299",
      "r300",
      "r302",
      "r304",
      "r329",
      "r332",
      "r409",
      "r411",
      "r427",
      "r665"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross funds received",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024:",
        "documentation": "The element represents schedule common shares under facility financing agreement table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of account payable and accrued liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The change in the April 2024 Notes is presented below:",
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The change in the Private Warrants liability is presented below:",
        "documentation": "The element represents schedule of changes in the fair value of the private warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfClassBCommonStockOfECRCTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ScheduleOfClassBCommonStockOfECRCTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CLASS B COMMON STOCK OF ECRC",
        "documentation": "The element represents schedule of class b common stock of e c r c table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The change in the April 2024 Warrant liability is presented below:",
        "documentation": "Tabular disclosure of derivative liabilities at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders:",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of excluded from the dilutive securities",
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r24",
      "r612"
     ]
    },
    "niobf_ScheduleOfExplorationExpendituresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ScheduleOfExplorationExpendituresTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ExplorationExpendituresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of exploration expenditures",
        "documentation": "The element represents schedule of exploration expenditures table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
     "presentation": [
      "http://niocorp.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table discloses the components of interest expense associated with the Convertible Debentures.",
        "documentation": "Tabular disclosure of the detailed components of other nonoperating expenses. This disclosure may include methodology, assumptions and amounts for : (a) losses on securities (net of profits) and (b) miscellaneous income deductions."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ScheduleOfOutstandingExercisableWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At September 30, 2024, the Company had outstanding exercisable Warrants, as follows:",
        "documentation": "The element represents schedule of outstanding exercisable warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs:",
        "documentation": "The element represents schedule of primary inputs into the monte carlo models table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r474",
      "r475",
      "r478"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement by range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "niobf_ScheduleOfStockOptionRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ScheduleOfStockOptionRollForwardTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option",
        "documentation": "The element represents schedule of stock option roll forward table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of warrant transactions",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period ended September 30, 2024:",
        "documentation": "The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value",
        "label": "Servicing Asset at Fair Value, Changes in Fair Value Resulting from Changes in Valuation Inputs",
        "documentation": "Amount of increase (decrease) in fair value from changes in the inputs used to calculate the fair value of contract to service financial assets under which the benefits of servicing are expected to more than adequately compensate the servicer."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_ServicingLiabilityAtFairValueAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ServicingLiabilityAtFairValueAdditions",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value",
        "label": "Servicing Liability at Fair Value, Additions",
        "documentation": "The value of new servicing liabilities, that are subsequently measured at fair value, acquired or created during the current period through assumptions of servicing obligations and servicing obligations that result from transfers of financial assets."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ServicingLiabilityAtFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ServicingLiabilityAtFairValueAmount",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value at June 30, 2024",
        "periodEndLabel": "Fair value at September 30, 2024",
        "label": "Servicing Liability at Fair Value, Amount",
        "documentation": "Fair value of a liability representing servicing arrangements under which the estimated future revenue from contractually specified servicing fees, late charges, and other ancillary revenues are not expected to adequately compensate the servicer."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r367",
      "r368",
      "r369",
      "r370",
      "r639",
      "r640",
      "r641"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock price on valuation date",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Implied volatility of public warrants",
        "verboseLabel": "Historic equity volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free rate",
        "verboseLabel": "Risk-free rate",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled/expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r268"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Beginning balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r268"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancelled/expired",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing common share price",
        "verboseLabel": "Strike price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingObservableDataPointsWereUsedInCalculatingFairValueOfPrivateWarrantsUsingBlackScholesPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected warrant life in years",
        "verboseLabel": "Term (years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2": {
     "xbrltype": "dateItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
     "presentation": [
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term (expiry)",
        "documentation": "The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonShares"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMON SHARES",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r90"
     ]
    },
    "niobf_SharesIssuedUnderTheYorkvilleEquityFacility": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "SharesIssuedUnderTheYorkvilleEquityFacility",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville equity facility draws",
        "documentation": "The element represents shares issued under the yorkville equity facility."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SharesIssuedUnderTheYorkvilleEquityFacilityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "SharesIssuedUnderTheYorkvilleEquityFacilityShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued under the Yorkville equity facility (in shares)",
        "documentation": "The element represents shares issued under the yorkville equity facility shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term lease cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r552"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r121",
      "r122",
      "r123",
      "r142",
      "r159",
      "r163",
      "r168",
      "r169",
      "r173",
      "r174",
      "r213",
      "r226",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r316",
      "r416",
      "r417",
      "r418",
      "r419",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r449",
      "r470",
      "r494",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r586",
      "r603",
      "r613"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r66",
      "r68",
      "r69",
      "r113",
      "r133",
      "r134",
      "r135",
      "r144",
      "r145",
      "r146",
      "r148",
      "r153",
      "r154",
      "r156",
      "r172",
      "r214",
      "r215",
      "r224",
      "r259",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r287",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r329",
      "r332",
      "r342",
      "r402",
      "r409",
      "r410",
      "r411",
      "r427",
      "r494"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r172",
      "r332",
      "r385",
      "r415",
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r468",
      "r472",
      "r473",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r494",
      "r558"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r172",
      "r181",
      "r332",
      "r385",
      "r415",
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r468",
      "r472",
      "r473",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r494",
      "r558"
     ]
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CompanyIssuedFollowingCommonSharesUnderYorkvilleEquityFacilityFinancingAgreementDuringThreeMonthsEndedSeptember302024Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of common shares issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r19"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversions (in shares)",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r37",
      "r66",
      "r68",
      "r88",
      "r245"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants traded prior to the closing",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares",
        "verboseLabel": "Stock issued, shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r65",
      "r66",
      "r88",
      "r416",
      "r494",
      "r515"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r65",
      "r66",
      "r88",
      "r270"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversions",
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of warrants",
        "documentation": "The element represents stock issued during period value issuance of financing warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issuance costs",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r65",
      "r66",
      "r88",
      "r427",
      "r494",
      "r515",
      "r564"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r68",
      "r69",
      "r80",
      "r451",
      "r467",
      "r495",
      "r496",
      "r553",
      "r565",
      "r605",
      "r623",
      "r645",
      "r665"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersDeficitEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r47",
      "r113",
      "r114",
      "r134",
      "r144",
      "r145",
      "r146",
      "r148",
      "r153",
      "r154",
      "r214",
      "r215",
      "r224",
      "r259",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r287",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r321",
      "r322",
      "r326",
      "r330",
      "r342",
      "r410",
      "r411",
      "r425",
      "r451",
      "r467",
      "r495",
      "r496",
      "r519",
      "r564",
      "r605",
      "r623",
      "r645",
      "r665"
     ]
    },
    "niobf_StrikePriceOfWarrantsIssued": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "StrikePriceOfWarrantsIssued",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price",
        "documentation": "The element represents strike price of warrants issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r552"
     ]
    },
    "us-gaap_SubsequentEventDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventDescription",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent event, description",
        "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://niocorp.com/role/GoingConcernDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r350"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://niocorp.com/role/GoingConcernDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r350"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://niocorp.com/role/GoingConcernDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r350"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://niocorp.com/role/GoingConcernDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r350"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://niocorp.com/role/GoingConcernDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r350"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://niocorp.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r351"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://niocorp.com/role/ChangeInPrivateWarrantsLiabilityIsPresentedBelowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://niocorp.com/role/GoingConcern"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GOING CONCERN",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Environmental accruals",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r97",
      "r659"
     ]
    },
    "niobf_TechnicalStudiesAndEngineeringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "TechnicalStudiesAndEngineeringMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technical Studies And Engineering [Member]",
        "documentation": "The element represents technical studies and engineering member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding, basic and diluted",
        "documentation": "The element represents total weighted average number of share outstanding basic and diluted."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransactionDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://niocorp.com/role/ChangeInApril2024WarrantLiabilityIsPresentedBelowDetails",
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfEarnoutSharesLiabilityForThree-monthPeriodEndedSeptember302024Details",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r251",
      "r256",
      "r303",
      "r315",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r403",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r554",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r619",
      "r620",
      "r621",
      "r622",
      "r636",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized loss on equity securities",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://niocorp.com/role/BasisOfPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r106",
      "r107",
      "r108",
      "r109"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r544",
      "r641"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r544",
      "r641"
     ]
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "presentation": [
      "http://niocorp.com/role/CompanyValuedContingentConsentWarrantsAt2262BasedOnBlackScholesValuationWithFollowingInputsDetails",
      "http://niocorp.com/role/TheseEarnoutSharesWereValuedUtilizingMonteCarloSimulationPricingModelWithFollowingPrimaryInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "documentation": "Valuation technique calculating price of option."
       }
      }
     },
     "auth_ref": [
      "r544",
      "r639",
      "r640",
      "r641"
     ]
    },
    "niobf_ValueOfWarrantsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "ValueOfWarrantsIssued",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of warrants issued",
        "documentation": "The element represents value of warrants issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable rent expense",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r337",
      "r552"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r556",
      "r559",
      "r560",
      "r561",
      "r562"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://niocorp.com/role/AtSeptember302024CompanyHadOutstandingExercisableWarrantsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiry date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r639",
      "r640",
      "r641"
     ]
    },
    "niobf_WarrantsEachExercisableFor1.11829212CommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "WarrantsEachExercisableFor1.11829212CommonSharesMember",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Each Exercisable For1.11829212 Common Shares [Member]",
        "documentation": "The element represents warrants each exercisable for1.11829212 common shares member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsNotSettleableInCashFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities",
        "documentation": "Fair value portion of warrants not settleable in cash classified as equity."
       }
      }
     },
     "auth_ref": [
      "r637",
      "r638",
      "r642"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding basic and diluted",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r169"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "niobf_YorkvilleConvertibleDebentureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "YorkvilleConvertibleDebentureMember",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Convertible Debenture [Member]",
        "documentation": "The element represents yorkville convertible debenture."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_YorkvilleConvertibleDebtFinancingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20240930",
     "localname": "YorkvilleConvertibleDebtFinancingAgreementMember",
     "presentation": [
      "http://niocorp.com/role/DebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Convertible Debt Financing Agreement [Member]",
        "documentation": "The element represents yorkville convertible debt financing agreement."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-13"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-14"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-2A"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Section": "S99",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-40/tableOfContent"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(14)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/820/tableOfContent"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481725/323-10-35-18"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.FF.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476188/405-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482864/845-10-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482864/845-10-50-3"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481260/860-50-45-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481260/860-50-45-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481260/860-50-45-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-12"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "35",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-35"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-36"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481639/420-10-35-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481879/410-20-45-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479365/842-20-25-6"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-13"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-14"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-15"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-15"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0001539497-24-002408-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001539497-24-002408-xbrl.zip
M4$L#!!0    ( !: ;5E%<Z?LV1(  ! 3   2    ;C(U-S0Q,'%I;6<P,#$N
M:G!GE5AG4-/=L_Z%)H0:FB@@AB+2%0A=$*0C50(((0@$!$*1)D(4%$00 >E(
MZ"'TWD-3D28@O0@D(KUWE2+M\K[WSG_NA_OE/CMGYLRS9\[N[#,[L^><3YS/
M $RZFCJ: (@, % 7!IQO !!U7WNT/P "*   4+J@M@ &592'G0. ^GS!@,Z)
MP&N BH*"@I*"BI*2BH;J8M%24U%1T]*!P;1@,!T3W;]@HF-@9&)DH&-A865E
M8>'BY.3DXOD/0)<N7:*GH^=@8N*XR@9AN\KS_\7Y9P!"#6@!:>0@"$ & 9%#
M0.?M0,5%?I0@$ CX#RX!Y!245-0@L@N2C/Q_>P *2C)R*M E)@!$3DY&1G$)
M#*:A_(<'D9%3 !!*9BKHI=LLK#ZJO%75,K+4QK:>KRHE^;S98+&M:B;!7Z1K
M?"]G>TF%S*NS<\@-W3/%PR$7%Y%14)!?(J?\[S#_1(100#V9*6^K2DH9O^+=
ML<UF895FBZU4&YK=-;'#G4\!=.07IR#D$$ %&'/P'ME5/',=3W\(R2?@QG-R
MM<?5XM&'#]2U/GA-I$!2C,=*DP>3.8UV<M7FPJN>3WEV[J-[W#3 Z]BJ.&T5
MQ6G<#7GT[?&&0(>"9 3JZQ,T_T]5?C+#5J3<(-SNP!A?H$3XYNZZ[X6TXKT\
M04M)F"%+8L95^&0]TP]C,7)#84B(+7".._8A2L)/7RF6R_2/5R)$F)?JUR__
MY1E'V]G=$>Y05LU-QB16HWS66B:0B6LQD!&Q(H,QD\_M9^OPQHP1IW8ZL93Z
MEY-(R_%74NA1B+5I-83&,H$A\=V[W8-U3+D;*"_SI)2^HIFW]AP8QI,$4X@\
M4*8%R6'.F#V]$J>$_)BL$#O61&9E7F%ULNG9?#VME1S#/S);5]."X,.'=,%[
M<DJ!JH\$O.9K]H85R-+N&M=WHA,2L4BK&7,;VC\5BNU"?TK==,/_2=M4O>"M
M,3-./*#?_EJWA^NHHTHMHZX_S>K8F+6#"@>KQJ>%Z;E-B_PG \+;J@H3GW0<
M'N?\AN\-L67*OJ#%K*?L%42HB(Y.R0>8K2ETQJ$2ZP)88W2$#E?4=B)"'_9&
M$>,&W/T&5^X_QT 8'5Y^'1ZQM]32>DUL0X+4G0 CP?HPV,*<E(3=[B#1WSA<
M;T );E<EKF:2ZH-L01:I+!LLG@/+FB<,Y\!X>/F^#8S?L9I^;@_":>L1ZBLA
M"7?3N5I3*/Q)FU4=MO_V]UCTS'LQW]&-EASL0GW_3K</PZ4M)3_?QWUY#2D!
M_>C"L"P4N]:'DQ)T0&\8U)]-=<.M-"NAAFNL].[/B'CWB%0' @<(,"NB/R.)
M4\-R68CEWM6]+?'@OOV#"3TCNZR,$C$GK0%XK<5#V5FDU6?W7*6&Q,V^S[6O
MO1>8NDX[MA:9C2/"\EM;YT\5BH@[E=Z>IN= 6O*IVE_TE*P/=#2%XT.$RYFD
MB;5:^,%;X2.1MBI-30:1H8]?&<2HLS.6P+9[NYR?>+B4DJT<.N<;<:F^Q31"
MQH:ALD4?7/\8[KTU9T&NABS50!OVXWNHW/9%0*?6 HLK0QY>WUO61G;<RDT*
M3XX+A]FK';T#'#$>6W3-D=[Z+\('?45KYMX_]"DT$S::_>7"UD_BPU@RFJ2C
M&QHUY=L?Z/8'-;A?EN,YS=Q9,Y]Y?WPS,_,<2%S93Z(X;3OD/P?"#%MY]@\%
ME\^!1:=/F9Q^IR+[/U&8VJ?1O?ON^+5UZ?6Q\AS-3/J/PN\.4Y0=(V8[BVR6
M[(\"5M\'YQ/WSSR[/YV9?A* FY:Q(B*X)D@=]]^T,K%_K+WNPS' *::2Y7%X
M\YUO7QC34I=GYRCKU \';:.5ZT4S0ZR!B+]U?C.)AROOA+I5M!?]I!;SPG'W
M@5]/V\D8]"]?"E]E5?=:PYZTGX'4[WZC)L>N A9T(?ODOU<BDJ<$1\P4@Y5J
MOS^HVC= Q_U4;!,8E.,A[/X8RY3!+CFLR9?E77NSP+K6ZJHFX<RHN6O]^R@7
M/MU%>JH;%KA9#\-\W;=4:NB*>QV'"%QX%;0)-ZXWY\EXGI">G;/:A>T^UI&9
MLGL489204767  3J"KMW&N3[W[3: 94B%\Z!^=<V18\/L)T2'Y5)R56G+_>7
MTO;]NCXGONH5ON^8:>* YR>\+GDUQA!U=P2#"2'>ZY:Y 1MJQ!%P5(<A8/'.
M@7VGS<HREJE&O,#E*OIR/+BTQE-*)A];TVQO1;LB% S!*,W?KM[S3S"(^(:O
M:Q.@\:\A,.N.85RHQOQ:M)=J&_79V+M8D,LN $Y">G]Z^GWOR<CN;NS#%W5J
MJ;YU5KIQOOGA1D!$<47ZDF/P?%>'E;O,;CC7/0USJ77SR;_N/G^^C\Q\C,:N
M.T?,%P?+;9X#""_,Z(5^GR5PI8]E]K>G%(,VJ1[X6PPC9%9%BT-"YF:*>#O3
M/WLA"@-IB\8$.8[IXP+T=.%$E<NL)Z8:98L#Q8\#:6RBPZO2XG]'FWLK6SI%
MB'ZR:CO$*ANK:RGP4CYJ<66<8SQK@9@<J_]UZ7JBE=2X]A39W>=EM?P,U7B)
M_.":8F/UT@CB6XL6;+1MD!2<;B$6KK$)71D7^9@I7=0T<1S=;;3]HVZIABOZ
MCV?T6=.9+_RR[W:F@,3C8\^E*N1P9N5,8)U67$1JI:_B]:SM4S$DZC\B[?TC
M4IQ-Q372Z(#CMM;>Z:ZRDYGBLI77PPWN>L?ZD];?/(JDS#UZL\F#5&S-QXTF
M?OY]]#%1]L?$WIBYU;;>\S'VUM&36-E49)GW)R.E.9<<]^UZF'?#BZ8]1/&9
MWO'/L;(1[.P17]+//UV"+7I[<!L5&TU-+4NW\:21MV"W]H12P2S\.X@Z8IVP
M.URW92/XAJ>Z^0'N'$@8+ZO,?<Z'"W]+:OCCNMTJLCO$_B N,+9GZW&O/D0C
M>?U9$(M6S\WP9?6[)3REKTY4SX'O.&$;ITQ]BRWJO>_6!KU3\F5ZS[?IDN_.
M?)SO\C-[/E'FB*S&KMFNN*O2^P]]NS-0*\DQ_J2_ANCUT+/K7I1 ;R$8L,B(
MQM8117-2RL07BF2M5J'>]^2+ GT-8F,6.[^G\X=J)]1E/,-;L)7)FY0H<>E[
M3'W@5/P\HU(4U:34^./UKLJ0ZQ'WVCS/J=_)6A'5^D]EW:[_0X-NU9]_+9N[
MSX$NZD^F ]NPA:#G+QKX/SVZTU"8T3?]?O%X[OE@B5]_W4+UA*)[G\=1R(JR
M7X/*PM72ZFU9V.,7DT^U=3:^'Y1Y-%4N%I753R<=%>F'%!Y1Z"]]+T[;'F64
MPQ82FS;[$.[68:@&\Y/D@T_%UHF>"!6!(3FW7(+]+]A)TV#/[=Y8J'-L(04K
M@979E?[P)ZD,].(*R\H[\KX[*;(RHP\)G0&K&\PC4<',IL.$:.'KSXJ.G"*>
M=G]QN$WD_N;32?N .M911T?YSN]=BFAIC?1%Y##)PI7T]LI-W>B>>?;A*CQG
ML:5^L\F+'MZ0%AF9#<UUC%28K6'V=Q9HLJ6)&O$)"(./'=0"\SZV47C1'?2J
MB#>V4D9FA;.PI-\V5,LML729?2W.;+Z8PH?LN7 #[D;#C]ZHMHQN]6^V]OM]
M=$_];P_C<UMS-71,U,()"B4NOUP^HMQ$_7%9/S9X^$(FA*OI!*<@;ZP<\"CF
M$1UJ-QG4I! [^?L6DX'!>(2R,,??':$U^!%W5+_8F(+<-_68-2*WE9> $!Y:
M<_.'^BK?0HNKPX\2,07PZ+%B0QHL9"D"T;.XI25144F(-$C.FU/ $5V@W"Y6
MZ&(CBIU+7R3@[+*EJ([^F47O(+OESQS38O?N&PAF$)QTNN;Y#*(@5;@WQJ,)
MP3G>Z)_XL9*JAU\W#7B+<#>W[=V3@LGL)6J.1AH0T>-(KD+5N(#@(V=J5>M:
MSN [/3TBJ=HN%FJ=5NCN@FLT&O0#U9(;7IXMM33QLKQM]Z_7?5\456!?2B6^
MG(>S'^C+VMR:H8?W=12'%D2"FRAWOY;6I[?:>KDZ0N5ION-SW:"]UCKTKSSM
MGL.2-A7YGXG!6OVKK3[>8-J];U;_03ED&1-_IEI@]F)I*>_G4^NXY6F+XJ>P
M]R3FNNHB31,IX[0UYBEN"5BIJC.-D7FD\I-:GZ:P7O%'\?@R&_>C+*6NT9LE
MDD=(?T?/\GG!5NR&_'6!I=?2605D]+4"0#1OK19W*A<7=<%!Z7 WAD]/6UIY
MX?L>^EE0CJ+'(_.I]&*;R0-#Z\G&%MG:S6*;A=]352?X()G$WR/O6VP/4P+A
MSFL[UA)?&C0F!#S5]4(AXJSJ!&/F677=N8NQS5\=.<2,$U#7_7>O&UY-:O]]
M69&4L:>O4W71+,SG0-5&3.ID]3;BIY]]+]S:HT6LSWB#V_ KWP_O=_FZ"1JQ
MG78L<1BHF)>-.^)Y:KI5H>=3^IJL>P$PIV$MAHA,T4; B2PTV_0>$-/0GJZZ
MG!GL?.5;R9*G29J+G&G7#W4KWTQU/'3@BIEYU"\%$3[RJPC*)W,5LI)RL(F
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M/KR\O%R^<)>J-OS E$JE#Z_HF7/KH:O7P.=8FF8^_'RX[P@C,.8O)$4W>$4
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M/V]_]A0V5\CV>J\LFX7#,_2?2_AI]%'R-Q"PMSVF9RM;BTKXIQA#L+W.B-<
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M'Q'=$P._-Q+YV0Q ;U%9@E$A"$8^0L^O.V!BX&CWC*,S%'K5OO0'7(-F^TV
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M3B;>3F;V+/CM*BQB'L,(8L;+2#) ?%#L@=*59?,O%1NV5/5N]8%B+AU*UJQ
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M[.;%0%H@*TC#+S0^6@\_W3G-CG&G3H#55EC'>$,U>!H8H?M0IX"257UQ%->
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ME]MDX+%SBPZHT0&M!=8P,HA%P:;@;?$^O\I[A@#OV0S-!#5V2,C]$&-V"P8
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MAF[PN,>X(_KFJF)2*K\?<R,ZJZO<&@[9=*B+X6*(S0HIT<4[&[7LQR\NCJA
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MD[AA+UI;@+] W>][;;?)V^1)G#-F,CF.V&Y]2JT7]!_LE]'/\N2GPNZB[O(
M^RUD2?9;2"7.,IX?_SS-[PM?&L6WT&\AZU;79.-MIA:V[.1;*F78")?*']2!
M+C*'T!.S/$^B-VZ^M.OK>XG7P.?S!W<R(C+IB3O\'#/4UU^,FT\6U[T]2"<^
M[+/;C@NOC>ZP,O]R<\OF#K$Y5,K=%\KI=5](Q5?I/_]2^,GPU[12.K[N"\D]
MDVT[318S7(3<\$&IZ]T=-4^^+"1VWW/TT:OZ0O;P7("HI!]+A\J=B\-Z#Z=
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M%38&I.HXZI=4&4+9U% PA:7$1 &:I>(-0'$9.PTWY@THT3JE\1+Z7#?[J,+
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M,<9(A=\VT1?Z,Y_W#CU\&'U3*"BP0VE[;^8L?&0GM)[!>(E" 8#HO^_DDJI
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M0W57([>,UO9^HT$9(J0P#G7'Q2:B7CP*8YZ79QB .@YOQ'12#CW-I@#;8R\
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MU)9\%.P@0!*6Z;/37NEA<_5Q8B1)&#NH 5Q2_(M_FA.%]73O8JF_V$&0IL1
MO7W($8*DOK]/\IZQQ'\9=M!V$1T/97EY@ A@*L%]LN .[KL.3H%E5O9>]H'?
M&Z@]6I ?KGH"+NZMAW85,J:^,>[R+EAVM_Z4^-7=59'F-.1I_8QOUL][A3%@
M=Q"H&:#?QF)#8 O7/]WA\X-45!^%E5.J'W.TNF>4I1BFI SEV>O?1#>NVE?W
MKS+S;!MR^.H)HZ*GH=>2]Q%R^)V&'%[W00Z/7UF17D$$E?^O3])9A9DA[ ]F
MB9E%(EZKL.671TU-"IFU[]V9VZ4?!WPO(!2C?BR+H[NK^RNN.C2C)WXKW.J[
M3<:I$W#-+WR> )E$H@<%L>[#5P:<=@M%3??D+G%-C<* )H<HKH,B)9)):W%9
MP9F)I;VKKKVJB> I8-P30DITP4=:6\WV$ S-Z,W?_=GP_7U>NGI@Y2^6L".I
M.Y<3O_5RC-G&ZG9(Y9/(K0^1R)(6"R;4<MF719TW5N;5FWY!P[%'3^JTN+TZ
MX(PXM#EK*^')N#6H&C,/XN[2LO<Y4C^[]SSK<W>W38E]BA>_>TN#P(O#\<\P
MBXG)_/$*!WQZ#]!X]-:,/NKY1TJ:V3.E3[>>V1B.3IHI@2&=A7H0'W\^]PJ?
ML]+#%T>[G06OY>[52#1<0Q<J3WW[?>$JBC]0ME]YH%X)G8) *UWQ=1POLRSY
M@W9^ZZ!MX9*@"K)[4= O<H2);@XK&W@Q* H0Z-+G!$YX IU$&7"@WA'4\^S^
M;C2[+IS1=0\\9(_!.4Y<HW9^Z#!I8+[*^N69OE84:C-5N>ZU0) M<<2CR*L)
MF^I]3K],Y31^+'BV4SIW%U,^=V\[/(2[.>Z>&!E>)VJ$39!Q'ZNUER"HAP01
M-:*X(3N(8NH&*"Z&[X'5G6>60T<N=+L3*QYQS-F2IQ@](8L>H0M_=A"6T,%3
MF)DV3>U?0X^F"GQ@>46TY>[;)N2=^N3TBMC*6[7_]?3Y/N2MWD[6$%8^GGMN
M;B(%'F4UY]UC:C%]]22"*9%"*4<!MK#VEPR[OUM=".M,CRK=L<+'^^QD]I<T
MDXY(K]VED@A#X.3N$O_H(!H'+1'V4SGE.>RUK)J@I@:XN'86-]"=1Z*\W%F'
M=]B(A!5_LZV@/3:S#JMPRH'Q7J5X5Z;4YW;>BO=&H,9>V%?!(;J !<53<50B
M. ;1B\I.NVK98J=&=';:THU]COS ']Z7BE(X<W;:I5&I1(H42WFOI-WDRJ93
M<.D\HRC>:A55.)]&D(L(N*L(TH\D+PW?1?:JAUOM.]"R]@IF1;J<B*GMDBCJ
MST</N9YL#;3%"^5PO+"EW.[QAS65%Y_FY?%)\<(N595,07RN$%U5)1QA;8##
MU7LQUWI]5FN/>W=IC C__K<*]$"O'AZS"A2UMD'OM-K6':#L,RP3GE$(N"UD
M]#Y!A%?AIUY!!WU H!Q=I73PKRT>_*/U)<(:L(-1LVEO3X0^;C;]VY%ES.$<
M+<=L/0F-JCS)ZCJV5>.4\RV*@\VX>-:\/06&@Q9HW8G(XSG=B<CCQ)Z%GE?M
MQ;,BM>\+8])RJ2<3B9N@%F[6M3%JTQ&M],VU!C]/(W^!Y\R?B/#%G73HL -M
M6A[:;7F*E[Z]Q## F3/4D,>7'O# 815^"EH72C<[9"Q9MXHH[>6<#"9;Q9P+
MHYB3<1=SZORN-<;*;[_'R78>#;XR?@V^.&8T]>BJ:7&PLYX/$%7$K!I5WV^A
MOH0+25S PY$H&'4"P>3<ZNIIO0A-T^M-6>P9=:5:>E!?>]3XW"RQ!<.9E-9Z
MLP458_>6XNBCB2924V"CK@Y02R*K%88"I84^ D=7GATHVA]WB.J.4D1C95OE
MJ>U7?GDG$S.I:+7[4] ]#" =RJG?V?(OW%I""JM>?.@S7Y>\AHV0-.\;-C'M
MZ:NB<2I+%OVK4!T5R5F]=!\6&7"?,&[JL<,5VPXWS89V1B2T"S@4P7J!3647
M Z4#D0A'">YE;]7OE%L?I4ZC9.7I<!*\@H.Y_2M8JK=K,[VG[9?E&'W+PL8A
MT);I.O:"L.T>I!KP[WVW[;^&WHFK%3*^Z@=C^17/:DT)X4/<%R N+# !#VO=
M] (!&*JP&55[K&N.MM2%)ZJZ/D8'#F%^*.N?RKC!, HP+AV7)DB"9]@\<S.2
MAA2NX+;; <3X6D4-6EO6*K'9F1\;9Y7)\5?8,()3)5C$_?:;O/1GKJR]+:"S
ME1G\RP16$ELM0N$#,E2..N,(;#:C_2XO9OP2UBE)W(A9\.!,KL?ZTDFA.%J+
MNZ2S@^B2?W90%562R$W!!)=LCSLS1D YLL%MD*J>V4%1!ARH^7ZAVGA<4%TF
M]0YD!R_<R0W4#LDSY+S_T/_*>Q7N>*C36"4[I?,A5>D<$H?^+04[1VE,TQ"E
M3(0JH?AM9 Y1,%3X+U@04'2:FQB^/"B]2B!3[5YS[(33M&YY:?YU1V60-)Q<
M*3GRGOFP3C8!Z]O*?G!WE D5_]XQY?#%0H4D,B *V5QQ-VKU*>9 ^)9=& WE
M$RX-:OB&S;2S+#_J:"\>\/<ZT[&\-]]UR>(B_]AY>[UA/(HEC/D'U0+YE#]X
MA\1<\XMW^59((M4 0MC&@?O?N[HA[:*?JNGIC$W]<4)Y$"5;9AB:J<UA#5*0
M+_?K^G5AN.%XZWK0:ZG))SGHN6+NR<;DW40R&W;W6SJ%4LKS+-@AH]CTP (>
M8EZAWE5I.9N_^]CTA*MXTC#V'BR<1.X#!71?])X&H6^\DU7,O[L&PBEFV<80
MC!S-W%O,J/-*Q+=^LS$Q[AG:;:\%CM5'L H349!Q!RNS+[.*I%[?=QY&0;Y
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M4AH#]>-=;57XI_N/R1#07Y\M],AE=) 0T83M/M,1\3UR2>)[A"U-C !8<&!
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MV% +@_!2!JB/.;]$#3%A8&',21S4&^ =T <"JGAHN$&<WS'8"M;^0/+!C$;
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M[QCI ^O-^>4TBU6G/#?&ZE_<2%E"7=T>C_D1S.[M (\&@A(MT5>L!ZI3X*N
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M=NUYZ?F*J2Y;RTU_?#RE$VG/DXBA%O+TT;3./@UCOOV^XL H$UY>:N>C,?*
MY"4S'I]0*Q@Z!>5E+ASXPLA(]>"B#39^)>7-W=,7=_,\C'5HCGJ@HOT/5#':
M+9S$IE53T#[!FW8]63WWKC8?^1&UUZ:EJIN"EN#23$FDH>!>Z0@)]?,X6(N<
M;[_[,.WA-'K;[/"D_--KU/O-38W@YO=/N7=[RU3/@'+R#6GB.53^+1_H1-JN
MD:GTFSDVC^S0?1:/N#6@VKA?/-Z\=-:%6O[T>61+R3DYI)!$# G/XB&B2"GW
M)"H/5+XV9U_SI?$G_1[SUCKH6AP?J%?X6[\HMTA&#3N^?\UI*K?D!=)=;-J"
MT(E<6ZOV%28MCI']K\;M$9#@+P[4(LG.Y-$C.QV'O@[?08R_I9UQRB_QW!'+
M/FU7Z)6!6GY]GTO/[_A7G?WVNU4O][8OS+>K.I/*#_=+#W?W[C-::Z8KAUN]
MEI#\0)\Y\#H^YQ! SV\,U W]MII6*SW1ABV:4FZ]BWB)XGFZ;__S U5:ED?2
M3:_"SCZ<N J\ED'. L$"1 $;A [#LH[9Z /5Z&:LP_!5JN $_YY\A7#?-A\W
MV"A?H@=>?KW"LB^Y_N1Y6@Q,?TA@)A$?M]_\6XL@!EZ.9ZG>?>G>#LGK>NA5
M'"Y%XV_6R=^LDSA9)R;3N[Q/W?B5A_(2GB@&/' PB#J_%+GGA_*#!6.2[MV/
MZ?]B:$88G-+/E"'#=C^8^(5$LI/QV%M;TFV#_^+8+LRIUH_::OFE6?]X'1:?
M5I,8V^H37 ]*/7+9[A+JV@RGA:'>?YPVL51S8/9).=$2/]UTC!<B*H9MF!.8
M1.)52'=:.4<'HO>.<$LQD92=!*GM(:JD30T_,1(/74Y3'8/31X=]>2>&;YOK
MV4%TL)>L&M/R%->T@!P#HW%;A(HIC4GD5^QFCR/9DB1(N$O DD@/V)> 'D)%
M.& _16F)L'Y,J>*U>'-RUB^,%*%Y7"PAX+)UK#XJ"VQ3)J88T2? !:=-PUUR
ME,3%IE>OT#WER(Z V%.&B&^;PDB<<P/^7K^T8?F!*I<?\ TE/+_V2@>R4O[7
M&TZATR<-0UI@UD=/!HA_!_]]!Q\Z=B>F'"=Q?YG8[?J/?_5F[5 8I23.$;LS
MM*)M5=@@@ZXXU)OEL)_O,<1+89BF*?;DFWMN:3/#".X.QW]IJ>T&6J\P\3N;
M'O(./:T;[3V-?BF);'0BE7OL?],^[=(3B8 K[/8L4LXVJ Q4ZJG<R>?>)O/[
MU*_A4KZM+'G<5FY?_AO83IL[9HE0R0)O,HD=J00[1ANH_)7\\-XH3NNW=/KD
M3?A6<^MNLPP\T@FY+):;C4H^K]UMSK6%P[)'B#J$5+\#50JVL32O."$(Y#8>
MS=;%YY_4#SG296>:5YCQ$ N"[Y3"CQGK.L>Z2BS9;D%7W(185$>$6IJ%OO'9
M;_$-!:;!Z9<G=R;'IT<-+Y^O$E87Z?U#Y)K"65!<\V6KW6IUU";%#M3)M%GI
M/[_R7T2<8,WN<V5D/(ZBN[&@7EH-DW$QB9LSO #=1DV]Z&B56^2WA8M])3,X
M].Z=.10^%A_X_9!>2;B-#<(F<YG%1&(@(3S*:'3<P>Q%&[PM($D985ZVQP8%
MNASLILRAKB,&W);%ZVISP>+JO'HU+Q>3.P'%4R$!817CCUJ[U-PEKJ7>P/5B
M"U$R<(D-=H>8;.:B3=BM VCD5%7L/A&">&\,CB7H8,$A>2Z"&,8+ LE@RN!O
M6U'=W3&&O1@A6C3"WMC11W79A'/$J65N1.>*9?RHQN?;[XZVGQ8@<K!]"3]P
M@!0E+R5[24&P-?+9S-!<7\HEDIA?W-UE-2FR>B=][.)N$_CTOFF+WJMTJ_K.
MUJBKQ^F96B$=\-ANC9(1D;_6)Y;@A0"F=<E?$G&JTNXZ\P,:FQ#BZ 55KDK]
M%_SMO5+OS-^/?.8)&TH7A0M# )UQE<V1Q8Y(1NPBQW@/;^G"@;Z[9"Z).O_B
M$60N;A29&*BUZ^&TW>XIE;)U41VIC"JW54<55,1&#]3N%_5 %-L?Y7Y2A5L)
MQZ-+N8(['FVV6W4WO0_1--&N]B*-,U!EI7O_*!3N"9%*B%1_:]QBU;CA[AHW
M)W;K_+7X<O7X0 IY\D S:I2;W<Q3N?58Q^[JY=YCMWY7O^_W#E#G=CIM5Y)M
MH:O=<\  #2*8C.DQ XP7-)L 30\SA(VN8*F(WC<' J+8+TV64]@L2^*PN2;@
M++PW&0.I-XZJ FQW!MOJ0%0]X*[(/"PDR_CT[X##VSM8@3^!6<$&[?R*FVVT
M!WB!!;*UY-"\;.^:&FVS[>V#M'4L$=C?IX)F;)6Y*;#ANZJA>;,<S,SC!4YK
M-&2->XDU!:-#4-;V=]GZ"FHZA'I28SB8'M1OQMC8IR)"O/ %4-7@*]\5@6'A
MCG+LCPSL9896!CGA Y(7]G-$/241]!4OR$!9H^/+)=;8\6+"_6*663+@/,3#
M@)RY3>)0YJ05W/!L!JV3D9TSS#K[^,D:R3<0E>/HMUW10AJN)L/<%VH-\_M_
M_^?B D,H(S^Q#C/A?H'O0<CY$90.^A>&S!5\$W9QH3N9++\R]1]!U@;JK-=X
MZ:EDX^UJ&GRO8W,)[;:$MAD7XPLTNLUT456 DCB+0%S=5KG=)NUZ:-N"H7?:
M"&*0XA<&^P;\Q,H2$/71+^P>> <:N>Y%2!><M'_K'^-K\"-(\?_] TAF(YZ9
M(S#A+H82QWQ<##G ZF!(9K9F-G)XZEC;D!NH'8%\9V[SL^$UYW(7]*59"MH^
M(_O,X9*T6=M8Q,4P]K>6!NI#:R0/KV^[]35WR#R$L#,$='EK7E4?B =J)GG0
M!9!Q^%OO2XO5+" P&6LM66#VA[^CO*TZ4!N/O>7RBEF++Q._MP'](AL=$ZIF
MM_2JO5MZ@Q<88<0#9N^9?=.C3J8^4*]K8^J]_SZ]'Q$^D]DV.U%? X[HW6GG
MZ^J*:SX3;D<5O>8[]P6MJ8P:_F*P6Z0,M"BR>H^7O4N,A7?EL(,E&)^#*F**
MD@]@6Q(P+^TWI+YA>U]9RTE;\^!<C7K*LS^0&5%8'O[L-7,;AW>5&7=A<KE]
M24ZM5ARH'^-/L<PT:X^%?$#UJ%-620]9)9&LVN1>5XWH"Y[!*<M]=[G4!OM#
MX37^]='E_SA6ND- *N35S6A,W36]63:]- O73IVP&04NVXH+X7>0AM\!F581
M+ ?#[H!DQGK%\=@4<\NYT9TZ1!-,YI>:SR9CZRGL%;5$_P*O$7B<2^"V8#QJ
M!YG5?2;-@X(]&XU76 -?;CD!B1Z;<=KWV%S95)@96"C7FW+<\DH2E04/^TU[
MYVY17B?F'4,,U%[A94;W-\H;=>B$+5>#B+W.?%[=)=S97$ W75=G+?#5=N&Z
MZ.P^X>^/ST*PIS./:[_(P6E!/WB6$P>G,>%!:M^_Z^>_!"0@%MS>$>>K'T?/
M;L;$V<WX-%J  /F$$9I@L 2/=4=2&G_'30N;6%?^^9PG?(+/U7>5D:?(>QK!
M'\ AG >6,##A,-EV(O:D<SB7LL#"_]2MB9CNC!7OAS>=5KM5]>VN3C]/F-LK
MSD)W]%W75NL0=S9FJ"NTT%,-?Y6&%Y-('_'L87E:N [6YI/[;_[ R^TU?[PV
MXKE(S;J:6)I/:==)Z!'<0#WF&^I+^>%]=34E3HACS#:7 7-W<54B>+)GQ56-
MN%SEW\<Y$=XB#-XJS/O7/7)2%S]+H7DK'.1YB3B+'E*5$]TATNRQT2FSHWSA
MD7YC$]\A/($=.F0WE6BI=$UAQ<G+N78+B.SN<H/)\/;.LXKDB$CZI)5U7UXQ
M_ P>UANBU ,,V#/G6T<+L'[7^GX[W8]JI3&ZOU[U)K=\!/<C,0A]+8D[XA+"
MNR5$$EEUNW-:CU^B&X^+&@EQ45I^S!/Q<LU^\$1^^G$&K!?=OR$2:2[TQ[)G
M:2_V/)1#5%<*PR^BIDXWH[V8-*P)IOZ\OC#[6;-#^55DY65$5;K3Q6.\J%G4
MC4ZV 5#B$1OW'(C035F(@S=ET6*#NX,Q+7;4NZ*IVUZ)-;TAM*3T^FKX3BV"
MEY-,\"6Z(2'VT2^'X8)"="Y(RYMA%;G0R:M?+\T=WLS!V2F&YY),9.:/9#DB
M+,L=RD.Y&JT;K]==[F5.[\5X(0T7&1#&.</M#*U!#N6'/"^HSXV\KO(C[B#;
M&1#SB;&=J=S]M:R4[+]HZ7\G$W,RJ;G(KC!C>2'Q,Y0[@@DP-30>*;QTE;V)
M/,HZ[3 ;>)ARN;FY7/>E?SUAU=XD0M OLB]BGT%X;Y9,(F9' 0VQNXU@LKRY
MRQ?PWY"T/$Z<D_.Y*^7VX_8]<!?#6H*\OR5(GY3E %(>RI-2*/Q:OATU\7PI
M$8(&Q'+2)VCQ> 0U?9DY_GC=:TZ;^9L]^L&'U3.!QQS2ZYA#)@'LG80N.D1W
M79>5JC.2 *O?>C =7]XN:=_+<'M?>*.0GLV7VQVPX=9/Q=[#YY7<IM.T9"$F
M%L' )1&NR6=I\LB(\=8>UO;9P[2,W]?ZM?_\(O4W-2X175TZE*[V)3-]0F0V
M3>)S;XI+W?'M[.LC"3+G X('!R)S_H3(;!K*T4.%S?79V^?&\&AJ++K]S">!
M*I6$JDO\:+=?HLDS(TD,1(NQ]N*$KN/L$2]]IC+PL7H<+$""3E93@#9VMW5>
MK1_+=_DO^K,X-JVSQ](3NTW;#TDY4'2BT2&\,Y!/XK2+9ZD2Y2$A?]0E,9X0
M5Z;E;W0*Y/"+++]41CNB[,E<#^<##N/GNL6UT]QBT]>1/ENY9NESL7G_=ZFL
M0,-/>!K^)*"U_A5JK7J:/&\ZGEV>'7ZM^U7QMG 0M78J62_AXR:GF@"3LY=5
M&W7GD:(K*V)*K4HCNJ^,]DT.CG 7F:)*#$F&".Y;(JDW>#9?],*)_A.OT&-Q
M8EH^VV-]\7+;9";+:G@@HWV46T ,Z0RWM7%BVVKZ:;=WX^IG_[U1'3'_$JT4
MW4.CDFB@MY>'=@8<CI\8AYM>V4VMV>@\;.KWW?UR"?\0#O<,/E))!!]+V6()
M3Y'#7?"]-D"D'>"K#OC-OV@MQDA.M!8'EJ;7N"$/"'^!6OX"M?P%:OD+U')^
MX_X%:G'?G,? ZJ!A,.2*GDT^QI7>2X,X&Z 6>BM@0272#S>;PW>WQ#T=R(;<
M_MN?5@3B<RZ1=]W>]/UJ?$(\$[T@B$JBE/G<^*J8!!1("MQE!D+4JY?^>_/M
M<;2F0G-7R%@6%9"[>CH[E B<3@H[9![DA6+CJWGSQ%8>BHGO4,!5RE^PE@->
M\5$)P&P@%Z3^+#YWZO1JU.;.'JS%PS5))"_VCT7#2(J+4@-KX:_Z'PJ]:<G[
MP2,<AO5B>#A)E#S_N>Q930S#(TV'Z+KWW&JK7Z_EA_T0A4*:8#I"*?2Y;'3Q
ME#?:]*NH8NENI#P7"OG\038Z0I'T7["6X R!$# =R!OJ4O?SUV=N4VV.3A:L
M9=O+H9,*P.QN+'Z&%ZZUZ'R0EC]S6UDQMZ77RDMA/YB%Y!DJNN]")Q6=^2.9
MCHR#\)&FER(O2V)N><?T2O@ATI+H")!R9["=L?!WTO1%6/)6J<\*Z\>'PVQG
MA!3:OX MIP]+\G<R?RY@2V4G/@AR=6^GQ<_AZXA:D<RQ 5L\/-HDXG:%;*Y8
M.@' ED*H#4G+YYR.UORT@+]WZGC@+H:U! >K68_*VX?RI,;=%EO9J*7)0R$)
M@A8.5IWN1=#J\0AJ^C+77.GY'5^\EFDV?3T3/>>SD$3.9Q*ZZ,\%;*G&A4=
MENR!%'IO^(VR$E.U9'L@'6P;N$(2(1LR6\0+IP+8$AOB(DWC)[V0M_?5FWKN
MTSNU-ZJN#BB0/A"9"R=$9M,DTB^OJGK[QKSV9XF0^6 89KYDSIT0F2VT^$ZC
M^S;,"_G[HVFQ&.8S";RS)#3=7[R6"/Q?3Z"$'!EG:DDJ5^W[>R;WD1I>RP$@
M"SPL>#*0:W'BW^=RK9L$#D&:WL$Z1\^[I8\O8GH0>)5"A%+=<]EBZC2WV/1,
M/KGGUOM4NNU*^^&K'$C%1*^Y+293<TM37A6)?P:/TJ?)HZ9;MYH5K[^J4X'G
M=MSEG &/>KJ Q20B*$26I+WJPH^8&'/^>"Y[H6@@_RY_L[KE6S=WMY4HP9?$
MDQ[VK ;?=N^*B8#HY;,E8G?UR1E>B)?V99RT?#KQ7GIM55:3]6UR.!T!/ETQ
M(")TAMM*GMBVFG[<*WOU=<>QK4<^Q<RI!)1(# <N&5B[. [<&3!D^<08TG3:
M<.7N_D68CM\YZGP9TMM;2R)@AY-9HI *1[K038Q7W"MS3N)'O_^W,+FG6*X,
MU/9]KOU2[HART3H 1H%!"7P!C@_46IGJ]S9/C_+S,.P+G%@W=CE"+W2\S[&U
M#4F<:UM;N,CA2]$.(<>!K5C J*2D<*X-+7YS\55/&<K +0,N67T%_;(^>$%E
M)HX^OCF6E[,'<'R_,U!+C=P]61GVJ#:;$ DB8\_8@(/,E_F_VP$T$^#Z@Q$0
M$(V[QC''"]_^\:A]S%W"V*X7!R>%BJ2/O01G.1D*Z4],62PX"3C:'! ZXM+M
MBIA[29 #]>ZK=U.M?1+$"W.@&?4>*[WZPV/]OH_5G\"_/?O\,DB635&V8(K"
M@PEI6PL(#Q[-:?]Z;,&[(B_Y\<;%8^F_[G OXG_WIQS6'BU%H,ZQ5U'Z6/&S
M&9>IBH(,A!7H,'TR?]:Z#[V?R4&;H9%,-R='^RO:&E#L$K^ YE-S:X#6(@8#
M_2?2YJ^XOMC?+#B71^-ZP@Q Y?-C:9)G'Z\H\PQO/8IQ\-DL,/SF1$R_)=!(
MX;F+'&'^1)J>B.<LG":KE-MALFKVR;2%C,'ZI(;+E<7N>;$J2@L,H15Q0!$*
M2Q'[SO_ &#A9*!0H0K%F>*#TL>]+(#[_[_\6P71_;4D1IDL1^AS_]0.8!0P^
M;Z5P9E#V$<;+L@)>!<<%'A\+G[,&62B2K,!;KZUO8QT%N*! 7V+EB<1Q<V-N
MWWG_Z8H3#E[D DNVG&:67K)OS#J+>:Q-_TSV7Q+FNZ06#WYI-LT%9<(LZ!*S
M*RCC]5F,F8O"!!/16I938-C!WP C<0(+W@I'!6XHK/?;8"RSY.#K;QA!8:0-
M1N)HJZEL!FRO,M(?!^,I8&",5;@ 0DLR!GQM8S;:0'ELN 'KQ)@)F/,$ODP<
M8_]Q"ZH]RZ7&#9=-008.%UQA$U&J(_' 85\P,V>[,Z)D2BQP&4?%4F])5E\F
MUU8/B[+YVH4QA+Z878>$P&E\\_$?2Q=$R11-W"5\1"(G4KS@BS\,MV8GJ0O^
MI!9&$@>VL<9I_T4Y#??<,HCF3PN"?*GEZ_3&TG'&.%NL$Y'D/M.)1?LDJJI(
MTI_R0)(S+#?F)*@4964T#2\RX"GP5T/^#/%#NF$AB?*" V\"A\J-IJ6@TM@
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M=?7+(VFO5B=5*V7U"VI'Y_AIP<8'DYIT%.FA\5-Z4Y>U4/7;=159.2@M,LM
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M47ST_%?UDF*5>X-]:;B_"\ZWC/NY]"DQ-('DG488.EC(A+X#](7HO3RC+T5
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MC7R0D"K.*5><O!4*J:*K'9^<7AK_SF>,#0V$BD28MT[&?I 0\6'!9-G3M++
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MR2 /;)K"6#H1@]&*L*N#=1'LS>2LZ6+\(57$;_*9"_%"C^A-JS76>S57!)B
MGTR4Z-@-133*Q@WWC$:RWX7SEIG9F9VY5DNZ=&=IW[''CJ8[.RQ3< @1@!BU
M3<JAT_TA1;2KN$RA"%*1;+78LR:@ RKF:V#TY^30,H6?6(1+(=]PSB/-\%AM
M)<YH<P@%]V*77"CK5S&*F.@<0S0(%DK8*R*C:IB?A3H&O%E:CZDKXYB>2WB'
M&0(3#NXPE(Y%P;)4@2_JRN-F.M&%8,Y:/>_E]["TMWZ?(E")9K*L8:F9-]Q?
MXSO,5?,<KBN&Y*GB^"0'YIO*DJL78^&X;SK:SC7)5M_>="&3\L5$MU=K +\2
M._YG3,=2+F.KX8SQ&Z-.%42>+>K'5.U!5LBF O-H6X'H-R!@+O;+RF:_KZK<
MP_VM RD[RIY7 6A,*K;39#P>R;J=P.CS'M:)"QA]R(#4I!8-AT:@RQ7Z<-8B
MB50+G$>7?#=UP4DF@ +X3W9# [>X$K@%:-*>H2QN-7?_:94!G"(@,RG41;)J
M[Q?N_=R)'Z<</M C7>_^PVUUFDUBJI0'6( !P-Q'+% $=WF#IVA6NLTHII:
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M"Q"CT.6+[%"''2R\6+XFF['@C3REFYIZ;W9]4"L'3*9>E^IH<TXE5D$(X(&
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M5I33!+GW@@7=MUV/P416SZ!$=;Q^H^#6%+GADK]PJ=1\&W"U>:XXKA:7M7=
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M(K*A+)-/@GZ!Z<6<=1GYLF!1:KRK0)I<>D);W<4]6+)%P^[#.M_AP6*]A#O
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M$G-+IE4R[31?$9E>@-GI_A+&/3]TSX#ZD&@O/C^!7)^+E78VGD 5=;7W@'B
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ME& .D%X6<N(M.+BLD6I#P%[7:,H]$W^-!9D&+H$DX>\ZJ6^#E'$5*2\NM@W
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MD?O #NC$$*/ADSJB3?2+[[G$UAS>\S1PAZ"##]2+]G'RHUHO$5AJIZE%#Z1
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M!YZM^,7WN\$W_[,T_7K])U!+ P04    "  6@&U9?HWI3V\$   .$   %0
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M'A\9O3^EN0M\RH3?>#N^DH8*C_G($F$0_'+Z:__\!.B=SR/1'%TTZ!WC1_\
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MT%83\8KC-Z:LLML!,VV:4P@[9Q32H1KE$P_-A+7(G!'W6K1GRO^ /Z8BQW7
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MSPE[3!8S2?0MUP?<[;2Y?TQ<:_F!H0\[J2@8A<\-VYU4]2=T.XVY77G>A_G
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M>REI%/#,O,@4@EVDN31BP'[<*H;74V4330F-@,M9A -4BF'NN:"DG.&*)!)
MFU)EUZWU&E?1[\IT I1&:#B<":5<&ZU17R^YO0(#K'<E0O=8,C9F@.1&2[%,
MFX=59L_+(89+%&1 UP:X N;^2?O29)$QJ<EX>&F#E!+8</J[)-!]Z_=DYY:Q
M=0396IS&[N>R:;(@/9I"@WSL@I4Z,,3<[D$[7.F2O#83C:]LU/0Y(!AH<Y6Y
MGDL<<OU%2R,Z$XW%KNV8?IV"A?!8^O6C<;;UY.=+]14ZL<17MC!SJ69FQW;,
MUC3UR)1Z#G9KF+-''!C-.LQ^)\IE7X'FO1&ZW4HLZV;>VP1*]/M96QZK8PQT
M] Q2/A[R4AB#>T)UD9A[MEPO.Z=<P;'A\U.KAYK'5CU3@]AT8NN[=%;$RZUH
M.Q2 )8][\H!D02E<=2W>"Q,[*(7=.*@B7\00@QH_K-56*><ZTTY5!V7:MKJE
MG,WSU& FH'T?I[.A/T&F7KJ@CRXR?41HG3B@)$M01MK6/=;%4%,MS-W(*.'U
M<),X5)P+K=OAKD00C6=&\6-QP;!$WG#)59[U,E&(YYLHQ&-'(3;$O'KM?^K9
M!%KLU\5,H;,-?,PNDO$<NM4R QW0 B=1@Y)F@0/27Z+[W4ZM*KMM,!;BM467
MEZ"Q[H''Z@6#6* /#?D]_->?#PI==*YQA2PF8NN24'ZIBKW>)Z[$X;SS:$CY
M)(J[C)FW-C,7/)!$N4P'5IR4 %.8J,NBC5<0$W X5"29[2&^G!(>1]6,DK1<
MG[R&2]P(J[68]1T=2HSK[EPAK8V<8HV&5J_!!+E;AB+G<I(UU%I*AR7R1'2<
M8*P08")U\^O2Z*;D@^5U]]/*'QZN66;Z,CG-4!",PCF!?N*Q$VWR?$(V/5=7
MFRA4O64PW4YOQ&HB_^JD-?%$_&ZC0ZR1+C_?\APPWP91+D"CODQTA3^:*ZDR
M_BI,,ILPN#@CRZ+3(Z*L*;OBY(_0P8#6*".Y/IJ-6<]G\*2]ER];YQ; U+PV
MKZ'/JIQ-M9%A#4)3VU5G70ZB+(KAI_J6;CC*6LQZ?NT7<91SY5GSGIUL]08M
MQ>1G;L1 U*8A,0O]'+;6;28OP<01.V @"[;L75!:<A@V$8CUDPE"1Y#L/0Y3
M,_!:@-D9X1U-?1#K!BM"]R/D@]+M7">PF-RX@)KJ&3&.+D]B$"I-Z\,V_<]J
MH]&!OZBH=!X%GL_K)$^]_. Z2Y/[%O$S/+2AMGP]((L( Z(.IR7N$K)1CEF)
M%@/,=[\[; H=-6$;0UJW\[+6<<=77S/N^"$IT3W->3.;B.,Z'*:E(HXGN>Z$
M#<;8P%9E!!^IF[).MO@Y.,'.]E65LGH(7/4@*J]:M-\X5YP2+AE3KNM7G+;<
MPZ3;T44BII>L3>4KS)@BMU9D3M6_3F7S+4.XV>8^>2THXFW0CD-N\<R.S+9T
M*>>6%SO!)S>F*N#Z)MD<"YGM'#7"-&4G2NC-5T7-F9>QD%CTQW>]+?E:9*=G
MN:2"L17@KH%;* ./SF#\].*2=LO#A*K9WQOQLA:SGA^I(@YPG)=P,RB:XRH,
M#M'0FHUT9/8#XI$:U<G-5_$\0*,<:--JG-J'I1)8R7KWL['M\FNAK<"ZC7QL
MO<14B*8TOHK'%_OCFWCCJZN(IM L&*FBXKQ?C51FP9^,*FS+Q32T*)T8Y_T<
MK#8C"-FJC]4D$S 3 Z6W #4PD;"UGT_!,68)(IL9>4JN24-V9D/!?ED%C/:[
M2TVZ^R3Z?$<HBY[9[;A+A+-./F->'L70,^[:JR&&!='5CI0X5)JHV5)#WG"=
MM9CU?&<Y<9T!)LI@I1P\ 1'=\(_WE(N/?ZEJ9(IYB0=@I5U.'B=$VU$Q 2YK
M#W%E,F3(BC/<@96":5*8\V1D-M:,B<RD9FL1/52R\CU/6^2AN4HO(*Y2YQ=I
M2'(JM].&*<,CR4^V58>D@6>P\I3)/5*,%>R^XFF?C^_L."P3"'VQ"81N J'?
M S%_JT!)3Q>2Q^*8>SQ_PYJ2QG)3WGO8"5^XQ5J^21"V5$?5XE4..%=('343
M"I*7JM#]MRAKS)(6QZ$D'ZH.C> FVS: @3D?&*T0HT*8S"@Q.FJ.98,5X)K2
MY(#0L!CL"< F:W7D0=]4DC8N=9,ID=0N.X9&LJDMO.,VG+(4E1@5I23]89_H
MFZN<T2%@])<ZF9 R;V=<.HBO,EE^"B$-L0IHF4E+1-Z== O:(C;ZJ%LB%5DB
M6,''Q9@&"EV#/I=:7[(C$N!XW1:VS>>O4_X$YJUT2A=%G3/113<,4//WI]$-
MAQMT35/H@IFX$<764B=>JWK39D..,L840P3Q0M,YLKE^IJ..E]G(TUQV:U#-
ME="0SA[Q(#$14+X%Q[RYQ8L>PPWEN!O#N!:9,4O@)SGBSG!31XR18Q*^/=@A
M%[EB0C_GD1*YW^I^11@^RA ^I2PU+'M +6@83IH([7=D4V"08K"8S&HZ!V4P
MHF8CC30:O]FJ9@?*A)"VV"=)K9@Y2]^_PTM$90AKPOC)J:M'7NAB53B8)KF3
MWK#]2$+Q4<3#ZLO#!U<!^N1?EO(!K]X:^-1-1/VP!.><CQ8F?+E!X+;\9+)+
M;QU3UVF$V5KZ@TT.%</RH)BH.7K@7JDA-U9SD<\N-<"2UV'=AS@2"*,Y1?0N
M2A!B)N&!0N9 8$GC6JJ(Q>"RL$.FN\%UGL3L7%.?22+0%[@P^1#5@TC@XD&O
MH"P0!^->@Z-@@6E9EZO ?&:B9PCGK6A_X7!?YJ"@C".*49<EL&V=*S>"6RD_
M'M=8<)ZX+(?>X!2Y.$Z)-)6R;9Y2V2KJV+NA2U-%1ZETW;\--&BHHUIPP^?(
MEUB1CPT)@&D6A*/7[30"&/C<2Y5AQI&#*("VXF5.M-1P)F*D LD/: ;E-\=V
MIE'A]UNJ@P$.\VN&<]!%NKK&B?@K2HQENKH;&"#S<JY,XW>'TD+'TS$\Q:+;
M6;3<A,40ZV:E];IE+9!P>U-UR=5F1-$+19._$* ;MDOMFBB%B<!,$/:*\ .*
M$5>W.0J3&N.VDQ[+C<:<*8L8Y4J-4%(0;-H4<YI2]UZXU0E4HOB@BWJ8Q[?8
MM ])Y%]P1LN8$Z^T. PM^8:^JJ8RO:UF]9",^5@"#T "=A"\6]3&M9(.:R@0
M]\D5!<R F:/CKF4M]R:?I8@L@)BCI#)F+NRHSE>>5VV"K$3KX&Y;%K^S$%;E
MR)-\*($V8;OX?-DD'_ID#HA[TJ3>Q3DUW8X]-7>=0TRCS&.4D@M.Y.;8/'UO
MTOQ,PC<?W_X"$K;@/G['T8W%C__W3)5,FD".([Y$)[8[44P-*@3B O-HI8\?
MZS*@UX#E5[7'6$VUV"4-0) 9R>+B%XB;1A[;6NK&]6G4?CN53&%)TJM$0X5%
M6K?=_JYH?)D8R<M-C&03(UDI8G[(&?Z6%Y]#]NZ@A769D*B6'C-4S9R-0;JS
M 8>N1D')P,QA,CCJ>D]E06/=O&6#=W&M#*N,,C:<7<4 K+U^1+ /B(9'/2X=
M_R)9,&A=2O2Y(1U\KE\VQ0*BV&7665C9+FREUT!8 ):\MHA77( ^)">#-54%
M45GC=;!;/BFTFPUG'(W'28K6&J4,"E!3:-S>H0<J'=+S,ORKVYDHU!AQ(C"P
M_%:)TP$KT,MM*\4$KPWD%/45*>&E%E;$ENKH*IU1/D,KK$P8Z%ZN.Q!;&JD'
MZ<+?"T%S3HI"7><CS@^:#2=)55H'D;S:5_4T!=Q_%-T.D6>PG[-?![[]$&57
MB)!BX8%1RXX=:I.2NNFL<EM$,AR,@\2M_;@,_2RHW XYU*A!9L]Y_J-969J<
M"TZ):ED=\I))4I80LN -HZ%=B)6 JTAY52;WPY)WJ '*DPEZ(4Q%!#X&;%,T
MJE/>!A?GK+[XIF,BK7?HQ"/FOQG?DDP8>H;6CMS1Y''+KE5&P2GX[TQ9M[F]
M>2=83#:\,&8& 7K"!&^''E*61A%3@C\@WZ,GA%HM8&@MM@NX>"Y#=(4D*;<F
M'^53@U097">16_^ Q@^[&.$#@7!C)(445#SP&NBRVZ$6J38;$.'7Y+=MX^P1
M#B;X%@+FG>CZ-5HW+MDL)6FPI?.70SK.KO%RZ;(Z)[A&OC]N V9"B',65U>+
MBAD6G.38%/I28V+6,XJ&RNF,1&XXLD3)O29H0)PWA+.GN*=^F5S%G%YJXZ:(
M9%U). .D 25+J83+6VG9]-28JY$Q+1H_[C/#^ML-)@<.\7F_,TF+WY3<?D"*
M0@_\ML1+BS+O<&G(0?9/)L-941H1H71=+CUJ[+!_&R84G)!26F@#!Q1T$MV@
MNY3Z)P3*SDKRY%*=8.Q:&M=H$EV*LQHF 6^,;)-E&"QZIKW\R[;CL,EF6(M9
MW]5!2JKXFN7 MB7!Z'.6WZ0JOM3LIR6]0 KLYL9UW;.7C$ER689+BB<<JZOH
MVB^4U7G8%'(!.41UR$,YV=F(D'J;^L2F4'4="7TIO-B3/".M@U/"^\)EF>1/
M<M*,2I'C42H%G QZG4:D]3D8V8; K=1S],Q,1Y8J&_+2HAJU*6F0$ 4R'LVJ
M^4&ZBNB&6WPK4FW=0B21(*5I4T,]3$O. ,&XDRJ;!3\H(&XMTGA[;^FPWD\4
MCR8'B7#-D!? HQ"W&I:B-$A7MU9[GO]HS.M)*'4&S42C%&C8[2".)M&E,H;$
M_ @R0@_ZC5-8SE%TCJ*31E![F(78A(=W_[9%VGIA:(RL(INBQ2.%)[Q3EH>!
MT\[Q2D-^3*=49J!<@Y4@*D6T^^!B9)ZDJ31MM\# 91#/E"W!LE8F!OX,K;#^
MH^^45CWS:80-&B+9#9M<BUE?+<<FR2 1-[ST%);,#;)43)4CJN:S3,SNDJN+
MR )*E ;_,8T&/#IW@5^;R1_=3AWX57JG 47W376^A7K+" >0R3ZV;98<ZYC
M!]0SM.9"3L7(. DE8!P]B5"/\LL,4[BZ'6OOH51(J"D5F5"AMN*43HE9-QKZ
MKD[.,K[]5QO?_L:WOU+$_) S]%J^_??N[FXP !9[%?P&"@KJ-L&@*A0V.QC,
M\-/>WJLP.,!LOBPC"^L@3_,BBD'_^>ONWM[S,.@AXBHRS=<P"E#;P :\"OUV
M=:^#__FO__JO?X24LT.Z&<L+OZ<=:M>VO5T]9TFP7!W7HF[F/;RMP9R)3&D5
M5C2$+Y96;KM[EE;WE3K=SO)B)Y@K=7RA0QT';<M LK>?S5E:PM"E]=,W4/=
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MXD70&U7;MI4$LV7!_[17^F.Q<\*[\67X).IYKF%DMOQ5T&]RUT"Z/"+:F/$
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M_&)EK.2YQNJ/^Z>'OQ$]O;_X</SV_P)02P,$%     @ %H!M63$R'ZS_"P
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M')R; _$_YG%B8%U2'^803H)9_V0^@I^3\D7Q!WER;CK6(X%4MNO_RD 9[B2
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MZ_XQ1&[2[_^20I4.?C/ O@#L"\ W"L!.07JIG3DUW]EW=6J^YN^_4$L#!!0
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M#IZ<M=<![#_@$OP$\0/_]"(21_!VRD+&?65E7T@B8*%PQB.VL-F4 C:XO,<
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M=(J[D4QX+/0K73Z#Z07EB\A+UY -\$?%>['GJQ<C,<*<6FH$)@?0A*#7IX8
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M4W7'C545'T4SU(IASHFU;MAH@^MSB9K)?K]JM_"F-\K=XRAWEP>#@]V="XG
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MK*G"$141H_ 7#P3^&\V\A$F],YW4R?[LC<>P*$S[270ZC"<0]X(0+I2VJ!K
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M<G*H00-G_":I+L?@LUD .XW@829P/(NC:TPS!?LGR6/( ;R#**-0?5_'TR%
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MK6E83\-Z5I57^("LQX6]Y4!4Q@Q7WA+I BDY4HA>,++OUD26X:',TT4>XA=
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MLFPL0"/T/5E[*SNX(%0@\54%8 <&<11CX5SY!10CTQ'IW1T5M*N8>9[IGZ3
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M66,2E!N2SZ0B2P3Y$9$_.A8*:#0-Q3<4OZKL\WJ2UXVF4S3W9*I'"0$I5O@
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ME10$K[7@+0T0)0&?>1:B=U&!LQO@F1!EG:3;@S;0IIO:[U&K($2XC!SD:F)
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M/B=&/#8DP0U)F(80]9M82-3A@))3X$ZKOS +R22.+ YIE_LT48B[8:[KSF*
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M"%W7<D&IE.BBOPJIC&ETJU4PJ5(M".3F?G23GXGMJ4W7:?F.-VS/WT=,CCR
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M< T.ORH;O%;KL.7(.,4H9 [E1+!\%*75;&0D;*R^&A.P<(M*10BZ&5X9R,]
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MP"&/S_T/0=J/16C"2-_,7(-692LJ1T1_I\^IUO"+3U1B(E)V2FK3JDZ<0[[
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M> J4/1$BQ8->G?Q^E-5=Q/XU1XB0"S R#%XWI5-476NE4A<<0;;CI^P8JLI
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MQ8>@W61"$D"?;O0Y?9Z_(_$5<81)H1:IB9F#(0?R0O)?GKU=G0#/R@/N,O)
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M6?O7#"[V2-F-\UA2:'/CM# (V -3FT 90H;T$ 115<LA?%T^+D"&<SA)I!Z
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M+R%K@-,G5!9W0$,C@-, 4404"HK:87A\."EB5%@@R NI.;0ID#MT_3$=&]Z
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MN6QHGOSCY45)NVRJ(Q(?$0;B76Z947RP[R@B0&7@)&_I3&<YN4[TNMT/M]W
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MYG#WS59W6WW#:2]XR;'QOEC)@'?C7#F>+\B?)0@P#@4\JF@Y8KT>-'=YN07
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M+8JSIU*1:+];G._-/CB?[,']%$>)'SR'6#IX)V+)22PMD3HC3)PZ4D*D0.J
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M-S1?>#(R-&5X:#0M.2YH=&WM??E3VUCV[^^N\O]P7^K-%)Y2:,C2,YW.4&7
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ML<&/3W_0E^Z:8U$45TYN4!6LWIC-F53.A/PG-TLB3(5YH.J!H4P"#. &BB.
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MT=;:#?9\X#>'D90PWL2VE][Q<0]M*W[CXNNCX[HL.%)^1:W Q!R/>CC\]!X
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M-#O'C\ZOKL]OKMZ]"/,L$+Z4(&<VG=(5P9^@O7!4QV(&XUO4UP5^=]%G8(\
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M'BX "?^=\6][R[:IM]=QKQL><LO1';0,[0GPX]KC#O(U$ FR@X:T%F\1<1?
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MU,B[*[=A'&V'YG;DGER4U[(,;?QH98>%F><[NG,=2O2(E]RV\>]O\:\0\X[
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M870/66P ?B'@ZYZM&]_  H"XB,;?7'$6I-@LQ$9, $>V$IT7=7=XN@.<O'%
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MHJ)&I#\'V$'>AC:!R?(LPEX %)J0,%=#/1)[1$]3(C#1&&NB"EV1FZ<13+]
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M12J@[\-'LE%CBIN#$%] %(=\B.)9B-HOV9U?3*<HAXSPYYX?D?7I-6#;^2E
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M0P,V2A)9U/ET0P-6FGH,Y%#Q1 -./R5IY/TRY>Z))@GD*0W2\09%)>R:+7K
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M5W-B^!P%%S2@I'2A7(R '!&"7DJ^WB5(R^M@K6HAU&)N&: &V6=!7P81$Y3
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MV%PL(DRNXF)!(@2=>[LE)@(?TV[Z@$\,\S:GT3*]A5 !& &+S"]Y_2O<H56
M/C\#<T_#IS3^!QL3FW8T#OM*/[NEA_MXZLW6_;\/345SX*1RNY"_DU0OX"OT
ME^EFRZHI'.9J#)+6(II=H -]L:N1[:3#O_9W4)>EC^B@/E^AVRESY.B^ZO45
MHITYOMC$YUNZ1:J.@--50 E8;Z6O>8J&A!(D:9J:9 7$S(?2=/5@9ZXXI@<8
M&4)B<9H6G(P+F%8_<K*>O+8BU4FQ!601[]:H[5K<<P>G8\.21A"S<#SX"(=_
MG;M38(?_:.UQLL.]RWN]<.2@=$8;(FJ^IB^;.'_] X[F]63<_9,I[O^<)<P,
MZ]U>#2OL3M[LO$-P\RFEGN:PK_5>5=W[*JU@K#=)3"/RW C#SM9F^Y#$(?F"
MY?K4O7Z?V[CX[2*GU&*WS,%[WVQ--GW&@]5CU4M_G[78X*ET*I2)OELQ69(S
M(?^5E>;/,:38J>>"KYUCU\;3R5::3BN,O2L]RH^K83RY8P_[+9W<,7L51;$I
M4ZBM,AY2#AVRYV6MB6VK<!)JQ,=\#MB8(#SF,P7VFSOF4UW/#F%D(FA,;&#K
M0BYTTFY36!LA]_.$*D71C+/,^$Q!*@7/WF?.T>JF4PH2NEQQ%TY9XQ7#'=?0
MC-W2D,;/;'1(\WLV;"R"$/ZJJV(3C3CMI&8YV&OW)EE 0\Y9L*6P^AS.XZ^V
M:520O%+TS]DV:E87!M@7\12[K S:ZS['PQ49E*$KS%:]'0PT;=EUEC)0E,TN
M7CO,AI,A<*"$\3Y[3.-_PCX@?[RBN>9SS#'DDF/S'>W="3W9"K8!^6P/WD8S
M-W<59RD6;I;;LBB#%*XJ$$<%]KU:I'_/FUA+'/M,>UD[U+T$Y;++@9R4<N;3
MQSCER>,>1,JXWU-5^X5"I#J-%JS]"AYI+Z#]\-_=_/8W6BUM/NF!*JOIU;_S
M*FSA^N^_8O_$MQTO4W$NCP\3#O3EE6]Z2Q76\*GV63D5K\$SC3J8;_* E4F^
MA3%J,<GE0W2>^T2 JC[N_]-.JJ?[>SVV::5[U]%6;]/Y=/YP68?Z"*=T.P]S
M#*').&!TU#K[@-(*MALD9GL@7<Y=/_?/X5UK<^V*UUYJ(H@WU5'-^L![[:LF
M(7@[P\U#N/V&*_K(U[C(\A6-RVW>?H\#C?.5;T)59>=_JGW.]12O0==A'LQ%
M*7P %E22A$;?\*,-;Z'"C;4_"N=]]*V38:"JJ@?ZR'OM7R=B^/WTL/,<WZGJ
M(^XV/&VU80Q*/)B3TOB,"]DLR+\-XF#=#/I]D\S*]=__=E#GBURF91ZG11R:
MKMP]X/M0C4%V_6P'JK#]E[V=4<6.'NK3E<6U.)+,C[//AH^V4,T%A:<9\SD(
MRVV0J-(6>$7BO [[^=12[78+ U>]]^+[L$6HU4D@]$G>W.<9MA9($J_\MQ'*
M/*&=3Z$[FS&JYCWGJ\*)T?2N'1V,\4>6F'<:*;HN)G>I>7W,(>85J;4K!Y\3
MZ&^;5^&N-M8'KMHH.+R#W@)XYSIZ@S26P IKI >*@YC&D1ZW)Q-&K>V9/2:7
M1JBD4GT#O#+ 1D6R&<S"0Z>I''I+Q#EX8,L.C=(.Y!GJ(V&2VJTI3=-;Y)@2
M.!K"\9VF*4Y5"MXIU0,^RB$N[7V-P!JB3(^]! /LU!I-9HI*VSMM]"Y-:X?<
M$VHOK=".)'MKBR<(]^NL,:/<X_6\=O+QC92GM2/S"]G-UDUUD?5RI=[.$B'C
MBVWYE.5P!O]S&M&\$T%^P]PH3EY[G^,6%L)--WL<^J5.-V2<?,#>WLM!W^A]
M".743>5MQ^_XNTBU=4,Z.SM'1-@^(K59PNT2;AC-11\[?##Y<UV-7.]QJ)?Y
MCXS8UP<;#XO8]4UX*NTAW=MS9;VRN[WCK8V(W8Z@3&2PAJJ^$A=3H;@; '^'
M9<JY'S=TRV#[N2]EYYZR!KY((X&\0\]/0;G-X_+U3)_/W5[=96\VU:DN:6UU
MT30R$P$KET1>272P1.=%7G:(R'YK2<A^^95U?>4JR]?+#>1US/+3_'539OSZ
M*]4,RD[%!=FF@ >"V<A[)]4$D-)UW)4:J?6.B- D7/6P<X/Y)-.-[NW5$)!-
M.>*VU<%.NK%1\"CQ+,>YN"/WU1?3'# IF\4+_<]0]_GA#GA7TIL\$[BKB])L
M%>:[8MA+LI1'[HL;)<?&'H=FE<W=C&ZW66R3^YC/+=V5>?P;EHG&7NFFNLOG
M4_ 2K[=K%VPWOO[--HH6']7I-535NW^?#>:XPZI+J0BB2ZGVVWV(&_;.XN<X
MHFPBZ_@VR/Y[WVP--GW&@]\$V7WI[[/.&CP=5M9:A+S&-$&2X63.B:VQNVNU
M]U8<\(5OXK2A]8?;RZ'"T;?AJI"'=%&QOLEEZKM7^6% N+[LE08Y@HM8MP]%
M',5!_KK,S_^QC<O73[1\RJ++])F-"BCMW'[#OHPD7(L9@TWV^@JGM>\ 'Z=7
MW_9H'T\-V[]3TL2RT2)93H0>$6\AM?X1@1?!'3O\54?DGGF+)T"D\:#S.71+
MP;9*?JJ&R0$UV54:".EK@*DGY(!V>UW\U<>6\SLQB\NTZ:26J\LT+N,@^;E>
MY1J.E"9I.HPIG^)*)Y[<1@W3J>#IL-] 5J#ZAE"^[]&Y'51V\Y86VZ1DHA>L
M[)O'C<^7Z69;CE[AN[?7>+GL=\\?27G#[)[>@6[M^3#^(;QJV$&CB.@ QQS8
M*,]P_&ZF[3BWG0[KZY!1\)1\S:?K?WAK>1]-7O^<)<P,7.3M=)VV_UJD#'/D
M])!J?XT+-BR+0T+%G/:Y4?L]$ _K!M_OFX(VGJOV^M[AV>M;A.%VO4T@A_RR
M?*(Y?)6</K$/$S\SO\)L3>&B6M,BY#03+B<$<YSK5I,I^FA666: EK)QMB8(
MMT%Z1HBP0KX&.W] L_!GZ?C84N!T,P@I;5PNG&KCK5%[;$EQ(KTMEQE=']O9
M]2S5VSB,HT(LI0JMCDF0,@\B5J8;-@_.29D15K8D3+*"*7MOG8S7EHF_7V2Y
M6'ZAVO6YB4;0W$^G==#Z;CK) II6:1;L-\EA90V]I4&1I<Q#<)6AO,^NLY2N
M-TGV2K5$GF7)>S9<.U='6V&S&32\GH]="IFB19C'?,X$VW=5N(;_"(V3+:M6
MM"A8]_\0IWPF"-FIF5MLUL=^*N((CIWT)XA%QQO-E]N#79=<W]MGZ#)_9Z-H
MZL&^/)'V0!HCD-&\M4*B5M77VI2I2[NF7_BCZ7UXHXEP76@:;O4!F)CK'Y&"
M:V&:++@[X_^]TY(M:7Z($_[?:ZOL>LTJ*"]?0GO'_8_(ADTD^1/O_1IGXR*-
M:L=D7O.5S!OV-IKG-!K*F^K(3F:=ST?V\!&DUFT'FVCZM#TYHFX&V72=-/,9
M89D(TT38/B+<^A%I[!-9TW\M:I)TW5*^6'03Y.7K/0-7!"%?_S]Y[3VQR@HW
MR9:?9&\SW%7G<)M@"$_-V &]M-<CY @7)!T;:-;,-3Z.K9&/J[EDKJT379*.
MZ:#AHR70"=2S7,]VPK^K+'V$(!# M%R=LIX@+C4?0BWJDF<FL%UNJ>30\,D
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MAPY@VWX,);R7N!'6L+BY&('1HVBS"_]K&#\'>0QSS(:Q&D8KY%RV!UJ8W?9
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M3MC=(<LQP-U3(&I)9!0;@6E]OJ/+&V[&[[&LKE<_O/^372FU@I@+24(YJXS
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MVWIWY+<_,_L613$/WIY>AK4FHJHW$?"<DJR-^-JNRE(VP:=ED+_>L]:["$)
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M(3"SNJSP.8@3:$\OLOR.P6N/F8C33NWO/+Y4'@5/-(!F;C,7M]0OU79@89:
MI<Y1G3JG6^<OW)JW,*62UCVR.@"I?8ZH*BIAR4%#3*@>'/B*<18'[(-D>IRZ
MI2JB4IF*6(J KO6[HS=,+:,86T(6#$6KUS[$TZ(I,"E&T7S #$**K]K]TQ7[
MB?VY_A/[UP,;A;"__']02P,$%     @ %H!M65>*]:.'/@  5LL# !8   !N
M:6]B9BTR,#(T,#DS,%]P<F4N>&UL[7WK<^,XDN?WB[C_@=M[L3$;,?6PW8^I
MGIG;D&6Y6C&VI9'DKNW[TD&3D,0MBE2#I!_SUQ\ /D21Q(LBE9#+&['3+AL
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MQS>OOI]9>:%QD.:A?,9DP>]/51L_=AK.;7\P@_O(4MXB+>9ZLH)=$G$27CF
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M7F"F*HK<JX2&ZJ9IM0(61$I_?QWB-+<*"3<]>N- ^W,=Z4@[^,R<_#-D1V%
MR*5T$U86X1WQ=3=;/WQ!(M&W&@SZ;*=/&Z$&)+@27-('D5 4$=8?O( AOW]?
MWW-I?<C]@'MTA2('>RRBSE>)#H:&=K0Z4I#.0 97%Z&INT-/[$]M5XA2?^AG
MLX^Q,M3@.FD?XJ0>L^SM&>\^5Y3>GZF,$3;!$1T$;LY;?>JP\]QISE:UO<3P
M'#0R]-:S2Y/4 <3P)9IGB($QM7'\4MJ7*YYZ?ZJ>>L]&-X/%Z,J:#F:+WZS%
M;' W'PP7X\F=04?@/);EA^+RGD SWEDC-Z%5M'@47K[L_452A+G=<&;$356E
M6YW1[7B&/U/GD%NS8,K:?&/:F?E!VET1LYQG^,-R&NZ?+$N;&,D!4W/SUR<[
M#J/@I^/E[6::K6?O?E-F5790JSV0&3(6ZFLU>467Q;Y.LLB79^@Q]!^)QS8D
M'IH77]L.R^H=K#!BY(B/630& (_0ME/0O=,8;;QZ.Q?[C *$;7].,V+5Q27K
M!1Y%[4!&:LB A[_45@+QHJ<SAAE6\@A>3"/WX,D899)DV1A-;<T0G[[2"F36
M:P*9Y'G[X=I#R]$SL1%T"SY9+CT'8:[M)#V$':"7-KYRE1ZO5V 9W"C2<MCH
MCX3F)3Y2BR_-*^-V,&.^=&GNN*R"U_UIH$SZ3 J_BR&2$VNB7#:FI,=62)/M
MOCC-H0]#I"HF%HAA9NXF#%;TXC -N$R6Z4:"+Y+FUL Y4:H!MXI<1)R#BX7#
MD_CFLK"328Z!AI04@.@SX;/0C'QS/8IBLC!ZT9KNXZY1DS3R9$F%OM";7%VA
M:+!FR$0:.$Z8D"W\U'ZA#@W9R9/?X 25+_D.$TRQ2G?Y3OH/05"P]8C0>3\M
MI^"A$)YT L@4ATL4100FV[\6Y@K66T*G^[24-X_EDY8C93K*K=90-L>;6T-[
MGFT='0'KX/8YKUA BWD$$6(Y('RY-+>&SF%I*1<1Z_!Y*+MX :'/#]-$3D8J
MT:)D5X:A,0_EAX_5/)1\."M<6F@W(/VY&/' QZ6X?MR.$ XK@D03-H+& ,#7
MN66)))5VP $.77";]]<5GN S0 J*:A9 ()$;X[(\&G6*!_Y-APD;_(<8PR@>
MDH]A7B@V?96PTNH4X&PD_-!$"@4<N<'1"D&&1$0;81(BV?<%W+3@DV/[\SAQ
MR4:([(!&P8I,!D133\5'X&I]P0(W'"0;X-8!H;=HS;6'?'=C!W9Z1&\';D@]
M*K$())W =NSJV"NQW1OHM\1A\_T$KZCT75KJ-MS*<S]DO< V6NJPJS'>8\Y-
MZ(<K+Z(1%Z8!9'E9+F49-Z(^BIC_!(BY"M/@&]JJ$QL)W/&FML"'*7S?M5J"
MA\OGR5<:I.\JC],HIGN#[ A1[8P&4?IFLWCC>R9ZJ]G+!K5\.JKET&$M.\J>
M63[X=66%#3!C1V._6VT/%+S+A2"_$=+0%&I&2:!LCM7Q..W1;7I&[HR>3G.M
M5>9G5-O!.J:JP'*(-V2U^-7&'MT/%G+G:W9#4[#CPS:JS6457 CS=8ACE@H@
MET)36]A=@J88^,S"RR%Y8 MC>NU3((-*.[!SME;X-S*I[S-]2MV5 *WHV0/L
MV9I\VNC/EIXV=VW78W,.9F[MF-XF\.B9'B.O= P_P*AP4P?Q'&UCMCFZ^$AE
M)O1;SYO\UDWQ*7ILDSJM_NYK%H&[Y+Y:=FP5G[0N/O[9HE]]<VJYLR:*$)IL
M68V48+4GRI>LX'MTE0CLH/H(I^4"Z^'27_H7(62PH:DODV7^W1G*H".4Y>>W
M/(53[W]"GK0N*.!.!4>1^+.*V^&DO&T)VZ:*19J9(^MW4KZX&@@G[1MR6%1)
MM%3H>E*>OS(4\#[F+OFG>&V&ACW)KM$+D'N9/D%ZD3YP2'S.^R!\B!!^I-O[
M*SNVA9[FA2@U:$D^9SVR[UEN\4'KX85XG^23UH7EL8\RUS,I?=9RR7</=#6[
M>Q!SQY]"$1MQ+^"G/0]X%$F2B]3A)\S(\%"1/N^MT,,Q@$][ZH*9&WG&5,>?
M,4QWNIIO/2C:C4DU>=[>B>]%/=0>A8<K[?/V*/RW^RC\69NGQ<],J2?3U]/B
M9X;EOR@\7*\FN7/P)+R>)7=^ I*[:".Y"TW)]78!KB_)71@FN:$=K<F23_]#
M'_,B^^<]1G?[$;X<-88 SE#K99M1K52M"RCDW4CN <;@T?9\ZO71=SH("UD=
M,@)3^N3;[M^\:W=L'.UAH$L-]*HA[2"!UY+#;](S,+6,BJ"+,>Y8CU9$BACX
MPG$7QBB_U\\7XWXK8]RQ'B77A,M)3UYFADHX:4UCI<[&^'H]JH4&BB>M+?FK
M"&0:S%$<^XC.@W% W2$MQ=$=![K PC%TJ!VVX"O%M1?8@>/9?ELCHCP =#6'
M8RB!)IJG?:.F4@!/[263'[ZO'1/?7\Y'_[P?W2VLT:_D?PUZP*3*H?S,E]_#
MB-*,LC(2C:W-B)++9"$IEVG*86J%KII!D0KEQK0C3I&*B85R8]+!XZNK"]Q:
M++6ROW#'@F]E?]_*_O8<5'Q=97\I^:_F22-U"\;A _Q)AK<7BT[PQ:)I@IVU
M':'B69<YPO0.EK@*AZP7=!RMBW=OU)#I[>(.Y_.7K01S"5Z4IG_!7!JV.E4L
MNM*[[*(^T#55)'LYL>=@XH/I5^@A'@=D8YU0)4H?VYUB+W"\K>WS923I9IB+
M)Y.3$@@G?0Y0X3!P,+VY<H72_[+3D#LDB'*I]H<^##Y,\!)8>EOFLBKLG(OW
M:9Y"N0GTP:TJRG7*X:<25PCS&'M?JX_7I[: )Q1A%VCW3TM("LQKW67+_D+_
MYX',)/*;_P]02P$"% ,4    "  6@&U917.G[-D2   0$P  $@
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M &XR-3<T7W@R,C1E>&@S,BTQ+FAT;5!+ 0(4 Q0    ( !: ;5E\U2/;=00
M )\/   5              "  01F 0!N,C4W-%]X,C(T97AH,S(M,BYH=&U0
M2P$"% ,4    "  6@&U9YD1\80!3  "T;@( %0              @ &L:@$
M;C(U-S1?>#(R-&5X:#0M,3 N:'1M4$L! A0#%     @ %H!M63$R'ZS_"P
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M7W@R,C1E>&@T+3DN:'1M4$L! A0#%     @ %H!M64'+-T$$$P  Y[L  !(
M             ( !D,H" &YI;V)F+3(P,C0P.3,P+GAS9%!+ 0(4 Q0    (
M !: ;5D%S!&5K!0  #O'   6              "  <3= @!N:6]B9BTR,#(T
M,#DS,%]C86PN>&UL4$L! A0#%     @ %H!M66+]EJ/W*0  R%," !8
M         ( !I/(" &YI;V)F+3(P,C0P.3,P7V1E9BYX;6Q02P$"% ,4
M"  6@&U9E 1_C.I:  !E_ 0 %@              @ '/' , ;FEO8F8M,C R
M-# Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( !: ;5E7BO6CASX  %;+ P 6
M          "  >UW P!N:6]B9BTR,#(T,#DS,%]P<F4N>&UL4$L%!@     0
- !  )P0  *BV P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>n2574_x224-10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:niobf="http://niocorp.com/20240930"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="niobf-20240930.xsd" xlink:type="simple"/>
    <context id="From2024-07-01to2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_CommonSharesWithoutParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:CommonSharesWithoutParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:WarrantsEachExercisableFor1.11829212CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-11-13</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-11-012024-11-30_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-07-172024-07-19_us-gaap_UnsecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-17</startDate>
            <endDate>2024-07-19</endDate>
        </period>
    </context>
    <context id="From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-17</startDate>
            <endDate>2024-07-19</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_YorkvilleConvertibleDebentureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:YorkvilleConvertibleDebentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-04-102024-04-12_us-gaap_UnsecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-12</endDate>
        </period>
    </context>
    <context id="From2024-04-102024-04-12_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-12_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="From2024-08-302024-09-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-08-30</startDate>
            <endDate>2024-09-01</endDate>
        </period>
    </context>
    <context id="From2024-11-292024-12-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-11-29</startDate>
            <endDate>2024-12-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-08-28</instant>
        </period>
    </context>
    <context id="From2024-08-262024-08-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-08-26</startDate>
            <endDate>2024-08-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-09-03</instant>
        </period>
    </context>
    <context id="From2024-09-022024-09-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-02</startDate>
            <endDate>2024-09-03</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="From2024-09-042024-09-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-04</startDate>
            <endDate>2024-09-06</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-09-16</instant>
        </period>
    </context>
    <context id="From2024-09-142024-09-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-14</startDate>
            <endDate>2024-09-16</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="From2024-09-182024-09-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-18</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-09-25</instant>
        </period>
    </context>
    <context id="From2024-09-232024-09-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-23</startDate>
            <endDate>2024-09-25</endDate>
        </period>
    </context>
    <context id="From2024-09-232024-09-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-23</startDate>
            <endDate>2024-09-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePrice9.70Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice9.70Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePrice4.60Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice4.60Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePrice3.54Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.54Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePrice2.20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePrice3.35Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.35Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePrice3.25Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePrice11.50Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.50Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ExercisePrice2.31Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.31Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_GXIIPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-09-152024-09-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-15</startDate>
            <endDate>2024-09-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-17_custom_LindConsentWarrantIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-17</instant>
        </period>
    </context>
    <context id="From2024-09-152024-09-17_custom_LindConsentWarrantIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-15</startDate>
            <endDate>2024-09-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-17</instant>
        </period>
    </context>
    <context id="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-15</startDate>
            <endDate>2024-09-17</endDate>
        </period>
    </context>
    <context id="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-15</startDate>
            <endDate>2024-09-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:NonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:GeneralSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-02</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-06_us-gaap_SubsequentEventMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-06</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_TechnicalStudiesAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:TechnicalStudiesAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_TechnicalStudiesAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:TechnicalStudiesAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_FieldmanagementandotherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldmanagementandotherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_FieldmanagementandotherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldmanagementandotherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_MetallurgicaldevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicaldevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_MetallurgicaldevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicaldevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_GeologistAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_GeologistAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-10-022024-10-03_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-02</startDate>
            <endDate>2024-10-03</endDate>
        </period>
    </context>
    <context id="From2024-09-292024-10-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-29</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="From2024-11-022024-11-04_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-02</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-04_us-gaap_SubsequentEventMember_custom_PurchaseAgreementSeriesAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-04_us-gaap_SubsequentEventMember_custom_PurchaseAgreementSeriesBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementSeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="From2024-11-102024-11-13_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-10</startDate>
            <endDate>2024-11-13</endDate>
        </period>
    </context>
    <context id="From2024-11-112024-11-12_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-11</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Number">
        <measure>niobf:N</measure>
    </unit>
    <unit id="CADPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-07-01to2024-09-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2024-07-01to2024-09-30" id="Fact000004">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-07-01to2024-09-30" id="Fact000005">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-07-01to2024-09-30" id="Fact000006">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="From2024-07-01to2024-09-30" id="Fact000007">0001512228</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0021">A1</dei:EntityIncorporationStateCountryCode>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RelatedPartyDepositLiabilities
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0099"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0122"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0138">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0140">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <niobf:ChangeInFairValueOfConvertibleNotes
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0183"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0192"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0194"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0200"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ChangeInFairValueOfConvertibleNote
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0234"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0240"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0279"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ValueOfWarrantsIssued
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0322"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0323"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0331"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0339"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants
      contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NumberOfReportableSegments
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="xdx2ixbrl0409"
      unitRef="Number">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="xdx2ixbrl0484"
      unitRef="USD">-2102000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="xdx2ixbrl0486"
      unitRef="USD">-3387000</us-gaap:NetIncomeLoss>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="From2024-09-042024-09-06"
      id="xdx2ixbrl0654"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="From2024-09-142024-09-16"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="From2024-09-182024-09-19"
      id="xdx2ixbrl0670"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0692"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0694"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0696"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0698"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0708"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2024-07-01to2024-09-30" id="xdx2ixbrl0710">P3Y2M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <niobf:ClassOfWarrantOrRightExercised
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0722"
      unitRef="Shares"
      xsi:nil="true"/>
    <niobf:ClassOfWarrantOrRightExercisePriceExercised
      contextRef="From2024-07-01to2024-09-30"
      id="xdx2ixbrl0724"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-07-012024-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0803">P3Y5M30D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0805">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0833">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012024-09-30_custom_TechnicalStudiesAndEngineeringMember"
      id="xdx2ixbrl0860"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012024-09-30_custom_GeologistAndFieldStaffMember"
      id="xdx2ixbrl0866"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0920"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0921"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0925"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0926"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0930"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0931"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0934"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0935"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0939"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0940"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0944"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0946"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0949"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0955"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0956"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0960"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0961"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0965"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0966"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0969"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0970"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0974"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0975"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0979"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0984"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-07-01to2024-09-30" id="Fact000015">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2024-07-01to2024-09-30" id="Fact000016">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-07-01to2024-09-30" id="Fact000017">2024-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2024-07-01to2024-09-30" id="Fact000018">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-07-01to2024-09-30" id="Fact000019">001-41655</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-07-01to2024-09-30" id="Fact000020">NioCorp Developments Ltd.</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-07-01to2024-09-30" id="Fact000022">98-1262185</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-07-01to2024-09-30" id="Fact000023">7000 South Yosemite Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-07-01to2024-09-30" id="Fact000024">Suite         115</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-07-01to2024-09-30" id="Fact000025">Centennial</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-07-01to2024-09-30" id="Fact000026">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-07-01to2024-09-30" id="Fact000027">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-07-01to2024-09-30" id="Fact000028">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-07-01to2024-09-30" id="Fact000029">334-7066</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2024-07-012024-09-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000030">Common Shares, without par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-07-012024-09-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000031">NB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-07-012024-09-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-07-012024-09-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember"
      id="Fact000033">Warrants, each exercisable for 1.11829212 Common Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-07-012024-09-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember"
      id="Fact000034">NIOBW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-07-012024-09-30_custom_WarrantsEachExercisableFor1.11829212CommonSharesMember"
      id="Fact000035">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2024-07-01to2024-09-30" id="Fact000036">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-07-01to2024-09-30" id="Fact000037">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-07-01to2024-09-30" id="Fact000038">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-07-01to2024-09-30" id="Fact000039">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-07-01to2024-09-30" id="Fact000040">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2024-07-01to2024-09-30" id="Fact000041">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-11-13"
      decimals="INF"
      id="Fact000042"
      unitRef="Shares">42512202</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000050"
      unitRef="USD">150000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000051"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000053"
      unitRef="USD">459000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000056"
      unitRef="USD">587000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000057"
      unitRef="USD">916000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000059"
      unitRef="USD">1196000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000060"
      unitRef="USD">2928000</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssets
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000065"
      unitRef="USD">35000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000066"
      unitRef="USD">35000</us-gaap:DepositsAssets>
    <us-gaap:LongTermInvestmentsAndReceivablesNet
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000068"
      unitRef="USD">4000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:LongTermInvestmentsAndReceivablesNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000069"
      unitRef="USD">4000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000071"
      unitRef="USD">167000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000072"
      unitRef="USD">181000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000074"
      unitRef="USD">836000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000075"
      unitRef="USD">837000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000077"
      unitRef="USD">16085000</us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties>
    <us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000078"
      unitRef="USD">16085000</us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties>
    <us-gaap:Assets
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000080"
      unitRef="USD">18323000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000081"
      unitRef="USD">20070000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000089"
      unitRef="USD">2736000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000090"
      unitRef="USD">1843000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000093"
      unitRef="USD">2365000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000095"
      unitRef="USD">5258000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000096"
      unitRef="USD">7660000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:RelatedPartyDepositLiabilities
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000098"
      unitRef="USD">33000</us-gaap:RelatedPartyDepositLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000101"
      unitRef="USD">97000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000102"
      unitRef="USD">96000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000104"
      unitRef="USD">8124000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000105"
      unitRef="USD">11964000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000110"
      unitRef="USD">1595000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000111"
      unitRef="USD">1651000</us-gaap:OtherLiabilitiesNoncurrent>
    <niobf:EarnoutLiabilityAtFairValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000113"
      unitRef="USD">4633000</niobf:EarnoutLiabilityAtFairValue>
    <niobf:EarnoutLiabilityAtFairValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000114"
      unitRef="USD">3817000</niobf:EarnoutLiabilityAtFairValue>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000116"
      unitRef="USD">87000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000117"
      unitRef="USD">104000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000119"
      unitRef="USD">14439000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000120"
      unitRef="USD">17536000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000125"
      unitRef="USD">1503000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000126"
      unitRef="USD">1534000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000134"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000136"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000142"
      unitRef="Shares">38720244</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000144"
      unitRef="Shares">38062647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000131"
      unitRef="USD">167275000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000132"
      unitRef="USD">163823000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000146"
      unitRef="USD">-163983000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000147"
      unitRef="USD">-161912000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000149"
      unitRef="USD">-911000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000150"
      unitRef="USD">-911000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000152"
      unitRef="USD">2381000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000153"
      unitRef="USD">1000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000155"
      unitRef="USD">18323000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000156"
      unitRef="USD">20070000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000161"
      unitRef="USD">330000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000162"
      unitRef="USD">322000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000164"
      unitRef="USD">450000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000165"
      unitRef="USD">1187000</us-gaap:ProfessionalFees>
    <niobf:ExplorationExpenditures
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000167"
      unitRef="USD">138000</niobf:ExplorationExpenditures>
    <niobf:ExplorationExpenditures
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000168"
      unitRef="USD">1100000</niobf:ExplorationExpenditures>
    <us-gaap:OtherGeneralExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000170"
      unitRef="USD">477000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000171"
      unitRef="USD">834000</us-gaap:OtherGeneralExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000173"
      unitRef="USD">1395000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000174"
      unitRef="USD">3443000</us-gaap:OperatingExpenses>
    <niobf:ChangeInFairValueOfEarnoutLiability
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000176"
      unitRef="USD">-816000</niobf:ChangeInFairValueOfEarnoutLiability>
    <niobf:ChangeInFairValueOfEarnoutLiability
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000177"
      unitRef="USD">2093000</niobf:ChangeInFairValueOfEarnoutLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000179"
      unitRef="USD">-56000</niobf:ChangeInFairValueOfWarrantLiability>
    <niobf:ChangeInFairValueOfWarrantLiability
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000180"
      unitRef="USD">73000</niobf:ChangeInFairValueOfWarrantLiability>
    <niobf:ChangeInFairValueOfConvertibleNotes
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000182"
      unitRef="USD">-17000</niobf:ChangeInFairValueOfConvertibleNotes>
    <us-gaap:InterestExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000185"
      unitRef="USD">-44000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000186"
      unitRef="USD">-2075000</us-gaap:InterestExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000188"
      unitRef="USD">8000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000189"
      unitRef="USD">-11000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OtherIncome
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000191"
      unitRef="USD">-122000</us-gaap:OtherIncome>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000195"
      unitRef="USD">1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000197"
      unitRef="USD">-2102000</niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1>
    <niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000198"
      unitRef="USD">-3488000</niobf:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000201"
      unitRef="USD">101000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000203"
      unitRef="USD">-2102000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000204"
      unitRef="USD">-3387000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000206"
      unitRef="USD">31000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000207"
      unitRef="USD">174000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000209"
      unitRef="USD">-2071000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000210"
      unitRef="USD">-3213000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000212"
      unitRef="USDPShares">-0.05</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000213"
      unitRef="USDPShares">-0.09</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000215"
      unitRef="Shares">38361344</niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000216"
      unitRef="Shares">31967091</niobf:TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000221"
      unitRef="USD">-2102000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000222"
      unitRef="USD">-3387000</us-gaap:NetIncomeLoss>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000227"
      unitRef="USD">816000</niobf:ChangeInFairValueOfEarnoutShareLiability>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000228"
      unitRef="USD">-2093000</niobf:ChangeInFairValueOfEarnoutShareLiability>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000230"
      unitRef="USD">-56000</niobf:ChangeInValuationOfWarrantLiabilities>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000231"
      unitRef="USD">73000</niobf:ChangeInValuationOfWarrantLiabilities>
    <niobf:ChangeInFairValueOfConvertibleNote
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000233"
      unitRef="USD">17000</niobf:ChangeInFairValueOfConvertibleNote>
    <us-gaap:AccretionExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000236"
      unitRef="USD">44000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000237"
      unitRef="USD">2075000</us-gaap:AccretionExpense>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000239"
      unitRef="USD">122000</niobf:OtheroperatingGainsLosses>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000242"
      unitRef="USD">-1000</niobf:FairValueOfCommitmentSharesIssued>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000243"
      unitRef="USD">53000</niobf:FairValueOfCommitmentSharesIssued>
    <us-gaap:Depreciation
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000245"
      unitRef="USD">1000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000246"
      unitRef="USD">1000</us-gaap:Depreciation>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000249"
      unitRef="USD">-1000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000251"
      unitRef="USD">-1000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000252"
      unitRef="USD">-1000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000254"
      unitRef="USD">-1404000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000255"
      unitRef="USD">-3278000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000260"
      unitRef="USD">130000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000261"
      unitRef="USD">-417000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000263"
      unitRef="USD">892000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000264"
      unitRef="USD">124000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000266"
      unitRef="USD">-642000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000267"
      unitRef="USD">-2737000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000272"
      unitRef="USD">692000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000273"
      unitRef="USD">1532000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000275"
      unitRef="USD">33000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000278"
      unitRef="USD">1943000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000281"
      unitRef="USD">2000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000282"
      unitRef="USD">38000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000284"
      unitRef="USD">-1220000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000285"
      unitRef="USD">1494000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000287"
      unitRef="USD">-1862000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000288"
      unitRef="USD">-1243000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000290"
      unitRef="USD">2012000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000291"
      unitRef="USD">2341000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000293"
      unitRef="USD">150000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-09-30"
      decimals="-3"
      id="Fact000294"
      unitRef="USD">1098000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <niobf:ConversionsOfDebtForCommonShares
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000299"
      unitRef="USD">501000</niobf:ConversionsOfDebtForCommonShares>
    <niobf:ConversionsOfDebtForCommonShares
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000300"
      unitRef="USD">5729000</niobf:ConversionsOfDebtForCommonShares>
    <niobf:ValueOfWarrantsIssued
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000302"
      unitRef="USD">2262000</niobf:ValueOfWarrantsIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000311"
      unitRef="Shares">31202131</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000305"
      unitRef="USD">140421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000306"
      unitRef="USD">-150477000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000307"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000308"
      unitRef="USD">-10967000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000309"
      unitRef="USD">2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <niobf:PrivatePlacementShares
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000319"
      unitRef="Shares">250000</niobf:PrivatePlacementShares>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000313"
      unitRef="USD">1000000</niobf:PrivatePlacementValue>
    <niobf:PrivatePlacementValue
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000316"
      unitRef="USD">1000000</niobf:PrivatePlacementValue>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000327"
      unitRef="Shares">145000</niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000321"
      unitRef="USD">585000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000324"
      unitRef="USD">585000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000335"
      unitRef="Shares">1316288</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000329"
      unitRef="USD">5729000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000332"
      unitRef="USD">5729000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000337"
      unitRef="USD">-38000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000340"
      unitRef="USD">-38000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000344"
      unitRef="USD">-3213000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000346"
      unitRef="USD">-3213000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012023-09-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000347"
      unitRef="USD">-174000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000355"
      unitRef="Shares">32913419</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000349"
      unitRef="USD">147697000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000350"
      unitRef="USD">-153690000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000351"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30"
      decimals="-3"
      id="Fact000352"
      unitRef="USD">-6904000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-09-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000353"
      unitRef="USD">1926000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000363"
      unitRef="Shares">38062647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000357"
      unitRef="USD">163823000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000358"
      unitRef="USD">-161912000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000359"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000360"
      unitRef="USD">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000361"
      unitRef="USD">1534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000371"
      unitRef="Shares">399250</niobf:SharesIssuedUnderTheYorkvilleEquityFacilityShares>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000365"
      unitRef="USD">691000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <niobf:SharesIssuedUnderTheYorkvilleEquityFacility
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000368"
      unitRef="USD">691000</niobf:SharesIssuedUnderTheYorkvilleEquityFacility>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000379"
      unitRef="Shares">258347</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000373"
      unitRef="USD">501000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000376"
      unitRef="USD">501000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000381"
      unitRef="USD">2262000</niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000384"
      unitRef="USD">2262000</niobf:StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000387"
      unitRef="USD">-2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000390"
      unitRef="USD">-2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000394"
      unitRef="USD">-2071000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000396"
      unitRef="USD">-2071000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012024-09-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000397"
      unitRef="USD">-31000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000405"
      unitRef="Shares">38720244</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000399"
      unitRef="USD">167275000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000400"
      unitRef="USD">-163983000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000401"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000402"
      unitRef="USD">2381000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-09-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000403"
      unitRef="USD">1503000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NatureOfOperations contextRef="From2024-07-01to2024-09-30" id="Fact000407">&lt;p id="xdx_80F_eus-gaap--NatureOfOperations_zYOu73kDNj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82C_zG0C54Bd2Ow7"&gt;DESCRIPTION
    OF BUSINESS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
Developments Ltd. (&#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;NioCorp&#x201d; or the &#x201c;Company&#x201d;)
was incorporated on February 27, 1987, under the laws of the Province of British Columbia and currently operates in &lt;span id="xdx_903_eus-gaap--NumberOfReportableSegments_dxL_uNumber_c20240701__20240930_zMxz1FFDWmP7" title="Number of reportable segments::XDX::1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0409"&gt;one&lt;/span&gt;&lt;/span&gt; reportable
operating segment consisting of exploration and development of mineral deposits in North America, specifically, the Company&#x2019;s
niobium, scandium, and titanium project (the &#x201c;Elk Creek Project&#x201d;) located in southeastern Nebraska.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
interim condensed consolidated financial statements have been prepared on a going concern basis that contemplates the realization
of assets and discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These
financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 3, these matters raised substantial doubt about the Company&#x2019;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfAccounting contextRef="From2024-07-01to2024-09-30" id="Fact000411">&lt;p id="xdx_80D_eus-gaap--BasisOfAccounting_zysVj0Atdfwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;

    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_827_zmncpzFAIFK6"&gt;BASIS
    OF PRESENTATION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAS8vA0YxUC9" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zbG62WJMUltc"&gt;Basis
    of Presentation and Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles of the United States of America (&#x201c;U.S. GAAP&#x201d;) and the rules and regulations of the Securities and Exchange
Commission (&#x201c;SEC&#x201d;). The interim condensed consolidated financial statements include the consolidated accounts of the
Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed
in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited
consolidated financial statements for the year ended June 30, 2024. Certain transactions include reference to Canadian dollars
(&#x201c;C$&#x201d;) where applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the opinion of management, all adjustments considered necessary (including normal recurring adjustments) for a fair statement
of the financial position, results of operations, and cash flows at September 30, 2024, and for all periods presented, have been
included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included
in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to appropriate
SEC rules and regulations. These interim condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements for the year ended June 30, 2024. The interim results are not necessarily indicative of results
for the full year ending June 30, 2025, or future operating periods.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zvMgGNB4otD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOCmPn7lNNj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_z3UoeJf1dJM6"&gt;Recent
    Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Not Effective&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) that are
adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of
recently issued standards did not or will not have a material impact on the Company&#x2019;s consolidated financial statements
upon adoption.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_z3GFShKbKQyh" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--UseOfEstimates_z3SiY5w94AGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_z5OQnemVNJh9"&gt;Use
    of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements, and the reported amounts of&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;expenses
during the reporting period. The Company regularly evaluates estimates and assumptions related to the carrying value of
long-term assets, deferred income tax assets and related valuations, liabilities related to the April 2024 Notes, Earnout
Shares, Private Warrants, and Contingent Consent Warrants (each, as defined below), and share-based compensation. The Company
bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be
reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The
actual results experienced by the Company may differ materially and adversely from the Company&#x2019;s estimates. To the
extent there are material differences between estimates and the actual results, future results of operations will be
affected.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The Company acquired a federal income tax payable of $&lt;span id="xdx_90D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20240701__20240930_zlBtMPIJ1op1" title="Federal income tax payable"&gt;443&lt;/span&gt; in connection with the GXII Transaction (as defined below). As a result of post-transaction losses at Elk Creek Resources Corp. (&#x201c;ECRC&#x201d;), a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable of $&lt;span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20230701__20230930_zPdI1r0unlw8" title="Income tax payable"&gt;101&lt;/span&gt; was recorded as an income tax benefit in the condensed consolidated statement of operations and comprehensive loss for the three months ended September 30, 2023. The Company maintains a full valuation allowance against future income tax assets as it is more likely than not that all of the assets will not be realized.

&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_850_zdE5GLaBrof5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zDPbzauHgqsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86C_z6q9i4Iyxf9j"&gt;Basic
    and Diluted Earnings per Share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zsGGon4HYLmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8BF_z4l8xyzsUWA6"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months &lt;br/&gt;Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify; padding-left: 0.125in"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLoss1_pn3n3_c20240701__20240930_zXURRH4Zq1Qf" style="width: 12%; text-align: right" title="Net loss"&gt;(2,102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetIncomeLoss1_pn3n3_c20230701__20230930_z3Nbict3AAE9" style="width: 12%; text-align: right" title="Net loss"&gt;(3,387&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less: Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20240701__20240930_zFzHDQM6k5Pj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230701__20230930_zrbmEO99sj22" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest"&gt;(174&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20240930_zO1oS9kkliB7" style="text-align: right" title="Net loss available to participating securities"&gt;(2,071&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20230930_zBwJ4DnmPTml" style="text-align: right" title="Net loss available to participating securities"&gt;(3,213&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less: Net loss attributable to vested shares of ECRC Class B common stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20240701__20240930_zOffFp98jZoe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock"&gt;(186&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20230930_zbjS9KFiAS9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock"&gt;(257&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20240930_z79TUoCxd7I6" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock"&gt;(1,885&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20230930_zU3Yo09f6yFl" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock"&gt;(2,956&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20240930_zCjQCklwt7i1" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;38,361,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20230930_zocTkntBB0de" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;31,967,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20240701__20240930_zIGXkG54ss4" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.05&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20230930_zfK9460Y3fkb" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.09&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zkIsFeClJGA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following common shares, no par value, of the Company (&#x201c;Common Shares&#x201d;) underlying options to purchase Common Shares
(&#x201c;Options&#x201d;), Common Share purchase warrants (&#x201c;Warrants&#x201d;), and outstanding convertible debt were&#160;antidilutive&#160;due
to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three-month
periods indicated below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_znZLZfAkFCH" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zhUeftbbcOy2" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months &lt;br/&gt;Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Excluded potentially dilutive securities &lt;sup id="xdx_F6F_zIte5Np7FUFf"&gt;(1)(2)&lt;/sup&gt;:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20240930_fKDEpKDIp_zbrcgLpWgE6d" style="width: 12%; text-align: right" title="Options"&gt;2,455,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20230930_fKDEpKDIp_z1MJsWfUsQR" style="width: 12%; text-align: right" title="Options"&gt;1,319,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20240930_fKDEpKDIp_zXvYfHZKQGNi" style="text-align: right" title="Warrants"&gt;20,932,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20230930_fKDEpKDIp_zNG0pUxA0mf7" style="text-align: right" title="Warrants"&gt;19,066,304&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20240701__20240930_fKDEpKDIp_zAvLv9qp0eW6" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;1,920,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20230930_fKDEpKDIp_zaVTCGQ29mda" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,448,730&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Total potential dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DilutiveSecurities_c20240701__20240930_fKDEpKDIp_zIbOnODh7Mgc" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities"&gt;25,308,485&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DilutiveSecurities_c20230701__20230930_fKDEpKDIp_zvnMIq7Frfoj" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities"&gt;22,834,034&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.375in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.375in; text-align: justify"&gt;&lt;span id="xdx_F02_zjAwZAoQHD6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zzr8bMTPhwY9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F0B_zvkAbz8xNUta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zU6ppeYGWiRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_z1aDhns6aQ6k" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zBEmehzoAVh8" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccounting>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000413">&lt;p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAS8vA0YxUC9" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_868_zbG62WJMUltc"&gt;Basis
    of Presentation and Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles of the United States of America (&#x201c;U.S. GAAP&#x201d;) and the rules and regulations of the Securities and Exchange
Commission (&#x201c;SEC&#x201d;). The interim condensed consolidated financial statements include the consolidated accounts of the
Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed
in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited
consolidated financial statements for the year ended June 30, 2024. Certain transactions include reference to Canadian dollars
(&#x201c;C$&#x201d;) where applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the opinion of management, all adjustments considered necessary (including normal recurring adjustments) for a fair statement
of the financial position, results of operations, and cash flows at September 30, 2024, and for all periods presented, have been
included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included
in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to appropriate
SEC rules and regulations. These interim condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements for the year ended June 30, 2024. The interim results are not necessarily indicative of results
for the full year ending June 30, 2025, or future operating periods.&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000415">&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOCmPn7lNNj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_z3UoeJf1dJM6"&gt;Recent
    Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Not Effective&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) that are
adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of
recently issued standards did not or will not have a material impact on the Company&#x2019;s consolidated financial statements
upon adoption.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-07-01to2024-09-30" id="Fact000417">&lt;p id="xdx_842_eus-gaap--UseOfEstimates_z3SiY5w94AGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_z5OQnemVNJh9"&gt;Use
    of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements, and the reported amounts of&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;expenses
during the reporting period. The Company regularly evaluates estimates and assumptions related to the carrying value of
long-term assets, deferred income tax assets and related valuations, liabilities related to the April 2024 Notes, Earnout
Shares, Private Warrants, and Contingent Consent Warrants (each, as defined below), and share-based compensation. The Company
bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be
reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The
actual results experienced by the Company may differ materially and adversely from the Company&#x2019;s estimates. To the
extent there are material differences between estimates and the actual results, future results of operations will be
affected.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The Company acquired a federal income tax payable of $&lt;span id="xdx_90D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_c20240701__20240930_zlBtMPIJ1op1" title="Federal income tax payable"&gt;443&lt;/span&gt; in connection with the GXII Transaction (as defined below). As a result of post-transaction losses at Elk Creek Resources Corp. (&#x201c;ECRC&#x201d;), a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable of $&lt;span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_c20230701__20230930_zPdI1r0unlw8" title="Income tax payable"&gt;101&lt;/span&gt; was recorded as an income tax benefit in the condensed consolidated statement of operations and comprehensive loss for the three months ended September 30, 2023. The Company maintains a full valuation allowance against future income tax assets as it is more likely than not that all of the assets will not be realized.

&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000426"
      unitRef="USD">443000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000428"
      unitRef="USD">101000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000430">&lt;p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zDPbzauHgqsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86C_z6q9i4Iyxf9j"&gt;Basic
    and Diluted Earnings per Share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zsGGon4HYLmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8BF_z4l8xyzsUWA6"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months &lt;br/&gt;Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify; padding-left: 0.125in"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLoss1_pn3n3_c20240701__20240930_zXURRH4Zq1Qf" style="width: 12%; text-align: right" title="Net loss"&gt;(2,102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetIncomeLoss1_pn3n3_c20230701__20230930_z3Nbict3AAE9" style="width: 12%; text-align: right" title="Net loss"&gt;(3,387&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less: Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20240701__20240930_zFzHDQM6k5Pj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230701__20230930_zrbmEO99sj22" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest"&gt;(174&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20240930_zO1oS9kkliB7" style="text-align: right" title="Net loss available to participating securities"&gt;(2,071&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20230930_zBwJ4DnmPTml" style="text-align: right" title="Net loss available to participating securities"&gt;(3,213&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less: Net loss attributable to vested shares of ECRC Class B common stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20240701__20240930_zOffFp98jZoe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock"&gt;(186&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20230930_zbjS9KFiAS9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock"&gt;(257&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20240930_z79TUoCxd7I6" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock"&gt;(1,885&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20230930_zU3Yo09f6yFl" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock"&gt;(2,956&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20240930_zCjQCklwt7i1" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;38,361,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20230930_zocTkntBB0de" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;31,967,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20240701__20240930_zIGXkG54ss4" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.05&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20230930_zfK9460Y3fkb" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.09&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zkIsFeClJGA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following common shares, no par value, of the Company (&#x201c;Common Shares&#x201d;) underlying options to purchase Common Shares
(&#x201c;Options&#x201d;), Common Share purchase warrants (&#x201c;Warrants&#x201d;), and outstanding convertible debt were&#160;antidilutive&#160;due
to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three-month
periods indicated below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_znZLZfAkFCH" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zhUeftbbcOy2" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months &lt;br/&gt;Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Excluded potentially dilutive securities &lt;sup id="xdx_F6F_zIte5Np7FUFf"&gt;(1)(2)&lt;/sup&gt;:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20240930_fKDEpKDIp_zbrcgLpWgE6d" style="width: 12%; text-align: right" title="Options"&gt;2,455,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20230930_fKDEpKDIp_z1MJsWfUsQR" style="width: 12%; text-align: right" title="Options"&gt;1,319,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20240930_fKDEpKDIp_zXvYfHZKQGNi" style="text-align: right" title="Warrants"&gt;20,932,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20230930_fKDEpKDIp_zNG0pUxA0mf7" style="text-align: right" title="Warrants"&gt;19,066,304&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20240701__20240930_fKDEpKDIp_zAvLv9qp0eW6" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;1,920,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20230930_fKDEpKDIp_zaVTCGQ29mda" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,448,730&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Total potential dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DilutiveSecurities_c20240701__20240930_fKDEpKDIp_zIbOnODh7Mgc" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities"&gt;25,308,485&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DilutiveSecurities_c20230701__20230930_fKDEpKDIp_zvnMIq7Frfoj" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities"&gt;22,834,034&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.375in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.375in; text-align: justify"&gt;&lt;span id="xdx_F02_zjAwZAoQHD6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zzr8bMTPhwY9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F0B_zvkAbz8xNUta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zU6ppeYGWiRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_z1aDhns6aQ6k" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000432">&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zsGGon4HYLmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8BF_z4l8xyzsUWA6"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months &lt;br/&gt;Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify; padding-left: 0.125in"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLoss1_pn3n3_c20240701__20240930_zXURRH4Zq1Qf" style="width: 12%; text-align: right" title="Net loss"&gt;(2,102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetIncomeLoss1_pn3n3_c20230701__20230930_z3Nbict3AAE9" style="width: 12%; text-align: right" title="Net loss"&gt;(3,387&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less: Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20240701__20240930_zFzHDQM6k5Pj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di_c20230701__20230930_zrbmEO99sj22" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to noncontrolling interest"&gt;(174&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20240930_zO1oS9kkliB7" style="text-align: right" title="Net loss available to participating securities"&gt;(2,071&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20230930_zBwJ4DnmPTml" style="text-align: right" title="Net loss available to participating securities"&gt;(3,213&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less: Net loss attributable to vested shares of ECRC Class B common stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20240701__20240930_zOffFp98jZoe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock"&gt;(186&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20230930_zbjS9KFiAS9" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Net loss attributable to vested shares of ECRC Class B common stock"&gt;(257&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20240930_z79TUoCxd7I6" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock"&gt;(1,885&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20230930_zU3Yo09f6yFl" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock"&gt;(2,956&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20240930_zCjQCklwt7i1" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;38,361,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20230930_zocTkntBB0de" style="text-align: right" title="Weighted average shares outstanding basic and diluted"&gt;31,967,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2pt; padding-left: 0.125in"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20240701__20240930_zIGXkG54ss4" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.05&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20230930_zfK9460Y3fkb" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted"&gt;(0.09&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <niobf:NetIncomeLoss1
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000434"
      unitRef="USD">-2102000</niobf:NetIncomeLoss1>
    <niobf:NetIncomeLoss1
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000436"
      unitRef="USD">-3387000</niobf:NetIncomeLoss1>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000438"
      unitRef="USD">31000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000440"
      unitRef="USD">174000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000442"
      unitRef="USD">-2071000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000444"
      unitRef="USD">-3213000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000446"
      unitRef="USD">-186000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000448"
      unitRef="USD">-257000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000450"
      unitRef="USD">-1885000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000452"
      unitRef="USD">-2956000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000454"
      unitRef="Shares">38361344</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000456"
      unitRef="Shares">31967091</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000458"
      unitRef="USDPShares">-0.05</niobf:EarningsLossPerShareBasicAndDiluted>
    <niobf:EarningsLossPerShareBasicAndDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000460"
      unitRef="USDPShares">-0.09</niobf:EarningsLossPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000462">&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_znZLZfAkFCH" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_8BC_zhUeftbbcOy2" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months &lt;br/&gt;Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Excluded potentially dilutive securities &lt;sup id="xdx_F6F_zIte5Np7FUFf"&gt;(1)(2)&lt;/sup&gt;:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20240930_fKDEpKDIp_zbrcgLpWgE6d" style="width: 12%; text-align: right" title="Options"&gt;2,455,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20230930_fKDEpKDIp_z1MJsWfUsQR" style="width: 12%; text-align: right" title="Options"&gt;1,319,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20240930_fKDEpKDIp_zXvYfHZKQGNi" style="text-align: right" title="Warrants"&gt;20,932,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20230930_fKDEpKDIp_zNG0pUxA0mf7" style="text-align: right" title="Warrants"&gt;19,066,304&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20240701__20240930_fKDEpKDIp_zAvLv9qp0eW6" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;1,920,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20230930_fKDEpKDIp_zaVTCGQ29mda" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,448,730&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Total potential dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DilutiveSecurities_c20240701__20240930_fKDEpKDIp_zIbOnODh7Mgc" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities"&gt;25,308,485&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DilutiveSecurities_c20230701__20230930_fKDEpKDIp_zvnMIq7Frfoj" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities"&gt;22,834,034&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.375in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.375in; text-align: justify"&gt;&lt;span id="xdx_F02_zjAwZAoQHD6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zzr8bMTPhwY9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F0B_zvkAbz8xNUta" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zU6ppeYGWiRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000464"
      unitRef="Shares">2455500</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000466"
      unitRef="Shares">1319000</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000468"
      unitRef="Shares">20932985</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000470"
      unitRef="Shares">19066304</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000472"
      unitRef="Shares">1920000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000474"
      unitRef="Shares">2448730</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000476"
      unitRef="USD">25308485000</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000478"
      unitRef="USD">22834034000</us-gaap:DilutiveSecurities>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000482">&lt;p id="xdx_807_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z3ot1tQpegTa" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;

    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82F_za61ndQ8GZvk"&gt;GOING CONCERN&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred a loss of $&lt;span id="xdx_907_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20240701__20240930_zR3aggC3yVq5" title="Net loss::XDX::-2102"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0484"&gt;2,071&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; for the three months ended September 30, 2024
(2023 - $&lt;span id="xdx_90A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20230930_zi4eiGAUmh17" title="Net loss::XDX::-3387"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0486"&gt;3,213&lt;/span&gt;&lt;/span&gt;) and had a working capital deficit of $&lt;span id="xdx_907_eus-gaap--InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward_iI_pn3n3_c20240930_zhDqDUrrZlPc" title="Capital deficit"&gt;6,928&lt;/span&gt; and an accumulated deficit
of $&lt;span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20240930_z12bkB9Yxdla" title="Accumulated deficit"&gt;163,983&lt;/span&gt; as of September 30, 2024. As a development stage issuer, the Company
has not yet commenced its mining operations and accordingly does not generate any revenue. As of September 30, 2024, the Company
had cash of $&lt;span id="xdx_90E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_c20240930_zPXvz8Fe2rb5" title="Cash"&gt;150&lt;/span&gt;, which will not be sufficient to&lt;/p&gt;




















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;fund normal operations or the repayment of the April 2024 Notes (as further
discussed in Note 5b) for the next twelve months. These conditions and events raise substantial doubt about the Company&#x2019;s
ability to continue as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;In response to these conditions
and events, the Company plans to obtain additional financing. As disclosed in Note 12, in November 2024 the Company closed an underwritten
public offering (the &#x201c;November 2024 Registered Offering&#x201d;) and a non-brokered private placement (the &#x201c;November
2024 Private Offering&#x201d;, and together with the November 2024 Registered Offering, the &#x201c;November Offerings&#x201d;) which
resulted in the receipt of net proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20241101__20241130__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zomX2bnvVDck" title="Net proceeds"&gt;6,000&lt;/span&gt;, after giving effect to certain fees but before estimated underwriting discounts and  offering
expenses. In addition, NioCorp expects to have access to up to $58,577 in net proceeds from the Standby Equity Purchase Agreement,
dated January 26, 2023 (the &#x201c;Yorkville Equity Facility Financing Agreement&#x201d;), between the Company and YA II PN, Ltd.,
an investment fund managed by Yorkville Advisors Global, LP (&#x201c;Yorkville&#x201d;), through April 1, 2026. The Company may pursue
additional sources of financing, and while it has been successful in doing so in the past, there can be no assurance it will be
able to do so in the future. Other than the funds received from the November Offerings, and the potential issuance of Common Shares
under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements
for additional financing as of September 30, 2024. The Company&#x2019;s plans to obtain additional financing have not been finalized,
are subject to market conditions, and are not within the Company&#x2019;s control and therefore cannot be deemed probable. Further,
the Company will be required to raise additional funds for the construction and commencement of operations. As a result, the Company
has concluded that management&#x2019;s plans do not alleviate substantial doubt about the Company&#x2019;s ability to continue as
a going concern. &lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
interim condensed consolidated financial statements do not include any adjustments related to the recoverability and classification
of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000488"
      unitRef="USD">6928000</us-gaap:InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000490"
      unitRef="USD">-163983000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000492"
      unitRef="USD">150000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2024-11-012024-11-30_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact000501"
      unitRef="USD">6000000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000503">&lt;p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zkrkxGif55Lc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;

    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82B_z5e1RjR1mCNg"&gt;ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zc59G9He5hEd" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_8B0_zqwCVXE70PI9" style="display: none; visibility: hidden"&gt;Schedule of account payable and accrued liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20240930_zplwfu8pkiia" style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240630_ziB5bavhMO39" style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 30,&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zk9amtW1T47i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Accounts payable, trade&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,056&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,417&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z52oa7ArvAm9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade payable accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;603&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zRJOO7YReM53" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Environmental accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zGEuJyfS4n3e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Loan origination fees payable to related party&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;29&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zDoC9z6fm5P2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Total accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;2,736&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;1,843&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zFYbuJRn2mT6" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000505">&lt;p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zc59G9He5hEd" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_8B0_zqwCVXE70PI9" style="display: none; visibility: hidden"&gt;Schedule of account payable and accrued liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20240930_zplwfu8pkiia" style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240630_ziB5bavhMO39" style="text-align: center"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 30,&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zk9amtW1T47i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Accounts payable, trade&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,056&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,417&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_z52oa7ArvAm9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade payable accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;603&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_pn3n3_zRJOO7YReM53" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Environmental accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zGEuJyfS4n3e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Loan origination fees payable to related party&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;29&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_zDoC9z6fm5P2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2pt"&gt;Total accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;2,736&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;1,843&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000507"
      unitRef="USD">2056000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000508"
      unitRef="USD">1417000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000510"
      unitRef="USD">603000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000511"
      unitRef="USD">350000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000513"
      unitRef="USD">48000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000514"
      unitRef="USD">48000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000516"
      unitRef="USD">29000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000517"
      unitRef="USD">28000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000519"
      unitRef="USD">2736000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000520"
      unitRef="USD">1843000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000522">&lt;p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zZ5pfSsOJpyd" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;

    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_822_zxcPXBGvzH6b" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;DEBT&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
    Convertible Debenture&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the remaining
outstanding principal and accrued interest of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20240717__20240719__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zBxJTYCjssz2" title="Principal and accrued interest"&gt;554&lt;/span&gt; under the unsecured convertible debentures (the &#x201c;Convertible Debentures&#x201d;)
issued to Yorkville pursuant to the Securities Purchase Agreement, dated January 26, 2023 (the &#x201c;Yorkville Convertible Debt Financing
Agreement&#x201d;), into Common Shares in exchange for a $&lt;span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_c20240717__20240719__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zLK4PEtrT2w7" title="Shares exchange"&gt;95&lt;/span&gt; make-whole payment. The Company recorded a gain on extinguishment of $&lt;span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebentureMember_zw5wPnhgKjy1" title="Gain on extinguishment"&gt;19&lt;/span&gt;
as part other gains in the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&#160;&lt;/p&gt;




















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ConvertibleDebtTableTextBlock_zS6nsQGSn1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_z5wqrivMG86e"&gt;The
change in the Convertible Debentures is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; padding-bottom: 1pt"&gt;Balance at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleDebt_iS_pn3n3_c20240701__20240930_zkt8cMGNGeCb" style="width: 13%; text-align: right" title="Balance at June 30, 2024"&gt;571&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20240701__20240930_zjjm9GQdsxd2" style="text-align: right" title="Accretion expense"&gt;43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Principal and interest converted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_c20240701__20240930_z9tSqczqRNid" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted"&gt;(614&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20240930_zqWS7ql9Qxe6" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, September 30, 2024"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0545"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zGnP7n6uRoYf" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p id="xdx_892_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zM25WlNMclH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table discloses the components of interest expense associated with the Convertible Debentures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months&lt;br/&gt;
Ended September &#160;30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-left: 0.25in"&gt;Component of Interest Expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left; padding-left: 0.25in"&gt;Contractual&#160;&#160;interest&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ContractualInterest_pn3n3_c20240701__20240930_zdBZCTxVqjbi" style="width: 18%; text-align: right" title="Contractual interest"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ContractualInterest_pn3n3_c20230701__20230930_zEaS59Mdnkjl" style="width: 18%; text-align: right" title="Contractual interest"&gt;130&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Amortization of discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20240701__20240930_zku8MA5zWO4b" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs"&gt;43&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20230701__20230930_zTe3k1Qjtuu7" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs"&gt;1,945&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.25in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccretionExpense_pn3n3_c20240701__20240930_z3irbjodGS1k" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20230701__20230930_zN1Qw54oVmAf" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;2,075&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zdj80LYWzDUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (&#x201c;Lind II&#x201d;, and together with
Yorkville, the &#x201c;April 2024 Purchasers&#x201d;) $&lt;span id="xdx_900_eus-gaap--DebtInstrumentRepaidPrincipal_pn6n6_c20240410__20240412__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zGOpWurON7f3" title="Aggregate principal amount"&gt;8.0&lt;/span&gt; million aggregate principal amount of unsecured notes (the &#x201c;April
2024 Notes&#x201d;), pursuant to a securities purchase agreement, dated April 11, 2024 (the &#x201c;April 2024 Purchase Agreement&#x201d;),
between the Company and each of the April 2024 Purchasers. The Company also issued to the April 2024 Purchasers, in proportion
to the aggregate principal amount of April 2024 Notes issued to each April 2024 Purchaser, Warrants (the &#x201c;April 2024 Warrants&#x201d;)
to purchase up to &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240410__20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zOYitMs2lr8" title="Number of shares"&gt;615,385&lt;/span&gt; Common Shares, which are equal to &lt;span id="xdx_90B_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zSvTPALk9PF9" title="Percentage value"&gt;25&lt;/span&gt;% of the aggregate principal amount of April 2024 Notes issued to
the April 2024 Purchasers divided by the exercise price of $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240412__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zd4aJcrb51u1" title="Common share price, per share"&gt;3.25&lt;/span&gt;, subject to any adjustment to give effect to any stock dividend,
stock split or recapitalization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_z4T7CFUp5Rac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zP3ia3mTQTx4"&gt;The
change in the April 2024 Notes is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Three Months Ended September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 57%"&gt;Fair value at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_pn3n3_c20240701__20240930_zrbgGu03Nak8" style="width: 10%; text-align: right" title="Fair value at June 30, 2024"&gt;7,089&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Principal payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPayment_iN_pn3n3_di_c20240701__20240930_zR38p4UPZYJa" style="text-align: right" title="Principal payments"&gt;(1,848&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ChangeInFairValue_pn3n3_c20240701__20240930_zXNwEH7byeif" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_pn3n3_c20240701__20240930_z2mB5jzrtlmj" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024"&gt;5,258&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Remaining Principal Balance, September 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20240701__20240930_zdXlBrzHNPQc" style="text-align: right" title="Remaining Principal Balance, September 30, 2024"&gt;5,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zXJmZE5LW0p4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zjM31nbkrrj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zvbowS805Aka"&gt;The
change in the April 2024 Warrant liability is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Three Months Ended September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 57%"&gt;Fair value at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBoDip8spjwb" style="width: 10%; text-align: right" title="Fair value at June 30, 2024"&gt;298&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcVmgTLASd83" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;149&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zpZsfpFgI7t1" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024"&gt;447&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AC_zw9CaRw9KkZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 4, 2024, NioCorp entered into (i) a consent and waiver (the &#x201c;September Yorkville Consent&#x201d;) to the April
2024 Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together
with the Yorkville Consent, the &#x201c;September Consents&#x201d;) to the April 2024 Notes issued and sold to Lind II pursuant
to the April 2024 Purchase Agreement. The September Consents, among other things, reduced the amounts due to the April 2024 Purchasers
on September 1, 2024 by an aggregate of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20240830__20240901_zkSVTOdGiCk3" title="Aggregate principal amount"&gt;1,176&lt;/span&gt; to an aggregate of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn5n6_c20240830__20240901_zL8itnvPTor7" title="Increased the amounts due"&gt;336&lt;/span&gt;, increased the amounts due to the April 2024 Purchasers
on December 1, 2024 by an aggregate of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20241129__20241201_zmFMjZAK2Die" title="Aggregate principal amount"&gt;1,176&lt;/span&gt;, and prospectively waived any term of the April 2024 Notes that would otherwise
be triggered upon a failure of the Company to pay to the April 2024 Purchasers the remainder of the amount due on September 1,
2024. Except as modified by the September Consents and the October Consents (as defined below), as discussed in Note 12, the terms
of the April 2024 Notes as previously disclosed are unchanged.&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-07-172024-07-19_us-gaap_UnsecuredDebtMember"
      decimals="-3"
      id="Fact000524"
      unitRef="USD">554000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact000526"
      unitRef="USD">95000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-07-012024-09-30_custom_YorkvilleConvertibleDebentureMember"
      decimals="-3"
      id="Fact000528"
      unitRef="USD">19000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000537">&lt;p id="xdx_896_eus-gaap--ConvertibleDebtTableTextBlock_zS6nsQGSn1ok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_z5wqrivMG86e"&gt;The
change in the Convertible Debentures is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 54%; padding-bottom: 1pt"&gt;Balance at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleDebt_iS_pn3n3_c20240701__20240930_zkt8cMGNGeCb" style="width: 13%; text-align: right" title="Balance at June 30, 2024"&gt;571&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_c20240701__20240930_zjjm9GQdsxd2" style="text-align: right" title="Accretion expense"&gt;43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Principal and interest converted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_c20240701__20240930_z9tSqczqRNid" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted"&gt;(614&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20240930_zqWS7ql9Qxe6" style="border-bottom: Black 2pt solid; text-align: right" title="Balance, September 30, 2024"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0545"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000539"
      unitRef="USD">571000</us-gaap:ConvertibleDebt>
    <us-gaap:AccretionExpenseIncludingAssetRetirementObligations
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000541"
      unitRef="USD">43000</us-gaap:AccretionExpenseIncludingAssetRetirementObligations>
    <niobf:PrincipalAndAccruedInterestConverted
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000543"
      unitRef="USD">-614000</niobf:PrincipalAndAccruedInterestConverted>
    <us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000547">&lt;p id="xdx_892_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_zM25WlNMclH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table discloses the components of interest expense associated with the Convertible Debentures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months&lt;br/&gt;
Ended September &#160;30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify; padding-left: 0.25in"&gt;Component of Interest Expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left; padding-left: 0.25in"&gt;Contractual&#160;&#160;interest&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ContractualInterest_pn3n3_c20240701__20240930_zdBZCTxVqjbi" style="width: 18%; text-align: right" title="Contractual interest"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ContractualInterest_pn3n3_c20230701__20230930_zEaS59Mdnkjl" style="width: 18%; text-align: right" title="Contractual interest"&gt;130&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Amortization of discount and issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20240701__20240930_zku8MA5zWO4b" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs"&gt;43&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AmortizationOfFinancingCosts_pn3n3_c20230701__20230930_zTe3k1Qjtuu7" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization of discount and issuance costs"&gt;1,945&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt; padding-left: 0.25in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccretionExpense_pn3n3_c20240701__20240930_z3irbjodGS1k" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccretionExpense_pn3n3_c20230701__20230930_zN1Qw54oVmAf" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;2,075&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock>
    <niobf:ContractualInterest
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000549"
      unitRef="USD">1000</niobf:ContractualInterest>
    <niobf:ContractualInterest
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000551"
      unitRef="USD">130000</niobf:ContractualInterest>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000553"
      unitRef="USD">43000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000555"
      unitRef="USD">1945000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AccretionExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000557"
      unitRef="USD">44000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000559"
      unitRef="USD">2075000</us-gaap:AccretionExpense>
    <us-gaap:DebtInstrumentRepaidPrincipal
      contextRef="From2024-04-102024-04-12_us-gaap_UnsecuredDebtMember"
      decimals="-6"
      id="Fact000561"
      unitRef="USD">8000000.0</us-gaap:DebtInstrumentRepaidPrincipal>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-04-102024-04-12_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact000563"
      unitRef="Shares">615385</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:InvestmentInterestRate
      contextRef="AsOf2024-04-12_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact000565"
      unitRef="Pure">0.25</us-gaap:InvestmentInterestRate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-04-12_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact000567"
      unitRef="USDPShares">3.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000569">&lt;p id="xdx_89C_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_z4T7CFUp5Rac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zP3ia3mTQTx4"&gt;The
change in the April 2024 Notes is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Three Months Ended September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 57%"&gt;Fair value at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_pn3n3_c20240701__20240930_zrbgGu03Nak8" style="width: 10%; text-align: right" title="Fair value at June 30, 2024"&gt;7,089&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Principal payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DebtInstrumentPeriodicPayment_iN_pn3n3_di_c20240701__20240930_zR38p4UPZYJa" style="text-align: right" title="Principal payments"&gt;(1,848&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ChangeInFairValue_pn3n3_c20240701__20240930_zXNwEH7byeif" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_pn3n3_c20240701__20240930_z2mB5jzrtlmj" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024"&gt;5,258&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Remaining Principal Balance, September 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iE_pn3n3_c20240701__20240930_zdXlBrzHNPQc" style="text-align: right" title="Remaining Principal Balance, September 30, 2024"&gt;5,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000571"
      unitRef="USD">7089000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000573"
      unitRef="USD">1848000</us-gaap:DebtInstrumentPeriodicPayment>
    <niobf:ChangeInFairValue
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000575"
      unitRef="USD">17000</niobf:ChangeInFairValue>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000577"
      unitRef="USD">5258000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000579"
      unitRef="USD">5280000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000581">&lt;p id="xdx_89E_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zjM31nbkrrj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zvbowS805Aka"&gt;The
change in the April 2024 Warrant liability is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Three Months Ended September 30, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 57%"&gt;Fair value at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zBoDip8spjwb" style="width: 10%; text-align: right" title="Fair value at June 30, 2024"&gt;298&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcVmgTLASd83" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;149&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zpZsfpFgI7t1" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024"&gt;447&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000583"
      unitRef="USD">298000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-012024-09-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000585"
      unitRef="USD">149000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000587"
      unitRef="USD">447000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="From2024-08-302024-09-01"
      decimals="-5"
      id="Fact000589"
      unitRef="USD">1176000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentIncreaseDecreaseOtherNet
      contextRef="From2024-08-302024-09-01"
      decimals="-5"
      id="Fact000591"
      unitRef="USD">336000000</us-gaap:DebtInstrumentIncreaseDecreaseOtherNet>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="From2024-11-292024-12-01"
      decimals="-5"
      id="Fact000593"
      unitRef="USD">1176000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000600">&lt;p id="xdx_809_ecustom--ScheduleOfClassBCommonStockOfECRCTableTextBlock_zScF5kDERuqf" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;
                                                                        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td id="xdx_821_z58BJeVrLEn2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CLASS
B COMMON STOCK OF ECRC&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zVhx1HrOm4u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
shares of Class B common stock of ECRC, an indirect, majority-owned subsidiary
of NioCorp formerly known as GX Acquisition Corp. II (&#x201c;GXII&#x201d;), include rights under which the holders may exchange
such shares into Common Shares, and certain of such shares are subject to certain vesting conditions (the &#x201c;Earnout Shares&#x201d;). &lt;span id="xdx_8B4_zxleVNVPRKUk"&gt;These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;September 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 63%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFuPGhTOBKs8" style="width: 15%; text-align: center" title="Closing common share price"&gt;$2.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgyhhAA1ZVQ5" style="width: 15%; text-align: center" title="Closing common share price"&gt;$1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcuZgTLgdxNd" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIbRx34QX4d5" style="text-align: center" title="Implied volatility of public warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;60&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z9IRMe7Lvndl" style="text-align: center" title="Implied volatility of public warrants"&gt;65.0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMKF4ux4RJvi" style="text-align: center" title="Risk-free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.74&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlDwrXLgIYP9" style="text-align: center" title="Risk-free rate"&gt;4.35%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zvCMA90fNIE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_zRfB1JhYU5M2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zgQyCBHZ4t53"&gt;The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period
ended September 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%; text-indent: -8.65pt; padding-left: 8.65pt"&gt;Fair value at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_ziKz0TaIDIYc" style="width: 15%; text-align: right" title="Fair value at June 30, 2024"&gt;3,817&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6r8WZwsTTm7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;816&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt"&gt;Fair value at September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zORTYqZwaPVe" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024"&gt;4,633&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_z8eDApJKrGDf" style="margin-top: 0; margin-bottom: 0; font-size: 10pt"&gt;&#160;&lt;/p&gt;

</niobf:ScheduleOfClassBCommonStockOfECRCTableTextBlock>
    <niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000602">&lt;p id="xdx_89A_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zVhx1HrOm4u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
shares of Class B common stock of ECRC, an indirect, majority-owned subsidiary
of NioCorp formerly known as GX Acquisition Corp. II (&#x201c;GXII&#x201d;), include rights under which the holders may exchange
such shares into Common Shares, and certain of such shares are subject to certain vesting conditions (the &#x201c;Earnout Shares&#x201d;). &lt;span id="xdx_8B4_zxleVNVPRKUk"&gt;These Earnout Shares were valued utilizing a Monte Carlo Simulation pricing model with the following primary inputs:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;September 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 63%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zFuPGhTOBKs8" style="width: 15%; text-align: center" title="Closing common share price"&gt;$2.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgyhhAA1ZVQ5" style="width: 15%; text-align: center" title="Closing common share price"&gt;$1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zcuZgTLgdxNd" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIbRx34QX4d5" style="text-align: center" title="Implied volatility of public warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;60&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z9IRMe7Lvndl" style="text-align: center" title="Implied volatility of public warrants"&gt;65.0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240101__20240930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zMKF4ux4RJvi" style="text-align: center" title="Risk-free rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.74&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zlDwrXLgIYP9" style="text-align: center" title="Risk-free rate"&gt;4.35%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000604"
      unitRef="USDPShares">2.18</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000606"
      unitRef="USDPShares">1.73</us-gaap:SharePrice>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      id="Fact000608">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      id="Fact000610">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000612"
      unitRef="Pure">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000614"
      unitRef="Pure">0.650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-012024-09-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000616"
      unitRef="Pure">0.0374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000618"
      unitRef="Pure">0.0435</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000620">&lt;p id="xdx_892_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_zRfB1JhYU5M2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zgQyCBHZ4t53"&gt;The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the three-month period
ended September 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%; text-indent: -8.65pt; padding-left: 8.65pt"&gt;Fair value at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_ziKz0TaIDIYc" style="width: 15%; text-align: right" title="Fair value at June 30, 2024"&gt;3,817&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ServicingLiabilityAtFairValueAdditions_pn3n3_c20240701__20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6r8WZwsTTm7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;816&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt"&gt;Fair value at September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240930__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zORTYqZwaPVe" style="border-bottom: Black 2pt solid; text-align: right" title="Fair value at September 30, 2024"&gt;4,633&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000622"
      unitRef="USD">3817000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <us-gaap:ServicingLiabilityAtFairValueAdditions
      contextRef="From2024-07-012024-09-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000624"
      unitRef="USD">816000</us-gaap:ServicingLiabilityAtFairValueAdditions>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2024-09-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000626"
      unitRef="USD">4633000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000628">&lt;p id="xdx_802_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z3x4D4f79sQh" style="margin-top: 0; margin-bottom: 0; font-size: 1pt"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_829_zZvwB2hYwkhj"&gt;COMMON
SHARES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issuance&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_893_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_zZFBKUMYKyMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z63Atz6HKOr5"&gt;The
Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended
September 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Date&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Common Shares Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Gross Funds Received&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Market Value of Shares Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;(Gain)/Loss &lt;br/&gt;on Issuance&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 27%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240828_zE6YmGburBKa" style="width: 15%; text-align: right" title="Common shares issued"&gt;75,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240826__20240828_z3Xu7SqEIsU6" style="width: 15%; text-align: right" title="Gross funds received"&gt;140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssued1_c20240826__20240828_zcyBLNQao1Ph" style="width: 15%; text-align: right" title="Fair value of common shares issued"&gt;133&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240826__20240828_zkfOcCJAp957" style="width: 15%; text-align: right" title="Gross funds received"&gt;(7&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240903_zOBtcwwCrJMf" style="text-align: right" title="Common shares issued"&gt;71,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240902__20240903_z6mlZYrlMbI2" style="text-align: right" title="Gross funds received"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssued1_c20240902__20240903_zV7XJsAvArZh" style="text-align: right" title="Fair value of common shares issued"&gt;123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240902__20240903_z7MXOIQfnlNi" style="text-align: right" title="Gross funds received"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 6, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240906_zGhd51WzSa43" style="text-align: right" title="Common shares issued"&gt;71,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240904__20240906_zQv3aE5FY8Rl" style="text-align: right" title="Gross funds received"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockIssued1_c20240904__20240906_zixMUsNz28mc" style="text-align: right" title="Fair value of common shares issued"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240904__20240906_zhW8OQ1wWUu9" style="text-align: right" title="Gross funds received"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0654"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 16, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240916_z5zeFtOqo3n1" style="text-align: right" title="Common shares issued"&gt;72,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240914__20240916_zpvPXrV0UqU6" style="text-align: right" title="Gross funds received"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssued1_c20240914__20240916_zaQUgyaTOp95" style="text-align: right" title="Fair value of common shares issued"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240914__20240916_z1c0TZqHobob" style="text-align: right" title="Gross funds received"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0662"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 19, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240919_zY7WMZmyTIld" style="text-align: right" title="Common shares issued"&gt;49,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240918__20240919_zpavCdSPDkAb" style="text-align: right" title="Gross funds received"&gt;85&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssued1_c20240918__20240919_zADFG43nCs2l" style="text-align: right" title="Fair value of common shares issued"&gt;85&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240918__20240919_z4vO1K4kVYed" style="text-align: right" title="Gross funds received"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0670"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 25, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240925_zRZZmusJel3j" style="text-align: right" title="Common shares issued"&gt;60,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240923__20240925_zbREIuEvVnz" style="text-align: right" title="Gross funds received"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssued1_c20240923__20240925_zZT86rJ2HWu3" style="text-align: right" title="Fair value of common shares issued"&gt;108&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240923__20240924_zZ7MwyFKw3kj" style="text-align: right" title="Gross funds received"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_z6ioMHfy5DUf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;(Gain)/loss on issuance
represents a non-cash amount equal to the difference between the proceeds received and the fair value of the Common Shares issued
based on the Nasdaq Stock Market LLC (the &#x201c;Nasdaq&#x201d;) closing price per Common Share on the issuance date and is recorded
in other operating expenses in the condensed consolidated statement of operations and comprehensive loss.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;














&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
Options&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_896_ecustom--ScheduleOfStockOptionRollForwardTableTextBlock_zMbMuSMK0yek" style="display: none; margin-top: 0; margin-bottom: 0; visibility: hidden"&gt;&#160;&lt;span id="xdx_8BF_zkjzLBiVNkgb"&gt;Schedule of stock option&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number of Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted &lt;br/&gt;Average Remaining Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20240930_zKN55L3yTxik" style="width: 15%; text-align: right" title="Beginning balance"&gt;2,495,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20240701__20240930_zBMran0dscw8" style="width: 15%; text-align: right" title="Beginning balance"&gt;4.78&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20240930_zWLhlpifZTQ5" style="text-align: right" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zc3qDApeTMv6" style="text-align: right" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0694"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20240930_z9l2E8nrjI32" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_z1fFzG6iVfe" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20240930_zJCiKUx2Sd3b" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;(40,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zBzceKZCe8S7" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;6.95&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20240930_z3otOCN6hc87" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;2,455,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20240701__20240930_zcswVa4G4Y3k" style="border-bottom: Black 2pt solid; text-align: right" title="Beginning balance"&gt;4.76&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20240930_z2c2YFk6rDbc" style="border-bottom: Black 2pt solid; text-align: right" title="Aggregate intrinsic value"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20240701__20240930_zXXc12Xgnri9" title="Weighted average remaining contractual life::XDX::P3Y2M19D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0710"&gt;3.22&lt;/span&gt;&lt;/span&gt; Years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zszTLJlspn3" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
transactions are summarized as follows. Weighted average exercise prices related to Canadian dollar denominated warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8lmPNryaG88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;&#160;&lt;span id="xdx_8B9_zTE6gwCssKXk"&gt;Schedule
of warrant transactions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 63%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20240930_z73Uhv3eLmDj" style="width: 15%; text-align: right" title="Beginning balance"&gt;18,563,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20240701__20240930_zkF85Xz5gmrh" style="width: 15%; text-align: right" title="Beginning balance"&gt;10.53&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20240930_zw0LT0Keyxfi" style="text-align: right" title="Granted"&gt;2,816,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20240930_zc3j9fsutXm4" style="text-align: right" title="Granted"&gt;2.31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20240930_zdgaI359Afzb" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0722"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20240930_zvvqp0p8H14j" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20240930_zCaJr1pjYYBg" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;(447,318&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20240930_zoJImAFnjTL7" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;8.94&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20240930_zkKpYJzzjipb" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;20,932,985&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20240701__20240930_zNwBoIsMvsS3" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;9.46&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zImxZqi4Yrg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zD3G1UZGTpZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zqZVR49RR594"&gt;At
September 30, 2024, the Company had outstanding exercisable Warrants, as follows:&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;Expiry Date&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zSSH4HKGlsI9" style="width: 27%; text-align: right" title="Number"&gt;855,800&lt;/td&gt;&lt;td style="width: 7%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z96DdCE2pNSb" style="width: 30%; text-align: right" title="Exercise price"&gt;C$&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.70&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z3qDQfD5uyvf" style="width: 26%; text-align: right; padding-left: 5.4pt" title="Expiry date"&gt;February 19, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdKYVXBP35ig" style="text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z3I8a1jjAO31" style="text-align: right" title="Exercise price"&gt;$4.60&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zSIluWBmR1nj" style="text-align: right; padding-left: 5.4pt" title="Expiry date"&gt;September 1, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zDwJjjKLuEX5" style="text-align: right"&gt;413,432&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zRNDlwyiVKU" style="text-align: right"&gt;$3.54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zg06YTA9Z3Zj" style="text-align: right; padding-left: 5.4pt"&gt;December 22, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmyxVhES6m55" style="text-align: right"&gt;315,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZiTM5L9CR9" style="text-align: right"&gt;$2.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zisv6jk38da6" style="text-align: right; padding-left: 5.4pt"&gt;June 24, 2026&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.35Member_zfjofJn54ZGf" style="text-align: right"&gt;615,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z3x6STfrvH7e" style="text-align: right"&gt;$3.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zPYjiobUWDY9" style="text-align: right; padding-left: 5.4pt"&gt;April 12, 2027&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6ZfccVjwzR2" style="text-align: right"&gt;15,666,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEr9ouHH2tul" style="text-align: right"&gt;$11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6UUacp3aFDj" style="text-align: right; padding-left: 5.4pt"&gt;March 17, 2028&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zzNZxDOiFh6b" style="border-bottom: Black 1pt solid; text-align: right" title="Number"&gt;2,816,742&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zJNy4Fn2EVrh" style="padding-bottom: 1pt; text-align: right" title="Exercise price"&gt;$2.31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zB5Cnjq5VNzb" style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt" title="Expiry date"&gt;September 17, 2028&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930_zthEr47AGJi5" style="border-bottom: Black 2pt solid; text-align: right"&gt;20,932,985&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zSwskhowbtXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Private
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 17, 2023, the Company closed a series of transactions (the &#x201c;GXII Transaction&#x201d;) pursuant to the Business Combination
Agreement, dated as of September 25, 2022, by and among the Company, GXII, and Big Red Merger Sub Ltd. In connection with the
closing of the GXII Transaction (the &#x201c;Closing&#x201d;), the Company assumed GXII&#x2019;s obligations under the agreement
governing the GXII share purchase warrants (the &#x201c;GXII Warrants&#x201d;), as amended by an assignment, assumption and amendment
agreement (the &#x201c;NioCorp Assumed Warrant Agreement&#x201d;), and issued an aggregate of &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAIsFIPHJTFj" title="Warrants traded prior to the closing"&gt;15,666,626&lt;/span&gt; Warrants (the &#x201c;NioCorp
Assumed Warrants&#x201d;). The Company issued (a) &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdwYmsdfh5Bg" title="Warrants traded prior to the closing"&gt;9,999,959&lt;/span&gt; public NioCorp Assumed Warrants (the &#x201c;Public Warrants&#x201d;)
in respect of the GXII Warrants that were publicly traded prior to the Closing and (b) &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20240930__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zvzWjvAbnQvk" title="Warrants traded prior to the closing"&gt;5,666,667&lt;/span&gt; NioCorp Assumed Warrants (the
&#x201c;Private Warrants&#x201d;) to GX Sponsor II LLC (the &#x201c;Sponsor&#x201d;).&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;













&lt;div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt"&gt;&lt;/div&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zX638s36zuEg" title="Description of warrants"&gt;Each
Private Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and
the like).&lt;/span&gt; No fractional shares will be issued upon exercise of any Private Warrants, and fractional shares that would
otherwise be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the
Company be required to net cash settle any Private Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#x2019;s option and (ii) will not
be redeemable by the Company, in either case as long as the Private Warrants are held by the Sponsor, its members or any of their
permitted transferees (as prescribed in the NioCorp Assumed Warrant Agreement). In accordance with the NioCorp Assumed Warrant
Agreement, any Private Warrants that are held by someone other than the Sponsor, its members or any of their permitted transferees
are treated as Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zKxXK5eB2hJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy as inputs into our pricing model are
based on observable data points. &lt;span id="xdx_8BF_zG8JelBVD2O7"&gt;The following observable data points were used in calculating the fair value of the Private Warrants
using a Black Scholes pricing model:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;September 30,&lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, &lt;br/&gt;&#160;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfdQybB2Uyjk" style="width: 17%; text-align: right" title="Stock price on valuation date"&gt;2.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMQahFwTLoWh" style="width: 17%; text-align: right" title="Stock price on valuation date"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6uaYRqmfsT7" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zVuUlzysqwtd" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfeqUWgK9oP2" title="Implied volatility of public warrants"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zH6AQzfbGZT1" title="Implied volatility of public warrants"&gt;69.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGnIPtuoeprh" title="Risk free rate"&gt;3.58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSXKEqPWoSY7" title="Risk free rate"&gt;4.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zub7uRmjb1K8" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdG3ykCh1E3e" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expected warrant life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4byd8V8fZ8g" title="Expected warrant life in years::XDX::P3Y5M30D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0803"&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyUY0S4ai7Zd" title="Expected warrant life in years::XDX::P3Y8M12D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0805"&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zF1n5yrcwNtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zSlc0UIsoLta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zcEEUId4Lp0h"&gt;The
change in the Private Warrants liability is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 42%; text-indent: -8.65pt; padding-left: 8.65pt"&gt;Fair value at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqhb9iCqpaV6" style="width: 15%; text-align: right" title="Beginning balance"&gt;1,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zRN43KszK6s7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;(205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt"&gt;Fair value at September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zorR7P4tzzi1" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;1,148&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_z3VG4xq0DWob" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contingent
Consent Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20240701__20240930_z4magsa70S5h" title="Contingent consideration description"&gt;As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#x201c;Lind Consent&#x201d;), between the Company and Lind Global Asset Management III, LLC (&#x201c;Lind III&#x201d;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#x201c;Contingent Consent Warrants&#x201d;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance.&lt;/span&gt; Further, the number of Contingent Consent Warrants issued will be proportionately adjusted based on the percentage
of Warrants currently held by Lind III that are exercised, if any, prior to the issuance of any Contingent Consent Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 17, 2024, the Company&#x2019;s Common Share price was below the threshold price set forth in the Lind Consent, and accordingly,
the Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240915__20240917_z1Z5olcDa9Yg" title="Stock issued, shares"&gt;2,816,742&lt;/span&gt; Contingent Consent Warrants to Lind III. Each Contingent Consent Warrant is exercisable for one Common Share
at an exercise price of $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zp1dhD6MECb" title="Common share exercise price, per share"&gt;2.308&lt;/span&gt; and may be exercised at any time prior to their expiration on September 17, 2028. The number of Contingent
Consent Warrants issued was based on $&lt;span id="xdx_90A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20240915__20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zjccZ0Ek9TRg"&gt;5,000&lt;/span&gt; divided by the five-day volume weighted average price of the Common Shares on September 16,
2024. The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

















&lt;p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zdWof341Pnzg" style="margin: 0"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt; &lt;span id="xdx_8B2_zesmbWpof813"&gt;The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;September 17, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 42%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1XpUJgWPBa" style="width: 15%; text-align: right" title="Closing common share price"&gt;1.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPrzuqE8U4eb" title="Term (years)::XDX::P4Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0833"&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z13R0iHC3zFf" title="Historic equity volatility"&gt;67.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUbpTPSOfn3k" title="Risk-free rate"&gt;3.44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_znvUdFHNJesc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized a gain of $103 on the issuance of the Contingent Consent Warrants. This gain was recorded as a part of other
gains in the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000630">&lt;p id="xdx_893_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_zZFBKUMYKyMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z63Atz6HKOr5"&gt;The
Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended
September 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Date&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Common Shares Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Gross Funds Received&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Market Value of Shares Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;(Gain)/Loss &lt;br/&gt;on Issuance&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 27%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240828_zE6YmGburBKa" style="width: 15%; text-align: right" title="Common shares issued"&gt;75,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240826__20240828_z3Xu7SqEIsU6" style="width: 15%; text-align: right" title="Gross funds received"&gt;140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssued1_c20240826__20240828_zcyBLNQao1Ph" style="width: 15%; text-align: right" title="Fair value of common shares issued"&gt;133&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240826__20240828_zkfOcCJAp957" style="width: 15%; text-align: right" title="Gross funds received"&gt;(7&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240903_zOBtcwwCrJMf" style="text-align: right" title="Common shares issued"&gt;71,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240902__20240903_z6mlZYrlMbI2" style="text-align: right" title="Gross funds received"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssued1_c20240902__20240903_zV7XJsAvArZh" style="text-align: right" title="Fair value of common shares issued"&gt;123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240902__20240903_z7MXOIQfnlNi" style="text-align: right" title="Gross funds received"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 6, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240906_zGhd51WzSa43" style="text-align: right" title="Common shares issued"&gt;71,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240904__20240906_zQv3aE5FY8Rl" style="text-align: right" title="Gross funds received"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockIssued1_c20240904__20240906_zixMUsNz28mc" style="text-align: right" title="Fair value of common shares issued"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240904__20240906_zhW8OQ1wWUu9" style="text-align: right" title="Gross funds received"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0654"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 16, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240916_z5zeFtOqo3n1" style="text-align: right" title="Common shares issued"&gt;72,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240914__20240916_zpvPXrV0UqU6" style="text-align: right" title="Gross funds received"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssued1_c20240914__20240916_zaQUgyaTOp95" style="text-align: right" title="Fair value of common shares issued"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240914__20240916_z1c0TZqHobob" style="text-align: right" title="Gross funds received"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0662"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 19, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240919_zY7WMZmyTIld" style="text-align: right" title="Common shares issued"&gt;49,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240918__20240919_zpavCdSPDkAb" style="text-align: right" title="Gross funds received"&gt;85&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssued1_c20240918__20240919_zADFG43nCs2l" style="text-align: right" title="Fair value of common shares issued"&gt;85&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240918__20240919_z4vO1K4kVYed" style="text-align: right" title="Gross funds received"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0670"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 25, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20240925_zRZZmusJel3j" style="text-align: right" title="Common shares issued"&gt;60,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240923__20240925_zbREIuEvVnz" style="text-align: right" title="Gross funds received"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssued1_c20240923__20240925_zZT86rJ2HWu3" style="text-align: right" title="Fair value of common shares issued"&gt;108&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240923__20240924_zZ7MwyFKw3kj" style="text-align: right" title="Gross funds received"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-08-28"
      decimals="INF"
      id="Fact000632"
      unitRef="Shares">75000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-08-262024-08-28"
      decimals="-3"
      id="Fact000634"
      unitRef="USD">140000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:StockIssued1
      contextRef="From2024-08-262024-08-28"
      decimals="-3"
      id="Fact000636"
      unitRef="USD">133000</us-gaap:StockIssued1>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="From2024-08-262024-08-28"
      decimals="-3"
      id="Fact000638"
      unitRef="USD">-7000</us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-09-03"
      decimals="INF"
      id="Fact000640"
      unitRef="Shares">71000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-09-022024-09-03"
      decimals="-3"
      id="Fact000642"
      unitRef="USD">124000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:StockIssued1
      contextRef="From2024-09-022024-09-03"
      decimals="-3"
      id="Fact000644"
      unitRef="USD">123000</us-gaap:StockIssued1>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="From2024-09-022024-09-03"
      decimals="-3"
      id="Fact000646"
      unitRef="USD">-1000</us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-09-06"
      decimals="INF"
      id="Fact000648"
      unitRef="Shares">71500</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-09-042024-09-06"
      decimals="-3"
      id="Fact000650"
      unitRef="USD">118000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:StockIssued1
      contextRef="From2024-09-042024-09-06"
      decimals="-3"
      id="Fact000652"
      unitRef="USD">118000</us-gaap:StockIssued1>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-09-16"
      decimals="INF"
      id="Fact000656"
      unitRef="Shares">72000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-09-142024-09-16"
      decimals="-3"
      id="Fact000658"
      unitRef="USD">124000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:StockIssued1
      contextRef="From2024-09-142024-09-16"
      decimals="-3"
      id="Fact000660"
      unitRef="USD">124000</us-gaap:StockIssued1>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-09-19"
      decimals="INF"
      id="Fact000664"
      unitRef="Shares">49750</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-09-182024-09-19"
      decimals="-3"
      id="Fact000666"
      unitRef="USD">85000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:StockIssued1
      contextRef="From2024-09-182024-09-19"
      decimals="-3"
      id="Fact000668"
      unitRef="USD">85000</us-gaap:StockIssued1>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-09-25"
      decimals="INF"
      id="Fact000672"
      unitRef="Shares">60000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-09-232024-09-25"
      decimals="-3"
      id="Fact000674"
      unitRef="USD">101000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:StockIssued1
      contextRef="From2024-09-232024-09-25"
      decimals="-3"
      id="Fact000676"
      unitRef="USD">108000</us-gaap:StockIssued1>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="From2024-09-232024-09-24"
      decimals="-3"
      id="Fact000678"
      unitRef="USD">7000</us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer>
    <niobf:ScheduleOfStockOptionRollForwardTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000686">&lt;p id="xdx_896_ecustom--ScheduleOfStockOptionRollForwardTableTextBlock_zMbMuSMK0yek" style="display: none; margin-top: 0; margin-bottom: 0; visibility: hidden"&gt;&#160;&lt;span id="xdx_8BF_zkjzLBiVNkgb"&gt;Schedule of stock option&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number of Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted &lt;br/&gt;Average Remaining Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 26%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20240930_zKN55L3yTxik" style="width: 15%; text-align: right" title="Beginning balance"&gt;2,495,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uUSDPShares_c20240701__20240930_zBMran0dscw8" style="width: 15%; text-align: right" title="Beginning balance"&gt;4.78&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20240930_zWLhlpifZTQ5" style="text-align: right" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zc3qDApeTMv6" style="text-align: right" title="Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0694"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20240930_z9l2E8nrjI32" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_z1fFzG6iVfe" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20240930_zJCiKUx2Sd3b" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;(40,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20240701__20240930_zBzceKZCe8S7" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired"&gt;6.95&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20240930_z3otOCN6hc87" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;2,455,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uUSDPShares_c20240701__20240930_zcswVa4G4Y3k" style="border-bottom: Black 2pt solid; text-align: right" title="Beginning balance"&gt;4.76&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20240930_z2c2YFk6rDbc" style="border-bottom: Black 2pt solid; text-align: right" title="Aggregate intrinsic value"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl0708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxL_c20240701__20240930_zXXc12Xgnri9" title="Weighted average remaining contractual life::XDX::P3Y2M19D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0710"&gt;3.22&lt;/span&gt;&lt;/span&gt; Years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfStockOptionRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000688"
      unitRef="Shares">2495500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000690"
      unitRef="USDPShares">4.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000700"
      unitRef="Shares">40000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000702"
      unitRef="USDPShares">6.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000704"
      unitRef="Shares">2455500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000706"
      unitRef="USDPShares">4.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000712">&lt;p id="xdx_897_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8lmPNryaG88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;&#160;&lt;span id="xdx_8B9_zTE6gwCssKXk"&gt;Schedule
of warrant transactions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 63%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20240930_z73Uhv3eLmDj" style="width: 15%; text-align: right" title="Beginning balance"&gt;18,563,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_uUSDPShares_c20240701__20240930_zkF85Xz5gmrh" style="width: 15%; text-align: right" title="Beginning balance"&gt;10.53&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20240930_zw0LT0Keyxfi" style="text-align: right" title="Granted"&gt;2,816,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20240930_zc3j9fsutXm4" style="text-align: right" title="Granted"&gt;2.31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20240930_zdgaI359Afzb" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0722"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20240930_zvvqp0p8H14j" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20240930_zCaJr1pjYYBg" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;(447,318&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20240930_zoJImAFnjTL7" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;8.94&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20240930_zkKpYJzzjipb" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;20,932,985&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_uUSDPShares_c20240701__20240930_zNwBoIsMvsS3" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;9.46&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000714"
      unitRef="Shares">18563561</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000716"
      unitRef="USDPShares">10.53</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <niobf:ClassOfWarrantOrRightGranted
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000718"
      unitRef="Shares">2816742</niobf:ClassOfWarrantOrRightGranted>
    <niobf:ClassOfWarrantOrRightExercisePriceGranted
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000720"
      unitRef="USDPShares">2.31</niobf:ClassOfWarrantOrRightExercisePriceGranted>
    <niobf:ClassOfWarrantOrRightExpired
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000726"
      unitRef="Shares">-447318</niobf:ClassOfWarrantOrRightExpired>
    <niobf:ClassOfWarrantOrRightExercisePriceExpired
      contextRef="From2024-07-01to2024-09-30"
      decimals="INF"
      id="Fact000728"
      unitRef="USDPShares">8.94</niobf:ClassOfWarrantOrRightExercisePriceExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000730"
      unitRef="Shares">20932985</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000732"
      unitRef="USDPShares">9.46</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000734">&lt;p id="xdx_891_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zD3G1UZGTpZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zqZVR49RR594"&gt;At
September 30, 2024, the Company had outstanding exercisable Warrants, as follows:&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;Expiry Date&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_zSSH4HKGlsI9" style="width: 27%; text-align: right" title="Number"&gt;855,800&lt;/td&gt;&lt;td style="width: 7%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z96DdCE2pNSb" style="width: 30%; text-align: right" title="Exercise price"&gt;C$&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.70&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice9.70Member_z3qDQfD5uyvf" style="width: 26%; text-align: right; padding-left: 5.4pt" title="Expiry date"&gt;February 19, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zdKYVXBP35ig" style="text-align: right"&gt;250,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_z3I8a1jjAO31" style="text-align: right" title="Exercise price"&gt;$4.60&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zSIluWBmR1nj" style="text-align: right; padding-left: 5.4pt" title="Expiry date"&gt;September 1, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zDwJjjKLuEX5" style="text-align: right"&gt;413,432&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zRNDlwyiVKU" style="text-align: right"&gt;$3.54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zg06YTA9Z3Zj" style="text-align: right; padding-left: 5.4pt"&gt;December 22, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmyxVhES6m55" style="text-align: right"&gt;315,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZiTM5L9CR9" style="text-align: right"&gt;$2.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zisv6jk38da6" style="text-align: right; padding-left: 5.4pt"&gt;June 24, 2026&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.35Member_zfjofJn54ZGf" style="text-align: right"&gt;615,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_z3x6STfrvH7e" style="text-align: right"&gt;$3.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zPYjiobUWDY9" style="text-align: right; padding-left: 5.4pt"&gt;April 12, 2027&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6ZfccVjwzR2" style="text-align: right"&gt;15,666,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zEr9ouHH2tul" style="text-align: right"&gt;$11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_z6UUacp3aFDj" style="text-align: right; padding-left: 5.4pt"&gt;March 17, 2028&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zzNZxDOiFh6b" style="border-bottom: Black 1pt solid; text-align: right" title="Number"&gt;2,816,742&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uCADPShares_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zJNy4Fn2EVrh" style="padding-bottom: 1pt; text-align: right" title="Exercise price"&gt;$2.31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zB5Cnjq5VNzb" style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt" title="Expiry date"&gt;September 17, 2028&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240930_zthEr47AGJi5" style="border-bottom: Black 2pt solid; text-align: right"&gt;20,932,985&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_ExercisePrice9.70Member"
      decimals="INF"
      id="Fact000736"
      unitRef="Shares">855800</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePrice9.70Member"
      decimals="INF"
      id="Fact000738"
      unitRef="CADPShares">9.70</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePrice9.70Member"
      id="Fact000740">2025-02-19</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_ExercisePrice4.60Member"
      decimals="INF"
      id="Fact000741"
      unitRef="Shares">250000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePrice4.60Member"
      decimals="INF"
      id="Fact000743"
      unitRef="CADPShares">4.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePrice4.60Member"
      id="Fact000745">2025-09-01</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_ExercisePrice3.54Member"
      decimals="INF"
      id="Fact000746"
      unitRef="Shares">413432</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePrice3.54Member"
      decimals="INF"
      id="Fact000747"
      unitRef="CADPShares">3.54</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePrice3.54Member"
      id="Fact000748">2025-12-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_ExercisePrice2.20Member"
      decimals="INF"
      id="Fact000749"
      unitRef="Shares">315000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePrice2.20Member"
      decimals="INF"
      id="Fact000750"
      unitRef="CADPShares">2.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePrice2.20Member"
      id="Fact000751">2026-06-24</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_ExercisePrice3.35Member"
      decimals="INF"
      id="Fact000752"
      unitRef="Shares">615385</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePrice3.25Member"
      decimals="INF"
      id="Fact000753"
      unitRef="CADPShares">3.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePrice3.25Member"
      id="Fact000754">2027-04-12</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_ExercisePrice11.50Member"
      decimals="INF"
      id="Fact000755"
      unitRef="Shares">15666626</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePrice11.50Member"
      decimals="INF"
      id="Fact000756"
      unitRef="CADPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePrice11.50Member"
      id="Fact000757">2028-03-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_ExercisePrice2.31Member"
      decimals="INF"
      id="Fact000759"
      unitRef="Shares">2816742</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ExercisePrice2.31Member"
      decimals="INF"
      id="Fact000761"
      unitRef="CADPShares">2.31</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2024-09-30_custom_ExercisePrice2.31Member"
      id="Fact000763">2028-09-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000764"
      unitRef="Shares">20932985</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000766"
      unitRef="Shares">15666626</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-07-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000768"
      unitRef="Shares">9999959</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-07-012024-09-30_custom_GXIIPrivateWarrantsMember"
      decimals="INF"
      id="Fact000770"
      unitRef="Shares">5666667</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="From2024-07-012024-09-30_us-gaap_WarrantMember"
      id="Fact000779">Each
Private Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and
the like).</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000781">&lt;p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zKxXK5eB2hJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;The
Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy as inputs into our pricing model are
based on observable data points. &lt;span id="xdx_8BF_zG8JelBVD2O7"&gt;The following observable data points were used in calculating the fair value of the Private Warrants
using a Black Scholes pricing model:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;September 30,&lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, &lt;br/&gt;&#160;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfdQybB2Uyjk" style="width: 17%; text-align: right" title="Stock price on valuation date"&gt;2.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zMQahFwTLoWh" style="width: 17%; text-align: right" title="Stock price on valuation date"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6uaYRqmfsT7" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zVuUlzysqwtd" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfeqUWgK9oP2" title="Implied volatility of public warrants"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zH6AQzfbGZT1" title="Implied volatility of public warrants"&gt;69.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGnIPtuoeprh" title="Risk free rate"&gt;3.58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zSXKEqPWoSY7" title="Risk free rate"&gt;4.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zub7uRmjb1K8" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zdG3ykCh1E3e" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expected warrant life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4byd8V8fZ8g" title="Expected warrant life in years::XDX::P3Y5M30D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0803"&gt;3.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyUY0S4ai7Zd" title="Expected warrant life in years::XDX::P3Y8M12D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0805"&gt;3.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000783"
      unitRef="USDPShares">2.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000785"
      unitRef="USDPShares">1.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000787"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000789"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-012024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000791"
      unitRef="Pure">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000793"
      unitRef="Pure">0.690</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-01-012024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000795"
      unitRef="Pure">0.0358</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000797"
      unitRef="Pure">0.0445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-07-012024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact000799"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000801"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000807">&lt;p id="xdx_89B_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zSlc0UIsoLta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zcEEUId4Lp0h"&gt;The
change in the Private Warrants liability is presented below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Three Months Ended September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 42%; text-indent: -8.65pt; padding-left: 8.65pt"&gt;Fair value at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqhb9iCqpaV6" style="width: 15%; text-align: right" title="Beginning balance"&gt;1,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zRN43KszK6s7" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;(205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt"&gt;Fair value at September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zorR7P4tzzi1" style="border-bottom: Black 2pt solid; text-align: right" title="Ending balance"&gt;1,148&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock>
    <niobf:ChangesInFairValueOfInitialValuation1
      contextRef="AsOf2024-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact000809"
      unitRef="USD">1353000</niobf:ChangesInFairValueOfInitialValuation1>
    <us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs
      contextRef="From2024-07-012024-09-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact000811"
      unitRef="USD">-205000</us-gaap:ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputs>
    <niobf:ChangesInFairValueOfInitialValuation1
      contextRef="AsOf2024-09-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact000813"
      unitRef="USD">1148000</niobf:ChangesInFairValueOfInitialValuation1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription contextRef="From2024-07-01to2024-09-30" id="Fact000815">As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#x201c;Lind Consent&#x201d;), between the Company and Lind Global Asset Management III, LLC (&#x201c;Lind III&#x201d;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#x201c;Contingent Consent Warrants&#x201d;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance.</us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-09-152024-09-17"
      decimals="INF"
      id="Fact000817"
      unitRef="Shares">2816742</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-17_custom_LindConsentWarrantIssuanceMember"
      decimals="INF"
      id="Fact000819"
      unitRef="CADPShares">2.308</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2024-09-152024-09-17_custom_LindConsentWarrantIssuanceMember"
      decimals="0"
      id="Fact000820"
      unitRef="USD">5000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000829">&lt;p id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zdWof341Pnzg" style="margin: 0"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt; &lt;span id="xdx_8B2_zesmbWpof813"&gt;The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;September 17, &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 42%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zu1XpUJgWPBa" style="width: 15%; text-align: right" title="Closing common share price"&gt;1.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPrzuqE8U4eb" title="Term (years)::XDX::P4Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0833"&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z13R0iHC3zFf" title="Historic equity volatility"&gt;67.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240915__20240917__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUbpTPSOfn3k" title="Risk-free rate"&gt;3.44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000831"
      unitRef="USDPShares">1.74</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact000835"
      unitRef="Pure">0.6714</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-09-152024-09-17_us-gaap_FairValueInputsLevel3Member"
      decimals="INF"
      id="Fact000837"
      unitRef="Pure">0.0344</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000839">&lt;p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zUu0JLuPb4ac" style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;span&gt;&lt;span id="xdx_822_z3M1qLcxwJ48"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;On September 11, 2024, the
Company and Mark Smith, Chief Executive Officer, President and Executive Chairman of NioCorp, entered into a loan agreement (the
&#x201c;Smith Loan Agreement&#x201d;), which provides for a $&lt;span id="xdx_90B_eus-gaap--LongTermLineOfCredit_iI_pn3n3_c20240911__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzaqdZ6tI4O8" title="Credit agreement"&gt;2,000&lt;/span&gt; non-revolving, multi-draw credit facility (the &#x201c;Smith Loan&#x201d;). The Smith Loan has an interest rate of &lt;span id="xdx_906_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_z5OM8LPGLPn" title="Interest at a rate"&gt;10&lt;/span&gt;% per annum, calculated monthly in arrears, through the date of repayment of the Smith Loan. The Company can pre-pay
the Smith Loan at any time without notice and without penalty, but any amount of principal or interest repaid by the Company prior
to the earlier of the date of expiration of the Smith Loan Agreement on June 30, 2025 and the occurrence of an event of default
under the Smith Loan Agreement will be subject to an early payment fee of &lt;span id="xdx_90F_ecustom--LineOfCreditFacilityEstablishmentFee_pid_dp_uPure_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzHRABZpZcal" title="Prepayment fee"&gt;2.5&lt;/span&gt;% of the value of any such payment. The Smith Loan is secured by all of the Company&#x2019;s assets pursuant to a general security agreement  between the Company and Mr. Smith dated September 11, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;As of September 30, 2024, the principal amount outstanding under the Smith Loan was $&lt;span id="xdx_905_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zwnLsrtQ7Uia" title="Accounts payable and accrued liabilities"&gt;33&lt;/span&gt; and accounts payable and accrued liabilities as of September 30, 2024, included $&lt;span id="xdx_901_eus-gaap--ProfessionalFees_pn3n3_c20240701__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zsWBVuhZKm95" title="Origination fees"&gt;29&lt;/span&gt; of loan origination fees payable to Mr. Smith. Additional drawdowns totaling $&lt;span id="xdx_908_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zLQxsix6Bkif" title="Additional drawdowns"&gt;471&lt;/span&gt; were received subsequent to September 30, 2024. On November 6, 2024, the Company repaid $&lt;span id="xdx_90C_eus-gaap--InterestExpenseOther_pn3n3_c20241101__20241106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zCYw3YEgP7D8" title="Repaid outstanding interest"&gt;250&lt;/span&gt; of the interest and principal outstanding under the Smith Loan, and $&lt;span id="xdx_90E_eus-gaap--ProfessionalFees_pn3n3_c20241101__20241106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWXMZIhOJ3vk" title="Origination fees"&gt;28&lt;/span&gt; related to the loan origination fees payable.
&lt;/p&gt;



</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2024-09-11_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="-3"
      id="Fact000841"
      unitRef="USD">2000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact000843"
      unitRef="Pure">0.10</us-gaap:RelatedPartyTransactionRate>
    <niobf:LineOfCreditFacilityEstablishmentFee
      contextRef="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact000845"
      unitRef="Pure">0.025</niobf:LineOfCreditFacilityEstablishmentFee>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-09-30_srt_ChiefExecutiveOfficerMember"
      decimals="-3"
      id="Fact000847"
      unitRef="USD">33000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ProfessionalFees
      contextRef="From2024-07-012024-09-30_srt_ChiefExecutiveOfficerMember"
      decimals="-3"
      id="Fact000849"
      unitRef="USD">29000</us-gaap:ProfessionalFees>
    <us-gaap:LinesOfCreditCurrent
      contextRef="AsOf2024-09-30_srt_ChiefExecutiveOfficerMember"
      decimals="-3"
      id="Fact000851"
      unitRef="USD">471000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:InterestExpenseOther
      contextRef="From2024-11-012024-11-06_us-gaap_SubsequentEventMember_srt_ChiefExecutiveOfficerMember"
      decimals="-3"
      id="Fact000853"
      unitRef="USD">250000</us-gaap:InterestExpenseOther>
    <us-gaap:ProfessionalFees
      contextRef="From2024-11-012024-11-06_us-gaap_SubsequentEventMember_srt_ChiefExecutiveOfficerMember"
      decimals="-3"
      id="Fact000855"
      unitRef="USD">28000</us-gaap:ProfessionalFees>
    <niobf:ExplorationExpendituresDisclosuresTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000857">&lt;p id="xdx_804_ecustom--ExplorationExpendituresDisclosuresTextBlock_zvuVvzBSmLja" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0px"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 24px"&gt;&lt;span style="font-size: 10pt"&gt;9.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-size: 10pt; text-transform: uppercase"&gt;&lt;span&gt;&lt;span&gt;&lt;span id="xdx_822_ztBToeqah4O2"&gt;EXPLORATION EXPENDITURES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zsL7dB5cGwa3" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span&gt;&#160;&lt;span id="xdx_8B5_zsdj9jQ4iAsk" style="display: none; visibility: hidden"&gt;Schedule of exploration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Technical studies and engineering&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zCypVUoyrM8" style="width: 15%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zlqTAXRCT5zf" style="width: 15%; text-align: right"&gt;200&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Field management and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zehYzmGChHga" style="text-align: right"&gt;91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zeGOggIDLlJk" style="text-align: right"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Metallurgical development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_zzQx5Yq14r13" style="text-align: right"&gt;47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_z9WGaCtLtyTf" style="text-align: right"&gt;746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Geologists and field staff&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zY3syMVxeJWb" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zHgvWSGyk4c5" style="border-bottom: Black 1pt solid; text-align: right"&gt;19&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20240701__20240930_zNyJD2emNV0j" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures"&gt;138&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20230930_zFNpUJXPw7D4" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures"&gt;1,100&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_ziDmdY49fq6j" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</niobf:ExplorationExpendituresDisclosuresTextBlock>
    <niobf:ScheduleOfExplorationExpendituresTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000859">&lt;p id="xdx_89F_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zsL7dB5cGwa3" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span&gt;&#160;&lt;span id="xdx_8B5_zsdj9jQ4iAsk" style="display: none; visibility: hidden"&gt;Schedule of exploration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Technical studies and engineering&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zCypVUoyrM8" style="width: 15%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--TechnicalStudiesAndEngineeringMember_zlqTAXRCT5zf" style="width: 15%; text-align: right"&gt;200&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Field management and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zehYzmGChHga" style="text-align: right"&gt;91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--FieldmanagementandotherMember_zeGOggIDLlJk" style="text-align: right"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Metallurgical development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_zzQx5Yq14r13" style="text-align: right"&gt;47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--MetallurgicaldevelopmentMember_z9WGaCtLtyTf" style="text-align: right"&gt;746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Geologists and field staff&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ExplorationExpense_c20240701__20240930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zY3syMVxeJWb" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ExplorationExpense_c20230701__20230930__custom--CostCentreAxis__custom--GeologistAndFieldStaffMember_zHgvWSGyk4c5" style="border-bottom: Black 1pt solid; text-align: right"&gt;19&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ExplorationExpense_pn3n3_c20240701__20240930_zNyJD2emNV0j" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures"&gt;138&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20230930_zFNpUJXPw7D4" style="border-bottom: Black 2pt solid; text-align: right" title="Exploration expenditures"&gt;1,100&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:ScheduleOfExplorationExpendituresTableTextBlock>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012023-09-30_custom_TechnicalStudiesAndEngineeringMember"
      decimals="-3"
      id="Fact000861"
      unitRef="USD">200000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012024-09-30_custom_FieldmanagementandotherMember"
      decimals="-3"
      id="Fact000862"
      unitRef="USD">91000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012023-09-30_custom_FieldmanagementandotherMember"
      decimals="-3"
      id="Fact000863"
      unitRef="USD">135000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012024-09-30_custom_MetallurgicaldevelopmentMember"
      decimals="-3"
      id="Fact000864"
      unitRef="USD">47000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012023-09-30_custom_MetallurgicaldevelopmentMember"
      decimals="-3"
      id="Fact000865"
      unitRef="USD">746000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012023-09-30_custom_GeologistAndFieldStaffMember"
      decimals="-3"
      id="Fact000867"
      unitRef="USD">19000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000869"
      unitRef="USD">138000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000871"
      unitRef="USD">1100000</us-gaap:ExplorationExpense>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000873">&lt;p id="xdx_80A_eus-gaap--LesseeOperatingLeasesTextBlock_z83dlscUdhfa" style="margin-top: 0; margin-bottom: 0; font-size: 1pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;10.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;span id="xdx_82B_zAYjmrWj1xEd"&gt;LEASES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--LeaseCostTableTextBlock_zy6ZvhCBSom7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zrtAcrJSBdlk"&gt;The
Company incurred lease costs as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240701__20240930_zuddX0TgWh8" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230701__20230930_z9ERXRKb3HE8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_z2EitoeWQAQc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating Lease Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--FixedRentExpense_zAXIEkYb8Vvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: 9pt"&gt;Fixed rent expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--VariableLeaseCost_zyPdXj2bZyHl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Variable rent expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Short-term lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zsAQ1y5nWYS9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt"&gt;Sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zJtbT4Sa2X7b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net lease cost &#x2013; other operating expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;20&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_z5VAP40ZgmN7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ziGsQjF8hEK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;span id="xdx_8BA_zsg3t8AIFB44"&gt;The
maturities of lease liabilities are as follows at September 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240930_zveg2pCc2z9l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Future Lease Maturities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zghIBTWYix23" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 82%; text-align: left"&gt;Total remaining lease payments&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;220&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zIpd1zmCGmA8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less portion of payments representing interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zcezAec608A1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Present value of lease payments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;184&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zz6LCjdD5GUh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less current portion of lease payments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(97&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zrTX1ZjBEPmj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Non-current lease liability&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;87&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zDHbhOOSuBA9" style="margin-top: 0; margin-bottom: 0; font-size: 10pt"&gt;&#160;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000875">&lt;p id="xdx_890_eus-gaap--LeaseCostTableTextBlock_zy6ZvhCBSom7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zrtAcrJSBdlk"&gt;The
Company incurred lease costs as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 1pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240701__20240930_zuddX0TgWh8" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230701__20230930_z9ERXRKb3HE8" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the Three Months Ended September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCostAbstract_iB_z2EitoeWQAQc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating Lease Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--FixedRentExpense_zAXIEkYb8Vvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 64%; text-align: left; text-indent: 9pt"&gt;Fixed rent expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;23&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--VariableLeaseCost_zyPdXj2bZyHl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Variable rent expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ShortTermLeaseCost_i_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Short-term lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pn3n3_di_zsAQ1y5nWYS9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt"&gt;Sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_zJtbT4Sa2X7b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net lease cost &#x2013; other operating expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;20&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <niobf:FixedRentExpense
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000880"
      unitRef="USD">23000</niobf:FixedRentExpense>
    <niobf:FixedRentExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000881"
      unitRef="USD">23000</niobf:FixedRentExpense>
    <us-gaap:VariableLeaseCost
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000883"
      unitRef="USD">3000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000884"
      unitRef="USD">3000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000886"
      unitRef="USD">3000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000887"
      unitRef="USD">2000</us-gaap:ShortTermLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000889"
      unitRef="USD">9000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000890"
      unitRef="USD">6000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2024-07-01to2024-09-30"
      decimals="-3"
      id="Fact000892"
      unitRef="USD">20000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000893"
      unitRef="USD">22000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000895">&lt;p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ziGsQjF8hEK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;span id="xdx_8BA_zsg3t8AIFB44"&gt;The
maturities of lease liabilities are as follows at September 30, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240930_zveg2pCc2z9l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Future Lease Maturities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pn3n3_mtLOLLPzI5d_zghIBTWYix23" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 82%; text-align: left"&gt;Total remaining lease payments&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; font-size: 10pt; text-align: right"&gt;220&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--LessAmountOfPaymentsRepresentingInterest_iI_pn3n3_zIpd1zmCGmA8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less portion of payments representing interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zcezAec608A1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Present value of lease payments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;184&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zz6LCjdD5GUh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less current portion of lease payments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(97&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zrTX1ZjBEPmj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Non-current lease liability&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;87&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000897"
      unitRef="USD">220000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <niobf:LessAmountOfPaymentsRepresentingInterest
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000899"
      unitRef="USD">-36000</niobf:LessAmountOfPaymentsRepresentingInterest>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000901"
      unitRef="USD">184000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000903"
      unitRef="USD">97000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000905"
      unitRef="USD">87000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000907">&lt;p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zsuRNUn7N2o5" style="margin-top: 0; margin-bottom: 0; font-size: 1pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;11.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_822_zmY8XGUQ3n43"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;FAIR
VALUE MEASUREMENTS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of September 30, 2024, and June 30, 2024, respectively, and indicate the fair value hierarchy of the valuation techniques the
Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted)
in active markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable,
such as quoted prices, interest rates, and yield&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;curves. Fair values determined by Level 3 inputs are unobservable data points
for the financial instrument and include situations where there is little, if any, market activity for the instrument.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zS7Xl6TyuZ56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;&lt;span id="xdx_8B8_zHClLontO7H8"&gt;Schedule of fair values determined by level 3 inputs are unobservable data&lt;/span&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of September 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930_zZME6WgaKGe4" style="width: 12%; text-align: right" title="Cash and cash equivalents"&gt;150&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ziFzXAQjvGh2" style="width: 12%; text-align: right"&gt;150&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7mTHS3gEoq9" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzPAdc47U6Zd" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0921"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930_zCBFcNHvSgKi" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zV2XHdki24hk" style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zEu7bx2Dzhyc" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0925"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3BXc5BRhpU2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240930_zLdcSG65KS9d" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;154&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdus7P4zxXIk" style="border-bottom: Black 2pt solid; text-align: right"&gt;154&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGcwFYHReXm6" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0930"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWp5qyswCice" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0931"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930_z00RXTHgdzSg" style="text-align: right" title="Cash and cash equivalents"&gt;5,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1es40GuKkKj" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0934"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zu51HsKcI149" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zm1UHSIhI4J3" style="text-align: right"&gt;5,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930_zewV8SQqGsO6" style="text-align: right" title="Cash and cash equivalents"&gt;4,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zxwYTWXrTyDe" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0939"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWSh1rRfKlxk" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0940"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcQBd0TdKWFb" style="text-align: right"&gt;4,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930_zvwUAM4x6q8f" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zP73bx3AXBc6" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrqL0I9qpyj" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRidbxwTCoK7" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0946"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930_zv2h5v9c6Tuc" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,486&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUEpXKIagtCh" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKMfCqTjFCca" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJDIFPQyENRk" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,891&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zG6lgkfBSXF2" style="width: 12%; text-align: right" title="Cash and cash equivalents"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqmr3MRShjGf" style="width: 12%; text-align: right"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzGXTjIZUcw5" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0955"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zn8FxIJVdBQ8" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0956"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zEWoWPE6vcOe" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zViGTku6yLs2" style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zHSWLOzxYAQk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0960"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z589McuW7744" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0961"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zR5NmYWeyCIc" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKBvaK9YBX7e" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zst9o0tMaS91" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0965"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd3KuEl7wUQ1" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iI_c20240630_zKh8qbYc5v3a" style="text-align: right" title="Cash and cash equivalents"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhcwih71jPE1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfRLdByz9gQ7" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0970"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHe9Wj1pYA6d" style="text-align: right"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zQ3nSZ1Juvoa" style="text-align: right" title="Cash and cash equivalents"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zrX3KNCJE0q4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6XYzzKZaYTl" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0975"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3PFRZb4n4N" style="text-align: right"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_z5t3uGONNa0k" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"&gt;4,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zw06mR9kx2h6" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0979"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqeWLjhrKRrj" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvl8HxChnie1" style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_z4JvKiLJMKBa" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;14,922&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoNrYLBvgwKa" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0984"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYdGxMedLUie" style="border-bottom: Black 2pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1uMNXnhfje5" style="border-bottom: Black 2pt solid; text-align: right"&gt;13,271&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zON0OXAPos8j" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000916">&lt;p id="xdx_895_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zS7Xl6TyuZ56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt; visibility: hidden"&gt;&lt;span id="xdx_8B8_zHClLontO7H8"&gt;Schedule of fair values determined by level 3 inputs are unobservable data&lt;/span&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of September 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930_zZME6WgaKGe4" style="width: 12%; text-align: right" title="Cash and cash equivalents"&gt;150&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ziFzXAQjvGh2" style="width: 12%; text-align: right"&gt;150&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7mTHS3gEoq9" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzPAdc47U6Zd" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0921"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930_zCBFcNHvSgKi" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zV2XHdki24hk" style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zEu7bx2Dzhyc" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0925"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3BXc5BRhpU2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20240930_zLdcSG65KS9d" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;154&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdus7P4zxXIk" style="border-bottom: Black 2pt solid; text-align: right"&gt;154&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zGcwFYHReXm6" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0930"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWp5qyswCice" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0931"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NotesPayable_iI_c20240930_z00RXTHgdzSg" style="text-align: right" title="Cash and cash equivalents"&gt;5,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1es40GuKkKj" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0934"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zu51HsKcI149" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NotesPayable_iI_pn3n3_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zm1UHSIhI4J3" style="text-align: right"&gt;5,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930_zewV8SQqGsO6" style="text-align: right" title="Cash and cash equivalents"&gt;4,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zxwYTWXrTyDe" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0939"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWSh1rRfKlxk" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0940"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcQBd0TdKWFb" style="text-align: right"&gt;4,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930_zvwUAM4x6q8f" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zP73bx3AXBc6" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrqL0I9qpyj" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zRidbxwTCoK7" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0946"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930_zv2h5v9c6Tuc" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,486&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUEpXKIagtCh" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKMfCqTjFCca" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJDIFPQyENRk" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,891&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630_zG6lgkfBSXF2" style="width: 12%; text-align: right" title="Cash and cash equivalents"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqmr3MRShjGf" style="width: 12%; text-align: right"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzGXTjIZUcw5" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0955"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zn8FxIJVdBQ8" style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0956"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630_zEWoWPE6vcOe" style="border-bottom: Black 1pt solid; text-align: right" title="Cash and cash equivalents"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zViGTku6yLs2" style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zHSWLOzxYAQk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0960"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z589McuW7744" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0961"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20240630_zR5NmYWeyCIc" style="border-bottom: Black 2pt solid; text-align: right" title="Total"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKBvaK9YBX7e" style="border-bottom: Black 2pt solid; text-align: right"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zst9o0tMaS91" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0965"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd3KuEl7wUQ1" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iI_c20240630_zKh8qbYc5v3a" style="text-align: right" title="Cash and cash equivalents"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NotesPayable_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhcwih71jPE1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zfRLdByz9gQ7" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0970"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHe9Wj1pYA6d" style="text-align: right"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630_zQ3nSZ1Juvoa" style="text-align: right" title="Cash and cash equivalents"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zrX3KNCJE0q4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6XYzzKZaYTl" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0975"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3PFRZb4n4N" style="text-align: right"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630_z5t3uGONNa0k" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"&gt;4,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zw06mR9kx2h6" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0979"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqeWLjhrKRrj" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvl8HxChnie1" style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630_z4JvKiLJMKBa" style="border-bottom: Black 2pt solid; text-align: right" title="Cash and cash equivalents"&gt;14,922&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoNrYLBvgwKa" style="border-bottom: Black 2pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0984"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYdGxMedLUie" style="border-bottom: Black 2pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1uMNXnhfje5" style="border-bottom: Black 2pt solid; text-align: right"&gt;13,271&lt;/td&gt;&lt;td style="padding-bottom: 2pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000918"
      unitRef="USD">150000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact000919"
      unitRef="USD">150000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000923"
      unitRef="USD">4000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact000924"
      unitRef="USD">4000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000928"
      unitRef="USD">154000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact000929"
      unitRef="USD">154000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000933"
      unitRef="USD">5258000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000936"
      unitRef="USD">5258000</us-gaap:NotesPayable>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000938"
      unitRef="USD">4633000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000941"
      unitRef="USD">4633000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000943"
      unitRef="USD">1595000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact000945"
      unitRef="USD">1595000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000948"
      unitRef="USD">11486000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact000950"
      unitRef="USD">1595000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000951"
      unitRef="USD">9891000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000953"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact000954"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000958"
      unitRef="USD">4000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact000959"
      unitRef="USD">4000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000963"
      unitRef="USD">2016000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact000964"
      unitRef="USD">2016000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000968"
      unitRef="USD">7089000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000971"
      unitRef="USD">7089000</us-gaap:NotesPayable>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000973"
      unitRef="USD">3817000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000976"
      unitRef="USD">3817000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000978"
      unitRef="USD">4016000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact000980"
      unitRef="USD">1651000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000981"
      unitRef="USD">2365000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000983"
      unitRef="USD">14922000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact000985"
      unitRef="USD">1651000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact000986"
      unitRef="USD">13271000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-07-01to2024-09-30" id="Fact000988">&lt;p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_z9F0N3BbS5Od" style="margin-top: 0; margin-bottom: 0; font-size: 1pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;12.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_823_zMxSJCDq22Xa"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;i&gt;The October Yorkville
Consent&lt;/i&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--SubsequentEventDescription_c20241002__20241003__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zv44frg4dUG5" title="Subsequent event, description"&gt;On
October 3, 2024, NioCorp entered into (i) a consent and waiver (the &#x201c;October Yorkville Consent&#x201d;) to the April 2024
Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with
the October Yorkville Consent, the &#x201c;October Consents&#x201d;) to the April 2024 Notes issued and sold to Lind II pursuant
to the April 2024 Purchase Agreement. The October Consents, among other things, extended the maturity date to January 31, 2025,
reduced the amounts due to the April 2024 Purchasers on October 1, 2024 by an aggregate of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentIssuedPrincipal_pn3n3_c20240929__20241001_zc89St3CXgHf" title="Aggregate principal amount"&gt;1,176&lt;/span&gt; to an aggregate of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentIncreaseDecreaseOtherNet_pn3n3_c20240929__20241001_zVp23XD4E6y5" title="Increased the amounts due"&gt;336&lt;/span&gt; and
deferred such amounts due to the April 2024 Purchasers until January 1, 2025, and prospectively waived any term of the April 2024
Notes that would otherwise be triggered upon a failure of the Company to pay to the April 2024 Purchasers the remainder of the
amount due on October 1, 2024. Except as modified by the September Consents, as discussed in Note 5b, and the October Consents,
the terms of the April 2024 Notes as previously disclosed are unchanged.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;i&gt;The November 2024 Offerings&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span id="xdx_90C_eus-gaap--SubsequentEventDescription_c20241102__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQY9JR5z1N9l" title="Subsequent event, description"&gt;On November 5, 2024, the Company closed the November 2024 Registered Offering, pursuant to the underwriting
agreement, dated November 3, 2024 (the &#x201c;Underwriting Agreement&#x201d;), with Maxim Group LLC, as underwriter (the &#x201c;Underwriter&#x201d;),
which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#x201c;Series A Public Warrants&#x201d;) to purchase up to an
additional 1,672,090 Common Shares and 836,045 Warrants (the &#x201c;Series B Public Warrants&#x201d; and, together with the Series
A Public Warrants, the &#x201c;November Public Warrants&#x201d;) to purchase up to an additional 836,045 Common Shares. Each Common
Share was sold together with one Series A Public Warrant and one-half of one Series B Public Warrant at a combined public offering
price of $1.57. The gross proceeds from the November 2024 Registered Offering were approximately $2,500 before deducting underwriting
discounts and offering expenses. The Company entered into a warrant agency agreement with Computershare Inc. and its affiliate,
Computershare Trust Company, N.A., together as warrant agent, setting forth the terms and conditions of the November Public Warrants.
The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will
expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable
beginning six months and one day from the date of issuance, and will expire on November 5, 2029. In addition, pursuant to the Underwriting
Agreement, the Company granted the Underwriter a 45-day over-allotment option to purchase (i) 238,853 additional Common Shares
and (ii) 358,280 Option Warrants (as defined below) to purchase up to an aggregate of 358,280 Common Shares. &#x201c;Option Warrant&#x201d;
means one Series A Public Warrant combined with one-half of one Series B Public Warrant.&lt;/span&gt; On November 4, 2024, the Underwriter partially
exercised its over-allotment option to purchase &lt;span id="xdx_902_eus-gaap--DebtInstrumentIssuedPrincipal_c20241101__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesAMember_zdbUYVtj9Jf2"&gt;79,734&lt;/span&gt; additional Series A Public Warrants and &lt;span id="xdx_907_eus-gaap--DebtInstrumentIssuedPrincipal_c20241101__20241104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesBMember_zTr5AGTVdwgl"&gt;39,867&lt;/span&gt; additional Series B Public Warrants, which amounts are included in the amounts, discussed above, issued at closing of the November 2024 Registered Offering.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;As of September 30, 2024,
the Company had accrued $&lt;span id="xdx_901_ecustom--AccruedCost_iI_pn3n3_c20240930_zHE4AH14fBWb" title="Aggregate principal amount"&gt;459&lt;/span&gt; of third-party costs related to the November 2024 Registered Offering. These costs were deferred until
the closing of the November 2024 Registered Offering, at which time all costs incurred were charged against the related share capital
account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span id="xdx_90F_eus-gaap--SubsequentEventDescription_c20241110__20241113__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zinDD1rYiPhj" title="Subsequent event, description"&gt;On November 13, 2024, the Company closed the November 2024 Private Offering, pursuant to binding subscription
agreements with certain accredited investors as part of a non-brokered private placement of 2,199,602 units of the Company (the
&#x201c;Units&#x201d;). Each Unit consists of one Common Share, one Warrant (collectively, the &#x201c;Series A Private Warrants&#x201d;)
to purchase one Common Share and one-half of one Warrant to purchase one-half of one Common Share (collectively, the &#x201c;Series
B Private Warrants&#x201d;). Each Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company purchased
November 2024 Units at a price of $1.7675 per Unit, which price includes $0.125 per Private Warrant and allows such directors and
officers to participate in the November 2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private
Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will expire on November
13, 2026.&lt;/span&gt; The Series B Private Warrants have an exercise price of $&lt;span id="xdx_902_ecustom--StrikePriceOfWarrantsIssued_pid_uUSDPShares_c20241111__20241112__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJeISY7Ku6Li" title="Exercise price"&gt;2.07&lt;/span&gt; per underlying Common Share, are exercisable beginning six months and one day from the date of
issuance, and will expire on November 13, 2029.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;NioCorp currently intends to use the net proceeds from
the November Offerings for working capital and general corporate purposes, including to (i) advance its efforts to launch construction
the Elk Creek Project and move it to commercial operation and (ii) repay the amount outstanding under the Smith Credit Facility. The Smith Loan will continue to be available to the Company following the close of the November Offerings.&lt;/p&gt;







</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubsequentEventDescription
      contextRef="From2024-10-022024-10-03_us-gaap_SubsequentEventMember"
      id="Fact000990">On
October 3, 2024, NioCorp entered into (i) a consent and waiver (the &#x201c;October Yorkville Consent&#x201d;) to the April 2024
Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) a consent and waiver (together with
the October Yorkville Consent, the &#x201c;October Consents&#x201d;) to the April 2024 Notes issued and sold to Lind II pursuant
to the April 2024 Purchase Agreement. The October Consents, among other things, extended the maturity date to January 31, 2025,
reduced the amounts due to the April 2024 Purchasers on October 1, 2024 by an aggregate of $1,176 to an aggregate of $336 and
deferred such amounts due to the April 2024 Purchasers until January 1, 2025, and prospectively waived any term of the April 2024
Notes that would otherwise be triggered upon a failure of the Company to pay to the April 2024 Purchasers the remainder of the
amount due on October 1, 2024. Except as modified by the September Consents, as discussed in Note 5b, and the October Consents,
the terms of the April 2024 Notes as previously disclosed are unchanged.</us-gaap:SubsequentEventDescription>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="From2024-09-292024-10-01"
      decimals="-3"
      id="Fact000992"
      unitRef="USD">1176000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentIncreaseDecreaseOtherNet
      contextRef="From2024-09-292024-10-01"
      decimals="-3"
      id="Fact000994"
      unitRef="USD">336000</us-gaap:DebtInstrumentIncreaseDecreaseOtherNet>
    <us-gaap:SubsequentEventDescription
      contextRef="From2024-11-022024-11-04_us-gaap_SubsequentEventMember"
      id="Fact000996">On November 5, 2024, the Company closed the November 2024 Registered Offering, pursuant to the underwriting
agreement, dated November 3, 2024 (the &#x201c;Underwriting Agreement&#x201d;), with Maxim Group LLC, as underwriter (the &#x201c;Underwriter&#x201d;),
which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#x201c;Series A Public Warrants&#x201d;) to purchase up to an
additional 1,672,090 Common Shares and 836,045 Warrants (the &#x201c;Series B Public Warrants&#x201d; and, together with the Series
A Public Warrants, the &#x201c;November Public Warrants&#x201d;) to purchase up to an additional 836,045 Common Shares. Each Common
Share was sold together with one Series A Public Warrant and one-half of one Series B Public Warrant at a combined public offering
price of $1.57. The gross proceeds from the November 2024 Registered Offering were approximately $2,500 before deducting underwriting
discounts and offering expenses. The Company entered into a warrant agency agreement with Computershare Inc. and its affiliate,
Computershare Trust Company, N.A., together as warrant agent, setting forth the terms and conditions of the November Public Warrants.
The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will
expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable
beginning six months and one day from the date of issuance, and will expire on November 5, 2029. In addition, pursuant to the Underwriting
Agreement, the Company granted the Underwriter a 45-day over-allotment option to purchase (i) 238,853 additional Common Shares
and (ii) 358,280 Option Warrants (as defined below) to purchase up to an aggregate of 358,280 Common Shares. &#x201c;Option Warrant&#x201d;
means one Series A Public Warrant combined with one-half of one Series B Public Warrant.</us-gaap:SubsequentEventDescription>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="From2024-11-012024-11-04_us-gaap_SubsequentEventMember_custom_PurchaseAgreementSeriesAMember"
      decimals="0"
      id="Fact000997"
      unitRef="USD">79734</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="From2024-11-012024-11-04_us-gaap_SubsequentEventMember_custom_PurchaseAgreementSeriesBMember"
      decimals="0"
      id="Fact000998"
      unitRef="USD">39867</us-gaap:DebtInstrumentIssuedPrincipal>
    <niobf:AccruedCost
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact001000"
      unitRef="USD">459000</niobf:AccruedCost>
    <us-gaap:SubsequentEventDescription
      contextRef="From2024-11-102024-11-13_us-gaap_SubsequentEventMember"
      id="Fact001002">On November 13, 2024, the Company closed the November 2024 Private Offering, pursuant to binding subscription
agreements with certain accredited investors as part of a non-brokered private placement of 2,199,602 units of the Company (the
&#x201c;Units&#x201d;). Each Unit consists of one Common Share, one Warrant (collectively, the &#x201c;Series A Private Warrants&#x201d;)
to purchase one Common Share and one-half of one Warrant to purchase one-half of one Common Share (collectively, the &#x201c;Series
B Private Warrants&#x201d;). Each Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company purchased
November 2024 Units at a price of $1.7675 per Unit, which price includes $0.125 per Private Warrant and allows such directors and
officers to participate in the November 2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private
Warrants have an exercise price of $1.75 per underlying Common Share, are exercisable immediately, and will expire on November
13, 2026.</us-gaap:SubsequentEventDescription>
    <niobf:StrikePriceOfWarrantsIssued
      contextRef="From2024-11-112024-11-12_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001004"
      unitRef="USDPShares">2.07</niobf:StrikePriceOfWarrantsIssued>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000464"
          xlink:label="Fact000464"
          xlink:type="locator"/>
        <link:footnote id="Footnote000479" xlink:label="Footnote000479" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have&#160;not&#160;been adjusted for the treasury stock method or weighted average outstanding
    calculations as required if the securities were dilutive.</link:footnote>
        <link:footnote id="Footnote000480" xlink:label="Footnote000480" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Earnout Shares are
    excluded as the vesting terms were not met as of the end of the reporting period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000464"
          xlink:to="Footnote000479"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000464"
          xlink:to="Footnote000480"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000466"
          xlink:label="Fact000466"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000466"
          xlink:to="Footnote000479"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000466"
          xlink:to="Footnote000480"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000468"
          xlink:label="Fact000468"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000468"
          xlink:to="Footnote000479"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000468"
          xlink:to="Footnote000480"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000470"
          xlink:label="Fact000470"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000470"
          xlink:to="Footnote000479"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000470"
          xlink:to="Footnote000480"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000472"
          xlink:label="Fact000472"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000472"
          xlink:to="Footnote000479"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000472"
          xlink:to="Footnote000480"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000474"
          xlink:label="Fact000474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000474"
          xlink:to="Footnote000479"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000474"
          xlink:to="Footnote000480"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000476"
          xlink:label="Fact000476"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000476"
          xlink:to="Footnote000479"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000476"
          xlink:to="Footnote000480"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000478"
          xlink:label="Fact000478"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000478"
          xlink:to="Footnote000479"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000478"
          xlink:to="Footnote000480"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
